0001354488-12-005989.txt : 20121116 0001354488-12-005989.hdr.sgml : 20121116 20121116172403 ACCESSION NUMBER: 0001354488-12-005989 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20120630 FILED AS OF DATE: 20121116 DATE AS OF CHANGE: 20121116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zevotek, Inc CENTRAL INDEX KEY: 0001364208 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-FOOD STORES [5400] IRS NUMBER: 050630427 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 333-137210 FILM NUMBER: 121212634 BUSINESS ADDRESS: STREET 1: 900 SOUTHEAST OCEAN BLVD. STREET 2: SUITE 130D CITY: STUART STATE: FL ZIP: 34994 BUSINESS PHONE: (772) 600-2676 MAIL ADDRESS: STREET 1: 900 SOUTHEAST OCEAN BLVD. STREET 2: SUITE 130D CITY: STUART STATE: FL ZIP: 34994 FORMER COMPANY: FORMER CONFORMED NAME: DIET COFFEE INC DATE OF NAME CHANGE: 20060526 10-K/A 1 zvtk_10k.htm ANNUAL REPORT zvtk_10k.htm


SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
____________________________________________________
 
FORM 10-K/A
Amendment No. 1
(Mark One)
 
þ
ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the fiscal year ended June 30, 2012.
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the transition period from _____________ to _________________.
 
Commission File No. 333-137210
 
ZEVOTEK, INC.
(Exact name of issuer as specified in its charter)
 
(Exact name of registrant as specified in its charter)
 
Delaware
 
05-0630427
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
     
19 Sylvan Avenue, Second Floor, Englewood Cliffs, New Jersey
 
07632
(Address of principal executive offices)
 
(Zip Code)
     
Registrant’s telephone number, including area code: (201) 820-0357
 
Securities registered under Section 12(b) of the Exchange Act:
 
None
     
Securities registered under Section 12(g) of the Exchange Act:
 
Common stock, par value $0.00001 per share
   
(Title of class)
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes o No þ
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes o No þ
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days.  Yes þ No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes þ No o
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  þ
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:
 
Large accelerated filer     o  
Accelerated filer                         o
Non-accelerated filer       o
Smaller reporting company       þ
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b)-2 of the Exchange Act).  Yes o No þ
 
The aggregate market value of the registrant’s common stock held by non-affiliates of the registrant on June 30, 2012, (based on the closing sale price of $0.12 per share of the registrant’s common stock, as reported on the Over the Counter Bulletin Board on that date) was approximately $38,200.  Common stock held by each officer and director and by each person known to the registrant to own five percent or more of the outstanding common stock has been excluded in that those persons may be deemed to be affiliates.  This determination of affiliate status is not necessarily a conclusive determination for other purposes.
 
At November 14, 2012, the registrant had outstanding 335,527 shares of common stock, par value $.00001 per share.
 


 
 

Table of Contents
 
Item 1.
Business.
    1  
Item 1A.
Risk Factors.
    5  
Item 1B.
Unresolved Staff Comments.
    5  
Item 2.
Properties.
    6  
Item 3.
Legal Proceedings.
    6  
Item 4.
Mine Safety Disclosures.
    6  
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
    6  
Item 6.
Selected Financial Data.
    8  
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
    8  
Item 8.
Financial Statements and Supplementary Data.
    13  
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
    13  
Item 9A.
Controls and Procedures.
    14  
Item 9A(T).
Controls and Procedures.
    14  
Item 9b.
Other Information.
    15  
Item 10.
Directors, Executive Officers and Corporate Governance.
    15  
Item 11.
Executive Compensation.
    17  
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
    18  
Item 13.
Certain Relationships and Related Transactions and Director Independence.
    19  
Item 14.
Principal Accounting Fees and Services.
    20  
Item 15.
Exhibits, Financial Statement Schedules.
    21  
 
 
 

 
 
EXPLANATORY NOTE
 
On November 14, 2012, we filed with the Securities and Exchange Commission our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.  At the time we filed our Annual Report, we did not have the required XBRL filing ready.  This Amendment No. 1 to our Form 10-K filed on November 14, 2012, is being filed to include the required XBRL information required by the rules of the Commission.
 
The filing of this Form 10-K/A, Amendment No. 1, is not an admission that our Form 10-K filed on November 14, 2012, when filed, knowingly included any untrue statement of a material fact or omitted to state a material fact necessary to make the statements made therein not misleading.
 
Except with respect to the required XBRL format, no other changes have been made to our Annual Report on Form 10-K filed November 14, 2012.  We have not updated the disclosures in this Form 10-K/A, Amendment No. 1, to speak as of a later date or to reflect events which occurred at a later date, except as noted.
 
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
In light of the risks and uncertainties inherent in all projected operational matters, the inclusion of forward-looking statements in this Form 10-K should not be regarded as a representation by us or any other person that any of our objectives or plans will be achieved or that any of our operating expectations will be realized.  Our revenues and results of operations are difficult to forecast and could differ materially from those projected in the forward-looking statements contained in this Form 10-K as a result of certain risks and uncertainties including, but not limited to, our business reliance on third parties to provide us with technology, our ability to integrate and manage acquired technology, assets, companies and personnel, changes in market condition, the volatile and intensely competitive environment in the business sectors in which we operate, rapid technological change, and our dependence on key and scarce employees in a competitive market for skilled personnel.  These factors should not be considered exhaustive; we undertake no obligation to release publicly the results of any future revisions we may make to forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
 
PART I
 
Except for historical information, this Report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934.  Such forward-looking statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses.  Such forward-looking statements include, among others, those statements including the words “expects,” “anticipates,” “intends,” “believes” and similar language.  Our actual results may differ significantly from those projected in the forward-looking statements.  Factors that might cause or contribute to such differences include, but are not limited to, those discussed in the section “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”  You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report.  We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances taking place after the date of this document.
 
ITEM 1.        BUSINESS.
 
We were organized on March 19, 2005 under the state laws of Delaware with an original name of “The Diet Coffee Company.” On March 1, 2006, we amended our Certificate of Incorporation and changed our name from “The Diet Coffee Company, Inc to Diet Coffee, Inc.  On June 25, 2008, we changed our name to Zevotek, Inc.  We market and sell innovative personal and home care items.
 
On September 26, 2011, we filed a Certificate of Amendment to the its Certificate of Incorporation in order to effect a reverse split on the outstanding shares of our common stock on a one for 5,000 basis (the “Reverse Split”).  All per share numbers in this Annual Report on Form 10-K are reflective of the Reverse Split and all references in the accompanying audited consolidated financial statements and notes there to have been retroactively restated to reflect the Reverse Split.
 
Overview of Business
 
Before February 24, 2009, we had been engaged in the direct marketing and distribution of consumer products.    On February 24, 2009, we had entered into an Exclusive License and Sales Agreement giving us the worldwide rights to manufacture, market, use, sell, distribute and advertise an air purifier that was contained in an energy saving compact fluorescent light bulb named the Ionic Bulb.  We had marketed the Ionic Bulb through TV infomercials, our website newionicbulb.com, Amazon.com and a consumer catalog.  

On December 10, 2010, we entered into an Exclusive License and Sales Agreement which gave us the worldwide rights to develop, manufacture, market, use, sell, distribute and advertise a U.S. patented new product named “Gung H2O” that reduced water use in the home.
 
 
1

 
 
Products
 
Ionic Bulb.  The Ionic Bulb is an air-purifying product.  The air-purifying component of the Ionic Bulb is placed in the base of a compact fluorescent light “CFL” bulb and consists of electronics and a spout through which negative ions produced by the air-purifying component are dispersed into the air.  The electricity used to operate the air-purifying component also lights the CFL bulb to illuminate a room in the same manner as ordinary CFL bulbs.
 
We sold the Ionic Bulb through our wholly owned subsidiary Ionicbulb.com, Inc.  The Ionic Bulb combined the performance features of ionic air cleaning technology with those of a 10,000 hour reduced energy use compact fluorescent light bulb (CFL).  The Ionic Bulb contained an air purifying microchip ion emitter that is powered by the bulb’s own energy.  The Ionic Bulb was designed for use in any U.S. home.  When illuminated, the Ionic Bulb via silent emission of negative ions had helped to eliminate smoke, dust, pollen, pet dander and odors from the air within a surrounding 100 square foot area.  The Ionic Bulb was designed for consumer use.  We had believed the Ionic Bulb product to be a less expensive and space saving alternative to air purifiers.
 
We have currently stopped working on the sales of the Ionic Bulb. At present, we are working on upgrading the bulb. The new ionic bulb will be made with a LED light, and will no longer use fluorescent light.
 
Gung H20.  Gung H20 was a patented plumbing valve that is installed in the traditional gravity toilet tank of a non-low flow toilet.  The Gung H20 valve regulated the amount of water used to fill and flush a toilet.  The valve was adjustable to enable the toilet to use more or less water as desired.  The Gung H20 valve enabled a traditional non-low flow toilet to use less water to achieve the equivalent level of flushing power of a non-low flow toilet.
 
After we tried to market the Gung H2O, we went back to the inventors to make changes due to feedback from the public. After the inventors make the desired changes we hope to market the product sometime in the second to third quarter of 2013.

Our chief executive officer, Jason Ryu has a history of being an innovator. We expect that he will bring a number of products on board in the upcoming year and believe Zevotek will be able to garner revenue from these products. We expect to release some of these products in the very near future. We are either waiting to put the finishing touches or most importantly file the proper patents in order to bring the greatest value to our stockholders.

Sales and Marketing
 
We plan to market our products once the development stage has been completed through TV Infomercials, on our website www.newionicbulb.com, and through a consumer catalog.  We have agreements with several sales agencies who market the Ionic Bulb to major U.S. retail, regional retail and specialty stores and distributors.

Manufacturing and Distribution
 
We are seeking a manufacturer who can economically produce the new Ionic Bulb and the Gung H20 product.  We may find a U.S. manufacturer for the Gung H20 product.
 
License Agreements, Trademarks and Patents
 
On February 24, 2009, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek obtained worldwide exclusive rights to manufacture, market use, sell, distribute and advertise certain licensed products.  The license is on a year to year basis with automatic renewal and is subject to becoming non-exclusive should Zevotek fail to files all quarterly and annual reports by due dates, inclusive of allowable extensions.  In exchange for the exclusive license, Zevotek issued 500 shares of its common stock to Jason Ryu.
 
On March 2, 2011, Zevotek and the Ionic Bulb patent holder entered into a non-exclusive Purchasing Representative Agreement whereby the patent holder shall introduce Zevotek to a new third party manufacturer that will produce a next generation version of the Ionic Bulb with new features and improved manufacturing cost.  Additionally, the patent holder affirms his obligation to defend against patent infringement.  Zevotek shall pay patent holder a fixed amount per Ionic Bulb ordered from the new manufacturer.  Zevotek agreed to make an advance fee payment by issuance of 5,000 shares of Zevotek’s restricted stock.  The value of the restricted shares applied to payment of the fees is to be based upon the average closing price of Zevotek’s common stock for the ten trading days preceding the date on which the restrictive stock legend may be removed.  The term of the agreement is three years with one-year automatic renewals that are subject to minimum fee payments to the patent holder for the first and second renewal term, respectively.
 
 
2

 
 
Patents and Trademarks
 
On April 2, 2005, Mr. Ryu (and Mr. Chang Min Lee the co-inventor) filed U.S. Patent Application No. 11/097,767 (Publication No. 20006/0078460) entitled “Anion General for Incorporation into Lighting Apparatuses and Other Appliances” with the U.S. Patent and Trademark Office (“U.S.PTO”).  The initial application was rejected on various grounds.  Mr. Ryu filed a response and amendment to the initial application with the U.S.PTO on September 9, 2007.  Mr. Ryu filed a continuation-in-part (CIP) application on August 7, 2008, Serial No. 12/221,908, which claims the benefit of No. 11/097,767, now abandoned.  The CIP application adds some new enhancements to the bulb design that further distinguish the invention over the prior art.  As of the date of this Annual Report, the CIP is pending and has not yet been examined.  We cannot offer any assurance that the application will ultimately be approved by the U.S.PTO..  In addition, there is an international patent application on file under the Patent Cooperation Treaty (PCT), No PCT/KR2005/002997 (Publication No. WO/2006/031036) entitled Negative Ion Emission Lamp.
 
A divisional application, Serial No. 11/820,915, was filed and a patent has been granted.  It is directed to an ionic air-purifying device in an appliance such as a fan (rather than in a CFL light bulb).
 
Notwithstanding Mr. Ryu’s and our efforts to protect proprietary rights in the Ionic Bulb, existing trade secret, copyright, and trademark laws afford only limited protection.  Further, the assignment of the U.S. Patent Application by the co-inventor has not been perfected by filing with the U.S.PTO.  Until such time as this filing is perfected, it is possible that the co-inventor could license the Ionic Bulb to another party.  Despite our efforts to protect our proprietary rights and other intellectual property, unauthorized parties may attempt to copy aspects of our products, obtain and use information that we regard as proprietary or misappropriate our copyrights, trademarks, trade dress, and similar proprietary rights.  In addition, the laws of some foreign countries do not protect proprietary rights to as great an extent as do the laws of the United States.  Our means of protecting our proprietary rights may not be adequate.  In addition, our competitors might independently develop similar technology or duplicate our products or circumvent any patents or our other intellectual property rights.
 
Competition
 
The air purifier market in which the Ionic Bulb competes is subject to competition since new products and sellers enter the market and compete for consumer dollars.  We have not yet achieved a market share, nor do we have a long operating history or large customer base.  Our products compete with other air purifier products that are sold over the Internet, through catalogs and in retail and specialty stores.  Our Ionic Bulb was competing with other products for placement on retail store shelves.  Retail store buyers had been presented with many new products and choose products they want to place on their stores” shelves.  Our Ionic Bulb competed with other products, including products that are wholly unrelated to air purifiers, for selection by retail store buyers.  Maintaining and gaining market share depends heavily on selection by retail store buyers of our Ionic Bulb product and, with respect to competition with other the air purifiers, the differentiation of our Ionic Bulb’s features, further product development and enhancement, pricing, quality, performance, packaging and availability, brand name recognition, patents, and marketing and distribution approaches.
 
The Gung H20 product is to be sold in the market for products that reduce water consumption from toilet usage and is subject to competition since new products and sellers enter the market and compete for consumer dollars.  We have not yet achieved a market share, nor do we have a long operating history or large customer base.  Our products compete with other wastewater saving products that are sold by retailers, over the Internet and through catalogs.  We expect that Gung H20 will face competition with other products for placement on retail store shelves.  Retail store buyers are presented with many new products and choose products they want to place on their stores” shelves.  Maintaining and gaining market share depends heavily on selection by retail store buyers of our Gung H20 product and, with respect to competition with other the water saving products, the differentiation of our Gung H20’s features, further product development and enhancement, pricing, quality, performance, packaging and availability, brand name recognition, patents, and marketing and distribution approaches.
 
 
3

 
 
Regulation
 
The formulation, manufacturing, packaging, labeling, advertising, distribution, and sale of the Ionic Bulb and Gung H20, such as those we plan to sell, are subject to regulation by one or more federal agencies, principally the Federal Trade Commission, or FTC, and to a lesser extent the Consumer Product Safety Commission.  Our activities are also regulated by various governmental agencies for the states and localities in which our products are sold, as well as by governmental agencies in certain countries outside the United States.  Among other matters, regulation by the FTC covers product safety and claims made with respect to a product’s ability to provide health-related benefits.
 
Federal agencies, primarily the FTC, have a variety of procedures and enforcement remedies available to them, including the following:
 
  
Initiating investigations;
 
  
Issuing warning letters and cease and desist orders;
 
  
Requiring corrective labeling or advertising;
 
  
Requiring consumer redress, such as requiring that a company offer to repurchase products;
 
  
Previously sold to consumers;
 
  
Seeking injunctive relief or product seizures;
 
  
Imposing civil penalties; or
 
  
Commencing civil action and/or criminal prosecution.
 
In addition, certain state agencies have similar authority.  These federal and state agencies have in the past used these remedies in regulating participants in the industry, including the imposition by federal agencies of civil penalties.  We cannot assure you that the regulatory environment in which we operate will not change or that such regulatory environment, or any specific action taken against us, will not result in a material adverse effect on our operations.  In addition, increased sales of, and publicity about, the Ionic Bulb, air purifiers, CFL bulbs, Gung H20 and water saving products may result in increased regulatory scrutiny, including consumer compliance with local regulations for properly disposing of used CFL bulbs which contain trace amounts of lead and mercury.
 
The sale of our products in countries outside the United States is regulated by the governments of those countries.  We are currently attempting to market our products outside of the United States.  Zevotek’s plans to commence sales in those countries may be prevented or delayed by such regulation.  While compliance with such regulation will generally be undertaken by international distributors, we may assist with such compliance and in certain cases may be liable if a distributor fails to comply.
 
We cannot predict the nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect such additional regulation, when and if it occurs, would have on our business in the future.  Such additional regulation could require, however, any or all of the actions listed below, which could have a material adverse effect on our operations:
 
  
The reformulation of certain products to meet new standards;
 
  
The recall or discontinuance of certain products;
 
  
Additional record keeping;
 
  
Expanded documentation of the properties of certain products;
 
  
Revised, expanded or different labeling; or
 
  
Additional scientific substantiation.
 
 
4

 
 
Key Personnel
 
Our future financial success depends to a large degree upon the personal efforts of our key personnel.  In our formative period, Jason Ryu, our chief executive officer, president, and chief financial officer, will play the major role in securing the services of those persons who can develop our business strategy and technology upon receipt of sufficient funds to pay for such services either through receipt of funds from borrowing or sales of our common stock.  While we intend to employ additional management and marketing personnel in order to minimize the critical dependency upon any one person, there can be no assurance that we will be successful in attracting and retaining the persons needed.  We do not have an employment contract with Mr. Ryu.
 
We Need To Hire Specialized Personnel
 
Although we are committed to the continued development and growth of our business, we will need to engage specialized key personnel to assist Zevotek in the execution of our business model, inasmuch as Jason Ryu, our chief executive officer, does not possess the requisite level of expertise to perform such functions.  It is possible that we will not be able to locate and hire such specialized personnel on acceptable terms.
 
Adequacy of Working Capital
 
We hope to generate sufficient capital to fund our business plan through continuing to issue convertible notes to our current note holders and issuance of common stock through a private placement .  See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Financing Activities,” and “Business.”  However, if our efforts are unsuccessful or do not generate sufficient cash to fund our anticipated operations, we still intend to proceed with our proposed business plan and we may try to raise what we feel is sufficient working capital for our current business plan, by means of a private placement or registered public offering of our shares.  If we are not able to raise additional capital through the sale of our shares or if we are unsuccessful in our other financing efforts, we would not be able to continue and our business would fail.  At the time of this Report, we are currently offering through a private placement shares of our common stock in order to raise needed capital.  In the future, we may raise additional capital though equity or debt offerings.
 
The Financial Results for Zevotek May Be Affected by Factors Outside of Our Control
 
Our future operating results may vary significantly from quarter to quarter due to a variety of factors, many of which are outside our control.  Our anticipated expense levels are based, in part, on our estimates of future revenues and may vary from projections.  We may be unable to adjust spending rapidly enough to compensate for any unexpected revenues shortfall.  Accordingly, any significant shortfall in revenues in relation to our planned expenditures would materially adversely affect our business, operating results, and financial condition.
 
We believe that period-to-period comparisons of our operating results are not necessarily a meaningful indication of future performance.
 
Employees
 
As of the date of this Report, Zevotek does not have any employees.  We do not currently anticipate that we will hire any employees in the next six months.  However, as our operations expand, we will employ the persons that we may need.  We do not feel that we would have any difficulty in locating needed help.
 
From time-to-time, we anticipate that we will use the services of independent contractors and consultants to support our business development.  We believe our future success depends in large part upon the continued service of our senior management personnel and our ability to attract and retain highly qualified managerial personnel.
 
ITEM 1A.     RISK FACTORS.
 
Not applicable.
 
ITEM 1B.     UNRESOLVED STAFF COMMENTS.
 
None.
 
 
5

 
 
ITEM 2.        PROPERTIES.
 
The principal executive offices of Zevotek are located at 19 Sylvan Avenue, Second Floor, Englewood Cliffs, New Jersey.  We do not own any property.
 
ITEM 3.        LEGAL PROCEEDINGS.
 
Metacomet Company, LLC v.  Zevotek, Inc., Case No. 3:10CV1754 (MRK), United States District Court, District of Connecticut.  On or about May 2010, an alleged assignee (the “Assignee”) of certain convertible promissory notes, commenced an action by the filing of a summons and complaint against Zevotek alleging a failure to comply with its demands to convert principal and interest under Zevotek’s promissory notes in Zevotek common stock..  The parties entered into a stipulation of settlement resolving this action on November 4, 2010, and a final judgment and injunction were entered on November 12, 2010, pursuant to which Zevotek agreed to issue stock once a month to the Assignee until it issued a total of 36,400 shares of common stock, which had been fully satisfied as of June 30, 2011.
 
Other than as discussed above, we are not engaged in any litigation, and we are unaware of any claims or complaints that could result in future litigation.  We will seek to minimize disputes with our customers but recognize the inevitability of legal action in today’s business environment as an unfortunate price of conducting business.
 
ITEM 4.        MINE SAFETY DISCLOSURES.
 
Not Applicable.
 
PART II
 
ITEM 5.        MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
 
As of the date of this Report, the shares of our common stock are quoted for sale on the OTCBB under the symbol “ZVTK.”  We currently have 335,527 shares of our common stock issued and outstanding, which are held of record and beneficially owned by approximately 65 stockholders.  The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of our common stock whose shares are held in the names of various securities brokers, dealers, and registered clearing agencies.
 
The following table sets forth, taking into consideration the one for one for 5,000 reverse split of our common stock which occurred on October 26, 2011, the high and low bid prices for our common stock on the OTCBB as reported by various Bulletin Board market makers.  These quotations reflect the closing inter-dealer prices, without mark-up, mark-down or commission, and may not represent actual transactions.'
 
   
High
   
Low
 
Quarter Ended:
           
September, 2010
  $ 150.00     $ 40.00  
December 31, 2010   $ 70.00     $ 3.00  
March 31, 2011   $ 32.50     $ 4.00  
June 30, 2011   $ 7.50     $ 2.00  
                 
September 30, 2011   $ 3.50     $ 0.50  
December 31, 2011   $ 2.00     $ 0.001  
March 31, 2012   $ 0.64     $ 0.06  
June 30, 2012   $ 0.12     $ 0.10  
 
Dividends
 
We have not paid or declared any dividends on our common stock, nor do we anticipate paying any cash dividends or other distributions on our common stock in the foreseeable future.  Any future dividends will be declared at the discretion of our board of directors and will depend, among other things, on our earnings, if any, our financial requirements for future operations and growth, and other facts as our board of directors may then deem appropriate.
 
 
6

 
 
Securities Authorized for Issuance Under Equity Compensation Plans
 
We do not have any equity compensation plans as of the date of this Report.
 
Recent Sales of Unregistered Securities
 
Since June 30, 2011, we have issued 114,717 shares of our common stock, as follows:
 
  
On July 6, 2011, we issued 8,000 shares to Serendipity Private Equity Fund in payment of principal and interest due on unregistered, unsecured convertible promissory notes in the amount of $4,000.
 
  
On July 7, 2011, we issued 9,000 shares to Steinhoff Resources in payment of principal and interest due on unregistered, unsecured convertible promissory notes in the amount of $4,500.
 
  
On July 8, 2011, we issued 9,000 shares to Interstellar Holdings in payment of principal and interest due on unregistered, unsecured convertible promissory notes in the amount of $4,500.
 
  
On July 13, 2011, we issued 10,000 shares to Steinhoff Resources in payment of principal and interest due on unregistered, unsecured convertible promissory notes in the amount of $5,000.
 
  
On July 14, 2011, we issued 8,000 shares to Serendipity Private Equity Fund in payment of principal and interest due on unregistered, unsecured convertible promissory notes in the amount of $4,000.
 
  
On July 25, 2011, we issued 7,821 shares to Serendipity Private Equity Fund in payment of principal and interest due on unregistered, unsecured convertible promissory notes in the amount of $3,911.
 
  
On July 26, 2011, we issued 9,300 shares to Steinhoff Resources in payment of principal and interest due on unregistered, unsecured convertible promissory notes in the amount of $4,650.
 
  
On August 5, 2011, we issued 2,500 shares to Lance Stephens in exchange for consulting services for a value of $3,750.
 
  
On August 5, 2011, we issued 2,500 shares to Kurt Streams in exchange for consulting services for a value of $3,750.
 
  
On August 5, 2011, we issued 2,500 shares to Sarah P. Young in exchange for consulting services for a value of $3,750.
 
  
On September 23, 2011, we issued 5,000 shares to Jason Ryu in exchange for consulting services for a value of $35,000.
 
  
On September 26, 2011 , we issued 4,318 shares in satisfaction of fractional shares resulting from a 1 to 5,000 reverse stock split.
 
  
On October 4, 2011, we issued 1,000 shares to Lance Stephens in exchange for consulting services for a value of $1,000.
 
  
On October 4, 2011, we issued 1,000 shares to Kurt Streams in exchange for consulting services for a value of $1,000.
 
  
On October 4, 2011, we issued 1,000 shares to Sarah P. Young in exchange for consulting services for a value of $1,000.
 
  
On February 2, 2012, we issued 17,045 shares to Jason Ryu in exchange for consulting services for a value of $3,750.
 
  
On May 25, 2012, we issued 16,733 shares to Interstellar in payment of principal and interest due on unregistered, unsecured convertible promissory notes in the amount of $1,673.
 
The issuances above have been adjusted to reflect the reverse split of Zevotek’s outstanding common stock on a one for 5,000 basis.
 
 
7

 
 
Any securities issued by Zevotek bear the following legend:
 
THE SECURITIES REPRESENTED BY THIS INSTRUMENT OR DOCUMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAW OF ANY STATE.  WITHOUT SUCH REGISTRATION, SUCH SECURITIES MAY NOT BE SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT UPON DELIVERY TO ZEVOTEK OF AN OPINION OF COUNSEL SATISFACTORY TO ZEVOTEK THAT REGISTRATION IS NOT REQUIRED FOR SUCH TRANSFER OR THE SUBMISSION TO ZEVOTEK OF SUCH OTHER EVIDENCE AS MAY BE SATISFACTORY TO ZEVOTEK TO THE EFFECT THAT ANY SUCH TRANSFER SHALL NOT BE IN VIOLATION OF THE SECURITIES ACT OF 1933, AS AMENDED, THE SECURITIES LAW OF ANY STATE, OR ANY RULE OR REGULATION PROMULGATED THEREUNDER.
 
The issuances of all our shares of common stock as above described were issued in reliance upon an exemption from registration pursuant to Section 4(2) of the Securities Act and Rule 506 of Regulation D promulgated under the Securities Act.  All of the investors took or will take their securities for investment purposes without a view to distribution and had or have had access to information concerning Zevotek and our business prospects, as required by the Securities Act.  In addition, there was no general solicitation or advertising for the purchase of the shares of Zevotek common stock.  Our securities were issued only to accredited investors, as defined in the Securities Act with whom we had a direct personal preexisting relationship, and after a thorough discussion.  Finally, our stock transfer agent has been instructed not to transfer any of such shares, unless such shares are registered for resale or there is an exemption with respect to their transfer.
 
All of the above described investors who received shares of our common stock were provided with access to the filings of Zevotek with the SEC, including the following:
 
·  
Zevotek’s annual report to stockholders for the most recent fiscal year, the definitive proxy statement filed in connection with that annual report, and, if requested by investors in writing, a copy of Zevotek’s most recent Form 10-K under the Exchange Act.
 
  
The information contained in an annual report on Form 10-K under the Exchange Act.
 
  
The information contained in any reports or documents required to be filed by Zevotek under sections 13(a), 14(a), 14(c), and 15(d) of the Exchange Act since the distribution or filing of the reports specified above.
 
  
A brief description of the securities being offered, and any material changes in Zevotek’s affairs that are not disclosed in the documents furnished.
 
Purchases of Equity Securities by the Registrant and Affiliated Purchasers
 
There were no purchases of our equity securities by Zevotek or any affiliated purchasers during any month within the fiscal year covered by this Report.
 
ITEM 6.        SELECTED FINANCIAL DATA.
 
Not applicable.
 
ITEM 7.        MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
 
The following discussion reflects our plan of operation.  This discussion should be read in conjunction with the financial statements which are attached to this Report.  This discussion contains forward-looking statements, including statements regarding our expected financial position, business and financing plans.  These statements involve risks and uncertainties.  Our actual results could differ materially from the results described in or implied by these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Report, particularly under the headings “Special Note Regarding Forward-Looking Statements.”
 
Unless the context otherwise suggests, “we,” “our,” “us,” and similar terms, as well as references to “Zevotek,” all refer to Zevotek as of the date of this Report.
 
 
8

 
 
Results of Operations
 
Year Ended June 30, 2012 Compared to Year Ended June 30, 2011.
 
Revenues
 
Our sales were $8,024 for the year ended June 30, 2012, as compared to $15,540 for the year ended June 30, 2011.  The decrease of $7,516 or 48.4 % was due to lack of merchandising.
 
Cost of Sales
 
Our cost of sales was $3,441 for the year ended June 30, 2012, as compared to $8,412 for the year ended June 30, 2011.  The decrease of $4,971 or 59.1% was mainly due to Zevotek writing off obsolete inventory.
 
Gross Profit
 
Our gross profit was ($81,530) for the year ended June 30, 2012, as compared to $7,128 for the year ended June 30, 2011.  The decrease of $88,658 or 1244% was mainly due to Zevotek writing off obsolete inventory.
 
Operating expenses
 
Operating expenses were $326,583 for the year ended June 30, 2012, as compared to $838,591 for the year ended June 30, 2011.  The decrease of $512,008 or 61.1% was primarily due to reductions in professional fees, CEO compensation and advertising expenses.
 
Selling expenses were $32,865 for the year ended June 30, 2012, compared to $310,208 for the years ended June 30, 2011.
 
General and administrative expenses were $253,718 for the year ended June 30, 2012, compared to $528,383 for the year ended June 30, 2011.
 
Interest expense
 
We incurred net interest expense of $1,074,055 for the year ended June 30, 2012, as compared to $412,649 for the year ended June 30, 2011, an increase of $661,406 that is attributable to the increase in our convertible promissory note debt and advances payable.  Interest expense for the years ended June 30, 2012 and 2011, consisted primarily of interest on the accretion of our convertible promissory notes and advances payable.
 
Net Income and Loss
 
Our net loss was $1,482,168 for the year ended June 30, 2012, as compared to $1,244,112 for the year ended June 30, 2011.  The increase of $238,056 or 12.7 % was due to our increase in interest expenses that is attributable to the increase in our convertible promissory note debt and advances payable.
 
Our net loss per common share ($4.89) (basic and diluted) for the year ended June 30, 2012, as compared to ($13.23) (basic and diluted) for the year ended June 30, 2011.  The decrease of $8.34 or 63.2 % was mainly due to the increase in the weighted average number of common shares outstanding during fiscal 2012 resulting from the issuances of shares of our common stock for the conversion of debt and interest and services provided.  The weighted average number of outstanding shares was 302,867 (basic and diluted) for fiscal year ended June 30, 2012, as compared to 94,050 (basic and diluted) for the fiscal year ended June 30, 2011.
 
Liquidity and Capital Resources
 
 As of June 30, 2012, we had a working capital deficit of $2,423,885.  As of June 30, 2011, we had a working capital deficit of $1,030,872.  Our cash position at June 30, 2012 was $231 as compared to $4,737 as of June 30, 2011.
 
 
9

 
 
For fiscal year ended June 30, 2012, net cash used in operating activities was $209,866, consisting primarily of a net loss of $1,482,168 adjusted primarily for amortization of beneficial conversion feature related to our convertible promissory notes of $921,312 and accounts payable and accrued expenses of $165,615.
 
Cash provided by financing activities totaled $205,360 consisting of proceeds from third party loans and convertible notes payable.
 
We had no capital expenditures for the years ending June 30, 2012 and 2011.
 
Seasonality
 
Our proposed business is not subject to seasonality.
 
Impact of Inflation
 
General inflation in the economy has driven the operating expenses of many businesses higher.  We will continuously seek methods of reducing costs and streamlining operations while maximizing efficiency through improved internal operating procedures and controls.  While we are subject to inflation as described above, our management believes that inflation currently does not have a material effect on our operating results.  However, inflation may become a factor in the future.
 
Critical Accounting Policies
 
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires us to make judgments, assumptions and estimates that affect the amounts reported.  Note 1 of Notes to Financial Statements describes the significant accounting policies used in the preparation of the financial statements.  Certain of these significant accounting policies are considered to be critical accounting policies, as defined below.
 
A critical accounting policy is defined as one that is both material to the presentation of our financial statements and requires management to make difficult, subjective or complex judgments that could have a material effect on our financial condition or results of operations.  Specifically, critical accounting estimates have the following attributes:
 
  
We are required to make assumptions about matters that are highly uncertain at the time of the estimate; and
 
  
Different estimates we could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on our financial condition or results of operations.
 
Estimates and assumptions about future events and their effects cannot be determined with certainty.  We base our estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances.  These estimates may change as new events occur, as additional information is obtained and as our operating environment changes.  These changes have historically been minor and have been included in the consolidated financial statements as soon as they became known.  Based on a critical assessment of our accounting policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that our financial statements are fairly stated in accordance with accounting principles generally accepted in the United States, and present a meaningful presentation of our financial condition and results of operations.
 
In preparing our financial statements to conform to accounting principles generally accepted in the United States, we make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes.  These estimates include useful lives for fixed assets for depreciation calculations and assumptions for valuing options and warrants.  Actual results could differ from these estimates.
 
Financing Activities
 
Since our inception on December 19, 2005 to June 30, 2012, we have raised an aggregate of $2,751,273 in financing through private placement of our common stock, advances and through the issuance of promissory notes to unaffiliated third party investors.
 
 
10

 
 
Financing Needs

Since our inception on December 19, 2005 to June 30, 2012, we have generated revenues of $1,413,825 and have incurred a net loss of $8,211,305. It is hoped that we will begin to achieve sustainable revenues within the next 12 months, of which there can be no guarantee. Our ability to achieve profitability is dependent on several factors, including but not limited to, our ability to: generate liquidity from operations and satisfy our ongoing operating costs on a timely basis. We still need additional investments in order to continue operations to cash flow break even. Additional investments are being sought, but we cannot guarantee that we will be able to obtain such investments. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. However, the trading price of our common stock and conditions in the U.S. stock and debt markets make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations again, attempt to further restructure financial obligations and/or seek a strategic merger, acquisition or a sale of assets.

The independent auditor's report on our June 30, 2012 financial statements included in this Annual Report states that our recurring losses raise substantial doubts about our ability to continue as a going concern. At present, we do not have sufficient capital on hand to fund our proposed operations for the next 12 months.  We estimate that we will need at least $500,000 to fund our operations over the next 12 months.  These funds will be spent for merchandising products, accommodating sales orders and paying our operating expenses.

Inflation

The effect of inflation on our revenue and operating results was not significant. Our operations are located in North America and there are no seasonal aspects that would have a material effect on our financial condition or results of operations.
 
We Need To Hire Specialized Personnel
 
Although we are committed to the continued development and growth of our business, we will need to engage specialized key personnel to assist Zevotek in the execution of our business model, inasmuch as Jason Ryu, our chief executive officer, does not possess the requisite level of expertise to perform such functions.  It is possible that we will not be able to locate and hire such specialized personnel on acceptable terms.
 
Quantitative and Qualitative Disclosures About Market Risk
 
We conduct all of our transactions in U.S. dollars.  We are therefore not directly subject to the risks of foreign currency fluctuations and do not hedge or otherwise deal in currency instruments in an attempt to minimize such risks.
 
Stock-Based Compensation
 
We recognize compensation cost for stock-based awards based on the estimated fair value of the award on date of grant.  We measure compensation cost at the grant date based on the fair value of the award and recognize compensation cost upon the probable attainment of a specified performance condition or over a service period.
 
Recently Issued Accounting Pronouncements
 
In October 2012, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2012-04, “Technical Corrections and Improvements” in Accounting Standards Update No. 2012-04. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update will be effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 is not expected to have a material impact on our financial position or results of operations.
 
 
11

 
 
In August 2012, the FASB issued ASU 2012-03, “Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update)” in Accounting Standards Update No. 2012-03. This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 is not expected to have a material impact on our financial position or results of operations.
 
In July 2012, the FASB issued ASU 2012-02, “Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment” in Accounting Standards Update No. 2012-02. This update amends ASU 2011-08, Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment and permits an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles, Goodwill and Other - General Intangibles Other than Goodwill. The amendments are effective for annual and interimimpairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim impairment tests performed as of a date before July 27, 2012, if a public entity’s financial statements for the most recent annual or interim period have not yet been issued or, for nonpublic entities, have not yet been made available for issuance. The adoption of ASU 2012-02 is not expected to have a material impact on our financial position or results of operations.
 
In December 2011, the FASB issued ASU 2011-12, “Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05.  This update defers the requirement to present items that are reclassified from accumulated other comprehensive income to net income in both the statement of income where net income is presented and the statement where other comprehensive income is presented.  The adoption of ASU 2011-12 is not expected to have a material impact on our financial position or results of operations.
 
            In December 2011, the FASB issued ASU No. 2011-11 “Balance Sheet: Disclosures about Offsetting Assets and Liabilities” (“ASU 2011-11”).  This Update requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position.  The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of IFRS.  The amended guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods.  Zevotek is currently evaluating the impact, if any, that the adoption of this pronouncement may have on its results of operations or financial position.
 
Off-Balance Sheet Arrangements
 
We do not have any off-balance sheet arrangements.
 
Reverse Stock Splits
 
On September 26, 2011, we filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a one to 5,000 basis that FINRA approved on October 26, 2011.  All shares and per share amounts quoted herein have been retroactively restated to reflect the 1:5,000 reverse split, unless otherwise stated.
 
Revenue Recognition
 
Revenues are recognized in the period that products are provided.  For revenue from product sales, Zevotek recognizes revenue in accordance with Accounting Standards Codification 605, “Revenue Recognition SEC Staff Accounting Bulletin Topic 13” (“ASC 605”).  ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured.  Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts.  Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded.  Zevotek defers any revenue for which the product has not been delivered or is subject to refund until such time that Zevotek and the customer jointly determine that the product has been delivered or no refund will be required.
 
 
12

 
 
ITEM 7A.     QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
 
Not applicable
 
ITEM 8.        FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
 
The financial statements and related notes are included as part of this Annual Report as indexed in the appendix on page F-1, et seq.
 
ITEM 9.        CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.
 
Dismissal of Former Certifying Accountants.  On August 27, 2012, Zevotek dismissed its independent auditor, RBSM LLP (“RBSM LLP”), which dismissal was reported in our Current Report filed on August 27, 2012.
 
RBSM LLP’s reports on Zevotek’s financial statements during the two most recent fiscal years and any subsequent interim period through August 27, 2012, did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting principles, except that RBSM LLP’s reports on Zevotek’s Form 10-K for the year ended June 30, 2011, raised substantial doubt about its ability to continue as a going concern.
 
The decision to dismiss RBSM LLP was recommended by Zevotek’s board of directors.
 
During the two most recent fiscal years and any subsequent interim period through August 27, 2012, there have not been any disagreements between Zevotekand RBSM LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of RBSM LLP, would have caused it to make reference to the subject matter of the disagreements in connection with its reports on the financial statements for such periods.
 
Engagement of New Certifying Accountants.  On August 27, 2012, Zevotek engaged M & K CPAs PLLC, certified public accountants, (“M & K CPAs”) as Zevotek’s independent accountants to report on Zevotek’s balance sheet as of June 30, 2012, and the related combined statements of income, stockholders’ equity and cash flows for the year then ended.  The decision to appoint M & K CPAs was approved by Zevotek’s Board of Directors.  See our Current Report filed with the Commission on August 27, 2012.
 
During Zevotek’s two most recent fiscal years and any subsequent interim period prior to the engagement of M & K CPAs, neither Zevotek nor anyone on Zevotek’s behalf consulted with M & K CPAs regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on Zevotek’s financial statements, and either a written report was provided to the registrant or oral advice was provided that the new accountant concluded was an important factor considered by Zevotek in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement (as defined in paragraph 304(a)(1)(iv) and the related instructions to Regulation S-K) or a reportable event (as described in paragraph 304(a)(1)(v) of Regulation S-K).
 
Zevotek has provided RBSM LLP with a copy of the disclosures it made in its amended Current Report on Form 8-K/A, Amendment No. 2, which RBSM LLP received no later than the day that the disclosures were filed with the Commission.  The registrant requested that RBSM LLP furnish the registrant with a letter addressed to the Commission stating whether it agreed with the statements made by the registrant in response to Item 304(a) of Regulation S-K, and, if not, stating the respects in which it does not agree.  A copy of RBSM LLP’s amended letter was filed with Current Report on Form 8-K/A, Amendment No. 2 on October 29, 2012.
 
Zevotek requested M & K CPAs to review the disclosure in its Current Report on Form 8-K/A, Amendment No. 3 before it was filed with the Commission and provided M & K CPAs the opportunity to furnish Zevotek with a letter addressed to the Commission containing any new information, clarification of Zevotek’s expression of its views, or the respects in which it does not agree with the statements made by Zevotek in response its Current Report on Form 8-K/A, Amendment No. 3.  Zevotek has filed on October 29, 2012, such letter from M & K CPAs as an exhibit to the report.
 
The financial statements included in this Report were audited by M & K CPAs.
 
 
13

 
 
ITEM 9A.     CONTROLS AND PROCEDURES.
 
See Item 9A(T) below.
 
ITEM 9A(T).  CONTROLS AND PROCEDURES.
 
Evaluation of Disclosure and Controls and Procedures.  We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined) in Exchange Act Rules 13a – 15(c) and 15d – 15(e)).  Based upon that evaluation, our chief executive officer and chief financial officer concluded that, as of the end of the period ended June 30, 2012, our disclosure controls and procedures were not effective (1) to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (2) to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to us, including our chief executive and chief financial officers, as appropriate to allow timely decisions regarding required disclosure.
 
The term disclosure controls and procedures means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act (15 U.S.C. 78a, et seq.) is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
 
Our management, including our chief executive officer and chief financial officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all error and all fraud.  A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.  Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs.  Because of inherent limitations in all control systems, internal control over financial reporting may not prevent or detect misstatements, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the registrant have been detected.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 
Management’s Annual Report on Internal Control over Financial Reporting.  Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act.  Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States.
 
The term internal control over financial reporting is defined as a process designed by, or under the supervision of, the issuer’s principal executive and principal financial officers, or persons performing similar functions, and effected by the issuer’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:
 
  
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
 
  
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the issuer; and
 
  
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the issuer’s assets that could have a material effect on the financial statements.
 
 
14

 
 
Our management assessed the effectiveness of our internal control over financial reporting as of June 30, 2012. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework.  Based on this assessment, management identified the following conditions that indicated that our internal control over financial reporting and our disclosure controls and procedures were not effective:
 
  
Accounts payable and accrued expenses are inadequately being maintained as there is no policy for unpaid invoice documentation.
 
  
Reconciliations of shares outstanding between the accounting records and the stock transfer agent are not performed timely.
 
  
Our closing process is deficient in assuring accurate information without the assistance of our auditors.
 
Changes in Internal Control Over Financial Reporting.  There have been no changes in Zevotek’s internal control over financial reporting through the date of this Report or during the period ended June 30, 2012, that materially affected, or is reasonably likely to materially affect, Zevotek’s internal control over financial reporting.
 
Independent Registered Accountant’s Internal Control Attestation.  This Report does not include an attestation report of Zevotek’s registered public accounting firm regarding internal control over financial reporting.  Management’s report was not subject to attestation by Zevotek’s registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the registrant to provide only management’s report in this Report.
 
Remediation plans for material weaknesses over internal controls.  Our plans to mitigate material weaknesses in disclosure controls and procedures for future filings will be dependent on our ability to obtain adequate financing to fund development of our financial reporting infrastructure.  At this time it is not cost beneficial for us to utilize capital to focus on mitigating financial reporting weaknesses; however, we expect to implement a plan for remediation of these deficiencies when sufficient funding to implement such a plan is available.
 
ITEM 9B.     OTHER INFORMATION.
 
None.
PART III
 
ITEM 10.      DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
 
The following table sets forth information concerning the directors and executive officers of Zevotek as of the date of this Report:
 
Name
 
Age
 
Position
 
Director Since
Jason Ryu
 
63
 
Chairman of the Board, President, Chief Financial Officer,
Principal Accounting Officer, Secretary and Treasurer
 
2012
 
The members of our board of directors are subject to change from time to time by the vote of the stockholders at special or annual meetings to elect directors.  Our current board of directors consists of one director who has expertise in the proposed business of Zevotek.  Upon receipt of sufficient funds to pay for consultants as described elsewhere in this Report either from receipt of funds from borrowing or sales of common stock, we intend to seek directors and officers who would be able to properly execute our proposed business plan.
 
The foregoing notwithstanding, except as otherwise provided in any resolution or resolutions of the board, directors who are elected at an annual meeting of stockholders, and directors elected in the interim to fill vacancies and newly created directorships, will hold office for the term for which elected and until their successors are elected and qualified or until their earlier death, resignation or removal.
 
Whenever the holders of any class or classes of stock or any series thereof are entitled to elect one or more directors pursuant to any resolution or resolutions of the board, vacancies and newly created directorships of such class or classes or series thereof may generally be filled by a majority of the directors elected by such class or classes or series then in office, by a sole remaining director so elected or by the unanimous written consent or the affirmative vote of a majority of the outstanding shares of such class or classes or series entitled to elect such director or directors.  Officers are elected annually by the directors.  There are no family relationships among our directors and officers.
 
 
15

 
 
We may employ additional management personnel, as our board of directors deems necessary.  Zevotek has not identified or reached an agreement or understanding with any other individuals to serve in management positions, but does not anticipate any problem in employing qualified staff.
 
A description of the business experience for each of the directors and executive officers of Zevotek is set forth below.
 
Jason Ryu has been President of Ionair Corporation since 2006 and President of Blink Innovation Group Inc. since 2010. Mr. Ryu, through Ionair Corporation, has a patent application pending with the U.S. Patent Office for the Ionic Bulb and holds patents internationally for the Ionic Bulb.  Zevotek markets and sells the Ionic Bulb under an Exclusive License and Sales Agreement dated February 24, 2009, and pursuant to a non-exclusive Purchasing Representative Agreement between Zevotek and Mr. Ryu dated March 2, 2011, Mr. Ryu has introduced Zevotek to a new third party manufacturer that will produce a next generation version of the Ionic Bulb with new features and improved manufacturing cost.  Mr. Ryu, through Blink Innovation Group Inc., holds a patent in Korea and has a patent application pending with the U.S. Patent Office for a cooking device and method with improved temperature control, on which his line of Jade Cookware is based. Mr. Ryu has over 15 years of executive officer experience managing international importing, exporting and trading businesses.  From 2001 to 2006, he was executive director of E-On Light USA Corp., an international trading firm specializing in the import and export of air-purifiers.  From 1997 to 2006, Mr. Ryu was a partner in Trans World Merchants Inc., an importer and exporter of consumer products.  Before coming to US in 1973, Mr. Ryu taught civil engineering at Dongyang Technical High school in Seoul Korea.  Mr. Ryu received his bachelor of science in civil engineering in 1972 from Hanyang University, Seoul, Korea.
 
Committees of the Board
 
We do not currently have an Audit, Executive, Finance, Compensation, or Nominating Committee, or any other committee of the board of directors.
 
Section 16(a) Beneficial Ownership Reporting Compliance
 
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our officers and directors, and persons who own more than ten percent of a class of our capital stock, to file reports of ownership and changes in their ownership with the Securities and Exchange Commission.  These persons are required to furnish us with copies of all Section 16(a) forms they file.  Based solely on a review of the copies of such forms received by us, to our knowledge, no person has failed to timely file a Section 16(a) form during the year ended June 30, 2012.
 
Other Matters
 
We have not yet drafted and adopted a Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or person performing similar functions.  We intend to do so once we reach and maintain greater financial stability.
 
Communication with Directors
 
Stockholders and other interested parties may contact any of our directors by writing to them at Zevotek, Inc., at 19 Sylvan Avenue, Second Floor, Englewood Cliffs, New Jersey 07632, Attention: Corporate Secretary.  Our principal executive offices are located at 19 Sylvan Avenue, Second Floor, Englewood Cliffs, New Jersey 07632, telephone and telecopier number (201) 820-0357, and email jryu@zevo-tek.com.
 
Our board has approved a process for handling letters received by us and addressed to any of our directors.  Under that process, the Secretary reviews all such correspondence and regularly forwards to the directors a summary of all such correspondence, together with copies of all such correspondence that, in the opinion of the Secretary, deal with functions of the board or committees thereof or that he otherwise determines requires their attention.  Directors may at any time review a log of all correspondence received by us that are addressed to members of the board and request copies of such correspondence.
 
 
16

 
 
ITEM 11.      EXECUTIVE COMPENSATION.
 
At present Zevotek has only one executive officer.  The compensation program for future executives will consist of three key elements which will be considered by a compensation committee to be appointed:
 
  
A base salary;
 
  
A performance bonus; and
 
  
Periodic grants and/or options of our common stock.
 
Base Salary.  Our chief executive officer and all other senior executive officers receive compensation based on such factors as competitive industry salaries, a subjective assessment of the contribution and experience of the officer, and the specific recommendation by our chief executive officer.
 
Performance Bonus.  A portion of each officer’s total annual compensation is in the form of a bonus.  All bonus payments to officers must be approved by our compensation committee based on the individual officer’s performance and company performance.
 
Stock Incentive.  Stock grants and options are awarded to executive officers based on their positions and individual performance.  Stock grants and options provide incentive for the creation of stockholder value over the long term and aid significantly in the recruitment and retention of executive officers.  The compensation committee considers the recommendations of the chief executive officer for stock grants and options to executive officers (other than the chief executive officer) and approves, disapproves or modifies such recommendation.  Stock grants and options for the chief executive officer will be recommended and approved by our board of directors.  See “Market Price of and Dividends on our Common Equity and Related Stockholder Matters - Securities Authorized for Issuance under Equity Compensation Plans.”
 
It is uncertain when, if ever, we will be in a position to compensate any of our officers or directors.
 
Summary Compensation Table
 
The following table sets forth, for our named executive officers for the two completed fiscal years ended June 30, 2012, and 2011:
 
Name and Principal Position
 
Year
 
Salary ($)
   
Bonus ($)
   
Stock Awards ($)
   
Option Awards ($)
   
Non-Equity Incentive Plan Compensation ($)
   
Nonqualified Deferred Compensation ($)
   
All Other Compensation ($)
   
Total ($)
 
Jason Ryu (1)
 
2012
    -0-       -0-       -0-       -0-       -0-       -0-     $ 18,000     $ 18,000  
Robert Babke (2)
 
2011
  $ 72,000       -0-       -0-       -0-       -0-       -0-     $ 15,000     $ 87,000  
Adam Engel (3)
 
2011
    -0-       -0-       -0-       -0-       -0-       -0-     $ 30,000     $ 30,000  
__________
(1)  
Mr. Ryu is our current chairman of the board, president, chief financial officer, principal accounting officer, and secretary.
(2)  
Mr. Babke was appointed president, chief executive officer, chief financial officer, principal accounting officer, and secretary on February 25, 2010.  He resigned on March 19, 2012.
(3)  
Mr. Engel was chief executive officer, chief financial officer and director. He resigned February 25, 2010.

It is uncertain when, if ever, we will be in a position to compensate any of our officers or directors.  In fiscal year ended June 30, 2012, we issued 22,045 shares of common stock to Jason Ryu, for services to Zevotek.  These shares were valued at $38,750.
 
 
17

 
 
Outstanding Equity Awards at Fiscal Year-End
 
The following table provides information for each of our named executive officers as of the end of our last completed fiscal year, June 30, 2012:
 
   
Option Awards
   
Stock Awards
 
Name
 
Number of Securities Underlying Unexercised Options (#) Exercisable
   
Number of Securities Underlying Unexercised Options (#) Unexercisable
   
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)
   
Option Exercise Price ($)
   
Option Expiration Date
   
Number of Shares or Units of Stock That Have Not Vested
   
Market Value of Shares or Units of Stock That Have Not Vested
   
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
   
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)
 
Jason Ryu (1)
    -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-       -0-  
__________
(1)
Mr. Ryu is our chairman of the board, president, chief financial officer, principal accounting officer, and secretary.
 
Employment Agreements
 
As of the date of this Report, Zevotek does not have any employment agreements with any of our officers or any employees, inasmuch as we do not have any employees.
 
Director Compensation
 
Our directors do not receive compensation for their services as directors.
 
ITEM 12.      SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.
 
The following table presents information regarding the beneficial ownership of all shares of our common stock as of the date of this Report by:
 
  
Each person who owns beneficially more than five percent of the outstanding shares of our common stock;
 
  
Each director of Zevotek;
 
  
Each named executive officer of Zevotek; and
 
  
All directors and officers of Zevotek as a group.
 
   
Shares of Common Stock
Beneficially Owned (2)
 
Name of Beneficial Owner (1)
 
Number
   
Percent
 
Jason Ryu
    17,196       5.125 %
All directors and officers as a group (one person)
    17,196       5.125 %
 
(1)  
Unless otherwise indicated, the address for each of these stockholders is c/o Zevotek, Inc., at 19 Sylvan Avenue, Second Floor, Englewood Cliffs, New Jersey 07632.  Also, unless otherwise indicated, each person named in the table above has the sole voting and investment power with respect to our shares of common stock or preferred stock which he beneficially owns.
(2)  
Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission.  As of the date of this Report, there were issued and outstanding 335,527 shares of our common stock.
 
 
18

 
 
Other than as stated above:
 
  
There are no arrangements, known to us, including any pledge by any person of our securities, the operation of which may at a subsequent date result in a change in control of Zevotek; and
 
  
There are no arrangements or understandings with respect to election of directors or other matters.
 
ITEM 13.      CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE.
 
Transactions with Related Persons
 
None.
 
Director Independence
 
We do not have any independent directors.
 
Board Meetings and Committees; Annual Meeting Attendance
 
We have not held any meeting of our board of directors during the fiscal year ended June 30, 2012.
 
Nominating Committee
 
As stated above, we do not currently have a Nominating Committee.  Inasmuch as we have only one director, there is no perceived need for a Nominating Committee to select members to our board of directors.  As we grow, we intend to provided for a Nominating Committee.  We do not have a policy that we would or would not consider director candidates recommended by our stockholders.  If a stockholder were to offer a recommendation, we would consider and vote upon the proposed director.
 
Audit Committee
 
As stated above, we do not currently have an Audit Committee.
 
 
19

 
 
ITEM 14.      PRINCIPAL ACCOUNTING FEES AND SERVICES.
 
Audit Fees
 
The aggregate fees billed by RBSM LLP for professional services rendered for the audit of our annual financial statements for fiscal years ended June 30, 2012, and 2011, were $0 and $20,000 respectively.
 
The aggregate fees billed by M & K CPAs for professional services rendered for the audit of our annual financial statements for fiscal year ended June 30, 2012, was $10,000.
 
The aggregate fees billed by RBSM LLP for professional services rendered for the review of our quarterly financial statements for fiscal years ended June 30, 2012, and 2011, were $15,000 and $15,000 respectively.
 
Audit Related Fees
 
We did not pay audit-related fees to RBSM LLP for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements for fiscal years ended June 30, 2012, and 2011.
 
We did not pay audit-related fees to M & K CPAs for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements for fiscal years ended June 30, 2012, and 2011.
 
Tax Fees
 
There were no fees billed by RBSM LLP or M & K CPAs for professional services rendered for tax services for fiscal years ended June 30, 2012, and 2011.
 
All Other Fees
 
There were no other fees billed by M & K CPAs for professional services rendered during the fiscal years ended June 30, 2012, and 2011.  RBSM LLP billed us $2,400 in fees relating to the review of our S-8 filings for the year ended June 30, 2011.
 
20

 
PART IV
 
ITEM 15.      EXHIBITS, FINANCIAL STATEMENT SCHEDULES.
 
(a)  
All financial statements are included in Item 8 of this Report.
 
(b)  
All finncial statement schedules required to be filed by Item 8 of this Report and the exhibits contained in this Report are included in Item 8 of this Report.
 
(c)  
The following exhibits are attached to this Report:
 
Exhibit No.
 
Identification of Exhibits
3.1**
 
Registrant’s Certificate of Incorporation, filed as an exhibit to our Registration Statement on Form SB-2 (File No. 333-137210), as amended, originally filed with the SEC on September 8, 2006 and incorporated herein by reference.
3.2**
 
Certificate of Amendment to Registrant’s Certificate of Incorporation, filed as an exhibit to our Registration Statement on Form SB-2 (File No. 333-137210), as amended, originally filed with the SEC on September 8, 2006 and incorporated herein by reference.
3.3**
 
Certificate of Designation, Powers, Preferences and Rights of Series A Preferred Stock, filed as an exhibit to our Registration Statement on Form SB-2 (File No. 333-137210), as amended, originally filed with the SEC on September 8, 2006 and incorporated herein by reference.
3.4**
 
Registrant’s By-Laws, filed as an exhibit to our Registration Statement on Form SB-2 (File No. 333-137210), as amended, originally filed with the SEC on September 8, 2006 and incorporated herein by reference.
3.5**
 
Certificate of Designations, Powers, Preferences and Rights of Series B Preferred Stock, filed as an exhibit to our Annual Report on Form 10-KSB, as amended, for the year ended June 30, 2008, and incorporated herein by reference.
3.6**
 
Certificate of Amendment to Certificate of Incorporation, filed as an exhibit to our Current Report on Form 8-K filed with the SEC on October 19, 2009, and incorporated herein by reference.
3.7**
 
Certificate of Amendment to Certificate of Incorporation, filed as an exhibit to our Current Report on Form 8-K filed with the SEC on September 27, 2010.
3.8**
 
Certificate of Amendment to Certificate of Incorporation, Filed as an exhibit to our Current Report on Form 8-K filed with the SEC on September 28, 2011.
4.1**
 
Form of Warrant, filed as an exhibit to our Registration Statement on Form SB-2 (File No. 333-137210), as amended, originally filed with the SEC on September 8, 2006, and incorporated herein by reference.
4.6**
 
Form of Convertible Note, filed as an exhibit to our Quarterly Report on Form 10-Q for the period ended March 31, 2008, and incorporated herein by reference.
4.9**
 
2010 Equity Incentive Plan, filed as an exhibit to our Registration Statement on Form S-8 filed with the SEC on August 26, 2010, and incorporated herein by reference.
4.10**
 
2011 Equity Incentive Plan, filed as an exhibit to our Registration Statement on Form S-8 filed with the SEC on November 19, 2010, and incorporated herein by reference.
4.11**
 
Fiscal 2012 Equity Incentive Plan, filed as an exhibit to our Registration Statement on Form S-8 filed with the SEC on May 20, 2011, and incorporated herein by reference.
10.1**
 
Form of Subscription Agreement, filed as an exhibit to our Registration Statement on Form SB-2 (File No. 333-137210), as amended, originally filed with the SEC on September 8, 2006 and incorporated herein by reference.
10.2**
 
Exclusive License and Sales Agreement, filed as an exhibit to our Current Report on Form 8-K filed with the SEC on February 27, 2009, and incorporated herein by reference.
10.3**
 
Distribution Agreement, filed as an exhibit to our Quarterly Report on Form 10-Q for the period ended March 31, 2009, and incorporated herein by reference.
10.4**
 
Amendment to the 10% Convertible Promissory Note dated as of July 28, 2009, filed as an exhibit to our Annual Report on Form 10-K for the period ended June 30, 2011, and incorporated herein by reference.
10.5**
 
Amendment to the 10% Convertible Promissory Note dated as of March 9, 2009, filed as an exhibit to our Annual Report on Form 10-K for the period ended June 30, 2011, and incorporated herein by reference.
10.6**
 
Amendment to the 10% Convertible Promissory Note dated as of March 9, 2009, filed as an exhibit to our Annual Report on Form 10-K for the period ended June 30, 2011, and incorporated herein by reference.
10.7**
 
Amendment to the 10% Convertible Promissory Note dated as of January 8, 2009, filed as an exhibit to our Annual Report on Form 10-K for the period ended June 30, 2011, and incorporated herein by reference.
10.8**
 
Amendment to the 10% Convertible Promissory Note dated as of January 8, 2009, filed as an exhibit to our Annual Report on Form 10-K for the period ended June 30, 2011, and incorporated herein by reference.
10.9**
 
Amendment to the 10% Convertible Promissory Note dated as of May 10, 2009, filed as an exhibit to our Annual Report on Form 10-K for the period ended June 30, 2011, and incorporated herein by reference.
10.10**
 
Amendment to the 10% Convertible Promissory Note dated as of August 6, 2009, filed as an exhibit to our Annual Report on Form 10-K for the period ended June 30, 2011, and incorporated herein by reference.
21.1*
 
Subsidiaries of the registrant, filed as an exhibit to our Annual Report on Form 10-K for the period ended June 30, 2011, and incorporated herein by reference.
23.1*
 
Consent of Independent Certified Public Accountants.
 
Certification of Jason Ryu, Chief Executive Officer of Zevotek, Inc., pursuant to 18 U.S.C.  §1350, as adopted pursuant to §302 of the Sarbanes-Oxley Act of 2002.
 
Certification of Jason Ryu, Chief Financial Officer and Principal Accounting Officer of Zevotek, Inc., pursuant to 18 U.S.C. §1350, as adopted pursuant to §302 of the Sarbanes-Oxley Act of 2002.
 
Certification of Jason Ryu, Chief Executive Officer of Zevotek, Inc., pursuant to 18 U.S.C.  §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002.
 
Certification of Jason Ryu, Chief Financial Officer and Principal Accounting Officer of Zevotek, Inc., pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002.
___________
*           Filed herewith.
**         Previously filed.
 
 
21

 
 
SIGNATURES
 
In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
  ZEVOTEK, INC.  
       
Date: November 16, 2012.
By:
/s/ Jason Ryu  
   
Jason Ryu, Chief Executive Officer
 
       
  By: /s/ Jason Ryu  
    Jason Ryu, Chief Financial Officer and  
   
Principal Accounting Officer
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
Signature
 
Title
 
Date
/s/ Jason Ryu
 
Chairman of the Board, President, and Chief Financial Officer,
 
November 16, 2012
JASON RYU   Principal Accounting Officer, and Secretary    
 
 
22

 
 
PART 1:
FINANCIAL INFORMATION

ITEM 8 – FINANCIAL STATEMENTS
 
ZEVOTEK, INC.

Index to Financial Statements

   
Page
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    F-2-3  
         
CONSOLIDATED FINANCIAL STATEMENTS
    F-4  
         
Consolidated Balance Sheets
    F-4  
         
Consolidated Statements of Operations
    F-5  
         
Consolidated Statements of Deficiency in Stockholders’ Equity
    F-6  
         
Consolidated Statements of Cash Flows
    F-7  
         
Notes to Consolidated Financial Statements
    F-8  
 
 
F-1

 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
To the Board of Directors and stockholders of
Zevotek, Inc.
Stuart, FL 34994
 
We have audited the accompanying consolidated balance sheets of Zevotek, Inc. and Subsidiary as of June 30, 2012, and the related consolidated statement of operations, changes in stockholders' deficit and cash flows for the year then ended. The financial statements for the year ended June 30, 2011 were audited by other auditors whose report expressed an unqualified opinion on those financial statements. These consolidated financial statements are the responsibility of Zevotek's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit.
 
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. Zevotek is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of Zevotek's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
 
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Zevotek, Inc. as of June 30, 2012, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the U.S. generally accepted accounting principles.
 
The accompanying consolidated financial statements have been prepared assuming that Zevotek will continue as a going concern.  As discussed in Note B to the consolidated financial statements, Zevotek has a working capital deficit and an accumulated deficit and may require additional financing to continue in operation.  These conditions raise substantial doubt about its ability to continue as a going concern.  Management’s plans in regard to these matters are also described in Note B.  The consolidated financial statements do not include any adjustments that might result from the outcome of the uncertainty.


/s/ M&K CPAs, PLLC
Houston, Texas
November 14, 2012
 
 
F-2

 
 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
Board of Directors and Shareholders of
Zevotek, Inc.
Englewood Cliffs, NJ
 
We have audited the accompanying consolidated balance sheet of Zevotek, Inc. (the "Company") as of June 30, 2011 and the related consolidated statements of operations, stockholders' deficit and cash flows for the year then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based upon our audits.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States of America). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatements.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.  An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe our audit provides a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Zevotek, Inc. as of June 30, 2011, and the results of its operations and cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As discussed in the Note B to the accompanying consolidated financial statements, the Company has suffered recurring losses and is experiencing difficulty in generating sufficient cash flow to meet its obligations and sustain its operations, which raises substantial doubt about its ability to continue as a going concern. Management's plans in regard to this matter are described in Note B. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 

 
  
Certified Public Accountants
 
 
New York, New York
October 13, 2011
 
 
F-3

 
 
PART 1:   FINANCIAL INFORMATION

ITEM 1 – FINANCIAL STATEMENTS

ZEVOTEK, INC.
CONSOLIDATED BALANCE SHEETS
JUNE 30, 2012 AND 2011
 
  
 
June 30,
   
June 30,
 
  
 
2012
   
2011
 
  
           
ASSETS
             
Current assets:
           
Cash and cash equivalents
 
$
231
   
$
4,737
 
Accounts receivable
   
-
     
4,043
 
Inventory
   
-
     
88,323
 
Total current assets
   
231
     
97,103
 
                 
Other assets:
               
Licensing agreement
   
-
     
40,000
 
Total assets
 
$
231
   
$
137,103
 
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT
                 
Current liabilities:
               
Accounts payable and accrued expenses
 
$
939,001
   
$
774,346
 
Advances payable
   
199,183
     
43,823
 
Convertible notes payable and demand notes (net of debt discount of -0- and $814,962 as of June 30, 2012 and 2011, respectively)
   
1,285,932
     
309,806
 
Total current liabilities
   
2,424,116
     
1,127,975
 
                 
Long term portion of convertible notes payable (net of debt discount of -0- and $106,350 as of June 30, 2012 and 2011, respectively)
   
50,000
     
86,080
 
Total Liabilities
   
2,474,116 
     
1,214,055 
 
Stockholders' deficit:
               
Series A Preferred stock, $0.00001 par value; 10,000,000 shares authorized; 50,000 shares issued and outstanding as of June 30, 2012 and 2011
   
1
     
1
 
Series B Preferred stock, $0.00001 par value; 1,000,000 shares authorized; 1,000,000 shares issued and outstanding as of June 30, 2012 and 2011
   
10
     
10
 
Common stock, $0.00001 par value, 5,000,000,000 shares authorized; 335,527 and 220,810 shares issued and outstanding as of June 30, 2012 and 2011, respectively
   
3
     
2
 
Treasury stock, 1 share outstanding as of June 30, 2012 and 2011
   
-
     
-
 
Additional paid in capital
   
5,737,406
     
5,652,172
 
Accumulated deficit
   
(8,211,305
)
   
(6,729,137
)
Total stockholders' deficit
   
(2,473,885
)
   
(1,076,952
)
Total liabilities and stockholders' deficit
 
$
231
   
$
137,103
 
 
The accompanying notes are an integral part of these consolidated financial statements. 
 
 
F-4

 

ZEVOTEK, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED JUNE 30, 2012 AND 2011
 
  
  
Years Ended June 30,
  
  
  
2012
  
  
2011
  
REVENUES:
           
Sales
 
$
8,024
   
$
15,540
 
                 
Cost of sales
   
3,441
     
8.412
 
Impairment of Inventory
   
86,113
     
-
 
                 
Gross profit
   
(81,530
)
   
7,128
 
                 
OPERATING EXPENSES:
               
Selling
   
32,865
     
310,208
 
General and administrative
   
253,718
     
528,383
 
Impairment of Licensing Agreement
   
40,000
         
Total operating expense
   
326,583
     
838,591
 
                 
Loss from operations
   
(408,113)
     
(831,463
)
                 
OTHER EXPENSE:
               
                 
Interest Expense
   
(1,074,055
)
   
(412,649
)
Total other expense
   
(1,074,055
)
   
(412,649
)
                 
Net loss before provision for income taxes
   
(1,482,168
)
   
(1,244,112
)
                 
Income taxes
   
-
     
-
 
                 
NET LOSS
 
$
(1,482,168
)
 
$
(1,244,112
)
                 
Net loss per common share, basic and fully diluted
 
$
(4.89
)
 
$
(13.23
)
                 
Weighted average number of common shares outstanding, basic and fully diluted
   
302,867
     
94,050
 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-5

 
 
ZEVOTEK, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT
For the Years Ended June 30, 2012 and 2011
 
   
Preferred stock
               
Common
               
Additional
             
  
 
Series A
   
Series B
   
Common stock
   
Stock To
   
Treasury stock
   
Paid in
   
Accumulated
       
  
 
Shares
   
Amount
   
Shares
   
Amount
   
Shares
   
Amount
   
Be Issued
   
Shares
   
Amount
   
Capital
   
Deficit
   
Total
 
BALANCE, June 30, 2010
   
50,000
   
$
1
     
1,000,000
   
$
10
     
34,719
   
$
   
$
30,000
     
1
   
$
   
$
4,000,804
   
$
(5,485,025
)
 
$
(1,454,210
)
Common stock issued for services rendered
   
     
     
     
     
29,272
     
     
     
     
     
235,413
     
     
235,413
 
Common stock issued for accounts payable
   
     
     
     
     
2,219
     
     
     
     
     
90,000
     
     
90,000
 
Conversion of debt and accrued interest for common stock
   
     
     
     
     
148,098
     
2
     
     
     
     
112,998
     
     
113,000
 
Common stock issued to officer and board members
   
     
     
     
     
4,950
     
     
     
     
     
45,000
     
     
45,000
 
Fair value of beneficial conversion feature
   
     
     
     
     
     
     
     
     
     
1,137,957
     
     
1,137,957
 
Common stock issued to former officer for accrued compensation
   
     
     
     
     
1,551
     
     
(30,000)
     
     
     
30,000
     
     
 
Net loss
   
     
     
     
     
     
     
     
     
     
     
(1,244,112
)
   
(1,244,112
)
BALANCE, June 30, 2011
   
50,000
   
$
1
     
1,000,000
   
$
10
     
220,810
   
$
2
   
$
     
1
   
$
   
$
5,652,172
   
$
(6,729,137
)
 
$
(1,076,952
)
Common stock issued for services rendered
   
     
     
     
     
32,545
     
     
     
     
     
53,000
     
     
53,000
 
Conversion of debt and accrued interest for common stock
   
     
     
     
     
77,854
     
1
     
     
     
     
32,234
     
     
32,235
 
Shares issued in satisfaction of fractional shares resulting from 1 for 5,000 reverse stock split
   
     
     
     
     
4,318
     
     
     
     
     
     
     
 
Net loss
   
     
     
     
     
     
     
     
     
     
     
(1,482,168
)
   
(1,482,168
)
BALANCE, June 30, 2012
   
50,000
   
$
1
     
1,000,000
   
$
10
     
335,527
   
$
3
   
$
     
1
   
$
   
$
5,737,406
   
$
(8,211,305
)
 
$
(2,473,885
)

The accompanying notes are an integral part of the consolidated financial statements.
 
 
F-6

 

ZEVOTEK, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years Ended June 30, 2012 and 2011
 
 
  
2012
  
  
2011
  
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net loss
 
$
(1,482,168)
   
$
(1,244,112
)
Adjustments to reconcile net loss to net cash used in operating activities:
               
Common stock issued for services rendered
   
53,000
     
235,413
 
Common stock issued for interest
   
-
     
4,050
 
Common stock issued to officer and board members as remuneration
           
45,000
 
Impairment of Inventory
   
86,113
         
Impairment of License Agreement
   
40,000
         
Amortization of beneficial conversion feature
   
921,321
     
293,254
 
Changes in operating assets and liabilities:
               
Accounts receivable
   
4,043
     
1,896
 
Inventory
   
2,210
     
9,924
 
Prepayments and other current assets
   
-
     
22,994
 
Accounts payable and accrued expenses
   
165,615
     
142,080
 
Net cash used in operating activities
   
(209,866)
     
(489,501
)
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
   
     
 
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Increase in advances payable; net
   
155,360
     
361,721
 
Proceeds from issuance of convertible notes payable
   
50,000
         
Net cash provided by financing activities
   
205,360
     
361,721
 
                 
Net (decrease) increase in cash and cash equivalents
   
(4,506
   
(127,780)
 
Cash and cash equivalents, beginning of year
   
4,737
     
132,517
 
                 
Cash and cash equivalents, end of year
 
$
231
   
$
4,737
 
                 
SUPPLEMENTAL DISCLOSURE OF CASH FLOW:
               
Interest paid
 
$
   
$
 
Taxes paid
 
$
   
$
 
NON CASH INVESTING AND FINANCING ACTIVITIES:
               
Common stock issued for settlement of accrued liabilities
 
$
     
$
120,000
 
Exchange of convertible debenture for advances payable
 
$
     
$
1,137,957
 
Accrued interest converted to convertible note
 
$
     
$
2,821
 
Debt and accrued interest converted for shares of common stock
 
$
32,235
   
$
108,949
 

The accompanying notes are an integral part of the consolidated financial statements.
 
 
F-7

 
 
ZEVOTEK, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
NOTE A - SUMMARY OF ACCOUNTING POLICIES

A summary of the significant accounting policies applied in the preparation of the accompanying consolidated financial statements follows.

Business and Basis of Presentation

ZEVOTEK, INC. (“Company” or “Registrant”) was organized on March 19, 2005 under the state laws of Delaware with an original name of “The Diet Coffee Company.” On March 1, 2006, we amended our Certificate of Incorporation and changed our name from “The Diet Coffee Company, Inc to Diet Coffee, Inc. On June 25, 2008, Zevotek changed its name to Zevotek, Inc.
 
Zevotek’s wholly owned subsidiary is Ionic Bulb.com, Inc., a Delaware corporation formed on August 21, 2007, through which it had sold the Ionic Bulb, a patented air purifier that silently emits negative ions using a microchip placed inside a 10,000-hour energy saving compact fluorescent light bulb (CFL). The Ionic Bulb was an eco-easy maintenance-free inexpensive alternative that is designed to clean the air in a 100 square foot area of unpleasant odors and indoor air pollutants that you breathe. Zevotek sold the Ionic Bulb through specialty retail shops, TV commercials, Amazon.com and newionicbulb.com, and it marketed the Ionic Bulb to major U.S. retail stores. It had acquired exclusive worldwide sales and manufacturing rights to a U.S. patented new product named Gung H2O that reduces water use in the home.

Zevotek has currently stopped working on the sales of the Ionic bulb. It is upgrading the bulb. The new ionic bulb will be made using LED light. The new Ionic Bulb will not no longer be using florescent light.

Zevotek plans to sell Gung H20 to major U.S. retail stores and directly to American consumers using TV ads and Internet marketing. After Zevotek tried to market the Gung H2O, it went back to the inventors to make changes due to feedback from the public. After the inventors make the changes Zevotek hopes to market the product sometime in the second to third quarter of 2013.

Our chief executive officer, Mr. Ryu has a history of being an innovator. We expect that he will bring a number of products on board in the upcoming year and believe Zevotek will make instant revenue from these products. We expect to release some of these products in the very near future. We are either waiting to put the finishing touches or most importantly file the proper patents in order to bring the greatest value to our stockholders.

General

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.

The consolidated financial statements include the accounts of the Registrant and its wholly-owned subsidiary, Ionic Bulb.com, Inc. The Registrant formed its Ionic Bulb.com, Inc. subsidiary on August 21, 2007 and started its operations during the fiscal year ended June 30, 2008. All significant inter-company transactions and balances have been eliminated in consolidation.

Zevotek has adopted the fiscal year end of June 30.

Reverse Stock Split

On September 26, 2011, Zevotek filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a 1 to 5,000 basis.  The Financial Industry Regulatory Authority (“FINRA”) effected the reverse stock split on October 27, 2011. Each holder of common stock received 1 share of Zevotek’s common stock in exchange for each 5,000 shares of Zevotek’s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing split.  Fractional shares were rounded up to the nearest whole share. All per share numbers quoted herein are reflective of the 1:5,000 reverse split. All references in the accompanying consolidated financial statements and notes there to have been retroactively restated to reflect the stock split.

 
F-8

 

Revenue Recognition

For revenue from product sales, Zevotek recognizes revenue in accordance with Accounting Standards Codification 605, “Revenue Recognition SEC Staff Accounting Bulletin Topic 13” (“ASC 605”). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Zevotek defers any revenue for which the product has not been delivered or is subject to refund until such time that Zevotek and the customer jointly determine that the product has been delivered or no refund will be required.  

ASC 605 incorporates Accounting Standards Codification 605-25, “Revenue Recognition Multiple Element Arrangements”.  ASC 605-25 addresses accounting for arrangements that may involve the delivery or performance of multiple products, services and/or rights to use assets.  Zevotek does not have any multiple element arrangements.
 
Consideration Paid to Customers
 
Zevotek offers our customers certain incentives in the form of cooperative advertising arrangements, product markdown allowances, trade discounts, cash discounts, and slotting fees. Markdown allowances, trade discounts, cooperative advertising program participation and cash discounts are all recorded as reductions of net sales.  No customer incentives are included in sales for the years ended June 30, 2012 and 2011.
 
Use of Estimates

The preparation of the financial statement in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

Cash and Cash Equivalents

For the purpose of the accompanying consolidated financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. Zevotek had no cash equivalents as of June 30, 2012 and 2011, respectively.

Inventories / Cost of Goods Sold

Zevotek has adopted a policy to record inventory at the lower of cost or market determined by the first-in-first-out method. The elements of cost that comprise inventory and cost good sold are FOB shipping point costs, freight and destination charges, customs and importation fees and taxes, customer broker fees (if any) and other related costs. Warehousing costs are charged to cost of goods in the period the costs are incurred. Zevotek provides inventory allowances based on estimates of obsolete inventories.

Inventories consist of finished products available for sale to distributors and customers. At June 30, 2012 and 2011, Finished Goods inventory was 0 and $88,323, respectively.

Allowance for doubtful accounts

Zevotek maintains an allowance for doubtful accounts to reduce amounts to their estimated realizable value, including reserves for customer and other receivable allowances and incentives. In estimating the provision for doubtful accounts, Zevotek considers a number of factors including age of the accounts receivable, trends and ratios involving the age of the accounts receivable and the customer mix of each aging categories.  As of June 30, 2012 and 2011, the allowance for doubtful accounts was $0.

Impairment of long lived assets

Zevotek has adopted Accounting Standards Codification 360 "Property, Plant and Equipment" (“ASC 360”). The Statement requires that long-lived assets and certain identifiable intangibles held and used by Zevotek be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. Zevotek evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.

 
F-9

 
 
Advertising

Zevotek charges the costs of advertising to expenses as incurred.  Zevotek charged $31,446 and $148,479 to operations for the years ended June 30, 2012 and 2011, respectively.
  
Income Taxes
 
Zevotek has adopted Accounting Standards Codification 740,  “Income Taxes” (“ASC 740”) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference

between financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant, except basis difference related to certain debts.
 
Effective January 1, 2007 Zevotek adopted an amendment to the requirements of ASC 740. The amended standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
 
ASC 740-10-25-5 “Income Taxes—Overall—Recognition—Basis Recognition Threshold”, (“Tax Position Topic”) provides guidance to address uncertainty in tax positions and clarifies the accounting for income taxes by prescribing a minimum recognition threshold, i.e. “more-likely-than-not”, that the income tax positions must achieve before being recognized in the financial statements. In addition, the Tax Position Topic requires expanded annual disclosures, including a roll forward of the beginning and ending aggregate unrecognized tax benefits as well as specific detail related to tax uncertainties for which it is reasonably possible the amount of unrecognized tax benefit will significantly increase or decrease within twelve months.

As a result of implementing ASC 740, there has been no adjustment to Zevotek’s financial statements and the adoption of ASC 740 did not have a material effect on Zevotek’s consolidated financial statements for the years ended June 30, 2012 and 2011.
 
Research and Development
 
Zevotek accounts for research and development costs in accordance with the Financial Accounting Standards Board's Accounting Standards Codification 730 "Research and Development" (“ASC 730”). Under ASC 730, all research and development costs must be charged to expense as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. Zevotek had no expenditures on research and product development for years ended June 30, 2012 and 2011.  

Stock Based Compensation
 
Effective January 1, 2006, Zevotek adopted the requirements of ASC 505 “Equity” and ASC 718-10 “Stock Compensation”, under the modified prospective transition method. The standards require the measurement of compensation cost at the grant date, based upon the estimated fair value of the award, and requires amortization of the related expense over the employee’s requisite service period.

Under ASC 718-10, stock based compensation cost will be recognized over the period during which an employee is required to provide service in exchange for the award. ASC 718-10 also requires an entity to calculate the pool of excess tax benefits available to absorb tax deficiencies recognized subsequent to adoption of ASC 718-10 (the “APIC pool”). Zevotek has evaluated its APIC pool and has determined that it was immaterial as of January 1, 2006. ASC 718-10 also amends ASC 230 “Cash Flows”, to require that excess tax benefits that had been reflected as operating cash flows be reflected as financing cash flows.

 
F-10

 
 
Loss per Share
 
Zevotek has adopted Accounting Standards Codification subtopic 260-10, Earnings Per Share (“ASC 260-10”) specifying the computation, presentation and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Potentially dilutive shares of common stock realizable from the conversion of our convertible debentures of 148,499,367 and 4,836,404,514 shares, respectively at June 30, 2012 and 2011, are excluded from the computation of diluted net loss per share as their inclusion would be anti-dilutive.  
 
Concentration of Credit Risk
 
Financial instruments and related items, which potentially subject Zevotek to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. Zevotek places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.

Recent Accounting Pronouncements
 
In October 2012, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2012-04, “Technical Corrections and Improvements” in Accounting Standards Update No. 2012-04. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update will be effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 is not expected to have a material impact on our financial position or results of operations.
 
In August 2012, the FASB issued ASU 2012-03, “Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update)” in Accounting Standards Update No. 2012-03. This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 is not expected to have a material impact on our financial position or results of operations.
 
In July 2012, the FASB issued ASU 2012-02, “Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment” in Accounting Standards Update No. 2012-02. This update amends ASU 2011-08, Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment and permits an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles, Goodwill and Other - General Intangibles Other than Goodwill. The amendments are effective for annual and interimimpairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim impairment tests performed as of a date before July 27, 2012, if a public entity’s financial statements for the most recent annual or interim period have not yet been issued or, for nonpublic entities, have not yet been made available for issuance. The adoption of ASU 2012-02 is not expected to have a material impact on our financial position or results of operations.
 
In December 2011, the FASB issued ASU 2011-12, “Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05.  This update defers the requirement to present items that are reclassified from accumulated other comprehensive income to net income in both the statement of income where net income is presented and the statement where other comprehensive income is presented.  The adoption of ASU 2011-12 is not expected to have a material impact on our financial position or results of operations.
 
In December 2011, the FASB issued ASU No. 2011-11 “Balance Sheet: Disclosures about Offsetting Assets and Liabilities” (“ASU 2011-11”).  This Update requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position.  The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of IFRS.  The amended guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods.  Zevotek is currently evaluating the impact, if any, that the adoption of this pronouncement may have on its results of operations or financial position.
 
 
F-11

 
 
NOTE B - GOING CONCERN MATTERS

The accompanying consolidated statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements for the years ended June 30, 2012 and 2011, Zevotek incurred net losses of $1,482,168 and $1,244,112, respectively.  At June 30, 2012, Zevotek had a working capital deficit of $2,423,885 and accumulated losses of $8,211,305. Zevotek is in default of payment and interest on certain convertible notes payable.

Zevotek is actively pursuing additional convertible debt financing through discussions with its current lenders.  Zevotek cannot predict whether the additional financing will be in the form of equity or debt, or be in another form.  Zevotek may not be able to obtain the necessary additional capital on a timely basis, on acceptable terms, or at all.  In any of these events, Zevotek may be unable to implement its current plans for expansion, repay its debt obligations as they become due, or respond to competitive pressures, any of which circumstances would have a material adverse effect on its business, prospects, financial conditions and result of operations. These factors, among others, may indicate that Zevotek will be unable to continue as a going concern for a reasonable period of time.

Zevotek has discontinued sales of one its major products, the Ionic Bulb and has re-entered the Development Stage after the year ended June 30, 2012. Zevotek has chosen to no longer sell the fluorescent version of the Ionic Bulb and to develop a next generation bulb utilizing “LEDs” Light Emitting Diodes.

Zevotek's existence is dependent upon management's ability to develop profitable operations. Management anticipates Zevotek may attain profitable status and improve its liquidity through the continued developing, marketing and selling of its products and additional investment in Zevotek. The accompanying consolidated financial statements do not include any adjustments that might result should Zevotek be unable to continue as a going concern.

NOTE C – INVENTORY

Since Zevotek has decided to develop a new Ionic Bulb, utilizing LEDs rather than the current fluorescent version the current finished goods inventory of the Ionic Bulb is obsolete.  Zevotek recorded an Impairment of Inventory of $86,113 for the year ended June 30, 2012.

NOTE D – LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT
 
On February 24, 2009, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to manufacture, market use, sell, distribute and advertise a patented ionic bulb.  

In exchange for the exclusive license, Zevotek issued 500 shares of its common stock.  The license was valued at the market price of the underlying security.

On March 2, 2011, Zevotek and the Ionic Bulb patent holder entered into a non-exclusive Purchasing Representative Agreement whereby the patent holder shall introduce Zevotek to a new third party manufacturer that will produce a next generation version of the Ionic Bulb with new features and improved manufacturing cost.  Additionally, the patent holder affirms his obligation to defend against patent infringement.  Zevotek shall pay patent holder a fixed amount per Ionic Bulb ordered from the new manufacturer.  Zevotek agreed to make an advance fee payment by issuance of 5,000 shares of Zevotek’s restricted stock.  The value of the restricted shares applied to payment of the fees is to be based upon the average closing price of Zevotek's common stock for the ten trading days proceeding the date on which the restrictive stock legend may be removed. The term of the agreement is three years with one-year automatic renewals that are subject to minimum fee payments to the patent holder for the first and second renewal term, respectively.  The related shares were issued and expensed during fiscal 2012 for a value of $35,000 based on the grant date fair value of the shares issued.

On December 10, 2010, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to develop, manufacture, market, use, sell, distribute and advertise a U.S. patented new product named Gung H2O that reduces water use in the home.

The Licensing Agreement was originally valued at $40,000.  Since Zevotek is no longer marketing and selling the Ionic Bulb, the agreement was considered totally impaired.  A Licensing Agreement Impairment of $40,000 was recorded for the year ended June 30, 2012.
 
 
F-12

 
 
NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities are as follows:

  
  
June 30,
2012
  
  
June 30,
2011
  
Accounts payable 
 
$
2,389
   
$
10,867
 
Accrued professional fees
   
217,262
     
225,163
 
Accrued payroll and payroll taxes
   
165,372
     
161,649
 
Old disputed accounts payable
   
136,505
     
160,756
 
Accrued interest
   
333,598
     
183,507
 
Other accrued liabilities
   
83,875
     
32,404
 
Total
 
$
939,001
   
$
774,346
 
 
NOTE F – ADVANCES PAYABLE
 
As of June 30, 2012 and 2011, Zevotek owed $199,173 and $43,823, respectively, to a note holder for cash advanced to Zevotek for operating purposes.  The advances accrue interest at 10% per annum and are repayable on demand.  

NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES

  
  
June 30,
2012
  
  
June 30,
2011
  
Notes Payable:
           
Convertible term note (a)
 
$
923
   
$
923
 
Convertible term note (b)
   
1,923
     
1,923
 
Convertible term note (c)
   
50,000
     
50,000
 
Convertible term note (d)
   
2,497
     
2,497
 
Convertible term note (e)
   
224
     
25,174
 
Convertible term note (f)
   
11,132
     
11,132
 
Convertible term note (g)
   
26,420
     
30,920
 
Convertible term note (h)
   
190,757
     
192,430
 
Convertible term note (i)
   
34,141
     
34,141
 
Convertible term note (j)
   
22,350
     
22,530
 
Convertible term note (k)
   
945,565
     
945,527
 
Convertible term note (l)
   
10,000
     
-
 
Convertible term note (m)
   
30,000
     
-
 
Convertible term note (n)
   
10,000
     
-
 
     
1,335,932
     
1,317,197
 
Less: discount on debt
   
-
     
921,311
 
     
1,335,932
     
395,886
 
Less: current portion
   
(1,285,932
)
   
(309,806
)
Long term debt
 
$
50,000
   
$
86,080
 

 
a)
On May 14, 2008, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of May 14, 2010.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below). Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holders about amending the conversion terms to cure the default.
 
 
F-13

 
 
 
b)
On May 27, 2008, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 27, 2010.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below).  Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.
     
 
c)
On January 1, 2008, Zevotek entered into a convertible term note for the principal amount of $50,000 bearing interest at 7% per annum with a maturity date of June 30, 2008.  This note is convertible into common stock at 90% of the common stock closing price at June 30, 2008, which is $7,200.  Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.
 
  
d)
On January 8, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of January 8, 2011.   Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below).
 
 
e)
On March 9, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of March 9, 2011.   The notes were amended on January 8, 2011 to extend the maturity date to January 8, 2012.  Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).
 
 
f)
Of the convertible term notes entered into on May 14, 2008, certain notes having a principal amount of $11,132 as of June 30, 2012 and 2011 were not amended with respect to their conversion price and, at any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.001 per share. Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.
 
 
g)
On July 28, 2009, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of July 28, 2011.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).
 
 
h)
On August 6, 2010, Zevotek converted $192,430 of advances payable into a convertible term note bearing interest at 10% per annum with a maturity date of August 6, 2012.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).
 
 
i)
On January 8, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of January 8, 2011.   The notes were amended on January 8, 2011 to extend the maturity date to January 8, 2012. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).
 
 
j)
On March 9, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of March 9, 2011.   Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).
 
 
k)
On May 10, 2011, Zevotek converted $945,527 of advances payable into a convertible term note bearing interest at 10% per annum with a maturity date of May 10, 2012.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).
 
 
l)
On March 19, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of March 19, 2014.  At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).
 
 
m)
On May 15, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 15, 2014.  At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).
 
 
n)
On May 18, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 18, 2014.  At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.01 per share (see below).
 
 
F-14

 
 
In accordance with Accounting Standards Codification 470-20-65, “Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratios (“ASC 470-20-65”), Zevotek recognized an imbedded beneficial conversion feature present in the notes. Zevotek allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid in capital. Zevotek recognized and measured an aggregate of $314,049 of the proceeds, which was equal to the intrinsic value of the imbedded beneficial conversion feature at the time, to additional paid in capital and a debt discount against the Notes issued during the year ended June 30, 2008. The debt discount attributed to the beneficial conversion feature was originally amortized over the Notes maturity period (two years) as interest expense, adjusted for conversion of debt to common stock. In January 2009 through March 2009, Zevotek restructured certain Notes to a conversion rate of $0.0001 per share with a two year term and accordingly fully amortized the remaining debt discount of $206,160. In accordance with ASC 470-20-65, Accounting for Convertible Securities with Beneficial Conversion Features, Zevotek recognized an imbedded beneficial conversion feature present in the notes. Zevotek recognized and measured an aggregate of $457,849 of the proceeds, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the Notes issued during the year ended June 30, 2009. The remaining debt discount attributed to the original beneficial conversion feature was expensed at the time the Notes were amended and the $457,849 assigned to the amended beneficial conversion feature is being amortized over the Notes maturity period.

On July 28, 2009, Zevotek issued a $44,000 convertible note having the same terms as the amended outstanding convertible notes.  Zevotek recognized and measured an aggregate of $44,000 of the proceeds, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note’s two-year term.

On August 6, 2010, Zevotek converted $192,430 of advances payable into a convertible note.  Zevotek recognized and measured an aggregate of $192,430 of the advances payable, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note’s two-year term.

On May 10, 2011, Zevotek converted $945,527 of advances payable into a convertible note.  Zevotek recognized and measured an aggregate of $945,527 of the advances payable, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note’s one-year term.

During the years ended June 30, 2012 and 2011, amortization related to the beneficial conversion feature on the convertible notes was $921,312 and $293,254, respectively.

In or about May 2010, an alleged assignee (the “Assignee”) of certain convertible promissory notes commenced an action by the filing of a summons and complaint against Zevotek alleging a failure to comply with its demands to convert principal and interest under Zevotek’s promissory notes in Company common stock.  Zevotek served and filed its Answer on July 21, 2010, in which it denied the material allegations of the complaint and asserted numerous affirmative defenses.  The parties have entered into a stipulation of settlement resolving this action on November 4, 2010 and a final judgment and injunction were entered on November 12, 2010, pursuant to which Zevotek agreed to issue stock once a month to the Assignee until it has issued a total of 36,400 shares of common stock. As of June 30, 2011, Zevotek has issued 36,400 shares of its common stock to the Assignee and fully satisfied the judgment.
 
NOTE H – STOCKHOLDERS EQUITY

Preferred Stock

Zevotek has authorized 10,000,000 shares of Preferred Stock of which 50,000 shares have been designated as Series A Preferred Stock, par value $0.00001, and 1,000,000 shares have been designated as Series B Preferred Stock, par value $0.00001 within the limitations and restrictions stated in the Certificate of Incorporation of Zevotek.

Zevotek issued 50,000 shares of Series A Preferred Stock. Each share of the Series A Preferred Stock is entitled to 10,000 votes on all matters submitted to the stockholders of Zevotek. The holders of the Series A Preferred Stock are not granted any preference upon the liquidation, dissolution or winding up of the business of Zevotek. The Series A Preferred Stock is not convertible into Common Stock.

Zevotek designated and issued 1,000,000 shares of Series B Preferred Stock.  On May 14, 2008, Zevotek and a third party note holder entered into an exchange agreement under which the third party note holder exchanged a $21,026 promissory note for 1,000,000 shares of Series B Preferred Stock.   Each share of Series B Preferred Stock is entitled to 5,000 votes on all matters submitted to the stockholders of Zevotek. Subsequently, the third party note holder, Anthony Intrieri, became Chairman of the Board of Directors. On September 12, 2011, the Estate of Anthony Intrieri ("Estate") sold 1,000,000 shares of Zevotek's Series B Preferred Stock to an unrelated third party.  The Estate obtained the shares following the passing of Mr. Intrieri, Zevotek's former Chairman of the Board of Directors and sole Series B Preferred stockholder.

 
F-15

 
 
Common Stock

Zevotek effectuated a 1 for 50 reverse stock split on June 26, 2008. All common stock and related information has been retroactively restated. In addition, contemporaneously with the stock split Zevotek increased its authorized Common stock, par value $0.00001 to 1,000,000,000 shares. Prior to this date, the authorized shares were 200,000,000 shares. On October 14, 2009, Zevotek authorized capital was increased to 5,000,000,000.

On September 24, 2010, Zevotek filed a certificate of amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware in order to effectuate a reverse split on a 1 to 20 basis (the “Reverse Split”).  On October 6, 2010, Financial Industry Regulatory Authority (“FINRA”) approved the Reverse Split and each holder of common stock received 1 share of Zevotek’s common stock for each 20 shares of Zevotek’s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing stock split.  Fractional shares were rounded up to the nearest whole share.  All per share numbers quoted herein are reflective of the Reverse Split.

On September 26, 2011, Zevotek filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a 1 to 5,000 basis.  On October 27, 2011, Financial Industry Regulatory Authority (“FINRA”) approved the Reverse Split and each holder of common stock received 1 share of Zevotek’s common stock for each 5,000 shares of Zevotek’s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing stock split.  Fractional shares were rounded up to the nearest whole share.  All per share numbers quoted herein are reflective of the Reverse Split.

At June 30, 2012 and 2011, common shares issued and outstanding were 335,527 and 220,810, respectively.

On November 17, 2010, Zevotek adopted its 2011 Equity Incentive Plan (“2011 Plan”). Zevotek is permitted to issue up to 12,000 shares of common stock under the Plan in the form of stock options, restricted stock awards, and stock awards to directors, officers, consultants, advisors and employees of Zevotek.  As of June 30, 2012, there were 12,000 shares issued under this 2011 Plan.

On May 5, 2011, Zevotek adopted its Fiscal 2012 Equity Incentive Plan (“2012 Plan”). Zevotek is permitted to issue up to 30,000 shares of common stock under the Plan in the form of stock options, restricted stock awards, and stock awards to directors, officers, consultants, advisors and employees of Zevotek.  As of June 30, 2012, there were 19,500 shares issued under this 2012 Plan.

During the year ended June 30, 2011, Zevotek issued 31,492 shares of common stock, valued at $325,413 for services, accrued expenses and accounts payable. Shares were valued according to the closing price of the common stock on the date it was granted.
 
During the year ended June 30, 2011, Zevotek converted debt and accrued interest of $113,000 into 148,098 shares of common stock.  The conversion was in accordance with the original note agreement, therefore no gain or loss was recorded for this transaction.
 
During the year ended June 30, 2011, Zevotek issued 4,950 shares of its common stock, valued at $45,000, to its Chief Executive Officer and two of its directors as compensation. Shares were valued according to the closing price of the common stock on the date it was granted.

During the year ended June 30, 2011, Zevotek issued 1,551 shares valued at $30,000 to a former officer to satisfy a claim included in common stock to be issued. Shares were valued according to the closing price of the common stock on the date it was granted.

During the year ended June 30, 2012, Zevotek issued 32,545 shares of common stock, valued at $53,000 for consulting services. Shares were valued according to the closing price of the common stock on the date it was granted.

During the year ended June 30, 2012, Zevotek converted debt and accrued interest of $32,235 into 77,854 shares of common stock.  The conversion was in accordance with the original note agreement, therefore no gain or loss was recorded for this transaction.
 
 
F-16

 

During the year ended June 30, 2012, Zevotek issued 4,318 shares of common stock in satisfaction of fractional shares resulting from a 1 for 5,000 reverse stock split.

Treasury Stock
As of June 30, 2012 and 2011, Zevotek had 1 share of common stock held in treasury, which carried at $0 based on cost.

NOTE I - INCOME TAXES
 
Zevotek recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns.

Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant. Management estimates that at June 30, 2012, Zevotek has available for federal income tax purposes a net operating loss carry forward of approximately $6 million expiring by the year 2031 that may be used to offset future taxable income. Due to significant changes in Zevotek's ownership, the future use of its existing net operating losses may be limited.

Zevotek has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of Zevotek; it is more likely than not that the benefits will not be realized. Components of deferred tax assets as of June 30, 2012 are as follows:
 
Net operating loss carry forward
 
$
2,400,000
 
Valuation allowance
   
(2,400,000
)
Net
 
$
 0
 

Zevotek has not filed their federal or state income tax returns for fiscal years ended June 30, 2006 through June 30, 2012. The above is determined under the assumption as if Zevotek has filed its income tax returns through June 30, 2012.
 
Although the taxing authorities impose penalties for non-filing, Zevotek does not believe any penalties will be enforced since there is no tax due.

NOTE J - STOCK OPTIONS AND WARRANTS

During the years ended June 30, 2012 and 2011, Zevotek did not issue any stock warrants or options.  As of June 30, 2012, there are no outstanding stock warrants or options.

NOTE K - COMMITMENTS AND CONTINGENCIES

U.S. Federal Trade Commission Settlement
On March 26, 2007, Zevotek received a letter from the U.S. Federal Trade Commission (“FTC”) whereby former management was informed that the FTC was conducting an investigation into advertising claims made for weight loss product known as “Slim Coffee.”  The purpose of the investigation was to determine whether former management, in connection with its sales of Slim Coffee, engaged in unfair or deceptive acts or practices and false advertising.  A negotiated settlement was reached with the FTC under which Zevotek, its former management did not admit any wrongdoing.  On January 10, 2008, pursuant to a stipulated final judgment and order, the United States District Court, Southern District of New York, entered a final judgment and order against Zevotek in the amount of $923,910.  The full amount of the judgment, and payment of any portion of it is suspended and cannot be reinstated so long as (a) Zevotek abides by the reporting and monitoring requirements of the judgment, (b) does not make false advertising claims in connection with any of its products in the future, and (c) its past financial disclosures to the FTC were materially accurate. Zevotek plans to comply with the terms of the stipulation and do not anticipate incurring a liability for the judgment, however there can be no assurance of compliance.  Should Zevotek fail to comply with the FTC’s final judgment, this could have a material adverse effect on Zevotek’s business, financial condition and results of operations.

Licenses

On February 24, 2009, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek obtained worldwide exclusive rights to manufacture, market use, sell, distribute and advertise certain licensed products.  The license is on a year to year basis with automatic renewal and is subject to becoming non-exclusive should Zevotek fail to files all quarterly and annual reports by due dates, inclusive of allowable extensions.  In exchange for the exclusive license, Zevotek issued 500 shares of its common stock.
 
 
F-17

 
 
On March 2, 2011, Zevotek and the Ionic Bulb patent holder entered into a non-exclusive Purchasing Representative Agreement whereby the patent holder shall introduce Zevotek to a new third party manufacturer that will produce a next generation version of the Ionic Bulb with new features and improved manufacturing cost.  Additionally, the patent holder affirms his obligation to defend against patent infringement.  Zevotek shall pay patent holder a fixed amount per Ionic Bulb ordered from the new manufacturer.  Zevotek agreed to make an advance fee payment by issuance of 5,000 shares of Zevotek’s restricted stock.  The value of the restricted shares applied to payment of the fees is to be based upon the average closing price of Zevotek's common stock for the ten trading days preceding the date on which the restrictive stock legend may be removed. The term of the agreement is three years with one-year automatic renewals that are subject to minimum fee payments to the patent holder for the first and second renewal term, respectively.  
 
Gung H2O License

On December 10, 2010, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to develop, manufacture, market, use, sell, distribute and advertise a U.S. patented new product named Gung H2O that reduces water use in the home. The license has a five-year initial term with automatic annual renewals and is not subject to minimum payments to the licensor.

Payroll Taxes
 
At June 30, 2012, Zevotek is delinquent with filing and remitting payroll taxes of approximately $92,000 including estimated penalties and interest related to payroll taxes withheld since April 2007. Zevotek has recorded the delinquent payroll taxes, which are included in accrued expenses on the balance sheet. Although Zevotek has not entered into any formal repayment agreements with the respective tax authorities, management plans to make payment as funds become available. Penalties and interest amounts are subject to increase based on a number of factors that can cause the estimated liability to increase further. Interest and penalties were accrued in an amount estimated to cover the ultimate liability.

Sales Taxes
 
At June 30, 2012, Zevotek is delinquent with remitting sales taxes of approximately $46,300, including related estimated penalties and interest related to sales taxes withheld since 2006 in the state of New York. Zevotek has recorded the delinquent sales taxes, which are included in accrued expenses on the balance sheet. Although Zevotek has not entered into any formal repayment agreements with the respective tax authorities, management plans to make payment as funds become available. Penalties and interest amounts are subject to increase based on a number of factors that can cause the estimated liability to increase further. Interest and penalties were accrued in an amount estimated to cover the ultimate liability.
 
Legal
 
On or about May 2010, an alleged assignee (the “Assignee”) of certain convertible promissory notes commenced an action by the filing of a summons and complaint against Zevotek alleging a failure to comply with its demands to convert principal and interest under Zevotek’s promissory notes in Company common stock.   The parties entered into a stipulation of settlement resolving this action on November 4, 2010 and a final judgment and injunction were entered on November 12, 2010, pursuant to which Zevotek agreed to issue stock once a month to the Assignee until it issued a total of 36,400 shares of common stock, which has been fully satisfied as of June 30, 2011.
 
NOTE L - FAIR VALUE MEASUREMENT
   
Fair Value Measurements under GAAP clarifies the principle that fair value should be based on the assumptions market participants would use when pricing an asset or liability and establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. Under the standard, fair value measurements are separately disclosed by level within the fair value hierarchy.  It only applies to accounting pronouncements that already require or permit fair value measures, except for standards that relate to share-based payments.

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.
 
 
F-18

 
 
To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment.  In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy.  In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

The carrying value of Zevotek’s cash, accounts receivable, prepayments, accounts payable, advances payable, convertible notes payable, and other current assets and liabilities approximate fair value because of their short-term maturity.  All other significant financial assets, financial liabilities and equity instruments of Zevotek are either recognized or disclosed in the consolidated financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed.
 
As of June 30, 2012, there were no financial assets or liabilities that were measured at fair value on a recurring basis.  
 
 
F-19
GRAPHIC 2 img001.jpg begin 644 img001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,# M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_ MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``@`*<#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]Z_"6%\)Z M7V`M(O;^`5\5?$G_`(+*ZQX\^,VO_#_]F/X%^+/VD-;\&7SZ=XDUBWU>W\.> M%=*N$4F2U&J7"/'-#(M,O=4UQM/B#+81+#!&86N) M#-,6:,A2S(&8D*``??OB?_@L=\:OV2+>WUS]IG]D[Q%\.?AX\UO'>^+_``MX MLM/%=EH(GD:-6O8H41XT1@H:1=R_.`!DJK???A#QQH_Q!\(:=X@T'5+#6="U MBU2]L=0LIUGM;R!U#)+'(I*NC*00P)!!S7YS_M":G^T[_P`%DO"M[\-_"?P^ MU+]F[]G[Q9:BV\2^*O',,!\6Z_I\BD36MEI:M(+?S$907N"K`;N59=C>2_\` M!P]^UCX\_P""4?["'@/X$?!SPC;V?P_\9^$[GP6GBJ2\EGOM"AM8(TEB6-%+ M;FLA,3,22/G8!3&"0#]!/AY_P5B_9F^+'Q"/A/P[\>/A5JGB)IC;Q6,?B2U6 M6ZE#%2D.YP)FR#@1ELCD9'-?0/FC`.1R,]:_F(_9=_X*0?`CXA?L'Z!\)?VD M?V,-=\57.D:$NF:=XV\#>%[>'4[B%5;[+()66"2.55*;I%FD60YD)9ZSXV\*:!%)*+8Q6-W* MJRW&U-B!U9RC0A%)#$`'[L^9\Q`&2*4,#TR17XT?!77OV2/CMXU'ACXP_M!? MM9^$?C&'-Y!9?%[QKJ?@G5M+D>50#:QPE;<#&HBW$[7V@A01]_P#_``2G M\&_&SX>_LSWNE?'+6V\0ZG9^(+U?"VH7>H0:AJ\_AW]V;$ZE<0`0RWF#)N>, ML"OEDL6+&@#Z9)P,XS3?-`)!P/TKYO\`^"LW_!0+3?\`@FC^PGXV^*=T^G2: MWI]O]A\-V-Z&:+5-6F#"V@*JRLZ9#2.%8'RXI"",9'AO_!)W_@I_K?Q,_P"" M)X_:3^.^OV%Q>Z1'KNHZM>Q6L5A&T%K>W"0P1I&H7<56.)``7=BH^9SD@'Z! MA]V.",TM?GC_`,&UO[3GQ(_;3_8I\;?%?XDZUK&IW?C;XC:O>:1:7]-AX9\&Z>]_=NI4R3$$+'#&"0&EED9(T7(R[J.]`'RU_P5/\` MVW?B#\/OVHOV=?@+\$=3LX/B1\2_%=OJOB)FMTO6TKPO:L3>2S1,C!(I?F`D MW(W^CR*IRV5^Y@,-GD_A7PO_`,$:_P!FSQ=K\7BK]J3XS6KI\9/CV([NWL92 MS?\`"&^'%._3](B#?ZOY"LLH`!9V7>"RDG[J(XR2:`/+/VU?VO\`PG^PA^R] MXO\`BQXU:Z;P]X0L_M,L-H$:XO)&=8XH(@[*IDDD=%&2!\V20`371_L_?&>Q M_:(^`W@KX@:;8:GI6F^.-"LM?M;/48UBO+6*ZMTG2.55+`2*K@,`2`0>37Y[ M_M\V4G_!83_@HQX>_9;TBYEG^"_P7EMO%OQFGA8K!JEX3OT[0O,4\EMK22KV M!)!#Q8K]-+>VCL[9(HD6.*)0B*H"J`!@``<=./PH`H^+O&>D_#_POJ&N:]J> MG:)HVDP/=7U_?W*6UK90H,O)+*Y"(B@$EF(``S7R%JW_``$'N8I!$9+>"\N+;)Q@B>.%HBO(^8-@=R.:^>_^#COQD?B-\^*K/X6?#CP2EJ+&=KVULM.L9855@(-K*%D&UF`C`).X@`Y-`'H/PF^,/ MA7X\>`=-\5>"O$.C>*?#>KQ":SU/2[N.ZM;A3_=="02.A'4'(.#Q17Y9_P#! M$O[#\2_^"I/QK^(W[._@O5_`7[(6O>'H(1'<6DVG:7XE\1>5'Y M/G(PC55&$R`655*`/&?^#H?Q/KO[4G[1O[*'[+?@U;*]UWQ@LE]<0W$:SQVC M7JK86]RZ;N##&+Z3<0-H&Y3D97],O%?_``1N_9Q^)?[+?A;X3^+_`(6^$_$. M@^$=#M=#L+U[);;4X(X$"B2.[BVSQNS;G8K)\S.Y;=N;/.2?\$M=/\>?\%7/ M`G[5FHZ_:78\)_#M?"VG:!+IK&2UO"\Q6_2X\W;_`*FZN(]ACXR#DD_+]C;! MDD]Z`/Q1_P""E7A[]KW_`((6=E=ZAXDTZ'7/%7P MQM/-$:BU>9UBN8&#B,&5#L*Q+A`?,KY:_:G^$7B']O/_`(*?_LI_"/1/VC_' MOQ^^%?Q>T$>))=1UNXM[26VTU[NY;5K=!!''Y;_9M**E&`<.#'P"0?Z0/&7@ MG1_B+X4U'0?$&EZ=KFAZQ;O:7^GW]LES:WL+C#1R1N"KH1D%2""#7Y[_``?_ M`.""%U^P?\4KSQ=^S/\`$_2/")>2\N+71/'7@JV\56VGFX5-\%I>)+:WMI`Y MC56"RN"O+!V&:`/T.\/Z#9>%M`L=+TVUBLM/TVWCM;6VA79'!$BA410.@50` M!V`K\-?^"_WQ[^&_[%G[?W@7XD?`OP9J=C^TEX%\1Z6_BR[TF*.PTOQ'9:E' M<.FFW:;@UW=7*QL?,BB`/\`@H#K&@W-A-\2/V6-'NGNY%BU M*Q\(:S<2I;;/D812W?EB4MU4EE`/5J\7UO\`X-PYOV@/CG%\9?CA^T3\0?&? MQLTY;;^QO$7AS1=/\.VWA]K:026YM[3RYU8QMO\`F^(G@WPUXTT-Y%N3IVMZ=%?V\FQ/J&I?!SQE>RZKX8U.*-&9TT^5V^T6,^"[#$ MI5WVAB%`%>BZC\!OV\?A7&EIX2^/GP.^)]H=JB?Q[X#N=*OH5^?@R:;/Y4F<=`02_)?%/]B']N+]LSPAJ?A#XF?M#_"GX5^#M73[-J,7PP\)7D^I: MI:,0);?[7>W"O;;T++YD0)&!E2"5(!\X_LB_$&Y_X.0_V^].^,-YHFIZ%^SM M^S]HHM/#VEZB=LM]XONX%>6YPA*M]D#!E'4?RS<2":ZO)78O+<3 MR`#?*[$DG`'0`!0%'J;(`I).<_AGVH`_-K_@VA\62:!\`OCA\(;^&TL]7^#' MQ=U_1WM+=41(;:6[UF%44WSNWRIA5E/R:`(KB\CM8'EF=(H8U+O(S!54#J23T&.LD+ M>=IT[8W>1,K8;85.54G<`5;F_`G_``1D_9-^'7AJVTG3_P!G+X,W-I:KM1]3 M\)66J73<`9:XN8Y)G/'5G/?U-`'IGPR_;+^#_P`:-1NK7P=\5_AMXMN[-%DN M(=&\365])`K,$0NL4C%06(4$]2<=>*\/_P""SO\`P4ZM/^"97[&]UXJTJT_M MWX@^+9QH'@G28T\YK[4YD;RY#&#NDBBX=@N2Q*)P9`:F^)'_``0=_8\^*CP- MJ?[/7PWM3;_<&CZ>=&!Z_>%FT0;K_%GH/08TOA[_`,$<_@;\+OC3\,/&FD:' MJRM\&M!GT'P=HMWJ.-.="B#5=/CFFML_Q0RD>9"W)^:-E89/->)_L1?\$J8O\`@G?\8]2N M/AI\5O'D'P9U*VN"OPPUAUU33-'NWE$B2Z?<2'SK6)MW.E7,D[WLT:2036[+ M+$VZ^@W%&4L(,$E>#];^`O\`@@-^RGX-\>2>*M2^&2^//$LDPG.I>-=8OO$D MQ8$$9%Y+(C#=SRI.2>>U=;X9_P"">TOAK_@KGXA_:;B\2H]IX@^&L?@6706M M"9$G6_BN?M*S;L"/9`B["I)9F.X`!3].4`0V&GP:7906UM#%;VUL@BBBC0(D 1:@8"J!P````!T`HJ:B@#_]D_ ` end EX-31.1 3 zvtk_ex311.htm zvtk_ex311.htm
EXHIBIT 31.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
 
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Jason Ryu, certify that:
 
1. I have reviewed this Form 10-K/A of Zevotek, Inc.;
 
2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;
 
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and
 
(d) Disclosed in this Report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and Report financial information; and
 
(b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: November 16, 2012.
By:
/s/ Jason Ryu  
   
Jason Ryu,
Chief Executive Officer
 
EX-31.2 4 zvtk_ex312.htm zvtk_ex312.htm
EXHIBIT 31.2
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER
 
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Jason Ryu, certify that:
 
1. I have reviewed this Form 10-K/A of Zevotek, Inc.;
 
2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;
 
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and
 
(d) Disclosed in this Report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and Report financial information; and
 
(b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: November 16, 2012.
By:
/s/ Jason Ryu  
   
Jason Ryu,
Chief Financial Officer and Principal Accounting Officer
 
EX-101.INS 5 zvtk-20120630.xml 0001364208 2011-07-01 2012-06-30 0001364208 2012-11-14 0001364208 2012-06-30 0001364208 2011-06-30 0001364208 us-gaap:SeriesAPreferredStockMember 2012-06-30 0001364208 us-gaap:SeriesAPreferredStockMember 2011-06-30 0001364208 us-gaap:SeriesBPreferredStockMember 2012-06-30 0001364208 us-gaap:SeriesBPreferredStockMember 2011-06-30 0001364208 2010-07-01 2011-06-30 0001364208 2010-06-30 0001364208 us-gaap:SeriesAPreferredStockMember 2010-06-30 0001364208 us-gaap:SeriesAPreferredStockMember 2011-06-30 0001364208 us-gaap:SeriesAPreferredStockMember 2012-06-30 0001364208 us-gaap:SeriesBPreferredStockMember 2010-06-30 0001364208 us-gaap:SeriesBPreferredStockMember 2011-06-30 0001364208 us-gaap:SeriesBPreferredStockMember 2012-06-30 0001364208 us-gaap:CommonStockMember 2010-07-01 2011-06-30 0001364208 us-gaap:CommonStockMember 2011-07-01 2012-06-30 0001364208 us-gaap:CommonStockMember 2010-06-30 0001364208 us-gaap:CommonStockMember 2011-06-30 0001364208 us-gaap:CommonStockMember 2012-06-30 0001364208 ZVTK:CommonStockToBeIssuedMember 2010-07-01 2011-06-30 0001364208 ZVTK:CommonStockToBeIssuedMember 2010-06-30 0001364208 us-gaap:TreasuryStockMember 2010-06-30 0001364208 us-gaap:TreasuryStockMember 2011-06-30 0001364208 us-gaap:TreasuryStockMember 2012-06-30 0001364208 us-gaap:AdditionalPaidInCapitalMember 2010-07-01 2011-06-30 0001364208 us-gaap:AdditionalPaidInCapitalMember 2011-07-01 2012-06-30 0001364208 us-gaap:AdditionalPaidInCapitalMember 2010-06-30 0001364208 us-gaap:AdditionalPaidInCapitalMember 2011-06-30 0001364208 us-gaap:AdditionalPaidInCapitalMember 2012-06-30 0001364208 us-gaap:RetainedEarningsMember 2010-07-01 2011-06-30 0001364208 us-gaap:RetainedEarningsMember 2011-07-01 2012-06-30 0001364208 us-gaap:RetainedEarningsMember 2010-06-30 0001364208 us-gaap:RetainedEarningsMember 2011-06-30 0001364208 us-gaap:RetainedEarningsMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteAMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteAMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteBMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteBMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteCMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteCMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteDMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteDMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteEMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteEMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteFMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteFMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteGMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteGMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteHMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteHMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteIMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteIMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteJMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteJMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteKMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteKMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteLMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteLMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteMMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteMMember 2011-06-30 0001364208 ZVTK:ConvertibleTermNoteNMember 2012-06-30 0001364208 ZVTK:ConvertibleTermNoteNMember 2011-06-30 0001364208 ZVTK:ChiefExecutiveOfficerAndDirectorMember 2010-07-01 2011-06-30 0001364208 us-gaap:OfficerMember 2010-07-01 2011-06-30 0001364208 ZVTK:ConsultingServicesMember 2011-07-01 2012-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure Zevotek, Inc 0001364208 10-K 2012-06-30 false --06-30 No No Yes Smaller Reporting Company FY 2012 335527 231 137103 40000 231 97103 88323 4043 231 4737 132517 2424116 1127975 1285932 309806 199183 43823 939001 774346 50000 86080 2474116 1214055 1 1 10 10 231 137103 -2473885 -1076952 -1454210 1 1 1 10 10 10 2 3 30000 4000804 5652172 5737406 -5485025 -6729137 -8211305 -8211305 -6729137 5737406 5652172 3 2 0 814962 0 106350 0.00001 0.00001 10000000 10000000 1000000 1000000 50000 50000 1000000 1000000 50000 50000 1000000 1000000 0.00001 0.00001 5000000000 5000000000 335527 220810 335527 220810 1 1 -81530 7128 86113 3441 8412 8024 15540 -408113 -831463 326583 838591 40000 253718 528383 32865 310208 -1074055 -412649 1074055 412649 302867 94050 -4.89 -13.23 -1482168 -1244112 -1244112 -1482168 -1482168 -1244112 45000 4050 53000 235413 921321 293254 -209866 -489501 165615 142080 22994 2210 9924 4043 1896 205360 361721 50000 155360 361721 -4506 -127780 32235 108949 2821 1137957 120000 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">A summary of the significant accounting policies applied in the preparation of the accompanying consolidated financial statements follows.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Business and Basis of Presentation</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">ZEVOTEK, INC. (&#147;Company&#148; or &#147;Registrant&#148;) was organized on March 19, 2005 under the state laws of Delaware with an original name of &#147;The Diet Coffee Company.&#148; On March 1, 2006, we amended our Certificate of Incorporation and changed our name from &#147;The Diet Coffee Company, Inc to Diet Coffee, Inc. On June 25, 2008, Zevotek changed its name to Zevotek, Inc.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek&#146;s wholly owned subsidiary is Ionic Bulb.com, Inc., a Delaware corporation formed on August 21, 2007, through which it had sold the Ionic Bulb, a patented air purifier that silently emits negative ions using a microchip placed inside a 10,000-hour energy saving compact fluorescent light bulb (CFL). The Ionic Bulb was an eco-easy maintenance-free inexpensive alternative that is designed to clean the air in a 100 square foot area of unpleasant odors and indoor air pollutants that you breathe. Zevotek sold the Ionic Bulb through specialty retail shops, TV commercials, Amazon.com and newionicbulb.com, and it marketed the Ionic Bulb to major U.S. retail stores. It had acquired exclusive worldwide sales and manufacturing rights to a U.S. patented new product named Gung H2O that reduces water use in the home.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek has currently stopped working on the sales of the Ionic bulb. It is upgrading the bulb. The new ionic bulb will be made using LED light. The new Ionic Bulb will not no longer be using florescent light.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek plans to sell Gung H20 to major U.S. retail stores and directly to American consumers using TV ads and Internet marketing. After Zevotek tried to market the Gung H2O, it went back to the inventors to make changes due to feedback from the public. After the inventors make the changes Zevotek hopes to market the product sometime in the second to third quarter of 2013.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Our chief executive officer, Mr. Ryu has a history of being an innovator. We expect that he will bring a number of products on board in the upcoming year and believe Zevotek will make instant revenue from these products. We expect to release some of these products in the very near future. We are either waiting to put the finishing touches or most importantly file the proper patents in order to bring the greatest value to our stockholders.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>General</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">The consolidated financial statements include the accounts of the Registrant and its wholly-owned subsidiary, Ionic Bulb.com, Inc. The Registrant formed its Ionic Bulb.com, Inc. subsidiary on August 21, 2007 and started its operations during the fiscal year ended June 30, 2008. All significant inter-company transactions and balances have been eliminated in consolidation.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek has adopted the fiscal year end of June 30.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Reverse Stock Split</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">On September 26, 2011,&#160;Zevotek filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a 1 to 5,000 basis.&#160;&#160;The Financial Industry Regulatory Authority (&#147;FINRA&#148;) effected the reverse stock split on October 27, 2011. Each holder of common stock received 1 share of Zevotek&#146;s common stock in exchange for each 5,000 shares of Zevotek&#146;s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing split.&#160;&#160;Fractional shares were rounded up to the nearest whole share. All per share numbers quoted herein are reflective of the 1:5,000 reverse split. All references in the accompanying consolidated financial statements and notes there to have been retroactively restated to reflect the stock split.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Revenue Recognition</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">For revenue from product sales, Zevotek recognizes revenue in accordance with Accounting Standards Codification 605, &#147;Revenue Recognition SEC Staff Accounting Bulletin Topic 13&#148; (&#147;ASC 605&#148;). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Zevotek defers any revenue for which the product has not been delivered or is subject to refund until such time that Zevotek and the customer jointly determine that the product has been delivered or no refund will be required. &#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">ASC 605 incorporates Accounting Standards Codification 605-25, &#147;Revenue Recognition Multiple Element Arrangements&#148;.&#160;&#160;ASC 605-25 addresses accounting for arrangements that may involve the delivery or performance of multiple products, services and/or rights to use assets.&#160;&#160;Zevotek does not have any multiple element arrangements.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Consideration Paid to Customers</u></font></p> <p style="margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek offers our customers certain incentives in the form of cooperative advertising arrangements, product markdown allowances, trade discounts, cash discounts, and slotting fees. Markdown allowances, trade discounts, cooperative advertising program participation and cash discounts are all recorded as reductions of net sales.&#160; No customer incentives are included in sales for the years ended June 30, 2012 and 2011.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Use of Estimates</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">The preparation of the financial statement in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Cash and Cash Equivalents</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">For the purpose of the accompanying consolidated financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. Zevotek had no cash equivalents as of June 30, 2012 and 2011, respectively.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Inventories / Cost of Goods Sold</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek has adopted a policy to record inventory at the lower of cost or market determined by the first-in-first-out method. The elements of cost that comprise inventory and cost good sold are FOB shipping point costs, freight and destination charges, customs and importation fees and taxes, customer broker fees (if any) and other related costs. Warehousing costs are charged to cost of goods in the period the costs are incurred. Zevotek provides inventory allowances based on estimates of obsolete inventories.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Inventories consist of finished products available for sale to distributors and customers. At June 30, 2012 and 2011, Finished Goods inventory was 0 and $88,323, respectively.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Allowance for doubtful accounts</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek maintains an allowance for doubtful accounts to reduce amounts to their estimated realizable value, including reserves for customer and other receivable allowances and incentives. In estimating the provision for doubtful accounts, Zevotek considers a number of factors including age of the accounts receivable, trends and ratios involving the age of the accounts receivable and the customer mix of each aging categories.&#160;&#160;As of June 30, 2012 and 2011, the allowance for doubtful accounts was $0.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Impairment of long lived assets</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek has adopted Accounting Standards Codification&#160;360 &#34;Property, Plant and Equipment&#34; (&#147;ASC 360&#148;). The Statement requires that long-lived assets and certain identifiable intangibles held and used by Zevotek be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a</font></p> <p style="margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">forecasted inability to achieve break-even operating results over an extended period. Zevotek evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC&#160;360 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Advertising</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek charges the costs of advertising to expenses as incurred.&#160;&#160;Zevotek charged $31,446 and $148,479 to operations for the years ended June 30, 2012 and 2011, respectively.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Income Taxes</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek has adopted Accounting Standards Codification&#160;740,&#160;&#160;&#147;Income Taxes&#148; (&#147;ASC 740&#148;) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">between financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant, except basis difference related to certain debts.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Effective January 1, 2007 Zevotek adopted an amendment to the requirements of ASC 740. The amended standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">ASC 740-10-25-5 &#147;Income Taxes&#151;Overall&#151;Recognition&#151;Basis Recognition Threshold&#148;, (&#147;Tax Position Topic&#148;) provides guidance to address uncertainty in tax positions and clarifies the accounting for income taxes by prescribing a minimum recognition threshold, i.e. &#147;more-likely-than-not&#148;, that the income tax positions must achieve before being recognized in the financial statements. In addition, the Tax Position Topic requires expanded annual disclosures, including a roll forward of the beginning and ending aggregate unrecognized tax benefits as well as specific detail related to tax uncertainties for which it is reasonably possible the amount of unrecognized tax benefit will significantly increase or decrease within twelve months.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;&#160;</font></p> <p style="margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">As a result of implementing ASC 740, there has been no adjustment to Zevotek&#146;s financial statements and the adoption of ASC 740 did not have a material effect on Zevotek&#146;s consolidated financial statements for the years ended June 30, 2012 and 2011.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Research and Development</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek accounts for research and development costs in accordance with the Financial Accounting Standards Board's&#160;Accounting Standards Codification&#160;730 &#34;Research and Development&#34; (&#147;ASC 730&#148;). Under ASC&#160;730, all research and development costs must be charged to expense as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. Zevotek had no expenditures on research and product development for years ended June 30, 2012 and 2011. &#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Stock Based Compensation</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Effective January&#160;1, 2006, Zevotek adopted the requirements of ASC&#160;505 &#147;Equity&#148; and ASC&#160;718-10 &#147;Stock Compensation&#148;, under the modified prospective transition method. The standards require the measurement of compensation cost at the grant date, based upon the estimated fair value of the award, and requires amortization of the related expense over the employee&#146;s requisite service period.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Under ASC&#160;718-10, stock based compensation cost will be recognized over the period during which an employee is required to provide service in exchange for the award. ASC&#160;718-10 also requires an entity to calculate the pool of excess tax benefits available to absorb tax deficiencies recognized subsequent to adoption of ASC&#160;718-10 (the &#147;APIC pool&#148;). Zevotek has evaluated its APIC pool and has determined that it was immaterial as of January&#160;1, 2006. ASC&#160;718-10 also amends ASC&#160;230 &#147;Cash Flows&#148;, to require that excess tax benefits that had been reflected as operating cash flows be reflected as financing cash flows.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Loss per Share</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek has adopted Accounting Standards Codification subtopic 260-10, Earnings Per Share (&#147;ASC 260-10&#148;) specifying the computation, presentation and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Potentially dilutive shares of common stock realizable from the conversion of our convertible debentures of 148,499,367 and 4,836,404,514 shares, respectively at June 30, 2012 and 2011, are excluded from the computation of diluted net loss per share as their inclusion would be anti-dilutive. &#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Concentration of Credit Risk</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Financial instruments and related items, which potentially subject Zevotek to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. Zevotek places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Recent Accounting Pronouncements</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">In October 2012, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2012-04, &#147;Technical Corrections and Improvements&#148; in Accounting Standards Update No. 2012-04. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update will be effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 is not expected to have a material impact on our financial position or results of operations.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">In August 2012, the FASB issued ASU 2012-03, &#147;Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update)&#148; in Accounting Standards Update No. 2012-03. This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 is not expected to have a material impact on our financial position or results of operations.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">In July 2012, the FASB issued ASU 2012-02, &#147;Intangibles &#150; Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment&#148; in Accounting Standards Update No. 2012-02. This update amends ASU 2011-08, <i>Intangibles &#150; Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment</i> and permits an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, <i>Intangibles, Goodwill and Other - General Intangibles Other than Goodwill</i>. The amendments are effective for annual and interimimpairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim impairment tests performed as of a date before July 27, 2012, if a public entity&#146;s financial statements for the most recent annual or interim period have not yet been issued or, for nonpublic entities, have not yet been made available for issuance. The adoption of ASU 2012-02 is not expected to have a material impact on our financial position or results of operations.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">In December 2011, the FASB issued ASU 2011-12, &#147;Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05.&#160; This update defers the requirement to present items that are reclassified from accumulated other comprehensive income to net income in both the statement of income where net income is presented and the statement where other comprehensive income is presented.&#160; The adoption of ASU 2011-12 is not expected to have a material impact on our financial position or results of operations.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">In December 2011, the FASB issued ASU No. 2011-11 &#147;Balance Sheet: Disclosures about Offsetting Assets and Liabilities&#148; (&#147;ASU 2011-11&#148;).&#160; This Update requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position.&#160; The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of IFRS.&#160; The amended guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods.&#160; Zevotek is currently evaluating the impact, if any, that the adoption of this pronouncement may have on its results of operations or financial position.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements for the years ended&#160;June 30, 2012 and 2011, Zevotek incurred net losses of $1,482,168 and $1,244,112, respectively.&#160;&#160;At June 30, 2012, Zevotek had a working capital deficit of $2,423,885 and accumulated losses of $8,211,305. Zevotek is in default of payment and interest on certain convertible notes payable.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Zevotek is actively pursuing additional convertible debt financing through discussions with its current lenders.&#160;&#160;Zevotek cannot predict whether the additional financing will be in the form of equity or debt, or be in another form.&#160;&#160;Zevotek may not be able to obtain the necessary additional capital on a timely basis, on acceptable terms, or at all.&#160;&#160;In any of these events, Zevotek may be unable to implement its current plans for expansion, repay its debt obligations as they become due, or respond to competitive pressures, any of which circumstances would have a material adverse effect on its business, prospects, financial conditions and result of operations. These factors, among others, may indicate that Zevotek will be unable to continue as a going concern for a reasonable period of time.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Zevotek has discontinued sales of one its major products, the Ionic Bulb and has re-entered the Development Stage after the year ended June 30, 2012. Zevotek has chosen to no longer sell the fluorescent version of the Ionic Bulb and to develop a next generation bulb utilizing &#147;LEDs&#148; Light Emitting Diodes.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Zevotek's existence is dependent upon management's ability to develop profitable operations. Management anticipates Zevotek may attain profitable status and improve its liquidity through the continued developing, marketing and selling of its products and additional investment in Zevotek. The accompanying consolidated financial statements do not include any adjustments that might result should Zevotek be unable to continue as a going concern.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since Zevotek has decided to develop a new Ionic Bulb, utilizing LEDs rather than the current fluorescent version the current finished goods inventory of the Ionic Bulb is obsolete.&#160;&#160;Zevotek recorded an Impairment of Inventory of $86,113 for the year ended June 30, 2012.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 24, 2009, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to manufacture, market use, sell, distribute and advertise a patented ionic bulb.&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In exchange for the exclusive license, Zevotek issued 500 shares of its common stock.&#160;&#160;The license was valued at the market price of the underlying security.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 2, 2011, Zevotek and the Ionic Bulb patent holder entered into a non-exclusive Purchasing Representative Agreement whereby the patent holder shall introduce Zevotek to a new third party manufacturer that will produce a next generation version of the Ionic Bulb with new features and improved manufacturing cost.&#160;&#160;Additionally, the patent holder affirms his obligation to defend against patent infringement.&#160;&#160;Zevotek shall pay patent holder a fixed amount per Ionic Bulb ordered from the new manufacturer.&#160;&#160;Zevotek agreed to make an advance fee payment by issuance of 5,000 shares of Zevotek&#146;s restricted stock.&#160;&#160;The value of the restricted shares applied to payment of the fees is to be based upon the average closing price of Zevotek's common stock for the ten trading days proceeding the date on which the restrictive stock legend may be removed. The term of the agreement is three years with one-year automatic renewals that are subject to minimum fee payments to the patent holder for the first and second renewal term, respectively.&#160;&#160;The related shares were issued and expensed during fiscal 2012 for a value of $35,000 based on the grant date fair value of the shares issued.</p> <p style="margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 10, 2010, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to develop, manufacture, market, use, sell, distribute and advertise a U.S. patented new product named Gung H2O that reduces water use in the home.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Licensing Agreement was originally valued at $40,000.&#160;&#160;Since Zevotek is no longer marketing and selling the Ionic Bulb, the agreement was considered totally impaired.&#160;&#160;A Licensing Agreement Impairment of $40,000 was recorded for the year ended June 30, 2012.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Accounts payable and accrued liabilities are as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June&#160;30,</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2012</b></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="vertical-align: top; padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June&#160;30,</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2011</b></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="width: 76%; vertical-align: bottom">Accounts payable&#160;</td> <td style="width: 1%; vertical-align: top; text-align: right">&#160;</td> <td style="width: 1%; vertical-align: top">$</td> <td style="width: 9%; vertical-align: top; text-align: right">2,389</td> <td style="width: 1%; vertical-align: top">&#160;</td> <td style="width: 1%; vertical-align: top; text-align: right">&#160;</td> <td style="width: 1%; vertical-align: top">$</td> <td style="width: 9%; vertical-align: top; text-align: right">10,867</td> <td style="width: 1%; vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom">Accrued professional fees</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">217,262</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">225,163</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Accrued payroll and payroll taxes</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">165,372</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">161,649</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom">Old disputed accounts payable</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">136,505</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">160,756</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Accrued interest</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">333,598</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">183,507</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt">Other accrued liabilities</td> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">83,875</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">32,404</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 3pt">Total</td> <td style="vertical-align: top; padding-bottom: 3pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; vertical-align: top">$</td> <td style="border-bottom: black 2.25pt double; vertical-align: top; text-align: right">939,001</td> <td style="vertical-align: top; padding-bottom: 3pt">&#160;</td> <td style="vertical-align: top; padding-bottom: 3pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; vertical-align: top">$</td> <td style="border-bottom: black 2.25pt double; vertical-align: top; text-align: right">774,346</td> <td style="vertical-align: top; padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2012 and 2011, Zevotek owed $199,173 and $43,823, respectively, to a note holder for cash advanced to Zevotek for operating purposes.&#160;&#160;The advances accrue interest at 10% per annum and are repayable on demand.&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June&#160;30,</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2012</b></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td style="vertical-align: top; padding-bottom: 1.5pt; font-weight: bold">&#160;</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June&#160;30,</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2011</b></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td></tr> <tr> <td style="vertical-align: bottom">Notes Payable:</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td colspan="2" style="vertical-align: bottom; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td colspan="2" style="vertical-align: bottom">&#160;</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="width: 76%; vertical-align: bottom">Convertible term note (a)</td> <td style="width: 1%; vertical-align: top; text-align: right">&#160;</td> <td style="width: 1%; vertical-align: top">$</td> <td style="width: 9%; vertical-align: top; text-align: right">923</td> <td style="width: 1%; vertical-align: top">&#160;</td> <td style="width: 1%; vertical-align: top; text-align: right">&#160;</td> <td style="width: 1%; vertical-align: top">$</td> <td style="width: 9%; vertical-align: top; text-align: right">923</td> <td style="width: 1%; vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom">Convertible term note (b)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">1,923</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">1,923</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Convertible term note (c)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">50,000</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">50,000</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom">Convertible term note (d)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">2,497</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">2,497</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Convertible term note (e)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">224</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">25,174</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom">Convertible term note (f)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">11,132</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">11,132</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Convertible term note (g)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">26,420</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">30,920</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom">Convertible term note (h)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">190,757</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">192,430</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Convertible term note (i)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">34,141</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">34,141</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom">Convertible term note (j)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">22,350</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">22,530</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Convertible term note (k)</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">945,565</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">945,527</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom">Convertible term note (l)</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">10,000</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">-</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">Convertible term note (m)</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">30,000</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">-</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt">Convertible term note (n)</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">10,000</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">-</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">1,335,932</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">1,317,197</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt">Less: discount on debt</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">-</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">921,311</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">1,335,932</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">395,886</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt">Less: current portion</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">(1,285,932</td> <td style="vertical-align: top; padding-bottom: 1.5pt">)</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">(309,806</td> <td style="vertical-align: top; padding-bottom: 1.5pt">)</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 3pt">Long term debt</td> <td style="vertical-align: top; padding-bottom: 3pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; vertical-align: top">$</td> <td style="border-bottom: black 2.25pt double; vertical-align: top; text-align: right">50,000</td> <td style="vertical-align: top; padding-bottom: 3pt">&#160;</td> <td style="vertical-align: top; padding-bottom: 3pt; text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; vertical-align: top">$</td> <td style="border-bottom: black 2.25pt double; vertical-align: top; text-align: right">86,080</td> <td style="vertical-align: top; padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table align="center" cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 4%">&#160;</td> <td style="width: 3%">a)</td> <td style="width: 93%; text-align: justify">On May 14, 2008, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of May 14, 2010.&#160;&#160;&#160;At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below). Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holders about amending the conversion terms to cure the default.</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table align="center" cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 4%">&#160;</td> <td style="width: 3%">b)</td> <td style="width: 93%; text-align: justify">On May 27, 2008, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 27, 2010.&#160;&#160;&#160;At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below).&#160;&#160;Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>c)</td> <td style="text-align: justify">On January 1, 2008, Zevotek entered into a convertible term note for the principal amount of $50,000 bearing interest at 7% per annum with a maturity date of June 30, 2008.&#160;&#160;This note is convertible into common stock at 90% of the common stock closing price at June 30, 2008, which is $7,200.&#160;&#160;Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table align="center" cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 4%">&#160;</td> <td style="width: 3%">d)</td> <td style="width: 93%"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 8, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of January 8, 2011.&#160;&#160;&#160;Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>e)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 9, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of March 9, 2011.&#160;&#160;&#160;The notes were amended on January 8, 2011 to extend the maturity date to January 8, 2012.&#160;&#160;Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>f)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Of the convertible term notes entered into on May 14, 2008, certain notes having a principal amount of $11,132 as of June 30, 2012 and 2011 were not amended with respect to their conversion price and, at any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.001 per share. Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>g)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 28, 2009, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of July 28, 2011.&#160;&#160;&#160;At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>h)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 6, 2010, Zevotek converted $192,430 of advances payable into a convertible term note bearing interest at 10% per annum with a maturity date of August 6, 2012.&#160;&#160;&#160;At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>i)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 8, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of January 8, 2011.&#160;&#160;&#160;The notes were amended on January 8, 2011 to extend the maturity date to January 8, 2012. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>j)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 9, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of March 9, 2011.&#160;&#160;&#160;Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>k)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 10, 2011, Zevotek converted $945,527 of advances payable into a convertible term note bearing interest at 10% per annum with a maturity date of May 10, 2012.&#160;&#160;&#160;At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>l)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 19, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of March 19, 2014.&#160;&#160;At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>m)</td> <td> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 15, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 15, 2014.&#160;&#160;At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>n)</td> <td style="text-align: justify">On May 18, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 18, 2014.&#160;&#160;At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.01 per share (see below).</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with Accounting Standards Codification 470-20-65, &#147;Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratios (&#147;ASC 470-20-65&#148;), Zevotek recognized an imbedded beneficial conversion feature present in the notes. Zevotek allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid in capital. Zevotek recognized and measured an aggregate of $314,049 of the proceeds, which was equal to the intrinsic value of the imbedded beneficial conversion feature at the time, to additional paid in capital and a debt discount against the Notes issued during the year ended June 30, 2008. The debt discount attributed to the beneficial conversion feature was originally amortized over the Notes maturity period (two years) as interest expense, adjusted for conversion of debt to common stock. In January 2009 through March 2009, Zevotek restructured certain Notes to a conversion rate of $0.0001 per share with a two year term and accordingly fully amortized the remaining debt discount of $206,160. In accordance with ASC 470-20-65, Accounting for Convertible Securities with Beneficial Conversion Features, Zevotek recognized an imbedded beneficial conversion feature present in the notes. Zevotek recognized and measured an aggregate of $457,849 of the proceeds, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the Notes issued during the year ended June 30, 2009. The remaining debt discount attributed to the original beneficial conversion feature was expensed at the time the Notes were amended and the $457,849 assigned to the amended beneficial conversion feature is being amortized over the Notes maturity period.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 28, 2009, Zevotek issued a $44,000 convertible note having the same terms as the amended outstanding convertible notes.&#160;&#160;Zevotek recognized and measured an aggregate of $44,000 of the proceeds, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note&#146;s two-year term.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 6, 2010, Zevotek converted $192,430 of advances payable into a convertible note.&#160;&#160;Zevotek recognized and measured an aggregate of $192,430 of the advances payable, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note&#146;s two-year term.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 10, 2011, Zevotek converted $945,527 of advances payable into a convertible note.&#160;&#160;Zevotek recognized and measured an aggregate of $945,527 of the advances payable, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note&#146;s one-year term.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2012 and 2011, amortization related to the beneficial conversion feature on the convertible notes was $921,312 and $293,254, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In or about May 2010, an alleged assignee (the &#147;Assignee&#148;) of certain convertible promissory notes commenced an action by the filing of a summons and complaint against Zevotek alleging a failure to comply with its demands to convert principal and interest under Zevotek&#146;s promissory notes in Company common stock.&#160;&#160;Zevotek served and filed its Answer on July 21, 2010, in which it denied the material allegations of the complaint and asserted numerous affirmative defenses.&#160;&#160;The parties have entered into a stipulation of settlement resolving this action on November 4, 2010 and a final judgment and injunction were entered on November 12, 2010, pursuant to which Zevotek agreed to issue stock once a month to the Assignee until it has issued a total of 36,400 shares of common stock. As of June 30, 2011, Zevotek has issued 36,400 shares of its common stock to the Assignee and fully satisfied the judgment.</p> <p style="margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"></font>Preferred Stock</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek has authorized 10,000,000 shares of Preferred Stock of which 50,000 shares have been designated as Series A Preferred Stock, par value $0.00001, and 1,000,000 shares have been designated as Series B Preferred Stock, par value $0.00001 within the limitations and restrictions stated in the Certificate of Incorporation of Zevotek.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek issued 50,000 shares of Series A Preferred Stock. Each share of the Series A Preferred Stock is entitled to 10,000 votes on all matters submitted to the stockholders of Zevotek. The holders of the Series A Preferred Stock are not granted any preference upon the liquidation, dissolution or winding up of the business of Zevotek. The Series A Preferred Stock is not convertible into Common Stock.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek designated and issued 1,000,000 shares of Series B Preferred Stock.&#160;&#160;On May 14, 2008, Zevotek and a third party note holder entered into an exchange agreement under which the third party note holder exchanged a $21,026 promissory note for 1,000,000 shares of Series B Preferred Stock.&#160;&#160;&#160;Each share of Series B Preferred Stock is entitled to 5,000 votes on all matters submitted to the stockholders of Zevotek. Subsequently, the third party note holder, Anthony Intrieri, became Chairman of the Board of Directors. On September 12, 2011, the Estate of Anthony Intrieri (&#34;Estate&#34;) sold 1,000,000 shares of Zevotek's Series B Preferred Stock to an unrelated third party. &#160;The Estate obtained the shares following the passing of Mr. Intrieri, Zevotek's former Chairman of the Board of Directors and sole Series B Preferred stockholder.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Common Stock</u></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Zevotek effectuated a 1 for 50 reverse stock split on June 26, 2008. All common stock and related information has been retroactively restated. In addition, contemporaneously with the stock split Zevotek increased its authorized Common stock, par value $0.00001 to 1,000,000,000 shares. Prior to this date, the authorized shares were 200,000,000 shares. On October 14, 2009, Zevotek authorized capital was increased to 5,000,000,000.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">On September 24, 2010, Zevotek filed a certificate of amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware in order to effectuate a reverse split on a 1 to 20 basis (the &#147;Reverse Split&#148;).&#160;&#160;On October 6, 2010, Financial Industry Regulatory Authority (&#147;FINRA&#148;) approved the Reverse Split and each holder of common stock received 1 share of Zevotek&#146;s common stock for each 20 shares of Zevotek&#146;s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing stock split.&#160;&#160;Fractional shares were rounded up to the nearest whole share.&#160;&#160;All per share numbers quoted herein are reflective of the Reverse Split.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">On September 26, 2011,&#160;Zevotek&#160;filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a 1 to 5,000 basis.&#160;&#160;On October 27, 2011, Financial Industry Regulatory Authority (&#147;FINRA&#148;) approved the Reverse Split and each holder of common stock received 1 share of Zevotek&#146;s common stock for each 5,000 shares of Zevotek&#146;s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing stock split.&#160;&#160;Fractional shares were rounded up to the nearest whole share.&#160;&#160;All per share numbers quoted herein are reflective of the Reverse Split.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">At June 30, 2012 and 2011, common shares issued and outstanding were 335,527 and 220,810, respectively.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">On November 17, 2010, Zevotek adopted its 2011 Equity Incentive Plan (&#147;2011 Plan&#148;). Zevotek is permitted to issue up to 12,000 shares of common stock under the Plan in the form of stock options, restricted stock awards, and stock awards to directors, officers, consultants, advisors and employees of Zevotek.&#160;&#160;As of June 30, 2012, there were 12,000 shares issued under this 2011 Plan.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">On May 5, 2011, Zevotek adopted its Fiscal 2012 Equity Incentive Plan (&#147;2012 Plan&#148;). Zevotek is permitted to issue up to 30,000 shares of common stock under the Plan in the form of stock options, restricted stock awards, and stock awards to directors, officers, consultants, advisors and employees of Zevotek.&#160;&#160;As of June 30, 2012, there were 19,500 shares issued under this 2012 Plan.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">During the year ended June 30, 2011, Zevotek issued 31,492 shares of common stock, valued at $325,413 for services, accrued expenses and accounts payable. Shares were valued according to the closing price of the common stock on the date it was granted.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">During the year ended June 30, 2011, Zevotek converted debt and accrued interest of $113,000 into 148,098 shares of common stock. &#160;The conversion was in accordance with the original note agreement, therefore no gain or loss was recorded for this transaction.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">During the year ended June 30, 2011, Zevotek issued 4,950 shares of its common stock, valued at $45,000, to its Chief Executive Officer and two of its directors as compensation. Shares were valued according to the closing price of the common stock on the date it was granted.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">During the year ended June 30, 2011, Zevotek issued 1,551 shares valued at $30,000 to a former officer to satisfy a claim included in common stock to be issued. Shares were valued according to the closing price of the common stock on the date it was granted.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">During the year ended June 30, 2012, Zevotek issued 32,545 shares of common stock, valued at $53,000 for consulting services. Shares were valued according to the closing price of the common stock on the date it was granted.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">During the year ended June 30, 2012, Zevotek converted debt and accrued interest of $32,235 into 77,854 shares of common stock. &#160;The conversion was in accordance with the original note agreement, therefore no gain or loss was recorded for this transaction.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">During the year ended June 30, 2012, Zevotek issued 4,318 shares of common stock in satisfaction of fractional shares resulting from a 1 for 5,000 reverse stock split.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif"><u>Treasury Stock</u></font></p> <p style="margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">As of June 30, 2012 and 2011, Zevotek had 1 share of common stock held in treasury, which carried at $0 based on cost.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Zevotek recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant. Management estimates that at June 30, 2012, Zevotek has available for federal income tax purposes a net operating loss carry forward of approximately $6 million expiring by the year 2031 that may be used to offset future taxable income. Due to significant changes in Zevotek's ownership, the future use of its existing net operating losses may be limited.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Zevotek has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of Zevotek; it is more likely than not that the benefits will not be realized. Components of deferred tax assets as of June 30, 2012 are as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%"> <tr style="background-color: #CCEEFF"> <td style="width: 88%; vertical-align: bottom">Net operating loss carry forward</td> <td style="width: 1%; vertical-align: top">&#160;</td> <td style="width: 1%; vertical-align: top">$</td> <td style="width: 9%; vertical-align: top; text-align: right">2,400,000</td> <td style="width: 1%; vertical-align: top">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt">Valuation allowance</td> <td style="vertical-align: top; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top">&#160;</td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: right">(2,400,000</td> <td style="vertical-align: top; padding-bottom: 1.5pt">)</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 3pt">Net</td> <td style="vertical-align: top; padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 2.25pt double; vertical-align: top">$</td> <td style="border-bottom: black 2.25pt double; vertical-align: top; text-align: right">&#160;0</td> <td style="vertical-align: top; padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Zevotek has not filed their federal or state income tax returns for fiscal years ended June 30, 2006 through June 30, 2012. The above is determined under the assumption as if Zevotek has filed its income tax returns through June 30, 2012.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although the taxing authorities impose penalties for non-filing, Zevotek does not believe any penalties will be enforced since there is no tax due.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2012 and 2011, Zevotek did not issue any stock warrants or options.&#160;&#160;As of June 30, 2012, there are no outstanding stock warrants or options.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>U.S. Federal Trade Commission Settlement</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2007, Zevotek received a letter from the U.S. Federal Trade Commission (&#147;FTC&#148;) whereby former management was informed that the FTC was conducting an investigation into advertising claims made for weight loss product known as &#147;Slim Coffee.&#148;&#160;&#160;The purpose of the investigation was to determine whether former management, in connection with its sales of Slim Coffee, engaged in unfair or deceptive acts or practices and false advertising.&#160;&#160;A negotiated settlement was reached with the FTC under which Zevotek, its former management did not admit any wrongdoing.&#160;&#160;On January 10, 2008, pursuant to a stipulated final judgment and order, the United States District Court, Southern District of New York, entered a final judgment and order against Zevotek in the amount of $923,910.&#160;&#160;The full amount of the judgment, and payment of any portion of it is suspended and cannot be reinstated so long as (a) Zevotek abides by the reporting and monitoring requirements of the judgment, (b) does not make false advertising claims in connection with any of its products in the future, and (c) its past financial disclosures to the FTC were materially accurate. Zevotek plans to comply with the terms of the stipulation and do not anticipate incurring a liability for the judgment, however there can be no assurance of compliance.&#160;&#160;Should Zevotek fail to comply with the FTC&#146;s final judgment, this could have a material adverse effect on Zevotek&#146;s business, financial condition and results of operations.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Licenses</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 24, 2009, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek obtained worldwide exclusive rights to manufacture, market use, sell, distribute and advertise certain licensed products.&#160;&#160;The license is on a year to year basis with automatic renewal and is subject to becoming non-exclusive should Zevotek fail to files all quarterly and annual reports by due dates, inclusive of allowable extensions.&#160;&#160;In exchange for the exclusive license, Zevotek issued 500 shares of its common stock.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 2, 2011, Zevotek and the Ionic Bulb patent holder entered into a non-exclusive Purchasing Representative Agreement whereby the patent holder shall introduce Zevotek to a new third party manufacturer that will produce a next generation version of the Ionic Bulb with new features and improved manufacturing cost.&#160;&#160;Additionally, the patent holder affirms his obligation to defend against patent infringement.&#160;&#160;Zevotek shall pay patent holder a fixed amount per Ionic Bulb ordered from the new manufacturer.&#160;&#160;Zevotek agreed to make an advance fee payment by issuance of 5,000 shares of Zevotek&#146;s restricted stock.&#160;&#160;The value of the restricted shares applied to payment of the fees is to be based upon the average closing price of Zevotek's common stock for the ten trading days preceding the date on which the restrictive stock legend may be removed. The term of the agreement is three years with one-year automatic renewals that are subject to minimum fee payments to the patent holder for the first and second renewal term, respectively.&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Gung H2O License</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 10, 2010, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to develop, manufacture, market, use, sell, distribute and advertise a U.S. patented new product named Gung H2O that reduces water use in the home. The license has a five-year initial term with automatic annual renewals and is not subject to minimum payments to the licensor.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Payroll Taxes</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At June 30, 2012, Zevotek is delinquent with filing and remitting payroll taxes of approximately $92,000 including estimated penalties and interest related to payroll taxes withheld since April 2007. Zevotek has recorded the delinquent payroll taxes, which are included in accrued expenses on the balance sheet. Although Zevotek has not entered into any formal repayment agreements with the respective tax authorities, management plans to make payment as funds become available. Penalties and interest amounts are subject to increase based on a number of factors that can cause the estimated liability to increase further. Interest and penalties were accrued in an amount estimated to cover the ultimate liability.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Sales Taxes</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At June 30, 2012, Zevotek is delinquent with remitting sales taxes of approximately $46,300, including related estimated penalties and interest related to sales taxes withheld since 2006 in the state of New York. Zevotek has recorded the delinquent sales taxes, which are included in accrued expenses on the balance sheet. Although Zevotek has not entered into any formal repayment agreements with the respective tax authorities, management plans to make payment as funds become available. Penalties and interest amounts are subject to increase based on a number of factors that can cause the estimated liability to increase further. Interest and penalties were accrued in an amount estimated to cover the ultimate liability.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Legal</u></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On or about May 2010, an alleged assignee (the &#147;Assignee&#148;) of certain convertible promissory notes commenced an action by the filing of a summons and complaint against Zevotek alleging a failure to comply with its demands to convert principal and interest under Zevotek&#146;s promissory notes in Company common stock.&#160;&#160; The parties entered into a stipulation of settlement resolving this action on November 4, 2010 and a final judgment and injunction were entered on November 12, 2010, pursuant to which Zevotek agreed to issue stock once a month to the Assignee until it issued a total of 36,400 shares of common stock, which has been fully satisfied&#160;as of June 30, 2011.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Fair Value Measurements</i> under GAAP clarifies the principle that fair value should be based on the assumptions market participants would use when pricing an asset or liability and establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. Under the standard, fair value measurements are separately disclosed by level within the fair value hierarchy.&#160;&#160;It only applies to accounting pronouncements that already require or permit fair value measures, except for standards that relate to share-based payments.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 - Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. &#160;In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. &#160;In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of Zevotek&#146;s cash, accounts receivable, prepayments, accounts payable, advances payable, convertible notes payable, and other current assets and liabilities approximate fair value because of their short-term maturity.&#160;&#160;All other significant financial assets, financial liabilities and equity instruments of Zevotek are either recognized or disclosed in the consolidated financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2012,&#160;there were no financial assets or liabilities that&#160;were measured at fair value on a recurring basis.&#160;&#160;</p> 29272 32545 53000 235413 235413 53000 2219 90000 90000 148098 77854 32235 113000 2 1 112998 32234 4950 45000 45000 1137957 1137957 1551 -30000 30000 50000 50000 50000 1000000 1000000 1000000 34719 220810 335527 1 1 1 4318 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">ZEVOTEK, INC. (&#147;Company&#148; or &#147;Registrant&#148;) was organized on March 19, 2005 under the state laws of Delaware with an original name of &#147;The Diet Coffee Company.&#148; On March 1, 2006, we amended our Certificate of Incorporation and changed our name from &#147;The Diet Coffee Company, Inc to Diet Coffee, Inc. On June 25, 2008, Zevotek changed its name to Zevotek, Inc.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek&#146;s wholly owned subsidiary is Ionic Bulb.com, Inc., a Delaware corporation formed on August 21, 2007, through which it had sold the Ionic Bulb, a patented air purifier that silently emits negative ions using a microchip placed inside a 10,000-hour energy saving compact fluorescent light bulb (CFL). The Ionic Bulb was an eco-easy maintenance-free inexpensive alternative that is designed to clean the air in a 100 square foot area of unpleasant odors and indoor air pollutants that you breathe. Zevotek sold the Ionic Bulb through specialty retail shops, TV commercials, Amazon.com and newionicbulb.com, and it marketed the Ionic Bulb to major U.S. retail stores. It had acquired exclusive worldwide sales and manufacturing rights to a U.S. patented new product named Gung H2O that reduces water use in the home.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek has currently stopped working on the sales of the Ionic bulb. It is upgrading the bulb. The new ionic bulb will be made using LED light. The new Ionic Bulb will not no longer be using florescent light.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek plans to sell Gung H20 to major U.S. retail stores and directly to American consumers using TV ads and Internet marketing. After Zevotek tried to market the Gung H2O, it went back to the inventors to make changes due to feedback from the public. After the inventors make the changes Zevotek hopes to market the product sometime in the second to third quarter of 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Our chief executive officer, Mr. Ryu has a history of being an innovator. We expect that he will bring a number of products on board in the upcoming year and believe Zevotek will make instant revenue from these products. We expect to release some of these products in the very near future. We are either waiting to put the finishing touches or most importantly file the proper patents in order to bring the greatest value to our stockholders.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The consolidated financial statements include the accounts of the Registrant and its wholly-owned subsidiary, Ionic Bulb.com, Inc. The Registrant formed its Ionic Bulb.com, Inc. subsidiary on August 21, 2007 and started its operations during the fiscal year ended June 30, 2008. All significant inter-company transactions and balances have been eliminated in consolidation.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek has adopted the fiscal year end of June 30.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">On September 26, 2011,&#160;Zevotek filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a 1 to 5,000 basis.&#160;&#160;The Financial Industry Regulatory Authority (&#147;FINRA&#148;) effected the reverse stock split on October 27, 2011. Each holder of common stock received 1 share of Zevotek&#146;s common stock in exchange for each 5,000 shares of Zevotek&#146;s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing split.&#160;&#160;Fractional shares were rounded up to the nearest whole share. All per share numbers quoted herein are reflective of the 1:5,000 reverse split. All references in the accompanying consolidated financial statements and notes there to have been retroactively restated to reflect the stock split.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">For revenue from product sales, Zevotek recognizes revenue in accordance with Accounting Standards Codification 605, &#147;Revenue Recognition SEC Staff Accounting Bulletin Topic 13&#148; (&#147;ASC 605&#148;). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Zevotek defers any revenue for which the product has not been delivered or is subject to refund until such time that Zevotek and the customer jointly determine that the product has been delivered or no refund will be required. &#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">ASC 605 incorporates Accounting Standards Codification 605-25, &#147;Revenue Recognition Multiple Element Arrangements&#148;.&#160;&#160;ASC 605-25 addresses accounting for arrangements that may involve the delivery or performance of multiple products, services and/or rights to use assets.&#160;&#160;Zevotek does not have any multiple element arrangements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek offers our customers certain incentives in the form of cooperative advertising arrangements, product markdown allowances, trade discounts, cash discounts, and slotting fees. Markdown allowances, trade discounts, cooperative advertising program participation and cash discounts are all recorded as reductions of net sales.&#160; No customer incentives are included in sales for the years ended June 30, 2012 and 2011.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The preparation of the financial statement in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">For the purpose of the accompanying consolidated financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. Zevotek had no cash equivalents as of June 30, 2012 and 2011, respectively.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek has adopted a policy to record inventory at the lower of cost or market determined by the first-in-first-out method. The elements of cost that comprise inventory and cost good sold are FOB shipping point costs, freight and destination charges, customs and importation fees and taxes, customer broker fees (if any) and other related costs. Warehousing costs are charged to cost of goods in the period the costs are incurred. Zevotek provides inventory allowances based on estimates of obsolete inventories.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Inventories consist of finished products available for sale to distributors and customers. At June 30, 2012 and 2011, Finished Goods inventory was 0 and $88,323, respectively.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek maintains an allowance for doubtful accounts to reduce amounts to their estimated realizable value, including reserves for customer and other receivable allowances and incentives. In estimating the provision for doubtful accounts, Zevotek considers a number of factors including age of the accounts receivable, trends and ratios involving the age of the accounts receivable and the customer mix of each aging categories.&#160;&#160;As of June 30, 2012 and 2011, the allowance for doubtful accounts was $0.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek has adopted Accounting Standards Codification&#160;360 &#34;Property, Plant and Equipment&#34; (&#147;ASC 360&#148;). The Statement requires that long-lived assets and certain identifiable intangibles held and used by Zevotek be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. Zevotek evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC&#160;360 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek charges the costs of advertising to expenses as incurred.&#160;&#160;Zevotek charged $31,446 and $148,479 to operations for the years ended June 30, 2012 and 2011, respectively.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek has adopted Accounting Standards Codification&#160;740,&#160;&#160;&#147;Income Taxes&#148; (&#147;ASC 740&#148;) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">between financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant, except basis difference related to certain debts.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Effective January 1, 2007 Zevotek adopted an amendment to the requirements of ASC 740. The amended standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">ASC 740-10-25-5 &#147;Income Taxes&#151;Overall&#151;Recognition&#151;Basis Recognition Threshold&#148;, (&#147;Tax Position Topic&#148;) provides guidance to address uncertainty in tax positions and clarifies the accounting for income taxes by prescribing a minimum recognition threshold, i.e. &#147;more-likely-than-not&#148;, that the income tax positions must achieve before being recognized in the financial statements. In addition, the Tax Position Topic requires expanded annual disclosures, including a roll forward of the beginning and ending aggregate unrecognized tax benefits as well as specific detail related to tax uncertainties for which it is reasonably possible the amount of unrecognized tax benefit will significantly increase or decrease within twelve months.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0; text-align: justify"><font style="font-size: 8pt">As a result of implementing ASC 740, there has been no adjustment to Zevotek&#146;s financial statements and the adoption of ASC 740 did not have a material effect on Zevotek&#146;s consolidated financial statements for the years ended June 30, 2012 and 2011.</font></p> <p style="margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek accounts for research and development costs in accordance with the Financial Accounting Standards Board's&#160;Accounting Standards Codification&#160;730 &#34;Research and Development&#34; (&#147;ASC 730&#148;). Under ASC&#160;730, all research and development costs must be charged to expense as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. Zevotek had no expenditures on research and product development for years ended June 30, 2012 and 2011.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Effective January&#160;1, 2006, Zevotek adopted the requirements of ASC&#160;505 &#147;Equity&#148; and ASC&#160;718-10 &#147;Stock Compensation&#148;, under the modified prospective transition method. The standards require the measurement of compensation cost at the grant date, based upon the estimated fair value of the award, and requires amortization of the related expense over the employee&#146;s requisite service period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Under ASC&#160;718-10, stock based compensation cost will be recognized over the period during which an employee is required to provide service in exchange for the award. ASC&#160;718-10 also requires an entity to calculate the pool of excess tax benefits available to absorb tax deficiencies recognized subsequent to adoption of ASC&#160;718-10 (the &#147;APIC pool&#148;). Zevotek has evaluated its APIC pool and has determined that it was immaterial as of January&#160;1, 2006. ASC&#160;718-10 also amends ASC&#160;230 &#147;Cash Flows&#148;, to require that excess tax benefits that had been reflected as operating cash flows be reflected as financing cash flows.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek has adopted Accounting Standards Codification subtopic 260-10, Earnings Per Share (&#147;ASC 260-10&#148;) specifying the computation, presentation and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Potentially dilutive shares of common stock realizable from the conversion of our convertible debentures of 148,499,367 and 4,836,404,514 shares, respectively at June 30, 2012 and 2011, are excluded from the computation of diluted net loss per share as their inclusion would be anti-dilutive. &#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Financial instruments and related items, which potentially subject Zevotek to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. Zevotek places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In October 2012, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2012-04, &#147;Technical Corrections and Improvements&#148; in Accounting Standards Update No. 2012-04. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update will be effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 is not expected to have a material impact on our financial position or results of operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In August 2012, the FASB issued ASU 2012-03, &#147;Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update)&#148; in Accounting Standards Update No. 2012-03. This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 is not expected to have a material impact on our financial position or results of operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In July 2012, the FASB issued ASU 2012-02, &#147;Intangibles &#150; Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment&#148; in Accounting Standards Update No. 2012-02. This update amends ASU 2011-08, <i>Intangibles &#150; Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment</i> and permits an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, <i>Intangibles, Goodwill and Other - General Intangibles Other than Goodwill</i>. The amendments are effective for annual and interimimpairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim impairment tests performed as of a date before July 27, 2012, if a public entity&#146;s financial statements for the most recent annual or interim period have not yet been issued or, for nonpublic entities, have not yet been made available for issuance. The adoption of ASU 2012-02 is not expected to have a material impact on our financial position or results of operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In December 2011, the FASB issued ASU 2011-12, &#147;Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05.&#160; This update defers the requirement to present items that are reclassified from accumulated other comprehensive income to net income in both the statement of income where net income is presented and the statement where other comprehensive income is presented.&#160; The adoption of ASU 2011-12 is not expected to have a material impact on our financial position or results of operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In December 2011, the FASB issued ASU No. 2011-11 &#147;Balance Sheet: Disclosures about Offsetting Assets and Liabilities&#148; (&#147;ASU 2011-11&#148;).&#160; This Update requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position.&#160; The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of IFRS.&#160; The amended guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods.&#160; Zevotek is currently evaluating the impact, if any, that the adoption of this pronouncement may have on its results of operations or financial position.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt">Accounts payable and accrued liabilities are as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: bottom; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt"><b>June&#160;30,</b></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt"><b>2012</b></font></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt; font-size: 12pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt; font-size: 12pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt"><b>June&#160;30,</b></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt"><b>2011</b></font></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; width: 76%"><font style="font-size: 8pt">Accounts payable&#160;</font></td> <td style="vertical-align: top; width: 1%; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; width: 9%; text-align: right"><font style="font-size: 8pt">2,389</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; width: 1%; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; width: 9%; text-align: right"><font style="font-size: 8pt">10,867</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Accrued professional fees</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">217,262</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">225,163</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Accrued payroll and payroll taxes</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">165,372</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">161,649</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Old disputed accounts payable</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">136,505</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">160,756</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Accrued interest</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">333,598</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">183,507</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt"><font style="font-size: 8pt">Other accrued liabilities</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right"><font style="font-size: 8pt">83,875</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 8pt">32,404</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 3pt"><font style="font-size: 8pt">Total</font></td> <td style="vertical-align: top; padding-bottom: 3pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; padding-bottom: 3pt"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right"><font style="font-size: 8pt">939,001</font></td> <td style="vertical-align: top; padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; padding-bottom: 3pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">774,346</font></td> <td style="vertical-align: top; padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: bottom; padding-bottom: 1.5pt"></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt"><b>June&#160;30,</b></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt"><b>2012</b></font></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt; font-size: 12pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt; font-size: 12pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1.5pt solid"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt"><b>June&#160;30,</b></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-size: 8pt"><b>2011</b></font></p></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr> <td style="vertical-align: bottom"><font style="font-size: 8pt">Notes Payable:</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; width: 76%"><font style="font-size: 8pt">Convertible term note (a)</font></td> <td style="vertical-align: top; width: 1%; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; width: 9%; text-align: right"><font style="font-size: 8pt">923</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; width: 1%; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; width: 9%; text-align: right"><font style="font-size: 8pt">923</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (b)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">1,923</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">1,923</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (c)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">50,000</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">50,000</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (d)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">2,497</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">2,497</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (e)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">224</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">25,174</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (f)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">11,132</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">11,132</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (g)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">26,420</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">30,920</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (h)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">190,757</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">192,430</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (i)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">34,141</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">34,141</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (j)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">22,350</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">22,530</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (k)</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">945,565</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">945,527</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (l)</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">10,000</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">Convertible term note (m)</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">30,000</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt"><font style="font-size: 8pt">Convertible term note (n)</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right"><font style="font-size: 8pt">10,000</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">1,335,932</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">1,317,197</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt"><font style="font-size: 8pt">Less: discount on debt</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 8pt">921,311</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">1,335,932</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; text-align: right"><font style="font-size: 8pt">395,886</font></td> <td style="vertical-align: top"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt"><font style="font-size: 8pt">Less: current portion</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right"><font style="font-size: 8pt">(1,285,932</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 8pt">(309,806</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 3pt"><font style="font-size: 8pt">Long term debt</font></td> <td style="vertical-align: top; padding-bottom: 3pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; padding-bottom: 3pt"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; padding-bottom: 3pt; text-align: right"><font style="font-size: 8pt">50,000</font></td> <td style="vertical-align: top; padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; padding-bottom: 3pt; text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">86,080</font></td> <td style="vertical-align: top; padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Zevotek has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of Zevotek; it is more likely than not that the benefits will not be realized. Components of deferred tax assets as of June 30, 2012 are as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt">&#160;</font></p> <p style="margin: 0"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; width: 88%"><font style="font-size: 8pt">Net operating loss carry forward</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; width: 9%; text-align: right"><font style="font-size: 8pt">2,400,000</font></td> <td style="vertical-align: top; width: 1%"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1.5pt"><font style="font-size: 8pt">Valuation allowance</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 8pt">(2,400,000</font></td> <td style="vertical-align: top; padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 3pt"><font style="font-size: 8pt">Net</font></td> <td style="vertical-align: top; padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="vertical-align: top; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">0</font></td> <td style="vertical-align: top; padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td></tr> </table> 2389 10867 217262 225163 165372 161649 136505 160756 333598 183507 83875 32404 939001 774346 1335932 1317197 923 923 1923 1923 50000 50000 2497 2497 224 25174 11132 11132 26420 30920 190757 192430 34141 34141 22350 22530 945565 945527 10000 30000 10000 921311 -1285932 -309806 50000 86080 1335932 395886 2400000 -2400000 0 0 0 31446 148479 148499367 4836404514 40000 .10 2423885 1551 32545 325413 45000 30000 53000 113000 32235 148098 77854 1 1 0 0 4318 6 0 0 0 92000 46300 36400 921312 293254 0.001 0.001 11132 11132 0 EX-31.1 6 zvtk_ex321.htm zvtk_ex321.htm
EXHIBIT 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the accompanying Annual Report on Form 10-K/A of Zevotek, Inc.  for the fiscal year ending June 30, 2012, I, Jason Ryu, Chief Executive Officer of Zevotek, Inc., hereby certify pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
 
1. Such Annual Report on Form 10-K/A for the fiscal year ending June 30, 2012, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in such Annual Report on Form 10-K for the fiscal year ending June 30, 2012, fairly presents, in all material respects, the financial condition and results of operations of Zevotek, Inc.
 
3. Date: November 16, 2012.
 
 
 
By:
/s/ Jason Ryu  
   
Jason Ryu, Chief Executive Officer of Zevotek, Inc.
 
                                       
 

 
EX-32.2 7 zvtk_ex322.htm zvtk_ex322.htm
EXHIBIT 32.2
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the accompanying Annual Report on Form 10-K/A of Zevotek, Inc.  for the fiscal year ending June 30, 2012, I, Jason Ryu, Chief Financial Officer and Principal Accounting Officer of Zevotek, Inc., hereby certify pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
 
1. Such Annual Report on Form 10-K for the fiscal year ending June 30, 2012, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in such Annual Report on Form 10-K for the fiscal year ending June 30, 2012, fairly presents, in all material respects, the financial condition and results of operations of Zevotek, Inc.
 
3. Date: November 16, 2012.
 
 
 
By:
/s/ Jason Ryu  
   
Jason Ryu, Chief Financial Officer and
Principal Accounting Officer of Zevotek, Inc.
 
 
EX-101.PRE 8 zvtk-20120630_pre.xml EX-101.CAL 9 zvtk-20120630_cal.xml EX-101.DEF 10 zvtk-20120630_def.xml EX-101.LAB 11 zvtk-20120630_lab.xml SeriesAPreferredStockMember StatementClassOfStock [Axis] SeriesBPreferredStockMember Preferred stock Series A Equity Components [Axis] Preferred stock Series B Common Stock Common Stock To Be Issued Treasury Stock Additional Paid-In Capital Accumulated Deficit ConvertibleTermNoteA [Member] Debt Instrument [Axis] ConvertibleTermNoteB [Member] ConvertibleTermNoteC [Member] ConvertibleTermNoteD [Member] ConvertibleTermNoteE [Member] ConvertibleTermNoteF [Member] ConvertibleTermNoteG [Member] ConvertibleTermNoteH [Member] ConvertibleTermNoteI [Member] ConvertibleTermNoteJ [Member] ConvertibleTermNoteK [Member] ConvertibleTermNoteL [Member] ConvertibleTermNoteM [Member] ConvertibleTermNoteN [Member] ChiefExecutiveOfficerAndDirectorMember DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividual [Axis] OfficerMember ConsultingServicesMember Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] Class of Stock [Axis] ASSETS Current assets: Cash and cash equivalents Accounts receivable Inventory Total current assets Other asset: Licensing agreement Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable and accrued expenses Advances payable Convertible notes payable and demand notes (net of debt discount of -0- and $814,962 as of June 30, 2012 and 2011, respectively) Total current liabilities Long term portion of convertible notes payable (net of debt discount of -0- and $106,350 as of June 30, 2012 and 2011, respectively) Total Liabilities Stockholders' deficit: Preferred Stock Common stock, $0.00001 par value, 5,000,000,000 shares authorized; 335,527 and 220,810 shares issued and outstanding as of June 30, 2012 and 2011, respectively Treasury stock, 1 share outstanding as of June 30, 2012 and 2011 Additional paid in capital Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Debt Discount, Current Portion (in Dollars) Debt Discount, Noncurrent Portion (in Dollars) Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock, shares Income Statement [Abstract] REVENUES: Sales Cost of sales Impairment of Inventory Gross profit OPERATING EXPENSES: Selling General and administrative Impairment of Licensing Agreement Total operating expense Loss from operations OTHER (EXPENSE): Interest Expense Total other expense Net loss before provision for income taxes Income taxes NET LOSS Net loss per common share, basic and fully diluted (in Dollars per share) Weighted average number of common shares outstanding, basic and fully diluted (in Shares) Beginning Balance, Amount Beginning Balance, Shares Common stock issued for services rendered, Amount Common stock issued for services rendered, Shares Common stock issued for accounts payable, Amount Common stock issued for accounts payable, Shares Conversion of debt and accrued interest for common stock, Amount Conversion of debt and accrued interest for common stock, Shares Shares issued in satisfaction of fraction shares resulting from 1 for 5,000 reverse stock split (in Shares) Fair value of beneficial conversion feature Common stock issued to officers and board members, Amount Common stock issued to officers and board members, Shares Common stock issued to former officers for accrued compensation, Amount Common stock issued to former officers for accrued compensation, Shares Net loss Ending Balance, Amount Ending Balance, Shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Common stock issued for services rendered Common stock issued for interest Common stock issued to officer and board members as remuneration Amortization of beneficial conversion feature Changes in operating assets and liabilities: Accounts receivable Inventory Prepayments and other current assets Accounts payable and accrued expenses Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: CASH FLOWS FROM FINANCING ACTIVITIES: Increase in advances payable; net Proceeds from issuance of convertible notes payable Net cash provided by financing activities Net decrease in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW: Interest paid Income taxes paid NON CASH INVESTING AND FINANCING ACTIVITIES: Common stock issued for settlement of accrued liabilities Exchange of convertible debenture for advances payable Accrued interest converted to convertible note Debt and accrued interest converted for shares of common stock Note - Summary Of Accounting Policies SUMMARY OF ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] GOING CONCERN MATTERS Inventory Disclosure [Abstract] INVENTORY Notes to Financial Statements LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED LIABILITIES ADVANCES PAYABLE Debt Disclosure [Abstract] CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES Equity [Abstract] STOCKHOLDERS EQUITY Income Tax Disclosure [Abstract] INCOME TAXES STOCK OPTIONS AND WARRANTS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENT Note - Summary Of Accounting Policies Policies Business and Basis of Presentation General Reverse Stock Split Revenue Recognition Consideration Paid to Customers Use of Estimates Cash and Cash Equivalents Inventories / Cost of Goods Sold Allowance for doubtful accounts Impairment of long lived assets Advertising Income Taxes Research and Development Stock Based Compensation Loss per Share Concentration of Credit Risk Recent Accounting Pronouncements Note E- Accounts Payable And Accrued Liabilities Tables ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Note G - Convertible Notes Payable And Demand Notes Tables CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES Note I - Income Taxes Tables INCOME TAXES Note - Summary Of Accounting Policies Details Narrative Finished Goods inventory Allowance for doubtful accounts Advertising cost Dilutive shares of common stock Note B - Going Concern Matters Details Narrative Incurred net losses Working capital deficit Accumulated losses Note C - Inventory Details Narrative Note D - Licensing Agreement And Distribution Agreement Details Narrative Licensing Agreement Impairment Note E- Accounts Payable And Accrued Liabilities Details ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payable Accrued professional fees Accrued payroll and payroll taxes Old disputed accounts payable Accrued interest Other accrued liabilities Total Note F - Advances Payable Details Narrative Zevotek owed Advances accrue interest Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Convertible notes payable Less: discount on debt Convertible notes payable Net Less: current portion Long term debt Note G - Convertible Notes Payable And Demand Notes Detail Narrative Notes principal amount Common stock conversion price Amortization related to beneficial conversion feature Common stock issued Deferred Bonus and Profit Sharing Plan by Title of Individual [Axis] common shares issued and outstanding Common Stock Issued Common Stock issued value converted debt and accrued interest Converted stock Stock held in treasury Stock issuing cost reverse stock split Note I - Income Taxes Details Net operating loss carry forward Valuation allowance Deferred tax assets Note I - Income Taxes Details Narrative Federal income tax purposes a net operating loss carry forward Note J - Stock Options And Warrants Details Narrative Issue of stock warrants or options outstanding stock warrants or options Note K - Commitments And Contingencies Details Narrative Remitting payroll taxes Remitting sales taxes Issue of Common stock Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Shares, Issued Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] ConvertibleNotesTableTextBlock Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Allowance for Doubtful Accounts Receivable Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. EX-101.SCH 12 zvtk-20120630.xsd 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - NOTE A - SUMMARY OF ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - NOTE B - GOING CONCERN MATTERS link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - NOTE C - INVENTORY link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - NOTE D - LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - NOTE E - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - NOTE F - ADVANCES PAYABLE link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - NOTE H - STOCKHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - NOTE I - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - NOTE J - STOCK OPTIONS AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - NOTE K - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0018 - Disclosure - NOTE L - FAIR VALUE MEASUREMENT link:presentationLink link:calculationLink link:definitionLink 0019 - Disclosure - NOTE A - SUMMARY OF ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 0020 - Disclosure - NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0021 - Disclosure - NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Tables) link:presentationLink link:calculationLink link:definitionLink 0022 - Disclosure - NOTE I - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 0023 - Disclosure - NOTE A - SUMMARY OF ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0024 - Disclosure - NOTE B - GOING CONCERN MATTERS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0025 - Disclosure - NOTE C - INVENTORY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0026 - Disclosure - NOTE D - LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0027 - Disclosure - NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 0028 - Disclosure - NOTE F - ADVANCES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0029 - Disclosure - NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Details) link:presentationLink link:calculationLink link:definitionLink 0030 - Disclosure - NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Detail Narrative) link:presentationLink link:calculationLink link:definitionLink 0031 - Disclosure - NOTE H - STOCKHOLDERS EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0032 - Disclosure - NOTE I - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 0033 - Disclosure - NOTE I - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0034 - Disclosure - NOTE J - STOCK OPTIONS AND WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0035 - Disclosure - NOTE K - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE I - INCOME TAXES (Details Narrative) (USD $)
Jun. 30, 2012
Note I - Income Taxes Details Narrative  
Federal income tax purposes a net operating loss carry forward $ 6
XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE C - INVENTORY (Details Narrative) (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Note C - Inventory Details Narrative    
Impairment of Inventory $ 86,113   
XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE C - INVENTORY
12 Months Ended
Jun. 30, 2012
Inventory Disclosure [Abstract]  
INVENTORY

Since Zevotek has decided to develop a new Ionic Bulb, utilizing LEDs rather than the current fluorescent version the current finished goods inventory of the Ionic Bulb is obsolete.  Zevotek recorded an Impairment of Inventory of $86,113 for the year ended June 30, 2012.

 

EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P-F)C,61B-U]B-#$P7S0X-SE?861E-U\S,&-F M,C8Q,S`Q,#DB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?0U])3E9%3E1/4ED\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DY/5$5?1U]#3TY615)424),15].3U1%4U]005E!0CPO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DY/5$5?2%]35$]#2TA/3$1%4E-? M15%52519/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?2E]35$]#2U]/4%1)3TY37T%.1%]705)203PO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?3%]&04E27U9!3%5%7TU%05-54D5-14Y4 M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DY/5$5?15]!0T-/54Y44U]005E!0DQ%7T%. M1%]!0S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?15]!0T-/54Y44U]005E!0DQ%7T%.1%]!0S(\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?2%]35$]#2TA/3$1%4E-?15%525197T1E M=#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?25])3D-/345?5$%815-?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O M#I! M8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E M;%=O7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^6F5V;W1E:RP@26YC/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$"!+97D\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^2G5N(#,P+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^9F%L2!A(%=E;&PM:VYO=VX@4V5A'0^3F\\ M2!A(%9O;'5N=&%R>2!&:6QE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^4VUA;&QE3QS<&%N/CPO M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,CQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6%B;&4@86YD(&%C8W)U960@97AP96YS97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA2!S M=&]C:RP@,2!S:&%R92!O=71S=&%N9&EN9R!A'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ MF5D/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ+#`P,"PP,#`\3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\P-F)C,61B-U]B-#$P7S0X-SE?861E-U\S M,&-F,C8Q,S`Q,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#9B M8S%D8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA'0^)FYB'0^)FYB7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4L(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-F)C,61B M-U]B-#$P7S0X-SE?861E-U\S,&-F,C8Q,S`Q,#D-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,#9B8S%D8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB6UE;G1S(&%N9"!O=&AE'0^)FYB M2!F:6YA M;F-I;F<@86-T:79I=&EE&5S('!A:60\+W1D/@T*("`@("`@("`\=&0@8VQA&-H86YG92!O9B!C;VYV97)T:6)L92!D96)E;G1U6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O M;G0Z(#AP="!4:6UE6EN9R!C M;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',-"F9O;&QO=W,N/"]F M;VYT/CPO<#X-"@T*/'`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`T*:6X@ M=&AE(%5N:71E9"!3=&%T97,@;V8@06UE2<^/&9O;G0@ M2<^/&9O;G0@'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UEF5D.B`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`@86YD("0X."PS,C,L(')E2X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`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`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2<^ M/&9O;G0@&5S/"]U/CPO9F]N=#X\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE'!E8W1E9"!F=71U"!R971U'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#AP="!4:6UE"!R871E M2!D:69F M97)E;F-E&%B;&4@:6YC;VUE(')E<&]R=&5D(&9O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE2`Q+"`R,#`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`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`T*8V%S:"!E<75I=F%L96YT'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4 M:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V9O;G0Z(#AP="!4:6UE2!T:&%N(&YO="!T:&%T(&%N(&EN9&5F:6YI=&4M;&EV M960@:6YT86YG:6)L92!A2`R M-RP@,C`Q,BP@:68@82!P=6)L:6,@96YT:71Y)B,Q-#8[65T(&)E96X@:7-S=65D(&]R+"!F;W(@ M;F]N<'5B;&EC(&5N=&ET:65S+"!H879E(&YO="!Y970@8F5E;B!M861E(&%V M86EL86)L90T*9F]R(&ES'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4 M:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE2`Q+"`R,#$S+"!A;F0@:6YT97)I;2!P97)I M;V1S('=I=&AI;B!T:&]S92!A;FYU86P@<&5R:6]D3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\P-F)C,61B-U]B-#$P7S0X-SE?861E-U\S M,&-F,C8Q,S`Q,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#9B M8S%D8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA'0^/'`@'0M86QI9VXZ(&IU6EN9R!C;VYS;VQI9&%T M960@9FEN86YC:6%L('-T871E;65N=',@9F]R('1H92!Y96%R'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!B92!U;F%B;&4@=&\@:6UP;&5M96YT(&ET2!I=',@9&5B="!O M8FQI9V%T:6]N2!I;F1I8V%T92!T:&%T(%IE=F]T96L@=VEL;"!B M92!U;F%B;&4@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C;VYC97)N(&9O2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^6F5V;W1E M:R!H87,@9&ES8V]N=&EN=65D('-A;&5S(&]F(&]N92!I=',@;6%J;W(@<')O M9'5C=',L('1H92!);VYI8PT*0G5L8B!A;F0@:&%S(')E+65N=&5R960@=&AE M($1E=F5L;W!M96YT(%-T86=E(&%F=&5R('1H92!Y96%R(&5N9&5D($IU;F4@ M,S`L(#(P,3(N(%IE=F]T96L@:&%S(&-H;W-E;B!T;R!N;R!L;VYG97(@2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^6F5V;W1E:R=S(&5X:7-T96YC92!I2!T;R!D979E;&]P#0IP6EN M9R!C;VYS;VQI9&%T960@9FEN86YC:6%L#0IS=&%T96UE;G1S(&1O(&YO="!I M;F-L=61E(&%N>2!A9&IU'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!$:7-C;&]S=7)E(%M!8G-T2<^4VEN8V4@6F5V;W1E M:R!H87,@9&5C:61E9"!T;R!D979E;&]P(&$@;F5W($EO;FEC($)U;&(L('5T M:6QI>FEN9PT*3$5$2!O9B`D.#8L,3$S(&9O65A'0M86QI9VXZ(&IU'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU&-L=7-I=F4@4'5R8VAA2!T:&4@<&%T96YT(&AO;&1E M0T*;6%N=69A8W1U&5D#0IA;6]U;G0@<&5R($EO;FEC($)U;&(@;W)D97)E M9"!F2!I M6UE;G0@;V8@=&AE(&9E M97,-"FES('1O(&)E(&)A6UE;G1S('1O('1H92!P871E;G0@:&]L9&5R(&9O M2XF(S$V,#LF(S$V,#M4:&4@'!E;G-E9"!D=7)I;F<@9FES8V%L(#(P,3(@9F]R(&$@=F%L M=64@;V8@)#,U+#`P,"!B87-E9"!O;B!T:&4@9W)A;G0@9&%T92!F86ER('9A M;'5E(&]F('1H92!S:&%R97,@:7-S=65D+CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#AP="!4:6UE2!:979O=&5K(&AA2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE($QI8V5N3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-F)C,61B M-U]B-#$P7S0X-SE?861E-U\S,&-F,C8Q,S`Q,#D-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,#9B8S%D8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA'0^/'`@ M6%B;&4@86YD(&%C8W)U960@ M;&EA8FEL:71I97,@87)E(&%S(&9O;&QO=W,Z/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E M'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)W9E6QE/3-$)V)A8VMG6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ('1O<"<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Y)3L@=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ('1O<"<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)V)A8VMG6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L M:6=N.B!R:6=H="<^,C$W+#(V,CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H="<^,C(U+#$V,SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W9E&5S/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W9E6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SXQ-C4L M,S6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SXQ-C$L-C0Y/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG6%B;&4\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=F5R=&EC M86PM86QI9VXZ('1O<"<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXX,RPX-S4\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!P861D:6YG+6)O M='1O;3H@,2XU<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M6QE/3-$ M)V)O6QE/3-$)W9E6QE/3-$)V)A8VMG M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`R+C(U<'0@9&]U8FQE.R!V97)T:6-A;"UA;&EG;CH@=&]P)SXD/"]T9#X- M"B`@("`\=&0@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXW-S0L M,S0V/"]T9#X-"B`@("`\=&0@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2<^07,@;V8@ M2G5N92`S,"P@,C`Q,B!A;F0@,C`Q,2P@6F5V;W1E:R!O=V5D("0Q.3DL,33X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\P-F)C,61B-U]B-#$P7S0X-SE?861E-U\S,&-F M,C8Q,S`Q,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#9B8S%D M8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E6%B;&4Z/"]T9#X-"B`@("`\ M=&0@6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$ M,B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`W-B4[('9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('9E'0M86QI9VXZ(')I9VAT)SXY,C,\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,24[('9E6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ('1O<"<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ('1O<"<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)V)A8VMG M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H M="<^,2PY,C,\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXU,"PP,#`\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT)SXR+#0Y-SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N M.B!R:6=H="<^,C(T/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXR-2PQ-S0\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/CPO='(^ M#0H\='(@6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXQ,2PQ,S(\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H="<^,C8L M-#(P/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SXS,"PY,C`\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SXQ.3`L-S4W/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXQ.3(L-#,P/"]T9#X- M"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXS-"PQ-#$\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P M.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W9E6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!T97AT+6%L:6=N.B!R:6=H="<^,C(L-3,P/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V)A8VMG6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXY-#4L-38U/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W9E M6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT)SXY M-#4L-3(W/"]T9#X-"B`@("`\=&0@6QE/3-$)V)A8VMG6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXQ,"PP,#`\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!T97AT+6%L:6=N.B!R:6=H="<^+3PO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W9E6QE/3-$)W9E6QE/3-$ M)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M)SXS,"PP,#`\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H="<^ M+3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O M6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXQ+#,S-2PY,S(\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXY,C$L,S$Q/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$ M)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT)SXQ+#,S-2PY,S(\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N M.B!R:6=H="<^,SDU+#@X-CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$ M)W9E'0M86QI M9VXZ(')I9VAT)SXH,2PR.#4L.3,R/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXH,S`Y+#@P-CPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W=I M9'1H.B`T)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Y,R4[('1E M>'0M86QI9VXZ(&IU2`Q-"P@,C`P."P@6F5V;W1E:R!E M;G1E2!T:6UE M(&%T('1H92!O<'1I;VX@;V8@=&AE(&YO=&4@:&]L9&5R+"!P6UE;G1S(&UA>2!B92!P86ED(&EN(&-O;6UO;B!S M=&]C:R!A="!A(&-O;G9E6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`S)2<^8BD\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=W:61T:#H@.3,E.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY/;B!-87D@ M,C6QE/3-$)W9E2<^3VX@2F%N=6%R>2`Q+"`R,#`X+"!:979O=&5K(&5N=&5R960@:6YT;R!A M(&-O;G9E6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I M9'1H.B`S)2<^9"D\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@.3,E M)SX-"B`@("`@("`@/'`@'0M86QI9VXZ(&IU M2`X+"`R,#$Q+B8C,38P.R8C,38P.R8C,38P.UIE=F]T96L@ M:7,@:6X@9&5F875L="!O9B!P87EM96YT(&]F('!R:6YC:7!A;`T*("`@("`@ M("!A;F0@:6YT97)E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E2<^3VX@36%R8V@@.2P@,C`P.2P@6F5V;W1E:R!E;G1E'1E M;F0@=&AE(&UA='5R:71Y(&1A=&4@=&\@2F%N=6%R>2`X+"`R,#$R+B8C,38P M.R8C,38P.UIE=F]T96L@:7,@:6X@9&5F875L="!O9B!P87EM96YT(&]F('!R M:6YC:7!A;"!A;F0@:6YT97)E6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)W9E2`Q-"P@,C`P."P@8V5R M=&%I;B!N;W1E2<^)B,Q-C`[/"]P/CPO=&0^/"]T'0M86QI9VXZ(&IU2!T:6UE(&%T('1H92!O<'1I;VX@;V8@=&AE(&YO=&4@ M:&]L9&5R+`T*("`@("`@("!P6UE M;G1S(&UA>2!B92!P86ED(&EN(&-O;6UO;B!S=&]C:R!A="!A(&-O;G9E'0M86QI9VXZ(&IU2!D871E(&]F($%U9W5S="`V+"`R,#$R+B8C M,38P.R8C,38P.R8C,38P.T%T(&%N>0T*("`@("`@("!T:6UE(&%T('1H92!O M<'1I;VX@;V8@=&AE(&YO=&4@:&]L9&5R+"!P6UE;G1S(&UA>2!B92!P86ED(&EN(&-O;6UO;B!S=&]C:R!A="!A M(&-O;G9E'0M86QI9VXZ(&IU2!T:6UE(&%T('1H92!O<'1I;VX@;V8@=&AE M(&YO=&4@:&]L9&5R+"!P6UE;G1S M(&UA>0T*("`@("`@("!B92!P86ED(&EN(&-O;6UO;B!S=&]C:R!A="!A(&-O M;G9E'0M86QI9VXZ(&IU M2!D871E(&]F M($UA6UE;G0@;V8@<')I;F-I<&%L#0H@("`@("`@(&%N M9"!I;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6%B;&4@:6YT;PT*("`@("`@("!A(&-O;G9E2!T:6UE(&%T#0H@("`@("`@('1H92!O<'1I;VX@ M;V8@=&AE(&YO=&4@:&]L9&5R+"!P6UE;G1S(&UA>2!B92!P86ED(&EN(&-O;6UO;B!S=&]C:R!A="!A(&-O;G9E M'0M86QI M9VXZ(&IU6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)W9E2<^3VX@36%Y(#$U+"`R,#$R M+"!:979O=&5K(&5N=&5R960@:6YT;R!A(&-O;G9E2!T:6UE(&%T('1H92!O<'1I;VX@;V8@=&AE(&YO=&4@:&]L M9&5R+"!P6UE;G1S M(&UA>2!B92!P86ED(&EN(&-O;6UO;B!S=&]C:R!A="!A(&-O;G9E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UEF5D#0IA;F0@;65A2`R M,#`Y('1HF5D(&%N9"!M96%S=7)E9"!A;B!A9V=R96=A=&4-"F]F("0T-3'!E M;G-E9"!A="!T:&4@=&EM92!T:&4@3F]T97,@=V5R92!A;65N9&5D(&%N9"!T M:&4@)#0U-RPX-#D@87-S:6=N960@=&\@=&AE#0IA;65N9&5D(&)E;F5F:6-I M86P@8V]N=F5R2!P97)I;V0N/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@2G5L M>2`R."P@,C`P.2P@6F5V;W1E:R!I6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UEF5D(&%N9"!M M96%S=7)E9"!A;B!A9V=R96=A=&4@;V8@)#$Y,BPT,S`@;V8@=&AE(&%D=F%N M8V5S('!A>6%B;&4L('=H:6-H(&ES#0IE<75A;"!T;R!T:&4@:6YTF5D(&]V97(@=&AE M(&YO=&4F(S$T-CMS('1W;RUY96%R('1E2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@36%Y M(#$P+"`R,#$Q+"!:979O=&5K(&-O;G9E6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V9O;G0Z M(#AP="!4:6UE2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE2!N;W1E2`R,2P@,C`Q,"P@:6X@=VAI8V@@:70@9&5N:65D('1H92!M871E M2!S871I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P M-F)C,61B-U]B-#$P7S0X-SE?861E-U\S,&-F,C8Q,S`Q,#D-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#9B8S%D8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA'0^/'`@'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UEF5D(#$P+#`P M,"PP,#`@2<^/&9O;G0@2<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE&-H86YG92!A9W)E96UE M;G0@=6YD97(@=VAI8V@@=&AE('1H:7)D('!A2!N;W1E(&9O2P@=&AE('1H:7)D('!A'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#AP="!4:6UE2<^/&9O;G0@2<^/&9O;G0@F5D($-O;6UO;B!S=&]C:RP@<&%R('9A;'5E("0P M+C`P,#`Q('1O(#$L,#`P+#`P,"PP,#`-"G-H87)E'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE2!!=71H M;W)I='D@*"8C,30W.T9)3E)!)B,Q-#@[*2!A<'!R;W9E9"!T:&4@4F5V97)S M92!3<&QI="!A;F0@96%C:"!H;VQD97(@;V8@8V]M;6]N('-T;V-K#0IR96-E M:79E9"`Q('-H87)E(&]F(%IE=F]T96LF(S$T-CMS(&-O;6UO;B!S=&]C:R!F M;W(@96%C:"`R,"!S:&%R97,@;V8@6F5V;W1E:R8C,30V.W,@8V]M;6]N('-T M;V-K('1H97D@;W=N960N(%IE=F]T96L@9&ED(&YO=`T*:7-S=64@9G)A8W1I M;VYA;"!S:&%R97,@:6X@8V]N;F5C=&EO;B!W:71H('1H92!F;W)E9V]I;F<@ M2<^ M/&9O;G0@2<^/&9O;G0@0T*075T M:&]R:71Y("@F(S$T-SM&24Y2028C,30X.RD@87!P'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#AP="!4:6UE2X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2<^6F5V;W1E:R!R96-O M9VYI>F5S(&1E9F5R"!L:6%B:6QI=&EE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE"!B87-I"!P=7)P;W-E2!F;W)W M87)D(&]F(&%P<')O>&EM871E;'D@)#8@;6EL;&EO;B!E>'!I2!T M:&4@>65A&ES=&EN9R!N970-"F]P97)A=&EN9R!L;W-S97,@;6%Y(&)E(&QI;6ET M960N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^6F5V;W1E M:R!H87,@<')O=FED960@82!V86QU871I;VX@F5D+B!#;VUP;VYE;G1S(&]F(&1E9F5R"!A M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ('1O<"<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$ M)W9E6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)W9E2<^6F5V;W1E:R!H87,@;F]T(&9I M;&5D('1H96ER(&9E9&5R86P@;W(@"!R971U2<^06QT:&]U9V@@=&AE M('1A>&EN9R!A=71H;W)I=&EE'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0Z(#AP="!4:6UE7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!W2!P M;W)T:6]N(&]F(&ET(&ES('-U2!A8V-U2!W:71H('1H92!& M5$,F(S$T-CMS(&9I;F%L(&IU9&=M96YT+"!T:&ES(&-O=6QD(&AA=F4@82!M M871E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2`R-"P@,C`P.2P@6F5V;W1E:R!E;G1E2!:979O=&5K(&]B=&%I;F5D('=O&-L=7-I=F4@'1E;G-I;VYS M+B8C,38P.R8C,38P.TEN#0IE>&-H86YG92!F;W(@=&AE(&5X8VQU2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@36%R8V@@,BP@,C`Q,2P@6F5V;W1E M:R!A;F0@=&AE($EO;FEC($)U;&(-"G!A=&5N="!H;VQD97(@96YT97)E9"!I M;G1O(&$@;F]N+65X8VQU2!M86YU9F%C M='5R97(@=&AA="!W:6QL('!R;V1U8V4@82!N97AT(&=E;F5R871I;VX@=F5R M&5D(&%M;W5N="!P97(@26]N:6,@0G5L8B!O2!I6UE;G0@;V8@=&AE(&9E97,@:7,@=&\@ M8F4@8F%S960@=7!O;B!T:&4@879E2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2!:979O=&5K(&AA65A M2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/'4^4&%Y6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2!F;W)M86P@'0M86QI M9VXZ(&IU'0M86QI9VXZ(&IU&5S/"]U/CPO<#X- M"@T*/'`@'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU M6UE;G0@87,@9G5N9',@8F5C;VUE(&%V86EL M86)L92X@4&5N86QT:65S(&%N9"!I;G1E2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/'4^3&5G86P\+W4^/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^3VX@;W(@86)O=70@36%Y(#(P,3`L(&%N(&%L;&5G960@87-S M:6=N964@*'1H92`F(S$T-SM!2!N;W1E2!C;VUM;VX@2!S871I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@'0M86QI9VXZ(&IU2!T M:&%T('!R:6]R:71I>F5S('1H92!I;F9O2!L979E;"!W:71H:6X@=&AE(&9A:7(@=F%L=64@:&EE2<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^3&5V M96P@,2`M(%%U;W1E9"!P'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!O8G-E6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^5&\@=&AE(&5X=&5N="!T:&%T('9A;'5A=&EO;B!I2X@)B,Q-C`[26X@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU M'0M M86QI9VXZ(&IU'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!/9B!!8V-O=6YT M:6YG(%!O;&EC:65S(%!O;&EC:65S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`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`@F4Z(#AP="<^6F5V;W1E:R!O9F9E'0^/'`@F4Z(#AP="<^5&AE M('!R97!A'0^/'`@F4Z(#AP="<^1F]R('1H92!P=7)P;W-E#0IO9B!T:&4@86-C;VUP86YY:6YG M(&-O;G-O;&ED871E9"!F:6YA;F-I86P@2!L:7%U:60@:6YV97-T;65N=',@=VET:"!A(&UA='5R:71Y(&]F('1H2X\+V9O M;G0^/"]P/CQS<&%N/CPO6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!A;F0@8V]S="!G;V]D('-O;&0@87)E($9/0B!S:&EP<&EN9R!P;VEN="!C M;W-T&5S+"!C=7-T;VUE2!A;&QO=V%N8V5S(&)A'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!W87,- M"C`@86YD("0X."PS,C,L(')E2X\+V9O;G0^/"]P/CQS<&%N M/CPO'0^/'`@F4Z(#AP="<^6F5V M;W1E:R!M86EN=&%I;G,-"F%N(&%L;&]W86YC92!F;W(@9&]U8G1F=6P@86-C M;W5N=',@=&\@F%B;&4@=F%L=64L(&EN8VQU9&EN9R!R97-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2P@4&QA;G0@86YD($5Q=6EP;65N="8C,S0[ M("@F(S$T-SM!4T,@,S8P)B,Q-#@[*2X@5&AE#0I3=&%T96UE;G0@2!:979O=&5K(&)E M(')E=FEE=V5D(&9O<@T*:6UP86ER;65N="!W:&5N979E2!I M;F-L=61E('-I9VYI9FEC86YT('5N9F%V;W)A8FQE(&-H86YG97,@:6X@8G5S M:6YE'0^/'`@F4Z(#AP="<^6F5V;W1E M:R!C:&%R9V5S#0IT:&4@8V]S=',@;V8@861V97)T:7-I;F<@=&\@97AP96YS M97,@87,@:6YC=7)R960N)B,Q-C`[)B,Q-C`[6F5V;W1E:R!C:&%R9V5D("0S M,2PT-#8@86YD("0Q-#@L-#6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&9O;G0@'!E8W1E9"!F=71U"!R971U'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0M"!B87-I&-E<'0@8F%S:7,@9&EF M9F5R96YC92!R96QA=&5D('1O(&-EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M<#X-"@T*/'`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`[('1E>'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M65A'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M2!R97-E87)C:"!A;F0@9&5V96QO<&UE;G1S(&-O'!E;G-E9"!W:&5N('1H92!C;VYT'!E;G-E9`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`T*6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^26X@ M075G=7-T(#(P,3(L#0IT:&4@1D%30B!I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!T:&%N(&YO="!T:&%T(&%N(&EN9&5F:6YI=&4M;&EV960@:6YT M86YG:6)L92!AF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP M="<^26X@1&5C96UB97(@,C`Q,2P-"G1H92!&05-"(&ESF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^26X@1&5C96UB97(@,C`Q,2P-"G1H92!&05-"(&ES2`Q+"`R,#$S+"!A;F0@:6YT97)I;2!P97)I;V1S('=I=&AI;B!T M:&]S92!A;FYU86P@<&5R:6]D'1087)T7S`V8F,Q9&(W7V(T,3!?-#@W.5]A9&4W7S,P8V8R-C$S,#$P.0T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-F)C,61B-U]B-#$P7S0X M-SE?861E-U\S,&-F,C8Q,S`Q,#DO5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@ MF4Z(#AP M="<^06-C;W5N=',@<&%Y86)L92!A;F0@86-CF4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0M MF4Z(#$R<'0[(&9O;G0M=V5I9VAT.B!B;VQD M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI M9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)V)A M8VMGF4Z(#AP="<^06-C;W5N=',@<&%Y86)L928C,38P.SPO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9E6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^,C(U+#$V,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@=&]P)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]TF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,38U+#,W,CPO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)V)A8VMG6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W9E6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE M/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0MF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/"]T6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^-SF4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^/"]T3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\P-F)C,61B-U]B-#$P7S0X-SE?861E-U\S,&-F M,C8Q,S`Q,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#9B8S%D M8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D M9&EN9STS1#`@6QE/3-$)W9EF4Z(#AP="<^/&(^2G5N M928C,38P.S,P+#PO8CX\+V9O;G0^/"]P/@T*("`@("`@("`\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#AP="<^/&(^,C`Q,CPO8CX\+V9O;G0^/"]P/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG MF4Z(#AP="<^0V]N=F5R=&EB;&4@=&5R;2!N;W1E("AA*3PO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M M6QE/3-$)W9E M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0MF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^0V]N M=F5R=&EB;&4@=&5R;2!N;W1E("AD*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#AP="<^,BPT.3<\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,BPT.3<\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,C4L,36QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0MF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,S`L.3(P/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,3DR+#0S,#PO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0MF4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^0V]N=F5R M=&EB;&4@=&5R;2!N;W1E("AJ*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^,C(L,S4P/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^.30U+#4R M-SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@=&]P)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/"]T6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O M;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$ M)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^,3`L,#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^+3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@=&]P.R!P861D:6YG+6)O='1O;3H@,2XU<'0G/CQF;VYT M('-T>6QE/3-$)V9O;G0M6QE/3-$)V)A8VMGF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^,2PS,36QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)V)A8VMGF4Z(#AP="<^3&5S6QE/3-$)V9O;G0MF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^,2PS,S4L.3,R/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W9E6QE/3-$ M)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,SDU+#@X-CPO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^/"]T6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#AP="<^*3PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!P861D:6YG+6)O M='1O;3H@,2XU<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^*#,P.2PX M,#8\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^*3PO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z M(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!P861D:6YG+6)O='1O;3H@,W!T.R!T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@F4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O M;G0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!W:61T:#H@.24[('1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,BPT,#`L M,#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE/3-$)V)A8VMGF4Z(#AP="<^3F5T/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\P-F)C,61B-U]B-#$P7S0X-SE?861E-U\S M,&-F,C8Q,S`Q,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#9B M8S%D8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4@3F5T/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ+#,S-2PY,S(\6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\P-F)C,61B-U]B-#$P7S0X-SE?861E-U\S,&-F,C8Q,S`Q,#D-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#9B8S%D8C=?8C0Q,%\T.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5C=71I=F5/9F9I8V5R06YD1&ER96-T;W)-96UB97(\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$"!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A"!P=7)P;W-E2!F;W)W87)D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XD(#8\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA7)O;&P@=&%X97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC'1087)T7S`V8F,Q9&(W7V(T,3!?-#@W.5]A9&4W 17S,P8V8R-C$S,#$P.2TM#0H` ` end XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Details) (USD $)
Jun. 30, 2012
Jun. 30, 2011
Debt Instrument [Line Items]    
Convertible notes payable $ 1,335,932 $ 1,317,197
Less: discount on debt    921,311
Convertible notes payable Net 1,335,932 395,886
Less: current portion (1,285,932) (309,806)
Long term debt 50,000 86,080
ConvertibleTermNoteA [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 923 923
ConvertibleTermNoteB [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 1,923 1,923
ConvertibleTermNoteC [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 50,000 50,000
ConvertibleTermNoteD [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 2,497 2,497
ConvertibleTermNoteE [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 224 25,174
ConvertibleTermNoteF [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 11,132 11,132
ConvertibleTermNoteG [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 26,420 30,920
ConvertibleTermNoteH [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 190,757 192,430
ConvertibleTermNoteI [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 34,141 34,141
ConvertibleTermNoteJ [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 22,350 22,530
ConvertibleTermNoteK [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 945,565 945,527
ConvertibleTermNoteL [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 10,000   
ConvertibleTermNoteM [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable 30,000   
ConvertibleTermNoteN [Member]
   
Debt Instrument [Line Items]    
Convertible notes payable $ 10,000   
XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE F - ADVANCES PAYABLE (Details Narrative) (USD $)
Jun. 30, 2012
Jun. 30, 2011
Note F - Advances Payable Details Narrative    
Zevotek owed $ 199,183 $ 43,823
Advances accrue interest 10.00%  
XML 20 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Detail Narrative) (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Note G - Convertible Notes Payable And Demand Notes Detail Narrative    
Notes principal amount $ 11,132 $ 11,132
Common stock conversion price $ 0.001 $ 0.001
Amortization related to beneficial conversion feature $ 921,312 $ 293,254
Common stock issued   36,400
XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE H - STOCKHOLDERS EQUITY (Details Narrative) (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
common shares issued and outstanding 335,527 220,810
Common Stock issued value   $ 325,413
converted debt and accrued interest   113,000
Converted stock   148,098
Stock held in treasury 1 1
Stock issuing cost 0 0
reverse stock split 4,318  
ChiefExecutiveOfficerAndDirectorMember
   
Common Stock issued value   45,000
OfficerMember
   
Common Stock Issued   1,551
Common Stock issued value   30,000
ConsultingServicesMember
   
Common Stock Issued 32,545  
Common Stock issued value 53,000  
converted debt and accrued interest $ 32,235  
Converted stock 77,854  
XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE B - GOING CONCERN MATTERS
12 Months Ended
Jun. 30, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN MATTERS

The accompanying consolidated statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements for the years ended June 30, 2012 and 2011, Zevotek incurred net losses of $1,482,168 and $1,244,112, respectively.  At June 30, 2012, Zevotek had a working capital deficit of $2,423,885 and accumulated losses of $8,211,305. Zevotek is in default of payment and interest on certain convertible notes payable.

 

Zevotek is actively pursuing additional convertible debt financing through discussions with its current lenders.  Zevotek cannot predict whether the additional financing will be in the form of equity or debt, or be in another form.  Zevotek may not be able to obtain the necessary additional capital on a timely basis, on acceptable terms, or at all.  In any of these events, Zevotek may be unable to implement its current plans for expansion, repay its debt obligations as they become due, or respond to competitive pressures, any of which circumstances would have a material adverse effect on its business, prospects, financial conditions and result of operations. These factors, among others, may indicate that Zevotek will be unable to continue as a going concern for a reasonable period of time.

 

Zevotek has discontinued sales of one its major products, the Ionic Bulb and has re-entered the Development Stage after the year ended June 30, 2012. Zevotek has chosen to no longer sell the fluorescent version of the Ionic Bulb and to develop a next generation bulb utilizing “LEDs” Light Emitting Diodes.

 

Zevotek's existence is dependent upon management's ability to develop profitable operations. Management anticipates Zevotek may attain profitable status and improve its liquidity through the continued developing, marketing and selling of its products and additional investment in Zevotek. The accompanying consolidated financial statements do not include any adjustments that might result should Zevotek be unable to continue as a going concern.

XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE I - INCOME TAXES (Details) (USD $)
Jun. 30, 2012
Note I - Income Taxes Details  
Net operating loss carry forward $ 2,400,000
Valuation allowance (2,400,000)
Deferred tax assets $ 0
XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
Jun. 30, 2012
Jun. 30, 2011
Cash and cash equivalents $ 231 $ 4,737
Accounts receivable    4,043
Inventory    88,323
Total current assets 231 97,103
Licensing agreement    40,000
Total assets 231 137,103
Accounts payable and accrued expenses 939,001 774,346
Advances payable 199,183 43,823
Convertible notes payable and demand notes (net of debt discount of -0- and $814,962 as of June 30, 2012 and 2011, respectively) 1,285,932 309,806
Total current liabilities 2,424,116 1,127,975
Long term portion of convertible notes payable (net of debt discount of -0- and $106,350 as of June 30, 2012 and 2011, respectively) 50,000 86,080
Total Liabilities 2,474,116 1,214,055
Common stock, $0.00001 par value, 5,000,000,000 shares authorized; 335,527 and 220,810 shares issued and outstanding as of June 30, 2012 and 2011, respectively 3 2
Treasury stock, 1 share outstanding as of June 30, 2012 and 2011      
Additional paid in capital 5,737,406 5,652,172
Accumulated deficit (8,211,305) (6,729,137)
Total stockholders' deficit (2,473,885) (1,076,952)
Total liabilities and stockholders' deficit 231 137,103
SeriesAPreferredStockMember
   
Preferred Stock 1 1
SeriesBPreferredStockMember
   
Preferred Stock $ 10 $ 10
XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Statement of Cash Flows [Abstract]    
Net loss $ (1,482,168) $ (1,244,112)
Common stock issued for services rendered 53,000 235,413
Common stock issued for interest    4,050
Common stock issued to officer and board members as remuneration    45,000
Impairment of Inventory 86,113   
Impairment of Licensing Agreement 40,000   
Amortization of beneficial conversion feature 921,321 293,254
Accounts receivable 4,043 1,896
Inventory 2,210 9,924
Prepayments and other current assets    22,994
Accounts payable and accrued expenses 165,615 142,080
Net cash used in operating activities (209,866) (489,501)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Increase in advances payable; net 155,360 361,721
Proceeds from issuance of convertible notes payable 50,000   
Net cash provided by financing activities 205,360 361,721
Net decrease in cash and cash equivalents (4,506) (127,780)
Cash and cash equivalents, beginning of period 4,737 132,517
Cash and cash equivalents, end of period 231 4,737
Interest paid      
Income taxes paid      
Common stock issued for settlement of accrued liabilities    120,000
Exchange of convertible debenture for advances payable    1,137,957
Accrued interest converted to convertible note    2,821
Debt and accrued interest converted for shares of common stock $ 32,235 $ 108,949
XML 26 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE K - COMMITMENTS AND CONTINGENCIES (Details Narrative) (USD $)
Jun. 30, 2012
Jun. 30, 2011
Note K - Commitments And Contingencies Details Narrative    
Remitting payroll taxes $ 92,000  
Remitting sales taxes $ 46,300  
Issue of Common stock   36,400
XML 27 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE I - INCOME TAXES (Tables)
12 Months Ended
Jun. 30, 2012
Note I - Income Taxes Tables  
INCOME TAXES

Zevotek has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of Zevotek; it is more likely than not that the benefits will not be realized. Components of deferred tax assets as of June 30, 2012 are as follows:

 

 

Net operating loss carry forward   $ 2,400,000  
Valuation allowance     (2,400,000 )
Net   $ 0  
XML 28 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE B - GOING CONCERN MATTERS (Details Narrative) (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Note B - Going Concern Matters Details Narrative    
Incurred net losses $ (1,482,168) $ (1,244,112)
Working capital deficit 2,423,885  
Accumulated losses $ (8,211,305) $ (6,729,137)
XML 29 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 30 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE A - SUMMARY OF ACCOUNTING POLICIES
12 Months Ended
Jun. 30, 2012
Note - Summary Of Accounting Policies  
SUMMARY OF ACCOUNTING POLICIES

A summary of the significant accounting policies applied in the preparation of the accompanying consolidated financial statements follows.

 

Business and Basis of Presentation

 

ZEVOTEK, INC. (“Company” or “Registrant”) was organized on March 19, 2005 under the state laws of Delaware with an original name of “The Diet Coffee Company.” On March 1, 2006, we amended our Certificate of Incorporation and changed our name from “The Diet Coffee Company, Inc to Diet Coffee, Inc. On June 25, 2008, Zevotek changed its name to Zevotek, Inc.

 

Zevotek’s wholly owned subsidiary is Ionic Bulb.com, Inc., a Delaware corporation formed on August 21, 2007, through which it had sold the Ionic Bulb, a patented air purifier that silently emits negative ions using a microchip placed inside a 10,000-hour energy saving compact fluorescent light bulb (CFL). The Ionic Bulb was an eco-easy maintenance-free inexpensive alternative that is designed to clean the air in a 100 square foot area of unpleasant odors and indoor air pollutants that you breathe. Zevotek sold the Ionic Bulb through specialty retail shops, TV commercials, Amazon.com and newionicbulb.com, and it marketed the Ionic Bulb to major U.S. retail stores. It had acquired exclusive worldwide sales and manufacturing rights to a U.S. patented new product named Gung H2O that reduces water use in the home.

 

Zevotek has currently stopped working on the sales of the Ionic bulb. It is upgrading the bulb. The new ionic bulb will be made using LED light. The new Ionic Bulb will not no longer be using florescent light.

 

Zevotek plans to sell Gung H20 to major U.S. retail stores and directly to American consumers using TV ads and Internet marketing. After Zevotek tried to market the Gung H2O, it went back to the inventors to make changes due to feedback from the public. After the inventors make the changes Zevotek hopes to market the product sometime in the second to third quarter of 2013.

 

Our chief executive officer, Mr. Ryu has a history of being an innovator. We expect that he will bring a number of products on board in the upcoming year and believe Zevotek will make instant revenue from these products. We expect to release some of these products in the very near future. We are either waiting to put the finishing touches or most importantly file the proper patents in order to bring the greatest value to our stockholders.

 

General

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.

 

The consolidated financial statements include the accounts of the Registrant and its wholly-owned subsidiary, Ionic Bulb.com, Inc. The Registrant formed its Ionic Bulb.com, Inc. subsidiary on August 21, 2007 and started its operations during the fiscal year ended June 30, 2008. All significant inter-company transactions and balances have been eliminated in consolidation.

 

Zevotek has adopted the fiscal year end of June 30.

 

Reverse Stock Split

 

On September 26, 2011, Zevotek filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a 1 to 5,000 basis.  The Financial Industry Regulatory Authority (“FINRA”) effected the reverse stock split on October 27, 2011. Each holder of common stock received 1 share of Zevotek’s common stock in exchange for each 5,000 shares of Zevotek’s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing split.  Fractional shares were rounded up to the nearest whole share. All per share numbers quoted herein are reflective of the 1:5,000 reverse split. All references in the accompanying consolidated financial statements and notes there to have been retroactively restated to reflect the stock split.

 

Revenue Recognition

 

For revenue from product sales, Zevotek recognizes revenue in accordance with Accounting Standards Codification 605, “Revenue Recognition SEC Staff Accounting Bulletin Topic 13” (“ASC 605”). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Zevotek defers any revenue for which the product has not been delivered or is subject to refund until such time that Zevotek and the customer jointly determine that the product has been delivered or no refund will be required.  

 

ASC 605 incorporates Accounting Standards Codification 605-25, “Revenue Recognition Multiple Element Arrangements”.  ASC 605-25 addresses accounting for arrangements that may involve the delivery or performance of multiple products, services and/or rights to use assets.  Zevotek does not have any multiple element arrangements.

  

Consideration Paid to Customers

  

Zevotek offers our customers certain incentives in the form of cooperative advertising arrangements, product markdown allowances, trade discounts, cash discounts, and slotting fees. Markdown allowances, trade discounts, cooperative advertising program participation and cash discounts are all recorded as reductions of net sales.  No customer incentives are included in sales for the years ended June 30, 2012 and 2011.

 

Use of Estimates

 

The preparation of the financial statement in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

For the purpose of the accompanying consolidated financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. Zevotek had no cash equivalents as of June 30, 2012 and 2011, respectively.

 

Inventories / Cost of Goods Sold

 

Zevotek has adopted a policy to record inventory at the lower of cost or market determined by the first-in-first-out method. The elements of cost that comprise inventory and cost good sold are FOB shipping point costs, freight and destination charges, customs and importation fees and taxes, customer broker fees (if any) and other related costs. Warehousing costs are charged to cost of goods in the period the costs are incurred. Zevotek provides inventory allowances based on estimates of obsolete inventories.

 

Inventories consist of finished products available for sale to distributors and customers. At June 30, 2012 and 2011, Finished Goods inventory was 0 and $88,323, respectively.

 

Allowance for doubtful accounts

 

Zevotek maintains an allowance for doubtful accounts to reduce amounts to their estimated realizable value, including reserves for customer and other receivable allowances and incentives. In estimating the provision for doubtful accounts, Zevotek considers a number of factors including age of the accounts receivable, trends and ratios involving the age of the accounts receivable and the customer mix of each aging categories.  As of June 30, 2012 and 2011, the allowance for doubtful accounts was $0.

 

Impairment of long lived assets

 

Zevotek has adopted Accounting Standards Codification 360 "Property, Plant and Equipment" (“ASC 360”). The Statement requires that long-lived assets and certain identifiable intangibles held and used by Zevotek be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a

forecasted inability to achieve break-even operating results over an extended period. Zevotek evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.

 

Advertising

 

Zevotek charges the costs of advertising to expenses as incurred.  Zevotek charged $31,446 and $148,479 to operations for the years ended June 30, 2012 and 2011, respectively.

  

Income Taxes

 

Zevotek has adopted Accounting Standards Codification 740,  “Income Taxes” (“ASC 740”) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference

 

between financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant, except basis difference related to certain debts.

 

Effective January 1, 2007 Zevotek adopted an amendment to the requirements of ASC 740. The amended standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

 

ASC 740-10-25-5 “Income Taxes—Overall—Recognition—Basis Recognition Threshold”, (“Tax Position Topic”) provides guidance to address uncertainty in tax positions and clarifies the accounting for income taxes by prescribing a minimum recognition threshold, i.e. “more-likely-than-not”, that the income tax positions must achieve before being recognized in the financial statements. In addition, the Tax Position Topic requires expanded annual disclosures, including a roll forward of the beginning and ending aggregate unrecognized tax benefits as well as specific detail related to tax uncertainties for which it is reasonably possible the amount of unrecognized tax benefit will significantly increase or decrease within twelve months.

  

As a result of implementing ASC 740, there has been no adjustment to Zevotek’s financial statements and the adoption of ASC 740 did not have a material effect on Zevotek’s consolidated financial statements for the years ended June 30, 2012 and 2011.

 

Research and Development

 

Zevotek accounts for research and development costs in accordance with the Financial Accounting Standards Board's Accounting Standards Codification 730 "Research and Development" (“ASC 730”). Under ASC 730, all research and development costs must be charged to expense as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. Zevotek had no expenditures on research and product development for years ended June 30, 2012 and 2011.  

 

Stock Based Compensation

 

Effective January 1, 2006, Zevotek adopted the requirements of ASC 505 “Equity” and ASC 718-10 “Stock Compensation”, under the modified prospective transition method. The standards require the measurement of compensation cost at the grant date, based upon the estimated fair value of the award, and requires amortization of the related expense over the employee’s requisite service period.

 

Under ASC 718-10, stock based compensation cost will be recognized over the period during which an employee is required to provide service in exchange for the award. ASC 718-10 also requires an entity to calculate the pool of excess tax benefits available to absorb tax deficiencies recognized subsequent to adoption of ASC 718-10 (the “APIC pool”). Zevotek has evaluated its APIC pool and has determined that it was immaterial as of January 1, 2006. ASC 718-10 also amends ASC 230 “Cash Flows”, to require that excess tax benefits that had been reflected as operating cash flows be reflected as financing cash flows.

 

Loss per Share

 

Zevotek has adopted Accounting Standards Codification subtopic 260-10, Earnings Per Share (“ASC 260-10”) specifying the computation, presentation and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Potentially dilutive shares of common stock realizable from the conversion of our convertible debentures of 148,499,367 and 4,836,404,514 shares, respectively at June 30, 2012 and 2011, are excluded from the computation of diluted net loss per share as their inclusion would be anti-dilutive.  

 

Concentration of Credit Risk

 

Financial instruments and related items, which potentially subject Zevotek to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. Zevotek places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.

 

Recent Accounting Pronouncements

 

In October 2012, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2012-04, “Technical Corrections and Improvements” in Accounting Standards Update No. 2012-04. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update will be effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 is not expected to have a material impact on our financial position or results of operations.

 

In August 2012, the FASB issued ASU 2012-03, “Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update)” in Accounting Standards Update No. 2012-03. This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 is not expected to have a material impact on our financial position or results of operations.

 

In July 2012, the FASB issued ASU 2012-02, “Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment” in Accounting Standards Update No. 2012-02. This update amends ASU 2011-08, Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment and permits an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles, Goodwill and Other - General Intangibles Other than Goodwill. The amendments are effective for annual and interimimpairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim impairment tests performed as of a date before July 27, 2012, if a public entity’s financial statements for the most recent annual or interim period have not yet been issued or, for nonpublic entities, have not yet been made available for issuance. The adoption of ASU 2012-02 is not expected to have a material impact on our financial position or results of operations.

 

In December 2011, the FASB issued ASU 2011-12, “Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05.  This update defers the requirement to present items that are reclassified from accumulated other comprehensive income to net income in both the statement of income where net income is presented and the statement where other comprehensive income is presented.  The adoption of ASU 2011-12 is not expected to have a material impact on our financial position or results of operations.

 

In December 2011, the FASB issued ASU No. 2011-11 “Balance Sheet: Disclosures about Offsetting Assets and Liabilities” (“ASU 2011-11”).  This Update requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position.  The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of IFRS.  The amended guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods.  Zevotek is currently evaluating the impact, if any, that the adoption of this pronouncement may have on its results of operations or financial position.

XML 31 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Jun. 30, 2012
Jun. 30, 2011
Debt Discount, Current Portion (in Dollars) $ 0 $ 814,962
Debt Discount, Noncurrent Portion (in Dollars) $ 0 $ 106,350
Preferred stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Common stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 5,000,000,000 5,000,000,000
Common stock, shares issued 335,527 220,810
Common stock, shares outstanding 335,527 220,810
Treasury stock, shares 1 1
SeriesAPreferredStockMember
   
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 50,000 50,000
Preferred stock, shares outstanding 50,000 50,000
SeriesBPreferredStockMember
   
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 1,000,000 1,000,000
Preferred stock, shares outstanding 1,000,000 1,000,000
XML 32 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE K - COMMITMENTS AND CONTINGENCIES
12 Months Ended
Jun. 30, 2012
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

U.S. Federal Trade Commission Settlement

 

On March 26, 2007, Zevotek received a letter from the U.S. Federal Trade Commission (“FTC”) whereby former management was informed that the FTC was conducting an investigation into advertising claims made for weight loss product known as “Slim Coffee.”  The purpose of the investigation was to determine whether former management, in connection with its sales of Slim Coffee, engaged in unfair or deceptive acts or practices and false advertising.  A negotiated settlement was reached with the FTC under which Zevotek, its former management did not admit any wrongdoing.  On January 10, 2008, pursuant to a stipulated final judgment and order, the United States District Court, Southern District of New York, entered a final judgment and order against Zevotek in the amount of $923,910.  The full amount of the judgment, and payment of any portion of it is suspended and cannot be reinstated so long as (a) Zevotek abides by the reporting and monitoring requirements of the judgment, (b) does not make false advertising claims in connection with any of its products in the future, and (c) its past financial disclosures to the FTC were materially accurate. Zevotek plans to comply with the terms of the stipulation and do not anticipate incurring a liability for the judgment, however there can be no assurance of compliance.  Should Zevotek fail to comply with the FTC’s final judgment, this could have a material adverse effect on Zevotek’s business, financial condition and results of operations.

 

Licenses

 

On February 24, 2009, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek obtained worldwide exclusive rights to manufacture, market use, sell, distribute and advertise certain licensed products.  The license is on a year to year basis with automatic renewal and is subject to becoming non-exclusive should Zevotek fail to files all quarterly and annual reports by due dates, inclusive of allowable extensions.  In exchange for the exclusive license, Zevotek issued 500 shares of its common stock.

 

On March 2, 2011, Zevotek and the Ionic Bulb patent holder entered into a non-exclusive Purchasing Representative Agreement whereby the patent holder shall introduce Zevotek to a new third party manufacturer that will produce a next generation version of the Ionic Bulb with new features and improved manufacturing cost.  Additionally, the patent holder affirms his obligation to defend against patent infringement.  Zevotek shall pay patent holder a fixed amount per Ionic Bulb ordered from the new manufacturer.  Zevotek agreed to make an advance fee payment by issuance of 5,000 shares of Zevotek’s restricted stock.  The value of the restricted shares applied to payment of the fees is to be based upon the average closing price of Zevotek's common stock for the ten trading days preceding the date on which the restrictive stock legend may be removed. The term of the agreement is three years with one-year automatic renewals that are subject to minimum fee payments to the patent holder for the first and second renewal term, respectively.  

 

Gung H2O License

 

On December 10, 2010, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to develop, manufacture, market, use, sell, distribute and advertise a U.S. patented new product named Gung H2O that reduces water use in the home. The license has a five-year initial term with automatic annual renewals and is not subject to minimum payments to the licensor.

 

Payroll Taxes

 

At June 30, 2012, Zevotek is delinquent with filing and remitting payroll taxes of approximately $92,000 including estimated penalties and interest related to payroll taxes withheld since April 2007. Zevotek has recorded the delinquent payroll taxes, which are included in accrued expenses on the balance sheet. Although Zevotek has not entered into any formal repayment agreements with the respective tax authorities, management plans to make payment as funds become available. Penalties and interest amounts are subject to increase based on a number of factors that can cause the estimated liability to increase further. Interest and penalties were accrued in an amount estimated to cover the ultimate liability.

 

Sales Taxes

 

At June 30, 2012, Zevotek is delinquent with remitting sales taxes of approximately $46,300, including related estimated penalties and interest related to sales taxes withheld since 2006 in the state of New York. Zevotek has recorded the delinquent sales taxes, which are included in accrued expenses on the balance sheet. Although Zevotek has not entered into any formal repayment agreements with the respective tax authorities, management plans to make payment as funds become available. Penalties and interest amounts are subject to increase based on a number of factors that can cause the estimated liability to increase further. Interest and penalties were accrued in an amount estimated to cover the ultimate liability.

 

Legal

 

On or about May 2010, an alleged assignee (the “Assignee”) of certain convertible promissory notes commenced an action by the filing of a summons and complaint against Zevotek alleging a failure to comply with its demands to convert principal and interest under Zevotek’s promissory notes in Company common stock.   The parties entered into a stipulation of settlement resolving this action on November 4, 2010 and a final judgment and injunction were entered on November 12, 2010, pursuant to which Zevotek agreed to issue stock once a month to the Assignee until it issued a total of 36,400 shares of common stock, which has been fully satisfied as of June 30, 2011.

XML 33 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information (USD $)
12 Months Ended
Jun. 30, 2012
Nov. 14, 2012
Document And Entity Information    
Entity Registrant Name Zevotek, Inc  
Entity Central Index Key 0001364208  
Document Type 10-K  
Document Period End Date Jun. 30, 2012  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Public Float   $ 0
Entity Common Stock, Shares Outstanding   335,527
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2012  
ZIP 34 0001354488-12-005989-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001354488-12-005989-xbrl.zip M4$L#!!0````(``:+<$&!!*E<`7\``,HV!``1`!P`>G9T:RTR,#$R,#8S,"YX M;6Q55`D``PN]IE`+O:90=7@+``$$)0X```0Y`0``[%U9<^,VMGZ_5?<_8#Q5 MJ9DJ2^:BU;U,>>THW6W[VDXRF9<434(2IBE2`4G;ZE]_SP%(B;0HB91H46XQ M#XDC`N=\.#L6@N__]3RRR2/E'G.=#P=J73D@U#%=BSF##P>_WM5.[LYZO0/R MKX__^S\$_GG_MUJ-_-^_>XY/N6'Z[)&26@V>O7]^X#8[QG\3H.AXQ\\>^W`P M]/WQ\='1T]-3_4FONWQPI"F*>O3OKU_NS"$=&37F>+[AF/0@ZF4SYUM:/[7; M[1Z)IU'3N9;(/.*A'^'C!\.;44:`2]K/(8&GEC_M$&_EJU)S3_D+(K2-X&C5DGMO0U/:R\\!]$X?)`"!IYPUZ9>:A_Q)*63XSI.,$K'9?G\R)^,Z1$TJD$K MRIDY[;>Z4[(#8,"?T]&))RGH_O/;_>=IA^_TT:WY]%O==$>BK=+2E8/(\-&> MCCUAM;>T3X0I'@^%@KX_^M]J48?ZLV<=A(^1[8<#CXW&-MC5441*^HKI@A,] M^X19'PXNN3L"`FI-:0-`WY5(6[49_VDWZOC,GTQ_G?[.+'S29Y03@9(FQ!>9 MV5GO\\%'!7Q0;S4TI?/^Z&7G&;NC5'XAMS&(WK7F48`/^:W[[2T0/E MI0EP%KGH8$1C(Y\^L@#,\]AF)O,E5F(Q:"D+IC!;'M_Y$*2P_YEM>#!J,;23 M9^8=?)PV63SZ]T>IC.(@C])1OB4GJ?2_@_K?OO^?[K7^4T>_5_Y?Z7^7]/^J M_A].:Y38M.9M%DR):8VRSK1&W<*T1GF3LHT9H[*%8*3L43%R\5<`N,_GE2WL@"ULHU!5]JA0S6(#NU:L M;C\WI$I`QH.&7MG"7N6&RA9VU19>-3Y<6];]SL^'U^\ MG5N9S$Z8S,[N3"N5F91K)B55FY6^R]?W-BO*2M_EZWL'JL9[]Y3V/"^@UEY8 M`1ZW.UXR_*J,S%@35'93JMV4M&5USZGA!7RR?VDC9>0_N,[52N<[I?-M%H>5 MSG=#YV45B">6Q7P0GV'?&,SJ.6?&F/F&O5>6L%0&59V8=;FQ,J5=-J6=7X:L MS&?'S*>D*K2R@]VU@VU6II4=[*X=E%6MWE+?8`ZU+@SN,&?@[94QI`^^JD^S MUJ>5\>R6\>Q\15H93.D&4U(-6FE^ES2_S:JSTOPN:7X;!_%GQR2<1\I]]F#3 M>\I'5ZY/3WX,[9_3![\'HN,!$DEL8$<+I_.C\M M7>^?GY_OG\[/2]=YR7Y>Z7S__/QB_W1^ M4;K.2_;S2N?[Y^>7^Z?SR])U7K*?5SK?/S__M'\Z_U2ZSDOV\TKG^^?G/^^? MSG\N7>5SG\T/U]VS>N0T?[%,S4#GSW2ZWZ?F92?.-8YX]3T7?ZC MV(+\$`2^O@C/#+P9XX1SPQF(=QM_9_ZPYUCLD5F!85\\FW9@,6=P-S0X/34\ M:MT8$VSG@6!N7#`IZH-X\)=3ZM`^\[W3R3WS;9#?C$S=O6]S;N8T@S MVE""E6UN9IL1@H0X*RO,_I$,QPML'Y5!^2-(\`=YY;OL8+E`K*4:YF[<.!(X M3%KEKW?G2TH_,8[X_6D1NGMT9>"HW;`@/]/DSG63F%X^2"ZG%V9V[II@=W$_&V4<%6>JS MI!_OGD;V1GCVA?3[S/3CD6,AM3B[$WAJ88M+VQAD9M,W;(]*#@D"<=RRU^$`649LW@-^I;7]VW"?G#HS4=:@E[M'GF=E>N7$#6$!M MGNUOKATX$-HGE\RFW%N3W0LJ*>8MY7!+QRX7>]!)K/KP,>I.Y9$";[3M39@K38."`9:\2#,@<2B)@-A M>Q\.>E>7!Q]UO=G4V@E%+V$5`9M>_^AYU/?2`U]Z,Y)S83-.%Z._=4I.R1P,T#(WR*VW5J/*RR6:CC;BNEG!X MB>;,\(8PV\/_X#5ACX8MYG_^F<'Y!$SZ-\,.:"$FFXE38?`R2:VMM\O"IV0* MM5I3W13A%V8\,)OYC&X<@!I:0U5;,SSSI-=CGBGMJ%J[VV[F81[;+,"-`N_& MF*`O;"@%5>LTN[H6T\I2-IN#RB(=7>EVE-:ZF*[](>5W0R@2<5/EU.7K=F+Q:!']37!D\F^]HZT!(PJ?H=#`X^`7B.56<:[4U;N*HLY'[`PL M"T:;18[M=D-OM`I!&S/,+ZXSB#;Q(E+KRK.9K-%6<"D`5*;2HZ5TU@<5D^7Z M`;N],&#G9)8'I;R^J%X=57,6)IP:! M1N]T8IY?%/VT8.Y%A)F"U;$,DJYH4-QH M[6U#RY`IRH*F%!@$7T>3J9BDN!KZUK%E2&6E84OYQ'8&#;Y";%K\G?>E\\37 ML^YE'X]>/G5-E.Y%PUK^0:E5Z[X=I?%Z-K0^M&:KJ:GM5[2J#:"U]78COA11 MM$(7?*MA:8YN-CI-17N]^F0M4*VVUE7C"Y!%*W$=4!U-574EEZ1>LCDQS6`4 MV(9/K7/:Q],^:]>5.M\"^AO`R"*9N?"4 M$4;BX\QY-QY6;;MD([Y@>*N(QY+?1ALF>GRY*$ER'999E*6M9BG.]N&9_'/F MB96_<''O!H\5N,ZZ@X6LOX+R!@`R+="IC6Y+6Q_%E>N8KR:).>*;P':ON%EPL$*I8[&X5T.NRQA[PYJ.6]\ M-:MNKL8K$6R&M1!3WA+6[=EO\9+=#;0KSPUNQQB6G"E<`_6V3+A8U-LSYM>4 M=DFX8_7_]DJX#$P+PKE9\;89SAR%1$:O>J'J);PVA#4OMBW!6IFRLI_$7L%C M`RB9I:-I2D==)IF,4+(%P`)$DRU0Y(EN!0AI":C$`H]LO9&`8KZ?0GI-[IDE MD8_[)^YZW@UW^R^6,Y>\,;%\X55MZC$UQ,CGY)SR"OCRHV:JULG$%WZU`A/7 M(FZI6&'MC<8&X^+MU6M^!E(:T,QOCRP_Q:6J>CRE9N!;&-@,XEN]-.GYU_U; M^DB=(//+7TO7*!N-1%J,D<_-.Z]Y=!JJEI'WG6%3+WR&[V5X+U\B6-<>%"V^ M)YC"95TD>86A-IL-)1^4ZS&^*@O!L^>8[HA^`?EN-I[?E+`M` MF-=>6AJXIX(ST;_RO7<9/1ID!) MX#''Y/'JA>PVPI4[X$)*;C6Z:\#J`6^H9?T"A30GHQ<\UH"05QXOQ;$`@=AC M^YVRP1#*P9-'D->`7@6XSG/=#V<]+R<\IX;'3'#%R\"V)^?,#GRZ1F1>-!U4 MP-/:X=[?YKBV,,SEBEDPS"Z8AU+X*"-=1P<_H@6AJ,_:REJR0%5KU#LQ,UO! MN@"D*QUA(5)5K\??P\H)%^,YC+?AQ55KVLWJ-]0S`0_F!"#& ML*AW'>^4]EU.IZBH]Y4Y+F?^),I"X&9)*O),WU?J#UT+7X[W?+$J\3I^ML4! M[)CL-H\1)_@MOVG.EJUHGIL\?YEY?735R:TNVT6HF*(R/[8H'G MGXMWNLWXIO7ZP"%1X+83/:?ROSTGRUO_AYD>+S54 M7G\\X#ICB._1%;!A10K$Q+T7*9=^%5H&%P0F=V31NMW&,MEF`;)Z.-&U4069 MN)9X87@INXVQY95HMZLM%6@N;/,W416SE=#0L_C3C&M12'/[?J?;V@SI@@@N MJ_4B,M\JW]X,0`&SW@4`+IEC.&;AN5]3FGI+69E!4[@7BSOW3D5+;6NK,W\& MW-#%I-2*IIG1G358I152_+\\HKB0VX;`"C"].$>1+XH2@MI,6EDJH[71;&H[ MF="D7T8G;W=]&>B*.6/03-QPEH-]T=#76,QIMQ-706T`/K:^@]/YUU[87,RE MD`5-N0KQJ@-9SJ*`4FS*M"&B+0PP=R&E=+KQ7=6"1B@6=\+)5F0I86JAUKU[EKQ& ML6`3W9QY[ME2!\-\/K[%&,,G$+NSKJF_C@,NAI3;.%6]W6VV-[5."2CUS@>Y MZ/A:\EO%(K<\M)0[74+Z<[QG4@HG0U"/[$IA\.^M#IF'3&/KEG(RBSK^@3N75'AG,H?S@D^+I-_QT9&7S`G&.BO"/( MI6;8@.J8_#>`&4Y_3MJB[\E/?U?U=UXP`CX3XO8)F`?Q9@,G MQG3D9!P.G1CCLXG[_,-3]QYTM?!T,>G+*M^P`2W\ M(#9U!(:^:]ONDU?'T1SA$**A'8W%7]A&_FL7Y?B3,1J_^[O:4MZ]4?S0-\`_ M3@./.=23.C$@/!&+0E]"S&%4Q'^/:&^\;5]9^+WZ[O+SX?"H2] MJ[,Z^4B'SCOB00,AL0DR%7""C`_HML8TG817G%/["M]J>F#\,C08(,1@]^+B#W_6!5C/N M]T#AG%&?G+G]/J71=S_J,;374^:"=^N0/$%$P8_)(+*`DS.L`3`^^8(X3@CX MV`TC$-JL.<3/BED"#G80,/H0FU<#$5\5(KX;?R9^JR.N7P*'$JTI<'4.2?@E MHH@?8;XG>4'_Z"M%4D70_VU:VIOW%*F&2.^M=S*R/0TAW4#">W)`;5[P`*4. MPPP(H:[G.LPDIX']4(MK>_RD?27DV``D(DFC;9]"+["W6`P M)$]#!K;,?#(T@!6>$@. MA(G1@3CJ3/!H!<&`/8#^(V9RUQRR,1G;ABG2,Q9P\$15#J'HJ0W1%?#4]&!" M/.,1>@D4(E.;/NG;@0LAWL3;N&T\?D@>`!GYQ]GEEW_6";K+#*\(%^#HU'1K MU/`FH$4&V#&UTUJ?@SM!$A'[&0C3L*&2=R1D,1Z0LD6QR@A]%-S%M*DARPD< M/E06"%LAWE\!BKSONE"*<&J@OP?.&!I[6)VXELL]X?+,L5P((UZG\/\G(^.[ZZ"E"!@.?6)(\&%J/@*@CX[\N%PA^K=_5 MI_Q\U$:=]*3A&.9?`_1,2RR*<@M(>?M6LI-^`6F$#W"3IQ,#,:%7Q#=T2K M<%9J.$.`0_#!\.XC"`U@+^,QZ!&LXAOJWI6ZDJ81EN72[H1MHEV!&P;C`3?$ MN['X7#Y!5T?[8-/61'RDZ('"Z,#:1,`1"+YL4CQ'8R0''=5QBNY`@ M.9*0X:IO)V--94ZEFQ-D#4?$"H^"WC`3/R&.N34\"/JH!7QT>I#\I77R>TD(!AD#3)D:/%B@>2!BG++ M`?TZ[B-^8K5.?J<$JQW3EXES2,.`R65EYHC7-[!S:"0>1N<'U^!6:''"4H*Q MB5]M'9`)-;CPE0=J,PJH(KL35(550FV'%0[XHWR!.;)I;VJ(7@*6"RUML6F$ M]AGF@UCC.(Y'"B-U$$,_@$*""D)8A5&&BX=0#S"Q'@1$QX$T_CZ^@#>4/P;F M$#,.)R,7ZF$VPB\\&B)%]:&,C7QE#(1D->*AI[C<"B,`4)5RPX8#+-OPO.FC MN$<2GF$-Z\4N?JW\I]SUHO`US&I!J%S\]V'RRK?P"M$-HLL#I4ZXB"L7=9$( MMW`N)U9U$FO`X)HF&V--.9":![^&YW3LTT0P^]5AR%5<123JS[`VJ/RU5/M8 M;1*@7SNPZ'09'\^`1?.'V=)A.*V%R:%82*F]7$@Y3%U&$1#NDX3"%12DE=8E MOC@SO\HB8`!XW!X4)-SI*R=0]DW32%]\;U?D50%!+B6*Q3Q=D8MY4`5";HWO M?.""!J^%[D3\V0:9K&,?#!L]).Y#D*W%5]>E%\U$#7TJLR]]?B,J.XX%(@3ND+;PFPDX$PPO"_0G`DEL]^VR=W5[$M]9D[#"H+,`UK7INT*B;2G1 M.KDPS"&1\@J[\?"L$(S%$S=*0H,%^QR)?I"4Z+-)[H0,7 M$[401JHV+E\2)$\41LW=0.3Q8!RM`>&D%6>+6)10V5;F=9QMBO\54.1\W"-_ M!2[J!>:T%*M>)$G[-B)\C*;(1#V6`IHJ3J`41#F^N$%%#1`6O6L<>Q";!OBM M320@[7A64(#1<]<0>&SQ`&.8CQS*XY9$SUY*Y#"-< M2VD>)DY=I%H&^?_VWK2Y;>1<%/Y^J^Y_0/DX%;L*TG#58B>IDF4K1SDS8[V6 M)ZGW?$F!1%/"&`08+)(UO_X^6R\`08J4*)&TF*HD%DF@G^Y^]O7RTRF^831R M7PDF4(RN<>]K.@&+J-UULB,<47-R>8K+.,(&&!-_!K!3O%!"H".4M2CNAMX0 MA!8<3."-X7`)'(SKJ`(X#O)BLVETXP^4/8[PG?>F_18Y:5X&%']46+Z!)T)+ M!,A!,Y0M)-_5=S#P<@"W\]8+P3`BIR*JX.F08E8A?-5]:YSN.7>O0O\"O##* M@6%^1P4"`PP*X$6[:A"K]_3)F]Y;X*XQ,D`N0J2X/::DI_BK.R\`.92A@/JH MG]7):6;WN+A^EY8+`ZRX1W$,6!3P/OZ<`Q*&5VP:@Z2">[9&)4((KRXS(RTJ MVS!FL_'ZRD'(QBBR4-F&UFI`M<@QY86,[WV/*F5RLCQ1;(=2D,QV:*8&Y&+! M&#K<:(I1%]_#`J@Q"0N0(64F-FN`*79DM7)<.B5_;A`BG?$6]5%,I#B'%M21 M#,QLF5`E@.@RU#!41Y\S1I8LK&@&*"-Q\3OKJH8W06#/ M"B'(T0_PNW%ECT#R>T@L($]+?!,&7`@-]<+F@.5,O-]!R4`GM$8G^7T=!I*[ M9FV^D`PCF+*HCH0*?<%6MYTY;CO\P/$(..1ZD;$?X*&%>/1>IXE->RZ+_J6, M"W1Y>I]BYFTGEL_EEODVJJX.<+`2D%H(/!D;:#H^520(AW4*RQX'=QC33.,; M]L49)@J_!B)$MQF)(V`78PV@9C0^,"+N`(%T\).6?B8;!',Y`JHO;@3:$&^J MF"A)(T4:-BLI.0H7[NU7/K><$HP:6LG=)WBIQ@AN_E2+B(>JI+O+>(#K$;-( M00JB$F9D-+E&@@CCR)@&`[1MS$BD;3;ZQ9V-U!=2Y0OG^CE$YQOIA;D((1CF M%2E?9$'($MUH#;Z'!1^>\S.T8&ZD,.OLEYDOH[[A'BVR2$05YX M5DZ0Q>+)HK,W;PX!M#MT#N1]V4Z,VW:*,>SKM]SX]SZ)'OM@?K4QF]ORR]$! MQ(9BGP;?EL2_D)&A=48F\W2\>$9@V9BNU@S3.5U,NAHGV*8!6V\\85[!ABCY M6PU[!7A3"@^*.25):_DP3M%(!%YW0K8]`!'?`2]$#S(RHQQ4'71]EC'^'!DX MN0TX1X7L,P/'CE^L6=T!@6*D"_[A.:7K.\:Q&;XW3K@$XRQ7#ZL2]$E+N`8C M!EA(',$-AY3TJ5T7G*H"V\'D]T**&;$480S07N?:E`<.PUK"4)1D=J@/%.LE MRF*.]6)@`GZ23OT`-14;-:XI$3[RD(D2Y_V.1:R713BMH0C:GSR<8G,L)C=9(^#*XSMV_:&L-LG>H$NP"P^,%!THQ6O-=&:V\?:%WN!. MM)4L+_:B9(__D98%>K^OTY!K&,2QD6L%E-Y'>@7RJBS*E;LX6C/X@RM`(BXI M0LYR]OF#EU]'DPE734=)0;^"S8XR:NPN?FUL4L6:U)#G+/EBTI"2PE%33I_E M6C,E*D^!O4]\:_X,LO0;JB?X_9MHA)Z:MXY_5_MI"89][U\`XG7*>?GT$7-# M@H!8X5`H`S=520QV?+_VP8CG;SL^7_$=Y^Y!&2O2,TYVJ\;!6ND`3@_NRCP3 M[=2J-<%?9Y4D)QDC.,T;KL]$-(*;((JI)1V:V&AL(P:%F-P7#NC([_;Z>X$[";`KP7LB:9P@I7"5&DY*$9E M;+)(=_)U<^0KU>O"?ZF*UW!GK_'>6.YB+:BQH3G?)LHJ<48`]P]B!52LX8L; MCNI0%<8CQ`^G>8&QV+24,MTM'6G!I;W:N[?OG1NYH<.P$QT<;0;>*=(7?3\W M%3E:QF/!+'(J"W!P53%22H[^:@#1$ZH2J6I?NNF[;Q(R2TPB)U;)>3"E^'*;; ML<[-89VN:7)OB-ENO'O0DCASM_?^@@K@BCO?NXAU-07ZK":$!?I7]5P?>$4E MUT?[9"^-V[6:]8-HM.>B$>MB.NX4(E<=1<214!HD5]A8+?>N5$LNH.C;%B.L6J1$R9#3OHU21C# M(,O($<0RAK*%$X:;8N&<'$(&(`[%`DCWO4\WDI<3DSQ@/U-J?\.Y01Q)YZH6 MM\"C3$;!39IQ0V4+Z$`Z(*'`""D#($=5$ZT,;7C6=&33V^%QP=8WO/&G8*!7L@N:KU M4Q:V5<4W-O;*"4MG`8\@H7Y"1#Q*(H(C:O_E75Z3R]WB%MX)EW\.E,&;T*\B M#?\`8+"(K&'0&3N\FN!D!30Y)XJ1Z@IR2J1`2HGY)?CD M),VC2B\T!(,2\ZK,((CSU!`L*T,,,'LC^4TJY)IC)XQ1ZBR?.<7*A(')R&[#01$]!#G+K_IJ72*6= M:Z^[;;_7.V`O!@AQOW=X3)4PMFI1,A4(%LI6\.9E*OQH/I`M1R0GW(`]J@E0 M:E2]H_#-H?`'ZN^'O9;?B*E&1>=+]_C"9R;LPWLJ?1?`@,* M948,NO[!,+1#@"0#`M4&G>/$+3]016=E!A]!WP7[WF_2&S+*)93B+P0P1@_<^(P.#&CVQUD7"/-V(MVV$\U` M%;2$'3='#S^V-0(6 M$41/SAPL)WN/:O/`(%88+L,Z4><13_:!BXJM2W1J-&I.9"L&];F(E>PPTH^S*(!(DV% MOV.62HZEOL8C/E8!YJ9QAGW!H31E"*2));OOJ[\!B9(HSEBF1?`-/0!9A8H& MBC_7W#]PF/P.1==:V@)(M==N[77Z>WUOKK[1;[__?$-9EO8#MP[5?,A=O=TJ MEZ\&"XUVXKNZ"RSC70@"L6*+M8FN*F/B_E=EQ*62Z'WBBA>O3(3G8;%>4D%' M<4O&088M;W,W:J++8RSW17Y^9VA)._VP^VT2C9VHNC M;V`T[8$2E.PE:>'NVW@E[<(.N%@YJ=UJNFR2VL(1++9BTINM0W$H"PZ'7LG. M+/>$I?+3^'.!4`-B)T&28'ZJD\#J!MH"AB"-8SRV6V0[XB(:*$#4A%O7A6A3 M4B0,VR7,>%TXV[BTVA(3_IYZX(.50:\,ND(Y`PT?L%>O4`5OJ M%Q6U$DTXS9R\='3;QN4["P[VXCEB-B:?+L]!PMB6GHF$68!X[`"S<'9._]M^ M#O9`7O;4+(JE&7I&R?TZGG`"%:*7P[Y\:6]@2BR3U*D[=?JENWTGYBJ=))C% M/!+!:_I0<+T:IH)BK6_,6>.L9<(#C1TN[FN+5:D@F>N3V7Y,VT[X8].#(5P\NYNYFMS)W]37A)Z&+X5MW=29&RG8S-QXS3C M/I%<>LQE^?#A.(I57J2),F%$ZT\2%0F`DN$:>_D$&6U&Z4)S+]Q1+0:I#!:9 M\``:>D)\6S8/T=U)-5UU.D%5TOGI]Z"`E=3Y**F"I*LJZY>!R+J`#-AU!5@W M_%H<4`,Y@O,#.1@1%0%-@EU?GO7#W^B"L9LR\W_JSI@9SA?[9+_E&LJ865.X M\Y"03*N,N'T$!K;S"+<=K."*-0]M`@-!,B;AP5G1.AC'_4+9E'/+"W(CG`1^ M?D/56S-TEN5L?+%&KZAC*FJI#(.37D&>?Y.,Z43^=18"&H.^=(P1HQ+,KJR( M_@C<;`7->+5LH:00>CEH]NF=4J[:3&^"7>H>/M1S0J>-;"=*;CM)D99!X#4@ MN.]QKSC&FVDTL\UMC`UN[E^DJ7359:L>DX4$+=B\EQDUV!F>G4$5Q*CW'S1X MN=](C94$&5H+5#?.:1H&\1`[,4H[^32-*:KU?8BNIJK[0AN4FCDC@; M`&F>(?K$WSAQ,9Z85%"R;C36-JVN/9S!,^><*#FF\^KWG:[+_$P][1GF/57\ M8JG#MX*B\<0EJ!CJ%H;4J)#;.MB<,R>M:J"J/QKI.?#T(U:Z=I,AUZ](_9S* M5$ALIGE)S31WZM/&6--+934@ARO(P=PY:)%<^!1DZ!S.O0M]N75SEG_I^OO9 M'7RG:QY0G)1EQ1]W2:0CJDW%OG%\8H M->(@=#).32[%+=5<(G/!T`C('CN/17>VE>ZW94'Z&MH"=8X8OL?.\$:@[^P0BDOI'2PXV._>\!=[7O^ M4??`[[5Z?K_=DX6KZ5ZH%SIX]E9^VN'?[8=O["8BFG\Q?<\2GH9*!`?(GR;SN6O5[X MC<=2HNQYD94VKJ&-+["HQO`8*]D3AQ'I)IAF3!I6:SLWSJR)KSN#Z_8]7;T[ MR<`TS**8$O51L6(>/=W2`L,KU.?+UJLYG3!HM&A.HS;H4?JYR;JACZ9Z5 M&;F%=8/_SE+!C-T`%0'?^%XBO?F M[.3RPUON]3]#U_QM@CXJ[\W)Y6]OZ?5[H,:XL[?5\#H!7326X$N6*6>RSOD8 MG0?U]JI(_O,6^S7=UTLY"5AZIA%GIY;\TR%7.GDT.Y=:*6I)25D7I@_CO7HT M+937EI+Q27J+."ZZLKW(V9[.)+,K$20SM'9N-\)=U:C8QZSJA$LBK]HD@]WTKI9F?:XJK,UJV-G`**'?]?)TO1X[DL1P%>85B%08-N(S/` M$7$:.ZF3FT,X@";4*5_^?N?^5KZ[","XRX*)M/JZ*+%1/;OPYC?9?W-Y`OP, M^4>[#6RJ$9[ZV[[(-$U\JMO=.^[T6WX=:`+CBZ5,.HMY+`P.I[77Z0!`L`)_ M]O8A#+!+46!-VAQL9Z??#:B`:9G3%B;FO##3V>R.LMYR_).;2\/AZ+.91]G= M!2B;=5Y-W=Z.LK`"U="K48MWCM*GV M7NL(-@7G%_%A-.V)X%G!OKSF/2&FT.J] MUVWYAI[JU^8W(>">)V-L/?>"^3LZ#OV,O8LI?8H\;EIYXI[^G*IK6KGA/$DP M4:N;R9V,&D?;XA23NJYE1Z]99>M3D*$K4#/E*!<,H4IWDQELM#D+E"<`U8_7 MA8B#3`&%G'6F,W,"'E0&!(_]YF22NB#D?2F:3MYCAY`#$@0&@Z'Y5CB&\R4,#$E4]@"3"=(PR%]SK\C[Z1(!Q[Z(WN04`,R9P,O-_<:5N#5114I11TB`SUF M^LE$.^$5^CCD-[>40^X^E&NHG)E*MBJ*?S\'!/?YZJ%4&('D4Q@\V#&#E\P, M#"&UVPX_^,#SH+W+:Z5@T8^V0,<+!DC(GTL&%$ M"C`'/,'LS=/$5@)S_WY1%9B5\6`#)2'/QCTYM>FFW/FW_0[]RN)PB/#A,!7)1T375:DN^D\P28,;+BF-PYM7:NYD6W.G&C!A0%(B8K MN-+(/!D_FOCM++;ZEY_*?.\J"";O+FUUF96C%]AZ&N[R*["<#W$Z_/:W__M_ M//C/7_13/U,G>B`R2_'FMY1*#W]\4:._OCH#T#XO!1JSA+%4!R=I@^-)['0%HU0(?8^!Y70\ M0K"(\A%/\Z6.84Z'`'&Z)\B9CPI0/=CDS!A[N77.)CH02-WF\JX+`K/ M2J8P6"V5!`2(3IC@[(W7;;]WU/';!T?2W,?O]'I^&U7&:H>>ICZ>M30.OU*H M$%`1!J?#38"CQ9*V2)ST=\4KZJ:3S7LLZQF9',Y#@E MN2F5O(2YE12?PB8T2@Y.EI97/`"KS'FJ)[DP**;.3-.+%#$;A?SA3X2]I(G."^'TJ&TO3Q0(KIAJ!P8KJ1`9_ M8%B.N]Q8%$4D'Y>>J(M7`V(A MH@R8WW'LIQGOB41UGB;1D`N;RGA@,L(=[/$=2H5T25PI43S,YUV&LK8 MJNGJ0]3[$K+64VKQB0F"V!&`6AO$98J]=2,JC=HH0C)Z!CSS0!`_VX(93 MD:%@I`X,\%=E`>K`'X@HUOKY^=-'-P_@9YJ@\0E=G/B[CX`U>E;$R\"7/^<\ M79N:"J'QH[".$2^8*H'&[O!JIP^LG+RDYJ:CB#FK2_V_V(%KZ'ZGR8T`L\L_ M@X*XNO,"U*[*2FH#H6RL]6)/2SQ=6THX3F`(2'"-O@QLT3:H'J0M)J:M\T0- MQ\H0FR6&TDK@%#_N_8HA%Z=8Y3!,28;I%`YDS>YL;![+2]@GS#/G7K5.?^2% MF-]^D_4QSXZHVQQZ1,=FVAR7V+"_PD)"-:1AXC7ZOW7X@V])GZX%B1Y;A)D0 M#/?+9_7(X3J>YCB5[_4@D:OJ()$&MH0&M\R>F:?@B#]43RA-G/@<&>SN"J^/ M#D#S[U8;FC6QV;7S+(M]\S!*8]___O/K_P":#M&%FER=7&6*Z.8D"3_J>2]P M$>;S#<+(SXEWI@89N3HZ/:J0.K9JH1:78/*D>+6?OE.Z._`QWJPR(;Q+DLMF MA^Q?=AJD(ZZ#M1:'E%FFS'OLY&V`OT3M"LY7LSQTIOG$\'P[.$<)I^.^LZC\ M(2M.3-$8(3!*S$:D73MB/<.RYPW%A/;$8[XYQW9G_VV_U9):"A-:H&X(MIBC M\4!1H,@KJ0Z/\NM,+VZYQTD6#4V]+3D_8Q(^.?:.!\:^?GI_AF6!U'ZA)@H= MO^8]T3X@A_DR3GO8H@O'!C`=ZF!YBC(B3?;LI5Z4\.*`&DE^4;:Z"+Z9)DFJ M"ZV\'JX]1HVA(%U"N3GT+(P*[)Q!,ZMYXI1#JQD+?S)Q)O+\M`8[6_DE`Q_7 M&*F`*WX<=2ETN((>RM;L*#**3WSGFX*>ZBZ#T0C$4NY=DV#3!BI+WI%"GG*% M8W\*_5B4C'!1.KRY%CX?'QK`M05!VGZ76Y,^7EA"Y&P>96:F8X/L#KAU&6$V M=]T`KS;4`X"I#V-XPS-ME#(N*[AQ)VF-@.G[+4/L>"4-;9_0P05$RZ[0>;1? M*:5WG^*W!Y-)'$G=LP"D9R,KX321[NM?J]G7-6DH=&4.,C,1J^Q72LTTJRO0 M),L":N,6!G>D(@_AH+27G2)!J=-%5308!IUJV>A]L;I"K!#72*;&Z8V27@7H M=QG)W-;%3I.&AC8,@C"\W/T"83D^OS:.;W/`6;5MK4>Y$MO";]*R M_$74+'%$4DQ/ZUO$K70WH"3`K*B_EX`6_]WYS+C-H]%PF!;Z5U@!?5^( M'PL)R]@%[@UB^AA<3T02RU&:7O=:2#>-5$K68SV8:#U/S6Z"JKCU:RP+X:A, M>RX('IVRV"QK[8XX[F3>5K7\9"NTAK$/E[#\_O+30\VJNE-`8I;Y!<=DX'GX M)(,3=U(,UN@OX&Z1NN>;!(X\B5@AF-4V\5Q_/$IQ@EW^[@G0>4&"81_7$/`L MGP081_GKJ]8K^GN"?BCY>UDH@(45U^^`7;;^],JNBN]^?%$W[*\(EWEZDDT>_>ICBL25_?=5Y==\F!J0F MFH4&<0"X2PCY'K=-P`N*PR=$ID>MML.OU>-7^ZGQ:\[UTC^S&D?4*PS@QJXR MD!_A'MQ[FKWS_NOT]-.GL[-7<\`23GMX\*?W7C-J-`JF97!=,_.&%>@0W#,G M975I:IJ_`KWN]<)O.5X.SH[?/3I>"8B[,]5P@H%T='#XA(>Z)!W=7D>%FD=% M\RF'M#>,""K*9\&L$R4SKY9G&8^_V57@WS($TC[T.P>=C8-KDX^LT_?;!]U5 MP[5ZZ;$(W@=W-&^!:O/DWX69^?8"+K-]T/>[ASO\7^K(VOY!;P&INK%<_W-, M[=PFU#LLJ"M/+^4:NP=^O]7?.+@V^<@.6OYA_^"'X/PZ1?JEW%VWV_7[QT<; M!]<&'UG["(ZLM8"FOXF,?I[YSF6H#9[;U;J&'G_A][E]5F.N/FB56=L#G#DZ M?)A4>7Y?\`N]HVX'6[-NK5=L48+O"EQ?,62VHMUVGQ!I.OL=O,\P+4$-?91C MYX&OG[6SX^ZQWVJU5W>$3T/2+_)N#@][?K?W,)UTV;MI(.6?*,2(']ETW`?& M<)J7?L4'IN"<\NN">:LOT5F$AY?&QWS[LU=>'NSPH^[\/8. MOUY4>/MA3JA?J?Y>1,2[Y_>G+(&:&^NU>8+=/C%8J[<$%\R/.'6:&E!>..E: M;X*W]^_PQP[E'W<6"&/NDB,VYD2?QW4ZCV8&"]#,#^+]]A>ZRUVXX$D/[+F\ MA_-P?OAB<+Y/Y0`;!]:+.['U\_GPQ>!\Q^\=KSS&N3NP+>3SZN7@?.=AT;^7 MBO%]OWVX\A-;/Y,?O1B$;[?]=G>7Y;GV$]L$-G_U8K"^<^#W.CMU?IG,F!88 ML3^@.G_]8G"^?8PYNCN%?JDC`Y6^NVZL?Q)>'[T8O._V_';O82E:+Q3MG^;$ MUL_K?W\Q.-_I^-W^3K]9[L3Z/R:G__9BL/ZXU_?[![O"K66/K+-NI^43\/KX M85B_Z??57F\<:E/>,>MX]GY$!C[^,5&YNT/E34;E)Z@NG('?R4,5E-5DD&]A MF=HCI,`FY]UO[X4\C%@WMV3PA6K#;;_;[?O'NWC8DH?6/O3;:\]\>`*!];/* M\W<\PPD;H%/!U^"AC2%VS'$GJ-9^%\<=)-=5%2S_2.)J4]ZQN;)I4]XQTZ`\ M[OM'1^MN0O1D8DA/P:(1T&FRXWS+<;XW;;]S]'`"FG=R._MUV;OHMH[]H]:J M>C/,N(GGDCZSFT7\C"-6R=.Q0KWQ13;S>$0UP:[/RM->S=&!WSIZGJMIH&C; M9L5\]%S3(V@??WTE!>G/V6WC7D6F^0;DC;T_+8V1\F27GURB//BX^Z=[ALK= M>6T>W7@T8[K0L,EKG'L#%=`<)Z=KBU?MV$(SK&B\-LWID]E9(V?-=O.L&ONO MDX+&Q>+H:CT5,)T4SC`XIS<-SN>.$ARNRUV##6!F#)9,XYH$$7Y;'0"&T[1D MJS1LS@P,>]W:!\[7IGW1F"GO3:X4O"=.;]_N.X,0\96A&@4R_MN96#8#+AEL M15O`+VJOJ@^RKVT7AQ"G)4`-JYCQ9,X&:+2[A_=79HIGES%P^SN*WCB*7J1X M>0F*[AS.I>B@F:8?2=*\Z/:3=!/0:Z/RIR+RI3%^4?Q^_.^>&]I%BJCGT-L_ M@H0&(+Y&LCQD8>($0:>6KZI!-^&%E85^&9<(*KP_]SHSY=#\W$Z/.+T45JPZT8K4*D M?_E4PSPUGSB:.R=]OK)=`79Y*5T!H=V^1U`O19$5R#:".EV`UJQS5&"Y7_^H MTO:*<',V`UFCZ)U7U_ZLQ,FSU8_71YH.`/<2YE=!6*`8G+%,M,%SDFL$#E=4 M`0OVKV1:?!4`V%WUTQ@7M7_,[*# MD8-34^1>80EI4@&IZDP;PM,!8`,_=QW)E/&/G$TK`"RR+6N$,)3^%3JW+G9[`+GK@)Z[W3R==( MQ?.Z&#ROQEW&=UYGOKY]CROLL0JWA>!>J;Z4CEJ!ZQFDTTN52/.Z$SPK+I^4 M5_"!=\`N5HO,@KW&:J MO//:;-:W&S4X:0;0I,$1S5:1_TF"^`+?8OJ;1O2ZYV'G2EL[TL]KO[`&4=1F M4=!9BQ5>`:'7B-D/9-RSI='.^'X\#L_KN_#\C+N_5@PV`.SP=VOP=Y&^"O=A MW=%CL.ZAF':T>DQ;=?K>7/3:L*2<)V%+YPF.S4RS$-5$ODZ9;HH7?UG`>0=9 MF'NG:1B-`+&I9`TAZAVV]CJMO0-@)P)Z[_"]\RAFI+F-0B[5$%$D4F(X?5") M@A=&<*>G]G+.%&(2_(:?QC?!!<=WWDF(4),*:W].@'Q!F'+OC0/%Y:EGP-,? M'[U_:[$_4\/T*HG^``(($B\:#U2(SI6!A#T2'GP(F`V;GT="[">)2\8\!8?622)MA M&.&+X"&#WL$D*H)XOV$[#`;0R%@%.':4]A=<767J2BCS=;?=\UN]XSI@.KWN M-E@$1G7/H1$<>A="WTCK_OPM\716JK*RY?K!50#K\SMXKEZ4YSC7/BPS;6/? M`:?RV$.FPYX$`F4L>E_)T*Z\LX!-#X"P9'QY,98(?[TYJ91I.IW")A M]7HS+";HOHA_P$W`P8S*ZO'@R61J#.OA35'U',)@6S'`2IW6@0]\C[8UQ8M< M4O:]E?$7QHZG8P?55\X@1X(!3Z#7/_2/9I-DM"1%:E_Q7/AKE$BP/"$U$E8R M)5;QH8DF"1C9K*:Z!0A4""IT&8X#9\6/'HB+W)Q]D.<@'`T_8$:ZR$'B]0P4 M)64LR!7JRNO32O@U*1:S`^>"+P&B3N!/#J$EU7>1)@I*`6((\)2$?3]NWWFKSTYE( M2]EUHC8=O,^1Y>\9EO]2D'<%D?(&VPJ/=C5XZ2Q.%%$#P"(G@?(\"'J/[&"> MND/030H#/!5Z.HO/1T_FG:[$_^'0,TW4"T//CU5=,)]6!IV,5%^?(3D7`,7B MH*8#SM>_)&([)?]))WS-G;)XM=>=XZ[?Z?=\G>X:W:CX[D7<"-A6J8Y.4Y4M M"34DVSA65TA5K/\J[PT>IN-,D<\=/XI6AK0EZ9X\*$=C()D43%.^!+1<%9`^ M\X@A7?'@CFYL%,6()G:X)')C&\V&HSFOT0L$1U[&`(HEC<)/3, M'5-I5.1`V7!.()#D8))3/0VIR6RL:L(KP1F!-*HF4R>6!RT;@\0R(5'*GBE(? M6$(WR1(@*<$2VW>]E>$6O MX)OYO4SX63+9]/KNB]"5S<<3V'/%P<0>GB20X!![< M(/)TYC$:SSWT+\1X^-=!;FV5(D6I`?OM'O@]L%G()T(74'7-G$REWCO"V7DC MOX;1P[P*\:+BNZ[#1BA$+I8<+B`?:>30YW<_*WL@A_K+3V6^=Q4$DWZUVD6*-H#-HMRP98D$`@!W`TY`_S@I:0GY^BU*:H#FG9Y\DPS29I9GB[ M'.K^=J+$CX+2+#$(SGX=C6?AX;[W*0!D9L^]:`FS?DM&&`B](F9IR?3BW9#. MDY*&B-H'"&$FK;P<`)8YH9/PS4CI)Q-@-J8'=@.=%+#LH\2E0^#=J\`T%0IAI9 MG-JB-#[E[42L'X4P+,\T84_1KJ88K265*9[:J`3/;&G&6BLPW"PD+?FNDOTK MJJKC_4L\]7UX'217BO51TG+9Y&!Y0X&*6:^31\E9#A9"JW-0MTHH#M:P74;2 M9;9L_U5E';->4F<;_9E,:[OE238J*4='F13^1 MK*22I-HJ.M>@VWO//S)_OL4FJLWH)]O[C49`2*457%Z;V'B_Y64*O9O:5Y%/ MXJA@%U&BO,Z!=.#R3N*XEN,&!*DY1I0@,;,.CPX',B\R561I(`Y/R@G!WR(O M8`C$4>ZS-3Y&(R!1:9EKEYIAV`*3T4V38::"7'Q:CM%UZH#7:+6@HJG9I(FP M,OO:!W8284.SE!U)F%3(/-E90#@=>8@ZK;J)M^\!9_\,W(KX>J\>@G;>HP," MMV(XVAUIF:;_NV-G:X'?%='L/>S58[+L50W((>W8LQ0H(H4+?8"`GW/M78/G MEPHPH,#D*M1^M!)`WQ1.ULY'H+=;U)$BM#M078-5+&D#.(:8-1DCH<./.BUO M$.2`V#57^Q?Y_27^WO&WS])0!;\)(!.G/HN2(*%0R7D2PA7`-KZH*W38HLIX MPH@/>I23+WEV_NN7$V<]+YB`EGDC*D4%*N(T"O5#45%K#E#Q.`Q5A(^WK1;9 MX%^O<##D?_3>3H/2-/,I@`]NZ39!5F:L@BA$)9&)F1R_HXQ=T7`F\FH.6B1J M6+UY`$)=I:@J.;RN\?3/IEY)C(@:T8MQ($Z';>1" M_6;K[2&,R%N("3&#>'I&Y"W%A`BJ'2/:+OA/BGH.?"790N.M(*$$.)-J,B4A M$0ZJPAP>>K;3\H]0OYC.G-BZ`]KV"_[,W,(&PP_K"G$0II-"C#+J$<(A6)0; MZ+(#>KV(@\3EOO0K_-#5.]WF!\`3K->?65HYT?Z\=J?&+RO,D=V=R!YH50D^ MH95*"00EDZ,;O&T;8;J:1LR@?@@0E3KD(J726)Q7\=[?NZ5@+J7B&3$0!>GI2.?;[ MS:3B:3+I$"P[4ED;_#9EDV!L+N%QZ4M'%3FONYV^WVMW M2CC,2"#ONN(U(V?;[_;9&2E<*V&.@?]7L[Q6^'AJOF<3V_ MVYYE42#:L#35=5"CAA@0_%?XW2A+QQAV(P@H&XBX8D-\;H-+"6;*I//J=:2$F.+X+L71\$@BKE+D2[5+'(SO1-] M8$.=%3@JN048/(9J$65$#YG/`$]`QQBU"K,E1*ZNSN6U.@Y/V7[<`SNC%V8* MWIWD3U'YO,XBY]^L2WFLBNLT]!K5939)Q4.K M'T3@[>>4#(C0M[B0+4O%"PF.%F/4NBSF'N>Q]+RK-Q#L+C.@ZZ M8IMTC_DB67X=33BY5=X&:VB/C_H>Y;0AV!X'."M;5*;Q)=7]J2=I++5.>G8Q M`G.!(FK_0;9C(+TBJ+:^TO4(ZZ-E)II.U>3\ERD,X;82H+$#/0Z59IOI)$I$ M7QM;[&6&H*O0/,`0[&"6>\!K*+'21LC>HVF)'`@M@#CZ!L@F`>&`AK@Q4MFV M%@4VK(O)C,"K!"D;8V+R/O4:2!/B+-0)T&%DFK$T"7ALUW9Y^J9!7!9JWCTWW^U[3W!RC_\&2/?[$][E/PW?P4:OM^@.N'^_ MC:XUE;GQ`:>?F)8,8#H%?A=594;@:O'K0*K,0YN@`/\845;[*X*-3K[';RU,"V!'S^*2SSP];.PPNYL56@Q_\P:L./'Z>CM M*DVH4W"*>4+42C1D8E![N:--B$Z+\8J6;"N91TCX' MV&<)7H*-NE@=YOPM:H5`YQ^6ZEE/V3J+YOE\IOH.H1^KXE@Z24+Z\`-J\!.`_FW_6V$M0M6)CDORU()[&4=CV,EHI$RI#\`]L^]-,N]4* M6`@V)A%K<4Y@P?Z164SOWV\JL$1'1Q[$[,%V0/.!X5T%5^RW+I-1`'H*[#&$ M.YM02E0P9&XSH>C94!R0HR#.A>_9TVKF$=N>Q9!(9_`G[YHS86#$%B)X<*W69IDL@)QQM-S`%QO,N'T,;9-%=,E. M=T@D[9N=AK\EZ/CC8K_<`[Y%&>%PM&56L!9P"3P<;BFQ7\+Y(Z']_VGVS3?= M%1M;,7)=<[T+ISC*V,?&W7X[7?^XW9K93Q)]Z]"=[:5/]!%*+S6SOBM,.;*3#$1I!1 MD9(8SA1(DDP<^E-@OAF\M=K4./BF&`U=@O6$6!LH`'>$$&T(CEW*=]4),!26V;A"*\S>&PQ)#"K8J81('26[[I#+Y M:ISGUOJR6;>])T(2IHS@(!VQ>2K;#&5&AQ68L,:=B6'9P[I.;Y6T1`;PX+[P MLD"G0/4_"W0;3@Z;3^!%\$DC`EV")AS;0:S8]+7>\54.PBW/K&*SSU&A(;V) M0F:!TU$UI)@)@<,!&(S\-)1\ZDYBOG,ER,PC$M\#7L$B8O(X\*D3ELHL3$$V(H`/XW56!@R0?Y%\?4,T]FK7`< M5-B7I#])6^>800L-HYK)WN67R*2I=IR;G'WH#'8MMN$SB&OC/5[\?Z=%W1!-C[GU`(-C5>,Y-WMP*X,1,.]!]\ZJ[Y`[@%+($-A)K MU9[4^I%"@A$]3QX#`P875-Q8^KX>YW2$H,+5%P7R_$Y#&TCQP\X"SN9)OT0= M5YMC>!#NXD2?*-S#7$L`.K&G&$`*C'B([MW:?2;GNQA MZ"LBWZS2;BQ";#/ZPK!^22HA]J]304`]="0`/'?G<]:]7AQ>MI'H`;NF]"J]TU8 MG9Z&H8SY*EH(QE&<3OPF7=#]"VA;='MT'ILH.XZ M9?.J:?8B5"%#C!?!79:"X/P:?']I%M/)S`1`BAO&44(]@!G39%0,F]C87$%+ MLXD<8($'V)#E=]R1$F#,C:6T2TE##)T(6&4>C.F\2]+:>3D"0LG0'!\[`7G, M3BUT-N]7*-\4>9"PM7NIO%`G4G/:I,W=G:J(%WU@$,2DP.372A78!)1#A)50 MGP[ZUA@9^ZC9&!(-Q,CMW+I0K*#D+#,;>6!-,2C.HJ`ZV")HZ%C:1@@)]/U&_:*K7O* M?>>HS-`G19V0!8K$10<>%&K*BDBQ9/75OID<4'K@%Y9PX,=VO9?%Q5@8[GC8 M?!YF&)>$08@):!]HC6WU#OQNJ^4[?$NSI67XE[-.G7M1!D=D1RJ89N!P[(R!,UL-:V)G8VI:E>6M@9^R! MC0A\UA&!G&[@3-M;Z:`];]$A>QP+?)I!>]Z]0_:`>K_PW%[:,1T( M_4#P_.\G)Q<8Q88%(L7SUH4NI!R+U&[*TV#GI\1E!HYXJZ9YYCH$19B.!$9R MFIY"*7=[#;>([DU)B0FPO(6JYHW`HWYT.2;I1J`PR(PW%XCK2&487;ACJV"" M$P2B@DHP.9W%3D7055SB@8'O,>_%`7??^\TDJU+Z6Y"%OKO8V#T_`@7E/2@C M&>MO$J>'98"/Q;B,.Z6M">KFGO?_%O"#>C,>C>F3U9MZ3VO6Y.;:]' MWPN+^R0OLMG;]_C4.`4# M:`_X`Z44FF+$W!;I8BC,K?Z4K5.%O3T0['?#23'Z74;]`)JGD!BUQ,FR=("M MWG5I\IW[$F&L85`$?$SE`*FXX$0@4P]9B=@TG>`+PLLNX.5O23J%F:*CV.I2 MKB%/X_3JS@2JV%AV[E:>J&OW9N1*1C%*C:X8G.ZV`SA-KN@"( MTBJ7%0D"3^L0:)MF_W'S%'* MWWF_K&7,T3"T!F)COLT*#;FNC/XB01RGCD=?F3F1.+U%(TD#`,?#EX=Y/=.$ MTKSHRR`&[$>&-<*HO1GFT#1:(LBO?<\TP.7T=41T7Z2B=GOESJ^D3:ZODR"< M3USKF^U4^V/,\B61C$F=[/1J;%KA."BU8:WO$6:O!1I%><\_^BG%K)B*?7:MHB M(.A>Z!CJA\FY\XWGZ0ZC-M1.*<#ZI-[SGF\CO&PR3+1#M&)?31#7$AT3P@P] MAQUIH]V\]$60?E.EE06EL*W2DW3ZRJIZ@S'![?.<_\WI'0NBG4[9G MS_)I7_4UNF<7#IG:78I+1R_8-8^0":-'!L\(BW' M(])FC\B_G3?^0KZH5R#S(WZ,W_0*BT2`(\7Y7U^=_WKVZF^=X\YAYR\_+0G0 M"O?1X-EYR#ZZG7ZOO[)]T`7.?'91!Y4%^K?+CR[$K5=_ZW=;K=8TO/,77AVX M#=@S%]Q.M]]K=S<*WG_;Y,V+(`K/DU,>2SF%,9NWFR:4!8&G\UT&]KGH>-PB=%QXS:<"\A$4M3%;>`:S^/3JW1 M["K&$C=S<77QLTI6W9ZK*DV7"UV[+5UD*T_NWZPVEMZ!E7&-K(Y=4;]/*'^TCONWR\+YL&VS$T\:G=S MR:#77UBFK7D;CZ#U+=KD:DCE)$1O*O=S2F>_3C@%VD7B)_=(M_O]]BQ'[C(@+N!-6NQU M#Z2/!WBW5@J/>_9?TP^RQ`)HO]=MW>=07`S09]_Q(S3!;=WRBM0JHAB&K[+R M2?YYQ"O3:AB]4_G)12:=U9Z@8;(>*3ZG6?&;+.QD+6>KA0[?8.*Z&#%=S<@^(7K:/VBJ_I M(8?1[?<[AZN]$SWA:CF*6NV-K!.&SG/`,#4!BW3F)\\MZ'7;=0?9+"CJ('^0 M]G:?H!9G\YW]-D^PD7I4)V^[H!J9GS*>EBC1UN&YTT;5GR6,I66 MG!_X?-CTN#F'SXCU4WFG7`D(W""^H]E4(5431&&$30VCW&GL;U6/PG+7`&T?#+!U>1Q,L]1Y2PF>.77D"[``$ M"LW>-:(V-FN[PC+"&]-V&9%X6'BCN$R!NPTIB9LZ+P^P>=F;T[.?WW++'+>? M&W;-23PU3/=`>&"K.,SGQ(P^M3?"[EC`0JD2GEH;QX7*$@99YTR'BFHD36VW%]?!&^*H*"-Z5O#FOH(`,<"LP);,.;7Z020\^L_ MN9`WPV_A[Y-Q\$>:(*80&(FZC?"%`X,^!%PA2?NJW@&0^XO\+A54U.1(KU?@ M;>Q[YXPXP9"2^4.GR9)MO,3]":C';Z6)GFW#M%@#)0)BP29*FTWV6\:>*&%8 M4M.E;S'<_V3"'5`INUK*34UO<8M'A&N()T!6Y>1*>N)1\PGZYJMT'(S,K\TP M#.JUS@SDYT\?F>SI`9;$\%"EAZ/,;TNX_S0@Q4`_/8JKO&.''BM%#VK>H5DE M]DO3_]]ZDD!"`CXJG$T5[9OM`L6CJB-J6\-XIOP:^?' M&HX;)1.V$X2!RV3H14Y!SVT0424\MFHK9?IGE$3Y-7]8#J]5SA6[H'_BR*0, M0<7BVD@J9F!5;$G+TI_6YI$'V)`UWGB@?^[]1..+Y(@?3OMLS$1DF+E6ID%5K]^KZ"*UN21#5OF>DH!;=$S:/8 M3G9[(DBCBERZ+\LX!#4I;*$7S\S@-IX\-P.P4"3`CJNM[+[=ZV6?0=,52ZLP M-G!T+:-H<=:Y(L8"J-QDGN[5S5._T3@E!<_QT!`0;)?BNQH?<4S>:=N5>PP7 M`83]&^M-`D"X[@F)5/L1$`?F=FDN32@< M^YP$@MGVN.&9'1JOW`@)PG2B,;GADIWZOMF28`X?O]\__(5'N],7EY,85,FM M8/V?<209G!QJ'HS^!]+_?[JC.P]_#*CVWO%)DKN2*F9%[L[U69K^?Y=JB%H_ M:TN7NL&A]E9IHX$GOI3X;4!:3);K%E8YG3)54+9Q:>X;/[N$$MG-F6%RYTD( M)P6K`P?"/EZHMIU(#\*[REBQ\U^_G-2;IS%8XA:9`=;G89&B/M($CLQ9IH5]9''8A3D7K::J,,`3% MD=D=B@=^;66$$CLG]=4"'.HJI5Z:>!B-MW$V]4*JDZ7!O]1G7QM@J&&B:H>R M1?%OF3U/>#8$EN62XESI38,UNZB,X"O5*)9&DR*YVN_X@,S%$93T4@K!JD3: MU!0UQ6B!*G3RIF$5OV9%W-[.R@5`^BP-I.$]=?;7/1X%4(D\&%RZ7W5=@!O5 M&=@7-@B^<-$]7L16:JYG:5:Q;:0#@YC,Z'.JS!GD!@.Y>:1!73VQZNJE:;AU MFH;,T)"#';3Z?B7&Q.]RCI*5UT^G^(;1R'TEJ#,Q.B>\K^D$M)MVUXD%.3SG MY/(4EW&X#F`G?V;;HW"C-V2XR/.&'E@M-#++&Z-2A%XRA?^'Q"B]#QA0:6MD M^RV\\]ZTWR(YY65`'EIU@[VRAN+UQI9O.%54&K*J[Z"PY0!NYRWUFD53D$1P M.B1/8`A?==^*CR*.S6P,YE:YGCB"+A[=!(8F4M-@M=Y;P+L8J4"WEHMRVY[A MCJ>3(9?Z6&\@8W:/B^MW(?G;)C:FJ>R?F3AU:QE;4[M<08)HY_6LT%>HNP=*[0I\30L#7X'3B!0X([%_Z M3U*#'7)Y$1K6QQ'I,_%^!TF#;@/3%\,S,SU=&*;73_2"(KW8MRST%;KM?C9; M#]X6.#4'BXQ"*%)R(9Z[U[F/[7J_8%_D"6@)GZ05ZXGE6[EEILW=;A@X6(7; M-(8A\%ALB.WX+Q#!'58H+!@[2D7)31K?*-.`FY@BMW:DSBLRVFBL`=2,`Z>( M<(TYXO5/*,TH]J75WS+7'>'FSEHR4R]Y>"+0I%E)R5&X<-^O4=RK'M3UB5_0 MEW^JV13_>"LU"C/*#QN#20-X=`+KK9G.8]BH/4$MSHX(3;F-WS`5Q\--=?:H M>P6^X4WHZP]I.K##PPN:MQ6-4^)I/<_[*9``)( M5UDPMHU@;98)+$TP."(*^Y:3QBS-YZD1/8U.1GD&YX#1&!(A#NYZOUIIYAYA MO2\]BQX]0LH9O4Y0-(]?OQ^M%\#2.F+_EJO/HT\B=!>N6EZ_/Y==LK;SE6YL M-VVSB"6'V(N:"FG!#>[99C^N;=9G6_;K0)DRIZ;G,@5.TV'6+7F@JZ8IG@9I M!M+E;H.KDM(*3DA=!R!PBAXF#-"<`1[KRO-CN:6?CG2@RF7@N!]!JK<]-9,> MJ`!;4,/_H9EU$V!Z2[Z5;.Y,*$O:%+HHLIS!ZQ,3N`:I!<@21W`LH4PG=^8] M!*;3'"O"F&E#K<>Y?1;U,N-L*S]TCKJ?L<;NC+]#4GOJ!-]U8W/*( M^KRY^Q!BH2NOX\FYA'NW6P+6W:H!9BC!=EA11S(T<>T[3Q1N[#8IOJV<>H3K M#KA.ATH].R#+B[THV>-_X%@#[NC*<0%16W+]+MO:')$SBW+E+DXS!V#!JS25 M7#64)V>?/WCY=329$,]"*X%^A2T+,T698FR%PNF('3F\AA/$`V419:9]8FC2 M<%(:"TE6"`]6,>)LD*7?D//@]V\BFI/^UK'&M%5%,.Q[_P(0KU/.8Z"/"&:& M0$9^Y-2$$#=E=`RVTHSE9A_DN=^NA2;67NX>E-$*K%ELN32.Q1[`Z:G"'FXT MFVMNB%6Q+=;/N3U1XJJ1(#6W@<2^^7:6L].ZD=I&!S$Y$X(2EWBHI1ABD-0F(A]0?QY]'.:7/V,D:<3\C-LN\HBWAM26^YWYMO[[1ZTQ+O4[:%? M%MOD@HEQ$>O\!E3_)C1+4?^J[K&'5U0\]CH?]=)86E7?/2:C[L44]'/:_QK_ M`HVK&$72P!?`O\)V*+E'<^+PEZ6,,-&[)^?E3:1NV-CC0&>#F=^P:YS]9YQGXJ9&9Z'P1YJ%D4M+4-2P8P!;Y(8WU M0_W+*EF*&^;+')O:SM(1]\>?NF=GEK@#'M4=$<*JT.DYO>]=\@@?YR[A''1W M;W-7H5^]*/J!9G06@30,VM_-00)\NEDEE![8VO%3`4W.B?Q/.ONUY#G,9NRF M=AL!NXETL,8,NJ"P5I4(@SA/+:$(L&P*\EM4R/F5CK>@9GPTX"N?0U9O?6 MUL;0ZV[;[_4.6$L%YNKW#H\IV<3F=U4\A9RB44GM>IP7X)[KFK;_<2#EU^#[ M5E]KW?Y?0I@>]EI^T\5:>%^6; M.6.$ZI,YV,&CDH#3Q1`5`IE%R4ED%=;E54;`V(NU<^P,QI(B15D^H&DJ]%%A M+IWSB*?W`8N*$DDT9\0F+FQ=NOPQN`?GUICOR.?DZ&MF5AV? MB`7$G7FLE=M0#6:'(3<$#;8%73\1&F$L[Q]!4@92F*%SHDW:A)A$-%_82=AD M)DHN[77 MZ>]QQL1M*_VG:P6''D&IN(WT$KW<`KC'IC5[KZ-.6X7=L"EQ#]CUU+F MG]2AV60_314S")"]?H%T-V.+PB2!&.Q3K#6]4D"HTC!W`2( M;H&%N-'&`\@ MA5!#PC)21^#@(_:*(_&*DHCEDRAJ&89PFGFD1S997\#+SN:#SA`"1BHW`[(H;,&9*5 MI.)LU%F63B\4-]5^9IXXH1C*97&+R$(F]9ZSN3!VCIFML588X< MD%$SPT9>)/+3;.9.YYKG"IO,%)L(C(>FO6**^AVEE=S-?FSO!;'E1 MR+/'V:>4%!G;4-A9PA*A9%AR1B]\.(YBE1=IHG/>V8]K[781CP"4=$':RR=( M-1E%U>;NV!$K@Q1N>\)%P3RTC_T'-H#K[,(5N9)E/1VMEV06>@:$;TF5.TD5 M))TRZ(*&R+H*8EZ`2!L;M4VUGOZL2Z?/=2018RCY-L5NIRTJ0QUM4R1ZX$_9 M5C-L*?MTO]5WE#TNU7&\7WA;55IL'X&.[3Q"!3V>>]R.=DB0V>9E8^(AG%6@ MG9UJ>4*W#I3;!+F0?-&=8Z M=/-#ZUS/!F>3X"!D]<59AGC*>#"--K;4PHY\U?V*NF;5UZ2F% MG278MM-I])Y3#JFC?Q;/]ANIJQ9P@A<`U^(8X3"(AU@<*NTHTC0FA_#W(5J. M56O$).R@;3D`>3*@'X2*!]L/]6Q09\]8S*X'W*=U17`*S#<(@B/-+\Y/":** M/'=]]SHTR;7PYO=$:SI0[KB4N<-906D*T=CHG)),._;[3 M=9D9)E5Z9QA'K#.Q(G7X4%`TGKCXXT-=54FUDYR&;N.X3JARH*H_$O6X\J,% M2BV7EWEUL:G[9U]()\^7%21"K"_(A]`Y0`>2[^GS\.!`/#J1NM;*OW0C06SQ MW^D,(&0Q):=H^EHMLPF;U23R*0FM]/JVH-B9E[SO?:#J2LPK<'YA]$_#(D*O M)O9N*<=4)\^B]^M*.;E0N@!;BK3+@F0P]:VZ2+'A343Y]V$44]LAIYJ[5C=N M,L%,"'YH)NE03F>9:>/0S!D/%="1*)DCCT*JQ\=^]X![:/3\H^Z!WVOU_'Z[ M)PM70Z8H^6>%5EGUE>B8ADD@,->$R]+6J*E?43_>()>4-W(AT4YN*0<"$Q;@ M:/;TL2Q0I6>)]Q[*FTKW3XF:.<3\)N&)+1*!7K2 M&%9F43MQ4$\79FI:IYQDYT@8&>W@A+OIHJM0`*Q$T4/\I`ZXAAMV#244P4Z9L08UYD:9*BXW)L MZPVV4E"<.XTP:*ZZSA)9Q$_BO3D[N?SPEGM0S$CG^VV"AH?WYN3RM[<>;[OG M%HI^5N8^!>P4D+Y;6EI#N3V>+0;E'7+ICMZ6A?TTH$245, M#`]1+\2-P"9*? M[3Z+'5FIHCK_IJ\&;05TH[K!P;I+->(FPOALJ4'0>&DSUC*;$#ARLHYVMN2J M6(3NY%7E$$#[AO3-M7:;B?O$8ANBKD/K>.W4C$/^?N?^5KZ["$`[RX+)-6BA M)?;!D(Q!_>C,/AYO+D^`/R$_:+>![33"H]^H%_LB+1;QJ6YW[[C3;_E30']A M*M-0T%G,8TDT(*+3`8!@!?[L[4,86I>\M894V8HC*&Y`HJ=E3EN8V/.:.+NC MR&2.?W*].QR./IMYE-I=@%)--K.A5F]'J6N@U'^4H-4M0J<=ET[/G?QU'>P' M4+`@B80!8C]/I7O#`>9NO_7V'9!33OAZGJ`?!1M#[E&.K6??YW&^K7'VV.S< MAV!_IPG[]:9`N3J"3<$Q17P8<_=D5(Q'[W)6GB@A#A74\_1"WDJV666G)5195.5G$XV]**Y4Y4K4-4 M&6N!^UG.$5?MO79%7'VDC.P@UK:_#0A^#"2!L:I#XH_<'M'XX!?T_V[S^634K&I7:;EC..5:$DZA2"+ M/B+*F35)OWF)$33J%1*$,>49-&;D[R=G7RZGV(ODS)N$ M8_AIHS[H%%VPRXOS)XRJQZR$%3Z)P?*HN';7K^ANVF.FTTSYUG@1^X+)Z[JK,4)[X&+QG@7 M;B&2*2#"T'>*#07R=T_.Y)]([A1<$Z[B.`?T!"3`P=KT]P0SU^7OI<&^C<+B M&G_:^M,KNRBNEYD_$9'HHU"_GV*J8*9I40:*3I&.WWL"RA[_#:_=[^O=/NY` MBG`):,`0?G90ABG>2_+75YU7]QW2@`:Z&,`&,0Y2(O`\2F2^#_8:OEMB&QD@1J(<'?WJH-K-:^M8"_D]5'*"6R^OA.`:B19=_ MO<)5CQ]S#AV_>W2\EB/8X<2FXD2[Y1\='&XJ4BS)]VZOHT(MS_66X'1DHH'= M/%)YSI-PL'7H*HYO(S!Y/=3S<(;6/O0[!YT7M^^7?.6=OM\^Z&[4OI]+.UN: M3P5W5,)/:0?R;VI[L$/>]6R]?=#WNX<[?O6"MMX^:/L'O15HW3^L5O69!D#D MD]*96&&-R1W:K@=MNP=^O]5_]-U:PHA*OR8H>KZ]EZ MM]OU^\='+V[?+_C*VT=PY:T5>*JV3I%Z9'B!,Q2;T@M6<)TSPF\;@>"/#U5O M`["/.&R@J*/#%>AX&W6,VXV1FPG58R1U!YL2;`../9>N.;V3[N+[^)H60?P4 MI]G=="+I['<0'W%&#XX>?\09KB3V]D`8'W'&Q]UCO]5J/]'E;P:SWBXLW#B$ M>_#)'1[V_&YO!;;_4^-6`Y/^B5)+\2.GY=,CTH5UZO'__O/K_V`O$-V`Y]>T M>%1F\0^0`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`H+Z[AY0I8\8_3ZW++Q.@+UB#:?K?; M]X\W+/=P=^E/?>GM0[^]W74[ZU$??U9Y_@[GUE![22]-O%`-5C(/8HN$]X\` M[(\NZK<3E!>G-AYWD!D_27?GG?*XV0)\^Y2&;=847\J:CW$6'_?]HZ.MG@2V M3J5P6&:9@M]-4E@B3;:!I>]TPE7IA&_:?N=H1>SQD4?YTCS9FPG58W"IVSKV MCUI/,I9A19CT7+K@H^9*_)PF5QSC>2H;?;OFEKS$Z3FKZJ"U&YZSH@O>.'Q[ M^!B]`[]UM`6HU<"KW=DY"\R[T:-QIL?L?!J-U+"(;M1Y,DS'ZFOP_4M0J"]J MF";#*(X"5(0?,3NG-G-AD;DX,X8N_%[F132Z6_18_U?=P#%\\ZZ#W)MDZ4T4 MJI!.+_!N@KBD?7F9RE5VH[S@*HB2O/"*:^6-RCCV@C$[AT?T4:+@GQ.5P4,@ MC^(TS[V!2M0H*GPOCY*A\J*$?IA.H@3?"\_!QH(K-49S8A#D*O3*24H_(B!4 MD"7PKMR[CO(BS>[P"8'XO1<57I1[XS137AQ]4_$=/!8DF.:`_V`H9?W>SPYE"-%%@VH5<$W[T@SU61\U'0MSA9P^NV M?`_OS@M@5?A\E,9Q>ILWS%ZPLS4,,C[FDE=!)O-`>NJ%GG\XU),H:;+>T='" M';M_G2:*89`!*H_2[#;(PE6PU4UI+/^L(F\5;=QQ=N?*]*;M;>;^2.OIGT90 M!,@-`^#T:[?H=I;YXRSSE5+&2[;-@?]OON:\,WP:(=Q^FV<5ADS=**I-'#WE M:,!)$OX*KY#0@&O[G.2?1XZ]XY5)Q%_\=OGQ%2C=PV@=PSD%\IE2^T@-L'W8..A4H%UURQ=`N M-ISK/R=.V=RZZWT%:/NOW6X?SU-(I\+JY5-CTQ>I6T<]0].NQ;I%QBQ14# MN\C9=3N]5F\EP"XRF'N5QWSMW>P^GW4/;^/ MYFI`U%U'),QX_R/`6(C6N^W#]O'A4X(AI_%OYY&O*AOC8R>_J/%`9?/QLM-] MAD/:4.CFG-V'!:!KK^_P-@&\.:=WN@!X_1;\9TW'MQ'PS3F_CPO`U^D]+6.9 M2+2!N;@N[K<8@)U>=UTG>+[(#??:O?::#G`C MX)MS?O]82'Z`%;^F\UL,OO[:\.]_%M'L>_W^07]-![@H@)UU:3`_+\)BUJ@_ MSX#O>QZ]2Z+XKZ^*K%2OO)^>YG!^64B`K>]P9L#W/(?SZX9CS@SX[CN__.$@+'((1P>M MHX5!:$R0%2+$-+;'>DKO>?\CP%C(LW_GV(JGV3RY0\.VO9:54Q98LU[P37)62/B02`23`Q)^^CY1 M25X%94Z"^URB;/?X&,484KZ\#C*5?RZ+O`@2S/TY"3$K?USGXPN=&;_,A??\US.&^/BXZV:D M/!"D)]S9_&N8L;/>4?>@U^KUV[V5;^U\/`FB#+_Y/#I/X.=7*`"889Q%`)>* MHQL5K@*Q>U5.N>#*U6R`\`:I-.=PYW))"!=EIJ9.=K_=TDD!C:^NK/ZO-/L& MAWD:3*(BB(&_1L/HX6E)O4[WZ$CG@#2^NB;]Q^,TN2S2X;?S/"^;KZ0!N_[] M>00O4]F4"3"+BOK]MM$(:DLN#U`#CJ"!DI8GRE6>)&"L9&I8I-.WVD!V?2*[ MYX%W%K+-=!:L'JP'HER#K=)=%$+7MF0U&C/U1*'&1"-M;IY0<5A[)?*YW:TI MGHNMO4J85W;47?3L/GXO]IG/([HKYB/F!0\X^-FZ1@OSUQ9>>26@KI:;'AX> M]:?BG0ML@0CB:Z:"O,SNZ)>L?,!C],1_JWAA\!0TS8M\%;J8:_L\`I2GWM:R3/&) MMN7\[F.9`:E=J"Q*1EMDP"^R,3) M4?_]BFGDL>`\Q_8>02NKWI[^''[R!:U4UQ1=@3-IWNLK8N"+&D<%BD8WW?_! MR<0=JPXVOKAYZ<8#'!KB++J9 M[WW0PHL9E(LM'*KHW:>DB(J[BW(01\.S.`UF[!;6;??NX^J-[X/%_O+3]T$6 M1^_P?^'/_P=02P,$%`````@`!HMP0>BL.]'M"P``Z8@``!4`'`!Z=G1K+3(P M,3(P-C,P7V-A;"YX;6Q55`D``PN]IE`+O:90=7@+``$$)0X```0Y`0``[5W= MD]HX$G^_JOL??.S#Y1X<8";);E*9VS)@)MX`9C$SR=[+EL<6@RO&FI7-?.2O MOY8!!QC)E@U&FKJ;AP&,U.Y?_UK=^C+Z^.OC(M3N$8D#'%TTVJ];#0U%'O:# MZ/:B<>7HAM.UK(86)V[DNR&.T$4CPHU?__WWOVGP]_$?NJ[]_M6*$D1<+PGN MD:;K\-W',(B^?:#_;MP8:7"/*/[P&`<7C7F2W'UH-A\>'EX_G+_&Y+9YUFJU MFU^'`\>;HX6K!Q&]EX<:FUI4"JM>^_W[]\WTVTW19R4?;TBXN<=YZPGZ-MK#R^:],MF#WO+!8H2(_+-*`F2)RN:8;)(E04` MJ;0Y0;.+QO?[Y!OG?>HK?\2:1N\G0'U,?!XBX$@S0K:MG%48S#P'<3 MY'?]_F./0A)O70+/""I)+FN9+JM7G7C>?]$#]4-ODS`W8Y!!R]`A>J*UC^>MAW]$L,-P$X>(M'032#/ M"*F96_%X^G5U*[H'SC!Y$M&*4?QXNO3T0>"A*`;8QBU!:!W1>T&!>Q.$02+HL>4D'0]!7S?\>QK[ M-_<5499;Z7AZ7>K0*J#'EP0@GE[8LDL/NCB1GUX4T;:DJ.-A^*1O!W?SKR5T M6D04SJMW/.TL:.9P`4W=1S$[,BL<3Y_?5JCMNS2+`S=?7$+'I^ M!G=:+((DS8)P)W`NFEY@/"+8U(4$'$_?@=YW`W+MADLT1&Z\),*Q-;_F:;+] ML;)^?=E?+')/Z3='S`2[\DX>=\7A5!)84Y03USJGVFG\OH<2-PCC$0UC=,;B M4/_GR:NY%UP%1BE!M?22JV@M4%U.+[H*F&/(/W6$7>MQO!"[)[#&/G<5BH2% MG#PWE""BFD1)B$K1L<@5=RMC)R:LG<)O\JK5Z]VI8PJ).`$(ZPJNI<6 M=J(16!4LE03FX?'>3 M:4Z=S;K31N$0>SM*AG3A"Y-=SM^29>XEK%^Z[IW3>H+310F\>9* MZAUZJ[U>Z?II??E/(XY!^^Z2D*TQ<.C>H#"][9__N9Y^WBO3E*&L4T(W+^A/:#@=IZ`YE()W'10)\A# MH#OM1*"DP/MRJXC1=2:-+A'`RK&4#?E`5PXKNT7$6#B7Q@(+D')67Z'(C<&* MA">FHS,Y4,W&5I2XT2T=O*ST!7\P'[UP2;?<7&+L/P1AR/5XD:I*Q"-V$Q!' MKAQM6],7^[CB%$EAEPYPAA[0?B!7:4X MQ^+@!<6Q+7<9X.B6-N]MMREN*>Q:ZD2U@C:2!UHYLOB[9_;X8164J/<89"%H M!WZJ5]X4#;.DY,:>LV<)%VBNJ!_126$<%9+QO)CD9BW&!`^=3O/5JP1Y-(13'&WLIE3-P"RI&WU1F#H;YP M'Z:XFCJ#@%Q/UH8(G=7/P_;Q^8^M`%\/OGZ+?OIL&PQ]UQ\ M,5=[M2/K7R=:C2YX:BQ#\B8/B3.%EZ$Y`A1V7[/'YL286E!`X@+U)<%Q/"9X MQHWR.R5DCL_<$,43=(^B):(SZC%_]8Q=5')$8UAZ)WCEP%,NZW1QG-BSM;;< M`[I"H1[;GV.RV&D4!5'/T*PN&[H7+)?80C MO`LJ/T#GE)>[A0L1%"?YNC\K);EQ%-I^;Z\6"Z)Z'O6C:?0![>KY@B4@_#$! MT4$S3-#6\R##(,(DW>^_P@B9D8`5'%`"[97,4M7K7NQP@EA1V/O3*RHRI+X]U(>GH?4(W6#-O:_SHP9.'/ MIG)+2V[-@E1S818D3WG+$((_FI9-X+\5FL"G\_?.U.Y^_F0/>N;$^:?6,_M6 MUYI*6(YX_HMJ&9AWXJL179JQ'TX1U``\.7^P`,TWFZBA$$@2PU M&O1W.//V,981\/]44"X^E&1F)UDSH\OQ(OGS!W3I7;>W8EEQO$1^'Q,'D?O` MHTLMT/0(XDW*B%65'[0/(*6,=93+NJNM-9\#VGM8=21XRQZ,@I*GU@ZCC8]< M.9*1E6\!Y0@S%I@DP?=427O60S=) M+XC3YXG&!"V"Y8+#G4`]R1O!#J-1V"[*,0IIEVX313VT>K6BYX],\X'VG)J]EK/,"J-T\A\WO'Q?4$2/SYY=")L,>+X!%""EWD.-[ZT<>UN-M(_+3 M!P5S'V.O*DR,]U]>"N]E+/@"'*+,;SP+Q_!\86(.\?ZE.$3Y7\E6R"&4V?35 M;JG)]Z&;POY'MHJT%9T<>EF;2#A8^T'D1MX!4Y1,`7*CCH>0GR[)I&F3CGKX M48955LTIRQRF]H(*'[]R7KFM[=8#V(*8XME"./_;/SHT1">@B MZ&YWAC=C74J$Y+99!>_>@D+9C*,:Y1P(JR7O`Q()4X#D!ET3W3FV.F3+3&T3 M_S69(2\N*O1PH/`16]GR]<_TQVB#V`LQ/48$/HSLJ:D9=%'[:C@T)G_0A6NC MV[6O1E-K=*F-[8'5M4RGQD7XX@.X,NU_86K?@3>7-M6V:X^ZYF2D#8WIU)S4 MK33K?*Y,U?=,5;OPQAI=FZ.I/?FC9O4JG8V+B?F M:N^&,>II/5Q7!J_-A&?"F[7S.]K8^,/H#,P4&UR< M7)D]P&YTK($UK;]%\(_VRC"<,3'T*8;>-7V^-\-0LZYE#_;*$)PS$5RNMM5< MFY.I10F@%W?IZ)E#^I)^43.VW#/`,B!OF$`^T;"ZM:5),W^_LJ9UMWOV\6"9 MJF^9JEII8.K:0U.;&E]KMVKQ,6&9ON^8^OZV,:UFC],'OE._^&),)@:TW9JU M%SLX+$/`SKF?4R\?#JWI:L,8U1^\GF9=#;37JU$ MUPVSVBED&4YVVBZ7,$X%->_HL@P0.X?O1^-3J5SIX+(,"SN;BS2RM6PM$UXW MT')'FV4(V6F>._Z0`$SD]+,,#KLKL#-&D0#A*&>>91C9W8?RXQ@)AJAV.EJ& MG-WM*)43UK+K!BI^A%H&CMTK88U])!!7\32U#!R[MU(VRYV(O`,/6-N`/F=W M8:J!/AW5I8YCR["RNS&-+QG:Z9_8EAX"R`40F!P9)[DX?$P9+XJCY) M):E4TJ??'^>N'AU5K?_CPH15_NTJ:2_EX';BK=QRW5G#6)>-O[6B=(9WX36OY93JIPR@Z M!3IT/H:Q)'W?,J-8JX6(%#`%^4]=)5/)([5]I!ZW7SV&]L&*A%C9@>^B,9HI MY._EV%B_]0>Z]]4(?7]E^?,6^;+5\ZW%''F1YMFZ%SG1D^'-_&`>@\4"Q*7= M!FCV^>#'??0=O[1]=/CV^)"\\A>>O-'3':XEH3._<[%"6A51=GTO]%W'-B-D M=TR7:'=RBU`4%D$LS-@PO@LSP`JZ19%CF6YEL-12ZD<^B?!O0F@XFHWN<",F M1)92,;N$!A&/9I/(M[[?^JZ-NZ\>FCF6$U5"SBRI69UWS?#VQ/4?*JL\5T`] M>(=^A-3)8CXW@Z?13+,L?X&;NW=S@3%8#BJ$RYN_/K0=]=3'+\!ZLE#@#'KJH9WCSGS@R<>5)3D]6'IJ7W'0EZ(Q=9N`H22'KWGA%'@7"]( M"UX_YP%;I;SZI-'5I'[A3O/)O'81?C5^$BR0W7?,:\=U(LX:6ZZD^B0X437[ MGO3]J_?R@`4SU8?K5,6M`@\.(P<73QZD]-+#0QS/CA_RH"U95'TRG*GISEW_ M[P(/6G@`L_+5A\[`S1P_0%/SD4^/U`SUX?FRE'IT%UMQS,TW,PA,KWC4Q96Y M/ISGN#K-YTX46T'\)ERYB'G!4Q?.ILY50'UX^^J)Z01?37>!!L@,%P%WW\K. MN1MK7Y?5;\[Z\_7<4_)-C98@6][.^UU^<2H5V%`OQX^:D6TW];Z'(M-QPR'I MQLCBQK;U'RJOX5%P%3%*%=3(*+D*:H[L8D;1582IH_Q=][`)COJZV(T"&QQS M5Z&(NY"=VX821%0K49!$I>C9KN1FYR!5JEN9Q$!O<1&!M;A&JNW, MB6TF;H_D16F=K4MQO*B%D[:2-"UJ`X6<%+BEQQ0_)F4<'AZV%559Y4A_Q,,-99E=R>1O"G6Q(W0- M^0CC7'N5\.?N:#@9]8V>-M5[2D?K:\.NKDS.='TZ67F=5WA=W\J`=(G;VP^H M=2+F1&X>I);!O4PW;BY_XE>7RU1H@U@PS\<2V) M:UXC-W[WU;^_3L]I"5L2X)ZFE^DAS$FB3;S/]4(+5LB3IL#9WRS;WT<+VU5< MDW0W?AMNP^@FO:(X"_PY6Y.)UGP8>UJO&,*!X@=XP/KYH'WXC,+U0V1_/HCP M?$\.EU4K`S^5EU:-:YBN2"ZCL72-4$!GBMI M%[A(%`1DHPB&/4B&P?3>#,YQ1:M[VQ&8'9?3R&&T#9\?-=B:VA+0TRE-#S7' MU6O)Z8%10_2\%DN/%H9X<*Q=AQ'9RPHPDDUT]4X`"7QC,@I02.]B.ZTET.XB M(!L>N;2_D58(";!ZG\C5"=CZ);%'`-I"@I)=8_A!9B MX:W@KB8RO1OB]%Y"QNU4?[3]4/6F]A7AH5Y^+T5!E\6;76**2HD`D?A!%A+Y)HUP!B%$5:&` MSF"IB:7@23['5C^^R0I'"1*WO[)2@'2*72B(AT.36S^(IBB8=_P@\!^PA84L M%Y1<8J*8D$%6Q"X!`)L=V>V*G4EBACB`@SR)70G@[O/VJFLKVX.)71Q(U9Z^ M[]V01IZN1<6-A99+8G9XD(-4B5U3H(3>PNU$8@HV48+J%KMX4'I:M)<3H8I3 MG[;8]8&L2Y7ECJ&DE)@-""U(@]AU!+)1W?<*.=A,)C$!5*B@]L4N`$R#.`[Z MJ5#_^802,P"`!9V-@N?SMAUKS'0O3,8+E^S^WCC2:(.=XHP2$\4)'N1,[(P=/F*D<(PE,2<` M6)`#:6;CU/78BLX`B?GA@@ZRE9JW?VIM2(5?^WW7T2STD_+6H2W'_*$MRJ^9 MLGY["75Y"77)]VTOH2XOH2YRA%B\A+K(P<-+J,M+J,M+J,M+J,LN0EWR9V<0 M&%<]=!WUG##>7)!XWR[\(!V?OJ%N.(/$$Y<"T.!8K#E=#WW/*JON7)X]T3@= M-]@!2>0HP=.Z41`+;,>ZG'Y3J#,$K-60@#0O$M$7XPVU!;1K1\X M/YY7#)BT;6;:&[JHP$$[(AU-1A@N2E&TS+!G]*1`0]2(W31!`SU:1/$]+HYW M4X*?5*X](VD3.<24V/T6*==K23O%D5-BQGC10ZR)W8F10L]IGA@Y]H.E4H9) MF@T:'%8)2+U/K'#8([&;-G*(BXT1*\L^<<-KA@2':&0VH"R1\^RK6::4F`\( M+4A#:KE`E(.SX%*MM7/S-F^9NO8+H?^LI,CORMV*N/\?CZZ` MX2B[J7#Z=*4]&ZQ>CV[]S:QV?F#@/#,'L5-L)B^Y=$*V/W"S08<+&J":G;VI MMT_]#EJNL_"J=S/'%:V+E5'15."@W1!;[3/S>R8SE)1"MI9P,P(!!KV!@@]0 MI0?-,#EAYKEZ(S,[Q=!!UZ!!H=A/B_Y$!K#@*W*5)B)K<6"Z2TZ64A/HSE5HK*E+D?I%:4 M"V15[(+2$$6&9_ESU/=#B-1,&HE)RN,$E9Y:%9)ADS>Y=N[$]1\H>[S?\N_Q M[FJ3,^6D/_K6X!YOBHISZ&C0G!K=<; MF%&$&W$>_'LJ^`[^<#HB8#$;77T\5`;:=*J/&\;<5==7K^61?J`B[>(/QO`K MKB&C\5_-HNNI?=P3>B'6JG83H+B^:IZ-,46!<[V(.X?5\QS\]B$5?@]_P+5! M'TZ(LK73L;X,`]"&/:5G3*9CHW-)@AJ>OVI61EWEN<$C+UV;*IV./R05?Z)< M:']IG;X>BX8?CB]Q\^X;6L?H&]/&6\.)JMGWY$R]S0/PGT4XHHIP0D3H?26G MZ*U%:!;JJ0K<_$#J&IJ;GAT_S`MP3!7@=-FE?M7'4X.HGSS,DM'3!^1/_$6S MHIVI\#Z`9SE>4^4X(_UI*C)&T?^X-*8--WE#7=K;J?E(T_@;*E(C[I*ZHX&N M3+4_F];IEZ5.1W=Q"!6N(]_,(#"]B`+W+17NEY5BE=%%'#\55XIOVGBLX6;; M+/ASE8P[G>6Z#KF=UH]M+?*HEK9-M[3G<0T?#(SIT/;5 M$],)XIG0(-[.!A@`NJ7MXP\GFC%6OFK]2UT9Z-KD MZBB_KLK\30;[%8?JY,4[HMMHG=^(*;\NBVY82DX3`8E)-];E#,6.),UTP)`\ M=,N]V0WO"#&K8?7(OCTW')(>.G+N\X.0([H-YVE@2=G*NO"&Y:3.+XH%I!MW M<+ZQ>[E2@#@,R<9/<2E)FG%(M('S24G[?L7@]\MB!!E1>W*2:5/A:AS75V3QNG<0-YHX]1REJW-77B5B[)V82&AQOM@B?X'DPM M<.TUBXD5AD]-*4Y;.06JDCKS/0AV: M<\2,\X:3"XB_9Z@9)",OX<]*B;31]]O1UDS4/>C470\.5I=\:@7QJE`&$4'T MA56??JLOCL"H^*W5'@:.JCQYE7>+:ORKL#0]RU5GH8.VH/F M5=XKJ_*>P"#X+56>A@YVY,VK7"^K]RT*%!@G955^(C!T M?4N5IZ%#*J\Y499E2<9KM[OG\K3T"&5OV]>Y5_*JCS)(&3'XY8J3T.'5/ZA>96? MEU7Y^7H^L7\ZSV"'ES6;UWJ_K-;[*^1[.`/-8(>GH,UK?5!6ZX,5\CV]]MC$ M*OVE9\[)/6X_D+VZX8UKN9Z23WJR."4`5],:Z\7256>((`+@#-)KO@@ZN)HF MM*7T?>^&]+E$T.2B28`:2DKI.0$Q@^MLTI#Q?`*DDW8X%*CR]/5T^'2&@G-N8DE^N9$MX9G._>.O3!=_=%R%^0&K>>3$'"/LPJ+N?!Q M)XLB9QE:TD$>IBP*.T]3TOI&L^=BF#NV1,&1]5X6T01)M\LIAY:H8(SU< MM\[=U->]B%@#UN:GTJ4(V:8FF'I_"WV]U)[G4B3>4;>W-6RWV_EN'333'Y&U M((/`Y+"1.%HE0!8NA+WZR959R(:B_P%U.1"MO/4T498\H`+"Z+]!_5>%2QBPT0-5P6S M-DLT=\D1[T79R>T">Z';%-:=K?!OO#P^_H!7JW'B?5+M,V`YE_/CA>[U,<3) MTB6R4Q$=<^($:C/\7SS9)::LE`ARN@'2YTBGNLRU+!![A?DDIHT/.X>#H(Y. M+7,;V7!!9,.H8D!GR`7U7Y1-8O5S08>T+_981Y[SH%,]./E-0N2[>"X-K9!N M4Z3$)&\M%E0!)+YX9(Q(MX*67`L``00E#@``!#D! M``#=??MSXSB2YN\7),4'``*4#*1N(W;*+66F/@`?$HE7XB]_?=J&Z!$G:1!' MO[QZ^\.;5PA'Z]@/HKM?7GU>G@^6H^GT%4HS+_*],([P+Z^B^-5?__-__@]$ M_N\O_^O\'/W7WZ91AA-OG06/&)V?D^_^$@;1UY_I_]QZ*4;D-Z+TYZ[-F[>O_W8U6Z[O\=8[#R+Z6VO\JM"B5D1Z M;W_ZZ:?7[-M"M"7Y=)N$Q6^\?UW`*2V3;P.%?`5)&OR<,GBS>.UEK*HZ?P9) M)>A_G1=BY_2C\[?OSM^__>$I]5\5-1GVZ0_]1'_H[8_TA_Z0?SSS;G'X"E')SS=3:;E^ MJMG*E5[;!GN-DR#V)U$_U$UM1_"7F9=D!Q2@JF^]"*LX\\)>X*N:UF'/<;\: MW^O9KVGBE'&_FJYHUF&'],,9^:L&'#]E./*Q7T"GMA0.COT4\[NY[=)ZO*[9 M#:FSC!-AC3"3&R^]979WZ?F=YST0^V_?O<9AEA:?G--/SM^\S;WC'_*/?U^2 MGH#3P34QB9,$DSX1K[]>X>TM+G^.E?675UH:KYLEH;J#I"B.EZP[ZB27>+V. MR8#QD)V'O/:Y^B:)MYI`\NJ+M<1_#V_+W^`U3F!("E,32W`:[Y(U-FKP:HGT MZS;'N`V)#@TI<'3^>?GJ/Q4:?WF]_PF'!,M(3]KB*!N%7IHN-@S@X"E(954@ ME[=*KB[8-6K)A.$0JP-ABU8B>?0;U?B_0'C%B#\T=EP2#?N.2PF][;B$XG#X MU8E1[+B$&BJ"G<9X\LYJPY!9YVU#C`J^<*`1*L$NREN^2YVXL()6WZ$074JB<1B#GG3C>V M)FT*R>/XD^-P9>#[`=W&\,)K+_"GT#P;0;G'E!A/V)ET1!=)`JJ<228-BDA->B MT7J]V^Y"NGN`QG@3K(/LQ2*?B`3[67`;XA5.MO,XPP-5X".7MACW=$&NA#TR M4>>\T,/7#GK:"N@WK@)D276,;[-IE&;)CD[>%4LH(D&;KD4.M.I6VE+.J=,) MK\Y9=(HC\ZSC-$IR10M)/ACC"FR!+A\^K(`M) M+>S-*,\PN()C]Z2$VTJOG\=P@\5Y/P=2`>VS)?;A@+I"FOM+Y4G*AHS-OBN$ M5^U0-0$P+!>A:E*O)O-RD7*Z"S-*69P\DI\3'YGMD+49)2OA5F-DH:!S`NB@ M$\3'0O$7XL0X7O,3=Y$_B;(@>YY&FSC9-K'P=\R"%_-$<:\M'O',4-O@LH M\BB;>UO<*+52`(D_/0) M/TL+UY*S2PP)S#HS&D*`J"%&)N%&+HR8-"+B+MA1^+$5,2LH5OUK6UP0@2HH M4/T.1,L+`$D'"RKCLI7+?'IC+U,U=T/.=KL+838)4!,"Q001,BDEN#`)(7Q$ MQ5VP8T"`^!3,1>C="K1+$HHQ M2-=>^'?L)7)G(!>UQ8`NL`499'(@>-$!KC51Y>*(RR.JX-0Y\&#E"P[#3U'\ M+5IB+XTC[+,\"LTE#@UYN^%D!^QZ6"D1!D$B'81-)DW38F+J(:IY_I6JHD*7 MI\)(_NJ.5+_&X2[*O.3Y(@AQTMP_466'+*) ML7E$QM&[.)&O@#2D[')'"+%.F9H((*:(<$E6/I@H*F3=$>)Z=QL&ZXLP]IJ+ M\1(9NV00P*M3H2(`B`AM5!(:<$'$)!V.,?NT8FS+.5WL,O9X!O%=H5+(\ MWF@4H#'J*#0`$4D#IFQIM9+X[0QQ9531=KD&QR=V?-GG@GPF"F<4LK;7XJ1P MF^MQ+4$03.I")UV7R^??^?(<4W'/&KH:H,>9BJ0;QK2@BOE2B@%D2Q-;%U?8 M6LW1F7*$I-4K[S9LKO#)A)RDI:X!%.:A9A+..:*$)7W:`/W&Q(`<1BMAS8(( M3\F?G?G+*X).V-$"*F1(*06/)4UH"J904<1DG64D/\Z#)/"RD7=";2W%4T$4 M;Q"\1TD&:8JS5'*23"9D->&K$&`MPVM-`DRG%<)J[>,MEY/5$A(5\M4U+4:T M9.T30P*WS8^&(#":B-')MO0\IO,S#-J,O/1^$/GT'_HDQJ,78GK$/AMY2?), MILB_>N%.%C-JZEI]Z,"D.+7'#W04P=#.!&V+AD0)>9&/UO0/O%>'0AWO M")H;O,8$&0F8YSC+NXZL$RI5K'HU#?`UYZ:0!T,V#9""K-1,!26E#@QV3:-' M@CI.GDD1),6MB]ADCPA`NZM-]JP&-8+6M6`(!C$6V3U.M*940DFK=_7D4&LW]MIB8!R''%OK]AZ5 MY$P!$C5/HXP`I%D6>`&([RLOK%[&L?\M".7^4D?5[K"C7YCZ<-2M!X9M!F"; M])L%:QRE]`B+=Y=@MG8$@X6\)$I7[&+HDH]9$`ACY.4OV79,63IJ]MDC&FAJIS2U07C@PP!M_S0=#"7$Q'TQ4XKNJM2*H4'/%18VU2+@V1$4C0 M52PJ7'O/=$&!="'R2;+#?KN,'2L96A9S,=;^@__XKL(9_0(@D_?9_.#E'D^^L'YFW,F_6__\?;?SW[Z\1V9 MLM"//^XBC-Z_.4.424R`_/'V#)%R/^`U3=X7/G\/@]3:H[?K05IO+'8\Y';. M>K6'U_HZ;249Q=%=D>VTZ'G=_52LY<@;JHH@<8,H3@2TQN_&4&&0]@*K+@"&(!%A[SLBN-*;\ M2N._O?GA#?F_MR0D2M`C53M#?SHCGQ3_CU)^Z=';9?=Q$OP+^W]&[]__Z>Q/ M[_X/#X#>O3G[C[>E6$!S@?CLFWA_3=(@?(+!UE6"O727/'?R521HD[%RH%7. MMJ7`L%8*K15;Y8(%<]]RRFG3#`:Q!KX?T'F)%UY[@3^-1MY#0&)&V1*W3-KJ MUH(:,?`1T&$UEP!!I=N<.8%$?8G7A+1E>C!>KW; M[D(OP_Z8!XJ2:M!1M,DP_8)4R=:M!89WVE`%.U2%8!'\P^!>>R*C/>-Q/874 MFSK"6GJ0XA.O0*2B62,,XG0=8>EY\@76H:,^AXU@$4X3K9A^E:5^%GZ]"!UE M#R;@VVRO"ZN@9AYJ2EC#@C4'!"&REP(7-:TO#((X/8P9^]VHM0 MZ"763:^]9)&PG`(^F_Y>TU,F9&*KM0PH5W:WNMI5(/F"JTS3.3U[P94OR^8K M&.626Y6CZ`$G?&4#)%MY"K1!N1BH55%M)7?LE!5`SLJF!E`V2F!VLK"UO@N7 M=BS1M`GE"@77=*L#[Z(:EP9-LQI$78KQO0&X])+GZ]360APB]S3CNSKG@`9WK6(I(SNIM%-RR6,ZB2A<4BFC.2&A((5R!GG7]52< MTJHC@@.=<=T`I!;+P`5NM<,JO&@ZQUH*26<'@^I0I2>#N!@8&LFQ=9T-XOR! MP9EIM(ZWN$P:VW'R6BIM-Y^+$G(]A8M0%`R'U/C:><:H-*JD42X4@*3KO<&/ M.-KAKNQ2;3&[QWG$(.N'=^HR8`@C`=9DRLWDU\G\\V0)Y"C^T@MQFD.GR8A2 M>79"L:C5(SD*L+5#.0(Y,#Q1@&O=X:"B,'@RBM-LLKA!<>JKXAJ*8,AF@K85WY2BE(K`LJI>)G&:DM)MI.>6:Q(VJ26`5B50 MY6M8I_C:P)J,8!+H@8G`H,'B`2<>?>]SDB?@ZWFNNF"W8MV8U,&(R7 MZ4+8RK!Z/;D9K*;S2S3YV_5DOH03&>,PW!=#%LPUA*Q&PT*`M3BX)@&&(D)8 MK=B7"\'@PB6."*M#FBG,WP910!E-;QVJR=&I974DTBM";712JX#ADQ[.U@#& MM7CJMIH>#,[M0Z[%9H:]%--S\++%*K&LU:4_%=S:PI]($`R75.C40?$^5_,` M5J[FUHBL.W([CH.TXA]88;,,GOBV2UQ(%RDC@?&%+VK/2)S?5=RJI!/.M*$* M6;,7`\J;%L!VGBHRZZ*54+`GC@Y>%)+<;V%Y*W,B2Z92"CEKMUE4,,M++"(A MYV-.%[+65&GU87*#OLOG2=\#F2=-HPR3&LG4L7!+RO(S$R*(C1A5$<1)DST4G(=/% MNA5^/_D*9_>Q3U>XTXPMC2O/!UA"8/\,A]6J;9\+L?+SL/JF_8(W>_L<9RBD M\>4M^R&ZN/\8I/0J+/E/%/`C+AG]84A.@-1$[L2&.,+R/2"IM/W.)87<[@@M M4>=1JQX^R0$I0.PA;.^S:FWMYGA54*[T'&[2.>V/6XYFMR@,(X];1A$SS?/=[SM)[1*% MNL=P-,IN\I+;X'WSM+VSVM#$G02QO\R\)%,-G0J$4>;[IBD.;J*,GUC^6@ MNADH+8+P[IVQM@L.:A9)1,(.57`LU,-[``V/XPB/F!"7EWB\2XB_OF9#`.N) M;'-0%2FH]:RGR]4I1BLJ4RDYIZ8I4EU2>HT71('%;N+2YM,.;1(%;\;Z-M]24&2,)!R_90"\3E&UX^[39+T& M]B/0WL&NWRJ^B),M/:_`89'_&O`Y@(+01[#G>&_0K-@=VX5ZQIQ3_%@ET"3Z MAEG<\SU?LF33RW7%JNVM1KVR&NP^FAETMR'9I^#R/4H3:^"HW[L(1^=^M\N' M.SC'-(F4MQH5*)NU/N'O=!N<=(-R>LS%,<.N M>A?AZZIQ6"NT>9[=Q6;DI?<78?RM*]N76L7N?*@;?+TOR^7!^$X-D*W%V3)9 M5GZ(3J*3X,105 M=\/(I_3O-1U^=BG?)-SG9?+*'SJXMQYP9KGO:5E@YY2[9_^G<$+^Q0['PQ@. M^![CIX!F$N"'-22]6"1H-6FW%&@M0W=+RCFA.J'I,J@X30.#.&9[5A"VI?1W MGH!O+AUO_ZB]?80\ZJ&VNRA/0@*#;(-MG&3!OQBBQ6:,;[-QD+)SR]<$;+#; MRD*/;CVKX:1N,6JQ89<2&&+J(FU%;16]$SG`0D)7^I(8'F/^;R58S<_K=#_? MI6W`])_]%#QW6)A)IBC.^.Q\&WFT0'F=2\5+D M'>270,CL#`>/]!J(=FV)5-T25EX8-57;>E9)2OS<;9QBU3J^`>:6CRVN^22E M)%0R%J_-R"\D=.BXI9\`OIIW%07XA&N#;6?^`O584+L()!AY('.Q,=[@A,S# MBUR\D<^.V`Z8Y]:N#SUC;AEI4F`U574L`1[9#>`W68[4]8[8 MB;)\N(=*^,+W7_,;GO3=#'Z*9+8/38Q''+4Q&!&`3H'U8@*5)?A.VZ`4TK@A MOQYMC\++JFD&6[1P:W.?1[0U.4I?`^@KM`` M`.HJ"J9!78$VF*##&'+748+I_-?)$N91`OVR]CLHHS0$D\4]#LHHK)P@JPT/ MREQ,YX/Y""2[26'7&/LLKSJ;']`%;=G>GEC6\J/&*F4:SY];ZJ,HSO;L@T$\B=>^"")2@`.B2J$!`..QHF`:X[!`^R0F1'+< MT@G10VX"W3ZC3:$.;E)$"SN(?/H/O2SRZ(5T]8W?I&VN<4BJS,R$30KW*5R5 MQ";ZL&C<`[F(R#[>#_Z,U'1ABOV!]U8=W1<2%W%`NF^2/).NQN[,ZK=J0Q%F M(G,SZ*UY@:P%S]!MF=>:C+@>VN#E'XRAT7`<0)$2[5JW9'H8;DEM`\CJA#VZ^O1KY@ MFJ=ZI-O4@K6;0_V*5MXA,E-W3J_^F%MSGL6<#TV5#:'Y&/(">N7ZU%O9"%X3 M<92D[*TP$*I\[YQ%"E#ZU\^R+"QOWQ<'."IGDV%PAJ=X#>ZB8!.LO2@C78=. M'E:)%Z4\5JS,_O-)7P?WY+^L4LPS[34V%%ZH:$^/XE5!)SYE@1-*U79G9C'67.)TU39 MV@!O7*!R;-?6=$[.7G`%1^OJ6=+7A05Z0Z^YMW3*_IG?3I"'`0=;A>^E6U5P MN*,N33KO#LXS!8DUAJ MA9^R(;'V535#,[5@S8'W*UKIQT6*#]K90 M80R&&]\%MKWI?70UN_DY7N0>CT>+SG"TC M7"]FT]%TLH1!S45RYT7Y97`Z3)"B^>P_!I%_36J3KO;S"^;Y&HH7EHGENO9I MCF3;:K1QS.JHQ1S',`RF6QRS-,U>4[5]AFK665A2M4^CC_(7T/XGP"4YG`7_ MW`5^D#W3%`UAG))9;Y??5ZO8[!0ZX*M<5\F#H;`&R"8S+Q?4?X\6\]'D9HZN M!JO5Y`:(&R]O`>]+TYD10Z%A=Q>K$WI]1TLJ#H9;W1BEM[C17@6<$Q,4J\N) MJ54\2S'Z)A)>$Z5D2W.Y8M%E\+G-#_3-A1\W8AOUXNES=3(>?5]/%?/\5 MC/$TSP^0%@D"O+!K1JW4L)L>M!-Z/4^H5-PY$?4QMFXJY1IL6EKH@(O:=+)1 MZ`=TO:U93?QX6)%KZ2#[F0+#ZL/PM_90^3+F$ET/_CX8SB;,Q9(/;SY/QF@V M'0RG,W8DZJ4V[_,S`GEAE*.^7-;>UGP'W/U.O$30.8MTT+4X,OYU,!]-2H[` M\()%>E2MM1&9L$T?I@9<=5%B2>?7-%_V!\\J50<\ZQCYTDN#YEIW3M/H\75!*T&?X,2<;&G76I>>1#Y^_=>KO,,Q)U# MK+$9ZP_Q]"ADZXD>`QM@:-H3N'#X18MKNHNP9-.'+X.;F\%\!83(]!I:P!_B MH_DC8G9,$4?KVN)>Q[AL:,-J]IX^Q:ME!#$Q`(:\?5"++BCF-M@V1H++TC8!9Q] MJ;KV=]4J-MFI`[[*194\&.9I@&SRC*H@IE-QEO`V>44EZW*.'3JNV:9T?4H% MT'SK:'VM^GT=9VSK"?@7O?H@%VH&^[2(,)I.L;I.@D>\ILG9$H7I(M-]8)(EP_L M8\BF8^Q?T*JW-+?BG-P'0V_2O##$9D%,GUX>JEIX(1][B>GCOB'K0,_*(RLR M26N>4PVU=))B,>>4Z<;6NM##A6'XM/86T0VFC_%B]L7R(0RD^3!U--UN[DF+ MHM[6:ZDY)YDYUB;I+I(1;0C>JBB"(-V5]X_XF2T2[-X2_H%+XP>\;0T;5+/H"A5\FFH@:&? M/M;V2G0E"0VB63_I=:+2%`PR?D[Q8C-)LV#K9=)W.II"-BDF!EAE4UT"#'&$ ML)H<(4(T*B_%8)!"\H2"EH_2U`7P%D:WG])2!$,X$[325/KLCXHZ#$*6UW[U M."@7=W(!6X-I,EDPY.H`*+O>3U?27J-1G+*TL)=Q[*=H2281,&AUG>!ML-NF M/$,OGC(D[&\>XVV^S"XD91[J3)8'Z%L_O8C\/X+J\.2:4=T;[= M5]F.7"WU-]R.9!Q,USAVB5KWBPIK+`NAG]NCV0J901A=:;I]\(*$[G$ODG&0 M/L2I%RXVLSBZF]'8U!V="H[Q(P[C!^I8)T\/ M.$JQ,ES5TK2[LJU=E/K:=J<:&+KI8VVO;W---FVOZ,)@X?[(^2C>TL+P])C% M?C;I-@0J&>.O29E2)2M[6;)^WZ!?45M7#LS,@&%Q?^RMBP=LDY"90E5;,%@] M\1+Z4BA]398566^4[M2R>J=9KPBU2\YJ%3`LU,/92J05IRE]*!0Q'1@\&\6L MQ^3O%P3IUU&"_2"C?\D6?U4:=D_Y=T*O'^F7BH/A53=&P=;?7H/.:;D&HBHP M&#;'WRH'*),X(G^N>7)#DQUIP-MA)F5R[8ALS=8+ M9E6=Z.3R6O$<=AVI5GN9LII_]8#"UI*R]K#CG+)'`"\\Y#TY+WB;HMPB&A2I M"TF`63&*N%48SGFYOL?^+L3E(??N^NB\LGV02:O3J2,4OC:O.L">U9[QB)/; M.,4SU3SK\+(`RW!(^^EEXSV[2J'&>.M%/D_BK.7H^]FRZND/*6[-U?Z.POT3FJF$0\@7?5[7.S^1?'\?<25C>+IG316AK6&*H'O>2A6AR*_]2' MZBZGGL)!3BNOQ^NY096&56?7#;WFTN3BYH2]U3=+`(:<$XV&TR? MC,=E(6^\C!V^C]8DK.`WS\P"SCXFW02<_0LO#CC-[4%QF$97F"#C-EU4-B:^^UA!XY?[@^^WPWQW"@JK:K8;..< M\1RK'Q`CW__^#IJ'$:)KY8@(HB`EGB@_01P4.C!&3]5QS_VA4-G!)4UEJ^?$ MC`I4.RZFI0F-@T:H3_)X;N6@6WZVI/L<72GHZ(AB`ZCD5&(NY7P8ZH2F.'N( MUG$*Y-S.%QS[[:W.!D'X8Y\QC;(T\4N2S,O\NDC5OX_=BE+ M;":IC-[6;%+NP")7>=G3%!CR'H:_];8%521Q$4J9*MT')U.';1RAE)[R><'@ M?W@9LX/`I.V3Z,K+,IP81_UF-JR&^WV*5XOS30PX)^HCG*&02+[8>OR7./E* MJ>,]!)D7CO&&S."$'5\B:*UW*X&675@H!:.?JJ`UVS^716LNC'PN[:C/W="^ M'V&_.$5()@"[[2[TR-`G:`=]+7A3;@/,K:!U+_JR/98ZZM'^M6?#L5M'T^J( MK5^4VCC=K0:CUQMA%8[)([8]4KX);S(.'\BRL?Z;O*8T/(IIJSP]8F74B'P$ MNW"8?KS""+O"F'2%\A=0:8H?8:C\2.6KH_>7HU\*WTPC,FV\HYOO_&8P7=+- M,+OF*UL9UM5V=/5;ITB2V]XJ5><\[X>W=:U"P."]1=>GAO,.]A-+L8E,PE!+D8C$%JD=WCI#WW-!BHC"S8'*QZ%*TZ8!FH.Z=A M?\PMCT0M4%?$N!KN;<"@J\ZZ2?]9J8$YAU-5XT(KYJ_:ML!0_,`"-/F^BK/# M7QA2K.]>#/Q'>MRVP&NZ*:>O;W4=U[18M;5;767GG.N+6+A&>X'.46&F7*2% MYCE:)`N=7$U[J74&<2^HTJ(*8!A$V2 MU"B2TDNE+>=]5$%NY'P4B8)ADQJ?(-=CF7,F8JEE0&WQU;O&Y\C;DN`M^!>F MZZILWJ?5I81Z[IR5HAARMR50`D,Y7:2M4U8X37^F"]Y,",41\HDE2UF-\GY1 MN79>#115TLZR&;4A2S,9[46=LT0/G[9C0D0'AG.BT1V=2%+ZCY3KBD))FPY( M`;7J<@1BSNG3C4WL5O)U/O1`?1&4%.S50G2N1LN$71%'O9(LE@1)G\Y58"J, MV+SM!0XWX0*,`TTEV5$"/O)(2B\[I>M1B'"/3)/\%*W>9TNLD MB-;!@Q<.MH+87B%GE;(RF#46-H7@$$N"3,05$G,5LLACPC!&T?I\HT)F_B<] M^4<*N<9OM>8K2GUWLT2-8LEGBPIEYTSLB[@]0]AGXT#K4H=R=@UR^:)2Q"&. MV%UE+]P7]@)[V2[16\37-06"OAJ%U6*RP@Y\4G>#;VT_\544_@I+@OFU]2Q& MMZ6E*NLWW-:++9[0OL:>MYJFZ0[[3=&4M(2N31[3-B=NF>Z=XR^HW:5FYJO>B64-DI6\G#Q/M" M?[M$'Z."C'GOX$Y?3SK'G MF&W]JQ?NA!=69)+N6KT&5=[T3`QH^U>Q*4F0.X!'*@]GOK4/K_/HF][$*`)R MON2A6A?04[<]KS(I5',NI:/KG(H]`;='J%R!+=RSL<]F7\;%IC(*EP66 M451#S_ZY&8UBM$_0*)3`L%$7J63SFK#N)7/%KA+LI;ODF2'CV6X)3(;P`P[% M4_1N'6MCIR[\Q:OZ/",#SNE[".K6@Z78)V%>B`+.8NHK'W(-Y+'WCEXR#E0XU(]L*KYX MH.,^/:3RA?8H4CY3YVINQZJC[5O,FM,U->*3C3E%8!-YYWDR`5I/6I' MS=!3>'PE\UO13^*$N'S6?V!TD*(8I$0W]-%/T>&\1HVI5:P^V:H!OO8NJT(> M#"$U0#;)5CDU^')\4T03G^AIIB`K3KR.XHA&-#A:!^;3M7ZVK$85AQ2W%EGT M,>2)JW5%D4FM'?7IJ!K;&;-%5=J6`E2]"G#M)QY+4=?\K4#IJ'&85:U3QXZJE@T8]W'H MXR2=_',79,_29:&:U.__#J:B%>"$9RAST3\B+HP&&7]TE^5WR6)T[<&@.IDH MZ;5.EP[,3J&&JN@I[-8*%W?42)=)G*;\GJZH/2I?`ZIZ$:IF+3.9_`:RJ\SZ MQ<[9Y(E>T19[_)80H'J68VN]'5-N$A:BKNN<;X#2`V_*6M^+0:QW`3IYS><' M$;ZCXM\[JOXBS7[.`E'5-T0`5;L,66O2F9C><\D[:ARE0[R)$UPY>G051'%"8H""6"2> MJ%OA(<(5SNYCOW+60]R]K/T\(.JX*'7;+53\+Z*D0'L@:(\$W3(H1#&V$L%HS+29TII$(XV6]"KTGBL>8_SN-BM?0;O`:!X^R)PQT]&#U8WVX M@@[(E-!WA?KW]()M^:+YW@281J2]/LJ('Q)/#I0*H)M-A%.SO2JJ8-I)Y^E! ML^ZGL@2Z98T*8-I%B]S$=%VD>#77_[2>N>UNPVO>"!%S1NF_[ M"K3AMZ\*M&'[EJ;$!#[=U2PD?X]OL=$9I-BK?"O\E`W#>/U5.&LYP!X@'ARE M&*JW#W6'[_PE1$2M(V;>=L9/X0-%7!&K.^_%DL\%T]-@O MW-QX&283.6*$D(HMJ)CT8W-[`-KWJ,50]>/2;&4!"E'+J&[:?3\NS]@4%\(O MXF0<[VZSS2[46QC1TP34^H:`6\>-"G5Z=P\5!@`LCC#O17-!%B\(Y@=TKOEC M7BUW+!?]W8_7UIJ*_!9+4NE5058=I5F\19.0I>'^P74S[%_.TFF) MEC37S"]7X/]`1FCO3M1R$NTR0 MFOIPD[!:]FCE`=C\K8/0Q/4O:Z2S"#0=_:"U)^>I*F)"H^ET\+ M>]B`U8[]"P"P10?^(PUNBY4->;/)!&&U30=*@`U0<>*K>(BY([_"=#16#5%- M65C-T`T4=DNPQ`"]0@>U)MA6TH(-N\VDZ'DPVRO>XZI@6TT/-^QFJS!O%9.B M;.DL9$,*DZ3DO_*8J?I8EV;OTS,&MFG[E@1V8YL42+?;FE@#V]R]BP*PO2]Q M1%.C7<=AL'Z6!Y1B,5@MI,0(L.J/NT,'JBFTL`)LDD5(YX8/=,&LL8O<:@ZY M**RFZ,0)L!D:BR]=:TJP*EP,#F`M5SKI"B=;VE$'TKFL3!16W7?B/(UF&.HW MP_!$FF%X@LTPTF^&T8DTP^@$FV&LWPSC$VF&\0DVPT2_&28GT@R3$VR&"_UF MN#B19K@XP6:XU&^&RQ-IALL3;(8/^LWPX42:X<,)-L-4OQFF)](,TQ-LAH_Z MS?#Q1)KAXPDVPR?]9OAT(LWPZ02;8:;?#+,3:8;9"3;#E7XS7)U(,UR=8#/, M]9MA?B+-,#^A9F#;(/G">^--N@Y1L,T@Q@FP&8IS9GQE7KZK(!2#5?U*C`"K MGG,D":)U\."%@RW=?VI5O$@(5K4K$`*L]'[IT4%5N!0?P.K^$B=?@^ANY#T$ MF1>.\298!VV2"Z5@5;H*(L!Z']T'>#-YPNL=OF<@//\JC4:$@L.90HP39``U_VCTB0*MR,;Q3J&MV/+2[ MPID8\%JO8@18]2N:F667/#/$Q2U)?@3S`PX%<5"7`JSFT$0+L&$.>2$+5!.H M($*N=\.7J6#6>0N@>8U7/YJ1O\C'Q4?D?VZ]%)-/_A]02P,$%`````@`!HMP M05LQO"F$(```_^\!`!4`'`!Z=G1K+3(P,3(P-C,P7W!R92YX;6Q55`D``PN] MIE`+O:90=7@+``$$)0X```0Y`0``[5U9=^.VDGZ?<^8_:/H^3.Z#XG9WMLY) MYAY:BZVV+#F2W)W,2PY-03+3%*'+Q4M^_0`D)5,DE@))"9"F\Q"[90"J^CX4 MED*A\,N_GE=>ZQ$%H8O]7]^ZW_YF?[O MW@Y1BWR''_[\'+J_OGF(HO7/9V=/3T_?/KW_%@?+LW=OWYZ?_7XSG#H/:&6W M79]^EX/>;&K15ECUSC]\^'"6_'53M%3R^3[P-M_Q_FPCSK9E\E=74#XG2>C^ M'";B#;%C1PE4TJ]I<4O0?[4WQ=KTH_;YN_;[\V^?P_F;#;()@@'VT`0M6O3G MW62P_=:_T2-N1^C+MPY>G=$_GG6Q$Z^0'UG^O.=';O0R\!?OWO[P_BW]RG]`ZD8O:T)]Z*[6'@'DK**4'>R'V'/G=H3F M%[9'T9T^(!2%,A&E%?4.0ZME=96&8KS4L^C#%>$\ND M1"I!+&YACQ*/%],(.U\>L#6(Z#8V+N_O*6R."X2"HNM'YSTEZT+S'Y`H*3@P+_QH[( M/`,24UBQ.?DZ[8'_2#C#P0M$*D;QYF3IMH>N@_R0J&TM`X2R$;WKAE'@WL?4 M@K>?0X2MTEYSVO3:6?\B@^:+?>\A\M7DDR!&\Z%KW[N>&P%[K%I+S6G0;UOS M1SKV;[X7(BRW4G-R7;:)59`57^22YND'.5RZ9(GCSY,/(=(J-M6<#E?M_.#> M^W=,%BT0@47UFI-N0,RS..'FLQT$MB]?=8$J M-R?G->E.JY4;);,@^2;2N>CT0O8C0%,'-="-W#/ZEP9G@MWV#C[NPM6IU.">1CFXU()JA^GW7139KA>. MZ#!&/19U^S^OO3VO@JNHH=307E;)5:0&5->SBJZB3!/M'WJ$S>1H;H@M-+C' M-7<5BL"-''QN4""B6HN:-%*BIU[+^]V#5.EN*NWL:?96Z%>B>ON53@E44`,' MV&%5D5VYL0/MP*KH4JE!D3[K`(6DK<0A/20?[%1!SQ'RYVB^:8CJ5?/,A'Q, MVWC[]NUYJ]W:U,C_2@:<5EJ]E:^?2;V1V\/.CJ@>/4C"@0S#__TTN_Y3)*=U M3Q8.MK/=.WKV/?*2YO^D=6%5SZH(F\&:'&V%R/EVB1_/YL@]H_+37Q)%VF_/ MLX.M?Y"/_DQEF*`E7>Z0+CVR5X@C.;MH4=)\=[`"IX4#,H@2NC:-VH&STPG* MAW%9B;-UJ6*9X89EFN3Q)3(!BHL*\:T*!IDVNN;@C\CS[OV\9,_17:(?30?A&&,`N%4S*T#Y.8'H[@! MX:"/H$_8BPF$P4O?]7+Q`TQB2F6!A/QH("$%6`M/QD("UB%/2QD_22#AE2E[G`%B8IA9)`+CX8R`539WT4W,;WGNOT/6SS M/`&,W.4RZ/OMU[R=ZUV:QO*3'[OC$?3\7#0M6:];NO"&EJC3J\UO>KU9M-* M+O)\[UK8X7U"5!RVE[:]3KL8\J)P\TFQKV4?_YF+$N^[/M'')::`0Q?@48=5 MK6TY#>@VR\>/\K3("LDLI]05FS72D'Y?+'1459_NV9@%Y&\H)U\;X(<1`2FL;(HRKH:SXB$5;0&/P!',X#. M9K"SO=%`!.2PL5M$:P0$#'V63F:@O3/.0F80S:$.*G,WOWNO-^NI8:HI5[!$ MJ@A'MI>4U$K5.'I``6BQQ2RI-0H"1IM`0S.L94#P\I?T=D4J)3'GWK/CQ?3H MYA+C^9/K>=PQ"U)5:V0$="R#8V`&:ZFB,NE`E@DV?T?A5R_12V"P*UH#=$0VU7 MI`")&5PF*Z7I`PZB&0I6%S@(\!.9?WF3'+^XWD@-A66A0%DS*.%I."S"H*/2S7"SU?0#`*L^3R) M*[6]6]N=#_R.O78CF^?5YI:&4J%U]R]6U0P^)C03C(_F/3OPZ:;7I?GZUV>?8+_]2Z/ M(7=(OM[E,8.'KW=YOM[E,9.;?=WEX25(1?=1UPV3,(?L0/"6ILC!O(%)5$'K MG1'8+D:N;UTO`0#H$?8=5:P9=8[@]@=(:S/\,KMV1_9HXR#1<9XX86]IA`D! M!736PJ]\!#=!U'`PD;LT:XX51P\X4HR5:HPL^F MPA'<,9'K:RXO\B1!B9OCJUE5AR M_L@MK344YQ'Y,9+=OBX7TYGL1@+[;J0-6S\S!JFI[:$P$Y'>,P[Y^2'81;5Z M+[G88IG8)G'0P6$T7F0BZ1? MMK#RE[WG-?)#Z9PN**_55:DPNTM5-L-XILCS7H7D'@CO%M+JC)0#B_F2FP3] M)?*))AZ]!3]?N7[R)B-]?%3,A;265M>C$CE``,Q@ZW4>'"^&9'.+:+0N;S?% M+JO5XZC$C%!9,_@HZ0.=2C2[&95XX"IY,@N"=$8=DA6/C+]\2;W^R&H4EC75 M1R(GJ";)_)$I!)#:A`^6M*]JOYQ;81]O&OP8OX$Y?7FHH$R*57XV&>JUV&[3P#J8)]H&A-E M7\\*+M`"!R@M-[.?47CC^CA(7EU*>SE9X.ZVDM[PND'1`Y[37+5AE/A7A+[Y M`TF@-^D.?/PX."FGT8\)%!F\%V3SQ?>8<4OKS=^CUC^XRIHQPX]0)%W]%LKH MS=ZCL+YBZG;L)K2Y$K\)C[JP0]*(&^TBK:4WG8\"J4#]]Q3Q_QFY MRP?R-=8C&>.7:!33FQSC11;V48SXV,C6CSWO14Q0$PWKS0.DP&%S*)H:QY%= M#,HNTQ=S5FSC.;X'Q7/0<([I;-RYOAH/N[W)]+];W5Y_T!G,S+AF7B&M&*BN M"9=LC_>BN5H^XZ\WS75?;QZ:>],\[3YD=%YCG^Y&(+?-V76.BQ*V#H;<=BX( M)[QXSBEK$ANB/K:S_&.KLCE/-.*:\RE=05D66Q/?2SS73 ME(NE%Y+#*'>,E##4J)V\@;.+S7W5#%^@]/8(%.-RC2-'NZS09@&FV0!V[B\( MZ6&6/$9:F(J8\N8M.W6HD!A)G6.D2*+2)O11,UG%#*)"EGB%CY$>GBZ;<$C= M:Z]#9$H]K42I:[)6P]2U&$3ZCQ\`-VLK7:?5FMQ6?(=6"UORE5MR23X5NH\# MLJ!_=!UZE<@G>$)N/0A$,=#S,.PW,2 M=^.`S)ZWB3$G?2LY]1?-5>)Z1Y"+`ZR]T61EQX?J;.U4/(*\''#]C>8KZ5[I M8U>`F\?OIHBAY04O"I5L\TC2/71"&I&=X"TPS;<`\"-'D-2D6:`,Z@3 M[.R/LI<^!:LC29UC2$4"4ML,AJSY7W$6=CK#'&>/:'I5J*_WG@#TP2!%.,Q@ M431O;.+FT)RZDY`?VH)\M54:TGMKH/[$*@;(:(+3$:4)AL4MZ0W1;V#>W"_' M2NZ;&2;[XQ6-@%R0'7(0DG]E3Y(#V*O7I-Y(^CI>'C70#N7X@4FEY@M2:U-O M='Y%_U`5V,P8AO=X?T*G+TAV=4+WQ%?M!.G/=W#TM6_Z2Y(WI[)C3:]:_>'XL\X\E;FX M^:U6\$L,C"IZ9R0JT&V`'UU"\L7+'5GC#OQM"@C+B=S'],E'L895&M*9]1)" M8F&.JPB4&1/A'I<>IO!CZAIDQRDT00[V'==#.P+/<#-6N)^O,B.2!M@1]HFV MQHB`&K$`IH35``E40<,,`T_=N] MMW+/7BX@(\?@?38G2_&>_5A0*SJ^C,6'RR6Y9T<6D*(C2"=IK>@CBG\G^(T7 M^7<6;P.TYCX*L$+"JAH0=5::1#T=E=^H0*9Z6/[K?U"1S*:"CX]?!ZZ]KWKB<)/JS9F2(14[?$?`MGQCQ3P MDX+:1RG&1%8U?HA2NSL8DH"1HW&:K;5&9V`V8$A\5KW.((#&C"D!+G>U(U-A M0X8$;#5.L9D[.R*X@]`\2;:<+%&H=X'OJ&25-21^"^Z9Y"ML'B>Y*RQ`9DHU M]*9!K<,/1WDS6.)8?M_U;=^I,>\Q&S`D2J_>H"B`YM@7051=LNBG/VB`XJ/M MT9..-+Z^N%O@G7,K-6%(_!_TP+L"/*?9)2QB&4'P0HP@B=U7Z@NENM!.8(8; M30D0W?E&CJ0/J(0"F^$R`ZO52#\P([P[7J^]!"/;VV#42S^01M6"JD)[@!G> M,Q4XS%CJ;2*!:&P0U_&9+P(EQ`R?%4L]4X#?/A4DQ+Y0"@J_&5XBCI)[BL0< M89]*]>J@\.>,=;G,KZ/8")000WPZE2`RPV)R0:7GO#EEIPB4&C.\-RSUS``^ MS5_A+GUWX3JV'Y%.Y!"-9H'MAW82"9DU!B MS7#[-`'?GD;,["1O,TMF3BEZ23?GGQKAB+>05Z@/YQJN5';R,%]E!/DV.@3W7R;LHM[*C>A5R3$VL,QYU>I-1Z\::S7H3G5>GQ\'2]K-8[=>; MXK0#^?/;''CC1;:GL+W72^2R]]V;:5NC&0_=?\?NW(U>7LF4&:^XBDZ3;93J MO"5#4#+$?COM32SL2]EJ/S"MMD-^&8P^]4:S\>0/C9:Z%?Q51.F]!$$-K6ZR MDEPRJQ)7T6E5`%IVO6=RW0VQE6Y[Z#J(+(?]I;4,4/HL+'VIEVCGWL<)N)O/ M2\9T_I9I3%WR"UE=]D93.@U:EY->^D2J->JVNH/I;#*XN)L-QJ/7/S6Y"J5: MA3.L/I-!*C:YAX<#+Y^.*K2DTY[@'.U.094!,\3:>FVEH.RMG9TS[:Q'?LFV M=-/6K?6'=3'L)49&/IS<];K$"*V+P7`PJ[K/:^J>?J)JN-'5]F26**RA\^XG M@#SX=%>Y-9V6"R"SX(ZK@Y@A9MMO6_-',E*AC1YE"WW'M-`^M=#N)XML!+<6 M^O]RKBO@)S4-;O'CF[5DJAO2QR_;!0=YSF:[:&7[\^3#XDU>W=T!_)'S3.3IN;ZZ#-%J^PQCEI5R2987%+Z[0K,05Y6Y(H M:X@I7;4%+\QM[>8[IMU<48_];-RYOAH/N[W)M-7[[6XPT^F22.67&$:QD.YH M@QWLDWTNV$04ZNLT&C8MX@RU$B`,,9]!.Q=]5+:;[YEV,T@<>)WQ3:\ULW[7 M.J-LI5?PX0EJF!#JIN+#$U71Z\.3TL*,@#/?8#ZF\\UX31ND.[//=A#8?L0P MGA^8QO-Q,^FTQK?4,3=-%FB?K,T51U;4:89, MV12DW(SA,U%%6`RQK^LV38[IIME-Z3T!G!QC(Y\9BG'.#L6X3C9$-S>#69I6 MFUH8V2#18(S>J'(D1D-70OCJ@>H?MONT&2>37#;*II.RS+'8XQY#\TK<&D]8G:WC7:]WTK.G=I/J953,]>*O0 MJ[PRAY^XBD9K9`DF,SY)'9VV!J$F;UH@]0VQ)%%$(C9R7J,2(&P(P(_K*W;8+HH[\H^<-T M[;G\5VH`-?4^!E&//@5HS."2BN?'B#YCL?23QV1AM@>HI_=-B'H\@F$Q@\4; M^R\<=.(PPBO2V5)183R":NI]0:(>DPK0F,'E78C&BUX8N2L[XB8O*A;2^Z)$ M/8;8"IM!!B=S#LBT@'7U/BQ1CSHE>,Q@=!NP#".17USO:Q/U>).!8`95V>L* MN:SNEN?A)QIBU,=!%\?WT2+V-G%WV0A"T+]!T0.>8P\O,_TXW#;8OM[W+.IU MAL9A-J/WY!Y8";INN,:A[8T70^POA_0.;)H+'#@(5&I*[],8-0>(&N"90;\U M3R+\PN1V8PAE6EI+\TL9]5@%8F(&@=NH!.A$S2NN^;6+NC.U&`4SN)H01(D, M#TD`[2/R\)H.'=GK"\(Y&%13\ZL4=5T)8&S,()/]X-]XXQTF/9+(3V:!6\_V M0R&YE5K2_!9%3?]?=>S,(+]G!S[1F2:'372!#;[26II?D:A'*A`3,PA,4CGX M49;PQ0V_=`(T=R/Z&S>^0U!#\XL/-=T3ZA';U74#(DQ@-V0G25W$$NQ!N_8]]%[\&NRK6_2IAL-.4CT@JL%N+I7 MJ36=JR?G`-5K;Z8W*(D(,#!1)2-FX-YB@6C":+05=&)'25"'[Y")(HUL4YN!JS2IVV+E MY+(GVNKPG8#5BB*`NRBR72\=BSB`5M2]KZA((1^<$O!"Y_.[RV8^=+FHGW_LA9KP.5V3`/`>IK/=M^'GL MI&_I)%WN-5`V'`<=LKY:CHP'G M\@`$/D,&`U@X3H9#V?K9J;"4XG&RMO4$Y&1?WE1$3JDYG9/V?K/R&QE0PZ%S M9\8&Y+<_?A?P+E:=.`C248Z^F)C^@^<3AM34/H0WU1D4<#)CDYQI29:="Q2& M!&[;ZR,4JA$,;T&[WZ-!HE5Q,XMP^X6@YB7!#!7(EM;6[A]IFF@@7GM*Z#3V MZ'IR34\?"GIQB!)5T'Y&TQ0W9`]&4=3?C!$N>=2Y MK);"**?4@M;$(XU:DSIN9A`.T;_ZBE6A.:VY3/:XC%5&U!!?1.D5+KGWD9W3 ME_4JUR'\BWV)_``W`[P)W4/V]`$'T0P%JPLT;257&2@.P M``4#C\(WVJ;#@VP]Q"FL?5-8AS0Q`H8,A,#K3ERO+#LCL^I]IWTY9F%7:>"> MV8KM:7[2;>`30>+D+5O!OI!94F:`I;Z\'S.LQ6/QT;>2DOF40L9018P;#2*T MXLUTW-(&4";H='PRQ.?C+P*M2F1WZ&EBTLZDEHWB`8UX+5;@O3@?NBR+'=/!^]N`>_W!\"[IXIW M[W3P[A7P_NX`>/=5\>Z?#M[]`M[?'P#O2U6\+T\'[\L"WC\<`.\K5;RO3@?O MJP+>/QX`[X$JWH/3P7M0P/NG`^#]417OCZ>#]\<"WA\.@/>U*M[7IX/W=6E[ M>0#`AZJ`#T\'\&%I@WD`P&]4`;\Y'DU=8:S1U13:,#954BA#BQT^^9^=3KQ8IM,?`2I50$Y5HRYKM-CD1 MI5\?N+[CKFW/6@FF?W91[;&4C9"TDV!(`(D9`^/NL)+3/_V57C0C\COH'+20 M$];7'G79.+W*X!G.^07RDTP\MO>J0!_9$1E85>D7-J7]KM[A>@(`TKWM"U8K M["?OUP_",$9SG@FS"FJ_L=R$.AB(0-\@Q69 MVLDW7]#*D'#GK5BE+1*/E:%10<[L'L4$?FA@:'-Z22C_B*)%^I*_3`3^[$8/ M`W_N/KKSV/9ZSXX7TVRVKX\ODD$^23Q&1OE;3+H>BMP@J9E.HU%X\3*C0Q_- M3[1I1AA`K4N)H=K@JD[*KW:&< M8I]L+^:'D+`+:W5?5L1U1T]SW-"O3M',WT=S/&TO,R;G):*3!UAUK36M"<9@V$-U-\-.7I]K"F?8FL_=*,G?>6N[Q,*S%TUR8S7]/TWQTB$[ M:YYKJUZ36O.&P1AN`C,SV,])V8T#^CP8"ERHU070,0>GXL?9<+N'*K0`Y M_DDCQQ61,>3`;N=]:%XFH_?0!Z+WE:MH4!92\8EHL_(.I9LR(ECZ+L%XC>A1 ME;^D3WAU["!X6>#@R0[FLC,!4`O:(Y(`[+$\^@KPF#%&E@2G^Y44YLW;IU`^ M636UAQ[5Y9$/AZ'\\F[*_"2()&$_?MJC6_IVV/3))+]LS696/2AH@.8 MYD>@1@`S56]*]QXN)V1YTY(X6&\WAP;%\J)-7:UFM1MVU1Y1V@]46=PF)75M8)B@"&\6G--^L`GB'P__=+\ MSB"VWSFU/12"T,^7U#ZR-8Y]&8`L``00E#@`` M!#D!``#M7%MWV[@1?F[/Z7]@]=+T@99E;]+&Q]X]E$39C"71*]%.TI<]$`G) M.*%(+0DZ]O[Z#D!25X`7Q=F@E?(04\#,<&8^#"X#`I>_/,]][0E',0F#JT;K MY+2AX<`-/1+,KAKW8]T8=RRKH?WR\]_^JL&_R[_KNO;K)RN@.$(N)4]8TW6H MNXS=1SQ'&D@+XJO&(Z6+BV;SZ]>O)U_/3\)HUCP[/6TU/PWZ8T[72`DOGGT2 M?!&1M]Z_?]_DM3GI#N7S)/)ST>=-5CU!,5Y*AEI20$^"F*+`W:#WZ))AG?AM M,ZW<("5"TG3-%01!21*%19R6L;+$@P32$@K]OZ(PH\+96CK0FZ;&Z+6!.OQ MK%01LF0%N:?W\GTG#.+0)QZBV&LCGT7M^!%C&J>.EU?+O7X&KAZ#=W#F]HX] M'-M]JVLX9E=K&WUCV#&U\8UI.N.CR]=]>H?#@+/T6VU-[`6,R>[,@,"1T9M^9(\.Q@.`( M1^XQ>SJFH?OE,?0]F%O!N$9<0@M@$=/+X7E;"1Z&SMBQ.[I?@#(M2*CD4_V*S*1*[?A@G$:Q2M*'MF)K!`+H?#(S1 M9P:"T>G8]T/'&EYK=X!3QS(/%XVV?AV":Z'YNS@*!HC"$F\-!G&UW/__%OJ_ M#0_7-O,WA$;''`VU@>$XT#4=K-L[NA4\@4%A]+)R]GJAW,7OA2[NP(,U?(!^ MQAY]/EBW=O4^<7$00Y,U9A'&V=(,W$4C,DG8^Y?E*[_7XI("TSH5`M.%!^AC MS.&8M7_C>F2F@[0Q[&I=:^R,K/8]FT:MJ@X6/5//^GI81+R@B8\!!"B)$NSU M"9H0'U18'R,JTLL1:PD1,^$A&R+&VIWQV6CW30X7%([N84CO6T;;ZEO.(8\; M/=WPGMBJ+_?]"I;=*CD"9T($>@R![@-;`BX1.%A/7^LP^C[AB!)P)2M8:^U= M/$>!QPM7_J_*($?E7(C*=3JU?3!'CL5"@A5N!DC7'+`_O.)@\;K1UQ=UYN\) MH6MCO+!6CL1/0B1NV'QV;86GF;_>6\[A#OL63)R@`#OH>3T0-HOE3GXK=++% M9U0=>V!JCO'I@!OTA[3)V@N>/8).Y".*(A30-4_+2>1>?R?T^H>\:6OV'<\N M\8[EHS$:&<,#3D)_@`4;,9YLK"DF]'`#QNKD/#SW#&FD/ M1O_>U`:F,;X?'?8:H2@O5"^+5)Y-:HF7VN79).U-+OPP]RJJ+\X<5E-[29=Q M28$[$R_%S>KK.NU-^H[#Q:_B*F(;P'IL<@3%2_-Z2Y`CB!LSX&VH1)5R0,0K M]>U)\M'E14-.%U-$_'C()L?L*ZIJ`]4.EQPD\<*]RH"5O41;ON5P$13N>>X:?.:SN%#]GDV,JSEG4FN-G+SE<"'>V:N2164XJATJJF\!R[.JQR?$39T1*-XG_OR%D_[$3J",\U?C)U0MV*O*J M$9/Y@GT4EY8]1GAZU?CCB7[1\T.+OX%I)\]S/R=AH@M.KO)&L.V-[,6Y"!2Y M.U)V3M:"D'#!YI(X;N;*YP(HH8S];NTU&GL/C)+-US#91Y.Z)@,+]K^CK7TF M_U6-A-97U\BM!ON=3.VLWO*J!D/HU#5X,]J^D[W=Y4O6S=\.BO26V?Z>>OD.?96FM918N6& M>DKD?'LH47P:7*(&5T%XR+V)?1HO9>DK657U*3QM7Z3.-@][V./]A4?W]W<' M*]E#FPK7`E1I*>NZ7Z]Y36_[I4 M_VNE];\IU?]&:?VM4OTMI?7_4*K_!Z7UORW5_U9I_?NE^O>5UG]0JO]`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`;WZ#OV-90;T*ZEV(]?.5=L6^$(.Z%2*E6: MM[5S`%Z$71&5<@@QA6N<)1?9NQ>[DHYH5SB9+?)`/3[E3/\81E^8_FA!*/*7 MUY!G^2A)I:K)1/X9A?0`MPB]*M3*8<:_MMC_[+/(#Z\B3DE'59I79#;M/2_9 MX5?.%;;/T%RP'/&60Q&%JA&_E7.0I"(4-H!_N5-R6EK4+*OS*-<4<\U3 MD':@D]561S";!\(D$*JA6Z-_ZL2^H"_94X!R"$K,&&(JF]9O4*@C MH=G.RQ0,T(5DR@6(1./"+J$:O9*F?JAXK%QD=GU>)5UP6^-TML@-^_$KYXH1 M!B-XKA&]1*'O9W?YIW;**E6=C2SU'2.?)8U%IFQ4_7A#+IOI$3QX_"]02P$" M'@,4````"``&BW!!@02I7`%_``#*-@0`$0`8```````!````I($`````>G9T M:RTR,#$R,#8S,"YX;6Q55`4``PN]IE!U>`L``00E#@``!#D!``!02P$"'@,4 M````"``&BW!!Z*P[T>T+``#IB```%0`8```````!````I(%,?P``>G9T:RTR M,#$R,#8S,%]C86PN>&UL550%``,+O:90=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`!HMP0:`]SZR)$0``K_0``!4`&````````0```*2!B(L``'IV=&LM M,C`Q,C`V,S!?9&5F+GAM;%54!0`#"[VF4'5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(``:+<$%T+<(S-S(```31`@`5`!@```````$```"D@6"=``!Z=G1K M+3(P,3(P-C,P7VQA8BYX;6Q55`4``PN]IE!U>`L``00E#@``!#D!``!02P$" M'@,4````"``&BW!!6S&\*80@``#_[P$`%0`8```````!````I('FSP``>G9T M:RTR,#$R,#8S,%]P&UL550%``,+O:90=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`!HMP0:*CTO5D"P``'WH``!$`&````````0```*2!N?```'IV M=&LM,C`Q,C`V,S`N>'-D550%``,+O:90=7@+``$$)0X```0Y`0``4$L%!@`` 0```&``8`&@(``&C\```````` ` end XML 35 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE L - FAIR VALUE MEASUREMENT
12 Months Ended
Jun. 30, 2012
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENT

Fair Value Measurements under GAAP clarifies the principle that fair value should be based on the assumptions market participants would use when pricing an asset or liability and establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. Under the standard, fair value measurements are separately disclosed by level within the fair value hierarchy.  It only applies to accounting pronouncements that already require or permit fair value measures, except for standards that relate to share-based payments.

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment.  In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy.  In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

 

The carrying value of Zevotek’s cash, accounts receivable, prepayments, accounts payable, advances payable, convertible notes payable, and other current assets and liabilities approximate fair value because of their short-term maturity.  All other significant financial assets, financial liabilities and equity instruments of Zevotek are either recognized or disclosed in the consolidated financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed.

 

As of June 30, 2012, there were no financial assets or liabilities that were measured at fair value on a recurring basis.  

XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
REVENUES:    
Sales $ 8,024 $ 15,540
Cost of sales 3,441 8,412
Impairment of Inventory 86,113   
Gross profit (81,530) 7,128
OPERATING EXPENSES:    
Selling 32,865 310,208
General and administrative 253,718 528,383
Impairment of Licensing Agreement 40,000   
Total operating expense 326,583 838,591
Loss from operations (408,113) (831,463)
OTHER (EXPENSE):    
Interest Expense (1,074,055) (412,649)
Total other expense (1,074,055) (412,649)
Net loss before provision for income taxes (1,482,168) (1,244,112)
Income taxes      
NET LOSS $ (1,482,168) $ (1,244,112)
Net loss per common share, basic and fully diluted (in Dollars per share) $ (4.89) $ (13.23)
Weighted average number of common shares outstanding, basic and fully diluted (in Shares) 302,867 94,050
XML 37 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE F - ADVANCES PAYABLE
12 Months Ended
Jun. 30, 2012
Notes to Financial Statements  
ADVANCES PAYABLE

As of June 30, 2012 and 2011, Zevotek owed $199,173 and $43,823, respectively, to a note holder for cash advanced to Zevotek for operating purposes.  The advances accrue interest at 10% per annum and are repayable on demand.  

XML 38 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE E - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
12 Months Ended
Jun. 30, 2012
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities are as follows:

 

   

June 30,

2012

   

June 30,

2011

 
Accounts payable    $ 2,389     $ 10,867  
Accrued professional fees     217,262       225,163  
Accrued payroll and payroll taxes     165,372       161,649  
Old disputed accounts payable     136,505       160,756  
Accrued interest     333,598       183,507  
Other accrued liabilities     83,875       32,404  
Total   $ 939,001     $ 774,346  
XML 39 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE A - SUMMARY OF ACCOUNTING POLICIES (Details Narrative) (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Note - Summary Of Accounting Policies Details Narrative    
Finished Goods inventory    $ 88,323
Allowance for doubtful accounts 0 0
Advertising cost $ 31,446 $ 148,479
Dilutive shares of common stock 148,499,367 4,836,404,514
XML 40 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE A - SUMMARY OF ACCOUNTING POLICIES (Policies)
12 Months Ended
Jun. 30, 2012
Note - Summary Of Accounting Policies Policies  
Business and Basis of Presentation

ZEVOTEK, INC. (“Company” or “Registrant”) was organized on March 19, 2005 under the state laws of Delaware with an original name of “The Diet Coffee Company.” On March 1, 2006, we amended our Certificate of Incorporation and changed our name from “The Diet Coffee Company, Inc to Diet Coffee, Inc. On June 25, 2008, Zevotek changed its name to Zevotek, Inc.

 

Zevotek’s wholly owned subsidiary is Ionic Bulb.com, Inc., a Delaware corporation formed on August 21, 2007, through which it had sold the Ionic Bulb, a patented air purifier that silently emits negative ions using a microchip placed inside a 10,000-hour energy saving compact fluorescent light bulb (CFL). The Ionic Bulb was an eco-easy maintenance-free inexpensive alternative that is designed to clean the air in a 100 square foot area of unpleasant odors and indoor air pollutants that you breathe. Zevotek sold the Ionic Bulb through specialty retail shops, TV commercials, Amazon.com and newionicbulb.com, and it marketed the Ionic Bulb to major U.S. retail stores. It had acquired exclusive worldwide sales and manufacturing rights to a U.S. patented new product named Gung H2O that reduces water use in the home.

 

Zevotek has currently stopped working on the sales of the Ionic bulb. It is upgrading the bulb. The new ionic bulb will be made using LED light. The new Ionic Bulb will not no longer be using florescent light.

 

Zevotek plans to sell Gung H20 to major U.S. retail stores and directly to American consumers using TV ads and Internet marketing. After Zevotek tried to market the Gung H2O, it went back to the inventors to make changes due to feedback from the public. After the inventors make the changes Zevotek hopes to market the product sometime in the second to third quarter of 2013.

 

Our chief executive officer, Mr. Ryu has a history of being an innovator. We expect that he will bring a number of products on board in the upcoming year and believe Zevotek will make instant revenue from these products. We expect to release some of these products in the very near future. We are either waiting to put the finishing touches or most importantly file the proper patents in order to bring the greatest value to our stockholders.

General

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.

 

The consolidated financial statements include the accounts of the Registrant and its wholly-owned subsidiary, Ionic Bulb.com, Inc. The Registrant formed its Ionic Bulb.com, Inc. subsidiary on August 21, 2007 and started its operations during the fiscal year ended June 30, 2008. All significant inter-company transactions and balances have been eliminated in consolidation.

 

Zevotek has adopted the fiscal year end of June 30.

Reverse Stock Split

On September 26, 2011, Zevotek filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a 1 to 5,000 basis.  The Financial Industry Regulatory Authority (“FINRA”) effected the reverse stock split on October 27, 2011. Each holder of common stock received 1 share of Zevotek’s common stock in exchange for each 5,000 shares of Zevotek’s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing split.  Fractional shares were rounded up to the nearest whole share. All per share numbers quoted herein are reflective of the 1:5,000 reverse split. All references in the accompanying consolidated financial statements and notes there to have been retroactively restated to reflect the stock split.

Revenue Recognition

For revenue from product sales, Zevotek recognizes revenue in accordance with Accounting Standards Codification 605, “Revenue Recognition SEC Staff Accounting Bulletin Topic 13” (“ASC 605”). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence that an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. Zevotek defers any revenue for which the product has not been delivered or is subject to refund until such time that Zevotek and the customer jointly determine that the product has been delivered or no refund will be required.  

 

ASC 605 incorporates Accounting Standards Codification 605-25, “Revenue Recognition Multiple Element Arrangements”.  ASC 605-25 addresses accounting for arrangements that may involve the delivery or performance of multiple products, services and/or rights to use assets.  Zevotek does not have any multiple element arrangements.

Consideration Paid to Customers

Zevotek offers our customers certain incentives in the form of cooperative advertising arrangements, product markdown allowances, trade discounts, cash discounts, and slotting fees. Markdown allowances, trade discounts, cooperative advertising program participation and cash discounts are all recorded as reductions of net sales.  No customer incentives are included in sales for the years ended June 30, 2012 and 2011.

Use of Estimates

The preparation of the financial statement in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

Cash and Cash Equivalents

For the purpose of the accompanying consolidated financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. Zevotek had no cash equivalents as of June 30, 2012 and 2011, respectively.

Inventories / Cost of Goods Sold

Zevotek has adopted a policy to record inventory at the lower of cost or market determined by the first-in-first-out method. The elements of cost that comprise inventory and cost good sold are FOB shipping point costs, freight and destination charges, customs and importation fees and taxes, customer broker fees (if any) and other related costs. Warehousing costs are charged to cost of goods in the period the costs are incurred. Zevotek provides inventory allowances based on estimates of obsolete inventories.

 

Inventories consist of finished products available for sale to distributors and customers. At June 30, 2012 and 2011, Finished Goods inventory was 0 and $88,323, respectively.

Allowance for doubtful accounts

Zevotek maintains an allowance for doubtful accounts to reduce amounts to their estimated realizable value, including reserves for customer and other receivable allowances and incentives. In estimating the provision for doubtful accounts, Zevotek considers a number of factors including age of the accounts receivable, trends and ratios involving the age of the accounts receivable and the customer mix of each aging categories.  As of June 30, 2012 and 2011, the allowance for doubtful accounts was $0.

Impairment of long lived assets

Zevotek has adopted Accounting Standards Codification 360 "Property, Plant and Equipment" (“ASC 360”). The Statement requires that long-lived assets and certain identifiable intangibles held and used by Zevotek be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. Zevotek evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.

Advertising

Zevotek charges the costs of advertising to expenses as incurred.  Zevotek charged $31,446 and $148,479 to operations for the years ended June 30, 2012 and 2011, respectively.

Income Taxes

Zevotek has adopted Accounting Standards Codification 740,  “Income Taxes” (“ASC 740”) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference

 

between financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant, except basis difference related to certain debts.

 

Effective January 1, 2007 Zevotek adopted an amendment to the requirements of ASC 740. The amended standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

 

ASC 740-10-25-5 “Income Taxes—Overall—Recognition—Basis Recognition Threshold”, (“Tax Position Topic”) provides guidance to address uncertainty in tax positions and clarifies the accounting for income taxes by prescribing a minimum recognition threshold, i.e. “more-likely-than-not”, that the income tax positions must achieve before being recognized in the financial statements. In addition, the Tax Position Topic requires expanded annual disclosures, including a roll forward of the beginning and ending aggregate unrecognized tax benefits as well as specific detail related to tax uncertainties for which it is reasonably possible the amount of unrecognized tax benefit will significantly increase or decrease within twelve months.

 

As a result of implementing ASC 740, there has been no adjustment to Zevotek’s financial statements and the adoption of ASC 740 did not have a material effect on Zevotek’s consolidated financial statements for the years ended June 30, 2012 and 2011.

Research and Development

Zevotek accounts for research and development costs in accordance with the Financial Accounting Standards Board's Accounting Standards Codification 730 "Research and Development" (“ASC 730”). Under ASC 730, all research and development costs must be charged to expense as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. Zevotek had no expenditures on research and product development for years ended June 30, 2012 and 2011.

Stock Based Compensation

Effective January 1, 2006, Zevotek adopted the requirements of ASC 505 “Equity” and ASC 718-10 “Stock Compensation”, under the modified prospective transition method. The standards require the measurement of compensation cost at the grant date, based upon the estimated fair value of the award, and requires amortization of the related expense over the employee’s requisite service period.

 

Under ASC 718-10, stock based compensation cost will be recognized over the period during which an employee is required to provide service in exchange for the award. ASC 718-10 also requires an entity to calculate the pool of excess tax benefits available to absorb tax deficiencies recognized subsequent to adoption of ASC 718-10 (the “APIC pool”). Zevotek has evaluated its APIC pool and has determined that it was immaterial as of January 1, 2006. ASC 718-10 also amends ASC 230 “Cash Flows”, to require that excess tax benefits that had been reflected as operating cash flows be reflected as financing cash flows.

Loss per Share

Zevotek has adopted Accounting Standards Codification subtopic 260-10, Earnings Per Share (“ASC 260-10”) specifying the computation, presentation and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Potentially dilutive shares of common stock realizable from the conversion of our convertible debentures of 148,499,367 and 4,836,404,514 shares, respectively at June 30, 2012 and 2011, are excluded from the computation of diluted net loss per share as their inclusion would be anti-dilutive.  

Concentration of Credit Risk

Financial instruments and related items, which potentially subject Zevotek to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. Zevotek places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.

Recent Accounting Pronouncements

In October 2012, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2012-04, “Technical Corrections and Improvements” in Accounting Standards Update No. 2012-04. The amendments in this update cover a wide range of Topics in the Accounting Standards Codification. These amendments include technical corrections and improvements to the Accounting Standards Codification and conforming amendments related to fair value measurements. The amendments in this update will be effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 is not expected to have a material impact on our financial position or results of operations.

 

In August 2012, the FASB issued ASU 2012-03, “Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update)” in Accounting Standards Update No. 2012-03. This update amends various SEC paragraphs pursuant to the issuance of SAB No. 114. The adoption of ASU 2012-03 is not expected to have a material impact on our financial position or results of operations.

 

In July 2012, the FASB issued ASU 2012-02, “Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment” in Accounting Standards Update No. 2012-02. This update amends ASU 2011-08, Intangibles – Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment and permits an entity first to assess qualitative factors to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test in accordance with Subtopic 350-30, Intangibles, Goodwill and Other - General Intangibles Other than Goodwill. The amendments are effective for annual and interimimpairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted, including for annual and interim impairment tests performed as of a date before July 27, 2012, if a public entity’s financial statements for the most recent annual or interim period have not yet been issued or, for nonpublic entities, have not yet been made available for issuance. The adoption of ASU 2012-02 is not expected to have a material impact on our financial position or results of operations.

 

In December 2011, the FASB issued ASU 2011-12, “Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05.  This update defers the requirement to present items that are reclassified from accumulated other comprehensive income to net income in both the statement of income where net income is presented and the statement where other comprehensive income is presented.  The adoption of ASU 2011-12 is not expected to have a material impact on our financial position or results of operations.

 

In December 2011, the FASB issued ASU No. 2011-11 “Balance Sheet: Disclosures about Offsetting Assets and Liabilities” (“ASU 2011-11”).  This Update requires an entity to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position.  The objective of this disclosure is to facilitate comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of IFRS.  The amended guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods.  Zevotek is currently evaluating the impact, if any, that the adoption of this pronouncement may have on its results of operations or financial position.

XML 41 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE I - INCOME TAXES
12 Months Ended
Jun. 30, 2012
Income Tax Disclosure [Abstract]  
INCOME TAXES

Zevotek recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns.

 

Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant. Management estimates that at June 30, 2012, Zevotek has available for federal income tax purposes a net operating loss carry forward of approximately $6 million expiring by the year 2031 that may be used to offset future taxable income. Due to significant changes in Zevotek's ownership, the future use of its existing net operating losses may be limited.

 

Zevotek has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of Zevotek; it is more likely than not that the benefits will not be realized. Components of deferred tax assets as of June 30, 2012 are as follows:

  

Net operating loss carry forward   $ 2,400,000  
Valuation allowance     (2,400,000 )
Net   $  0  

 

Zevotek has not filed their federal or state income tax returns for fiscal years ended June 30, 2006 through June 30, 2012. The above is determined under the assumption as if Zevotek has filed its income tax returns through June 30, 2012.

 

Although the taxing authorities impose penalties for non-filing, Zevotek does not believe any penalties will be enforced since there is no tax due.

 

XML 42 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES
12 Months Ended
Jun. 30, 2012
Debt Disclosure [Abstract]  
CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES
   

June 30,

2012

   

June 30,

2011

 
Notes Payable:            
Convertible term note (a)   $ 923     $ 923  
Convertible term note (b)     1,923       1,923  
Convertible term note (c)     50,000       50,000  
Convertible term note (d)     2,497       2,497  
Convertible term note (e)     224       25,174  
Convertible term note (f)     11,132       11,132  
Convertible term note (g)     26,420       30,920  
Convertible term note (h)     190,757       192,430  
Convertible term note (i)     34,141       34,141  
Convertible term note (j)     22,350       22,530  
Convertible term note (k)     945,565       945,527  
Convertible term note (l)     10,000       -  
Convertible term note (m)     30,000       -  
Convertible term note (n)     10,000       -  
      1,335,932       1,317,197  
Less: discount on debt     -       921,311  
      1,335,932       395,886  
Less: current portion     (1,285,932 )     (309,806 )
Long term debt   $ 50,000     $ 86,080  

 

  a) On May 14, 2008, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of May 14, 2010.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below). Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holders about amending the conversion terms to cure the default.

 

  b) On May 27, 2008, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 27, 2010.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below).  Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.
     
  c) On January 1, 2008, Zevotek entered into a convertible term note for the principal amount of $50,000 bearing interest at 7% per annum with a maturity date of June 30, 2008.  This note is convertible into common stock at 90% of the common stock closing price at June 30, 2008, which is $7,200.  Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.

 

  d)

On January 8, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of January 8, 2011.   Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.0001 per share (see below).

 

  e)

On March 9, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of March 9, 2011.   The notes were amended on January 8, 2011 to extend the maturity date to January 8, 2012.  Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).

 

  f)

Of the convertible term notes entered into on May 14, 2008, certain notes having a principal amount of $11,132 as of June 30, 2012 and 2011 were not amended with respect to their conversion price and, at any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.001 per share. Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default.

 

  g)

On July 28, 2009, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of July 28, 2011.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).

 

  h)

On August 6, 2010, Zevotek converted $192,430 of advances payable into a convertible term note bearing interest at 10% per annum with a maturity date of August 6, 2012.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).

 

  i)

On January 8, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of January 8, 2011.   The notes were amended on January 8, 2011 to extend the maturity date to January 8, 2012. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).

 

  j)

On March 9, 2009, Zevotek entered into convertible term notes bearing interest at 10% per annum with a maturity date of March 9, 2011.   Zevotek is in default of payment of principal and interest on the note and Zevotek is in discussions with the note holder about amending the conversion terms to cure the default. At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).

 

  k)

On May 10, 2011, Zevotek converted $945,527 of advances payable into a convertible term note bearing interest at 10% per annum with a maturity date of May 10, 2012.   At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).

 

  l)

On March 19, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of March 19, 2014.  At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).

 

  m)

On May 15, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 15, 2014.  At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.1 per share (see below).

 

  n) On May 18, 2012, Zevotek entered into a convertible term note bearing interest at 10% per annum with a maturity date of May 18, 2014.  At any time at the option of the note holder, principal and interest payments may be paid in common stock at a conversion price of $0.01 per share (see below).

 

In accordance with Accounting Standards Codification 470-20-65, “Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratios (“ASC 470-20-65”), Zevotek recognized an imbedded beneficial conversion feature present in the notes. Zevotek allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid in capital. Zevotek recognized and measured an aggregate of $314,049 of the proceeds, which was equal to the intrinsic value of the imbedded beneficial conversion feature at the time, to additional paid in capital and a debt discount against the Notes issued during the year ended June 30, 2008. The debt discount attributed to the beneficial conversion feature was originally amortized over the Notes maturity period (two years) as interest expense, adjusted for conversion of debt to common stock. In January 2009 through March 2009, Zevotek restructured certain Notes to a conversion rate of $0.0001 per share with a two year term and accordingly fully amortized the remaining debt discount of $206,160. In accordance with ASC 470-20-65, Accounting for Convertible Securities with Beneficial Conversion Features, Zevotek recognized an imbedded beneficial conversion feature present in the notes. Zevotek recognized and measured an aggregate of $457,849 of the proceeds, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the Notes issued during the year ended June 30, 2009. The remaining debt discount attributed to the original beneficial conversion feature was expensed at the time the Notes were amended and the $457,849 assigned to the amended beneficial conversion feature is being amortized over the Notes maturity period.

 

On July 28, 2009, Zevotek issued a $44,000 convertible note having the same terms as the amended outstanding convertible notes.  Zevotek recognized and measured an aggregate of $44,000 of the proceeds, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note’s two-year term.

 

On August 6, 2010, Zevotek converted $192,430 of advances payable into a convertible note.  Zevotek recognized and measured an aggregate of $192,430 of the advances payable, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note’s two-year term.

 

On May 10, 2011, Zevotek converted $945,527 of advances payable into a convertible note.  Zevotek recognized and measured an aggregate of $945,527 of the advances payable, which is equal to the intrinsic value of the imbedded amended beneficial conversion feature, to additional paid in capital and a debt discount against the note issued, with the discount being amortized over the note’s one-year term.

 

During the years ended June 30, 2012 and 2011, amortization related to the beneficial conversion feature on the convertible notes was $921,312 and $293,254, respectively.

 

In or about May 2010, an alleged assignee (the “Assignee”) of certain convertible promissory notes commenced an action by the filing of a summons and complaint against Zevotek alleging a failure to comply with its demands to convert principal and interest under Zevotek’s promissory notes in Company common stock.  Zevotek served and filed its Answer on July 21, 2010, in which it denied the material allegations of the complaint and asserted numerous affirmative defenses.  The parties have entered into a stipulation of settlement resolving this action on November 4, 2010 and a final judgment and injunction were entered on November 12, 2010, pursuant to which Zevotek agreed to issue stock once a month to the Assignee until it has issued a total of 36,400 shares of common stock. As of June 30, 2011, Zevotek has issued 36,400 shares of its common stock to the Assignee and fully satisfied the judgment.

 

XML 43 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE H - STOCKHOLDERS EQUITY
12 Months Ended
Jun. 30, 2012
Equity [Abstract]  
STOCKHOLDERS EQUITY

Preferred Stock

 

Zevotek has authorized 10,000,000 shares of Preferred Stock of which 50,000 shares have been designated as Series A Preferred Stock, par value $0.00001, and 1,000,000 shares have been designated as Series B Preferred Stock, par value $0.00001 within the limitations and restrictions stated in the Certificate of Incorporation of Zevotek.

 

Zevotek issued 50,000 shares of Series A Preferred Stock. Each share of the Series A Preferred Stock is entitled to 10,000 votes on all matters submitted to the stockholders of Zevotek. The holders of the Series A Preferred Stock are not granted any preference upon the liquidation, dissolution or winding up of the business of Zevotek. The Series A Preferred Stock is not convertible into Common Stock.

 

Zevotek designated and issued 1,000,000 shares of Series B Preferred Stock.  On May 14, 2008, Zevotek and a third party note holder entered into an exchange agreement under which the third party note holder exchanged a $21,026 promissory note for 1,000,000 shares of Series B Preferred Stock.   Each share of Series B Preferred Stock is entitled to 5,000 votes on all matters submitted to the stockholders of Zevotek. Subsequently, the third party note holder, Anthony Intrieri, became Chairman of the Board of Directors. On September 12, 2011, the Estate of Anthony Intrieri ("Estate") sold 1,000,000 shares of Zevotek's Series B Preferred Stock to an unrelated third party.  The Estate obtained the shares following the passing of Mr. Intrieri, Zevotek's former Chairman of the Board of Directors and sole Series B Preferred stockholder.

 

Common Stock

 

Zevotek effectuated a 1 for 50 reverse stock split on June 26, 2008. All common stock and related information has been retroactively restated. In addition, contemporaneously with the stock split Zevotek increased its authorized Common stock, par value $0.00001 to 1,000,000,000 shares. Prior to this date, the authorized shares were 200,000,000 shares. On October 14, 2009, Zevotek authorized capital was increased to 5,000,000,000.

 

On September 24, 2010, Zevotek filed a certificate of amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware in order to effectuate a reverse split on a 1 to 20 basis (the “Reverse Split”).  On October 6, 2010, Financial Industry Regulatory Authority (“FINRA”) approved the Reverse Split and each holder of common stock received 1 share of Zevotek’s common stock for each 20 shares of Zevotek’s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing stock split.  Fractional shares were rounded up to the nearest whole share.  All per share numbers quoted herein are reflective of the Reverse Split.

 

On September 26, 2011, Zevotek filed a certificate of amendment to our Certificate of Incorporation with the Secretary of State of Delaware to effectuate a reverse stock split on a 1 to 5,000 basis.  On October 27, 2011, Financial Industry Regulatory Authority (“FINRA”) approved the Reverse Split and each holder of common stock received 1 share of Zevotek’s common stock for each 5,000 shares of Zevotek’s common stock they owned. Zevotek did not issue fractional shares in connection with the foregoing stock split.  Fractional shares were rounded up to the nearest whole share.  All per share numbers quoted herein are reflective of the Reverse Split.

 

At June 30, 2012 and 2011, common shares issued and outstanding were 335,527 and 220,810, respectively.

 

On November 17, 2010, Zevotek adopted its 2011 Equity Incentive Plan (“2011 Plan”). Zevotek is permitted to issue up to 12,000 shares of common stock under the Plan in the form of stock options, restricted stock awards, and stock awards to directors, officers, consultants, advisors and employees of Zevotek.  As of June 30, 2012, there were 12,000 shares issued under this 2011 Plan.

 

On May 5, 2011, Zevotek adopted its Fiscal 2012 Equity Incentive Plan (“2012 Plan”). Zevotek is permitted to issue up to 30,000 shares of common stock under the Plan in the form of stock options, restricted stock awards, and stock awards to directors, officers, consultants, advisors and employees of Zevotek.  As of June 30, 2012, there were 19,500 shares issued under this 2012 Plan.

 

During the year ended June 30, 2011, Zevotek issued 31,492 shares of common stock, valued at $325,413 for services, accrued expenses and accounts payable. Shares were valued according to the closing price of the common stock on the date it was granted.

 

During the year ended June 30, 2011, Zevotek converted debt and accrued interest of $113,000 into 148,098 shares of common stock.  The conversion was in accordance with the original note agreement, therefore no gain or loss was recorded for this transaction.

 

During the year ended June 30, 2011, Zevotek issued 4,950 shares of its common stock, valued at $45,000, to its Chief Executive Officer and two of its directors as compensation. Shares were valued according to the closing price of the common stock on the date it was granted.

 

During the year ended June 30, 2011, Zevotek issued 1,551 shares valued at $30,000 to a former officer to satisfy a claim included in common stock to be issued. Shares were valued according to the closing price of the common stock on the date it was granted.

 

During the year ended June 30, 2012, Zevotek issued 32,545 shares of common stock, valued at $53,000 for consulting services. Shares were valued according to the closing price of the common stock on the date it was granted.

 

During the year ended June 30, 2012, Zevotek converted debt and accrued interest of $32,235 into 77,854 shares of common stock.  The conversion was in accordance with the original note agreement, therefore no gain or loss was recorded for this transaction.

 

During the year ended June 30, 2012, Zevotek issued 4,318 shares of common stock in satisfaction of fractional shares resulting from a 1 for 5,000 reverse stock split.

 

Treasury Stock

As of June 30, 2012 and 2011, Zevotek had 1 share of common stock held in treasury, which carried at $0 based on cost.

XML 44 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE J - STOCK OPTIONS AND WARRANTS
12 Months Ended
Jun. 30, 2012
Equity [Abstract]  
STOCK OPTIONS AND WARRANTS

During the years ended June 30, 2012 and 2011, Zevotek did not issue any stock warrants or options.  As of June 30, 2012, there are no outstanding stock warrants or options.

 

XML 45 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE J - STOCK OPTIONS AND WARRANTS (Details Narrative) (USD $)
12 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Note J - Stock Options And Warrants Details Narrative    
Issue of stock warrants or options $ 0 $ 0
outstanding stock warrants or options $ 0  
XML 46 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Tables)
12 Months Ended
Jun. 30, 2012
Note G - Convertible Notes Payable And Demand Notes Tables  
CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES
 

June 30,

2012

   

June 30,

2011

 
Notes Payable:            
Convertible term note (a)   $ 923     $ 923  
Convertible term note (b)     1,923       1,923  
Convertible term note (c)     50,000       50,000  
Convertible term note (d)     2,497       2,497  
Convertible term note (e)     224       25,174  
Convertible term note (f)     11,132       11,132  
Convertible term note (g)     26,420       30,920  
Convertible term note (h)     190,757       192,430  
Convertible term note (i)     34,141       34,141  
Convertible term note (j)     22,350       22,530  
Convertible term note (k)     945,565       945,527  
Convertible term note (l)     10,000       -  
Convertible term note (m)     30,000       -  
Convertible term note (n)     10,000       -  
      1,335,932       1,317,197  
Less: discount on debt     -       921,311  
      1,335,932       395,886  
Less: current portion     (1,285,932 )     (309,806 )
Long term debt   $ 50,000     $ 86,080  
XML 47 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE D - LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT (Details Narrative) (USD $)
12 Months Ended
Jun. 30, 2012
Note D - Licensing Agreement And Distribution Agreement Details Narrative  
Licensing Agreement Impairment $ 40,000
XML 48 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (USD $)
SeriesAPreferredStockMember
USD ($)
SeriesBPreferredStockMember
USD ($)
Common Stock
USD ($)
Common Stock To Be Issued
USD ($)
Treasury Stock
Additional Paid-In Capital
USD ($)
Accumulated Deficit
USD ($)
Total
USD ($)
Beginning Balance, Amount at Jun. 30, 2010 $ 1 $ 10   $ 30,000   $ 4,000,804 $ (5,485,025) $ (1,454,210)
Beginning Balance, Shares at Jun. 30, 2010 50,000 1,000,000 34,719   1      
Common stock issued for services rendered, Amount           235,413    235,413
Common stock issued for services rendered, Shares     29,272          
Common stock issued for accounts payable, Amount           90,000    90,000
Common stock issued for accounts payable, Shares     2,219          
Conversion of debt and accrued interest for common stock, Amount     2     112,998    113,000
Conversion of debt and accrued interest for common stock, Shares     148,098          
Fair value of beneficial conversion feature           1,137,957    1,137,957
Common stock issued to officers and board members, Amount           45,000    45,000
Common stock issued to officers and board members, Shares     4,950          
Common stock issued to former officers for accrued compensation, Amount       (30,000)   30,000      
Common stock issued to former officers for accrued compensation, Shares     1,551          
Net loss             (1,244,112) (1,244,112)
Ending Balance, Amount at Jun. 30, 2011 1 10 2     5,652,172 (6,729,137) (1,076,952)
Ending Balance, Shares at Jun. 30, 2011 50,000 1,000,000 220,810   1      
Common stock issued for services rendered, Amount           53,000    53,000
Common stock issued for services rendered, Shares     32,545          
Conversion of debt and accrued interest for common stock, Amount     1     32,234    32,235
Conversion of debt and accrued interest for common stock, Shares     77,854          
Shares issued in satisfaction of fraction shares resulting from 1 for 5,000 reverse stock split (in Shares)     4,318          
Net loss             (1,482,168) (1,482,168)
Ending Balance, Amount at Jun. 30, 2012 $ 1 $ 10 $ 3     $ 5,737,406 $ (8,211,305) $ (2,473,885)
Ending Balance, Shares at Jun. 30, 2012 50,000 1,000,000 335,527   1      
XML 49 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE D - LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT
12 Months Ended
Jun. 30, 2012
Notes to Financial Statements  
LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT

On February 24, 2009, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to manufacture, market use, sell, distribute and advertise a patented ionic bulb.  

 

In exchange for the exclusive license, Zevotek issued 500 shares of its common stock.  The license was valued at the market price of the underlying security.

 

On March 2, 2011, Zevotek and the Ionic Bulb patent holder entered into a non-exclusive Purchasing Representative Agreement whereby the patent holder shall introduce Zevotek to a new third party manufacturer that will produce a next generation version of the Ionic Bulb with new features and improved manufacturing cost.  Additionally, the patent holder affirms his obligation to defend against patent infringement.  Zevotek shall pay patent holder a fixed amount per Ionic Bulb ordered from the new manufacturer.  Zevotek agreed to make an advance fee payment by issuance of 5,000 shares of Zevotek’s restricted stock.  The value of the restricted shares applied to payment of the fees is to be based upon the average closing price of Zevotek's common stock for the ten trading days proceeding the date on which the restrictive stock legend may be removed. The term of the agreement is three years with one-year automatic renewals that are subject to minimum fee payments to the patent holder for the first and second renewal term, respectively.  The related shares were issued and expensed during fiscal 2012 for a value of $35,000 based on the grant date fair value of the shares issued.

  

On December 10, 2010, Zevotek entered into an Exclusive License and Sales Agreement whereby Zevotek has worldwide exclusive rights to develop, manufacture, market, use, sell, distribute and advertise a U.S. patented new product named Gung H2O that reduces water use in the home.

 

The Licensing Agreement was originally valued at $40,000.  Since Zevotek is no longer marketing and selling the Ionic Bulb, the agreement was considered totally impaired.  A Licensing Agreement Impairment of $40,000 was recorded for the year ended June 30, 2012.

XML 50 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) (USD $)
Jun. 30, 2012
Jun. 30, 2011
Note E- Accounts Payable And Accrued Liabilities Details    
Accounts payable $ 2,389 $ 10,867
Accrued professional fees 217,262 225,163
Accrued payroll and payroll taxes 165,372 161,649
Old disputed accounts payable 136,505 160,756
Accrued interest 333,598 183,507
Other accrued liabilities 83,875 32,404
Total $ 939,001 $ 774,346
XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 67 162 1 false 26 0 false 4 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://zevo-tek.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://zevo-tek.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://zevo-tek.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://zevo-tek.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 0005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT Sheet http://zevo-tek.com/role/ConsolidatedStatementOfStockholdersDeficit CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT false false R6.htm 0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://zevo-tek.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 0007 - Disclosure - NOTE A - SUMMARY OF ACCOUNTING POLICIES Sheet http://zevo-tek.com/role/Note-SummaryOfAccountingPolicies NOTE A - SUMMARY OF ACCOUNTING POLICIES false false R8.htm 0008 - Disclosure - NOTE B - GOING CONCERN MATTERS Sheet http://zevo-tek.com/role/NoteB-GoingConcernMatters NOTE B - GOING CONCERN MATTERS false false R9.htm 0009 - Disclosure - NOTE C - INVENTORY Sheet http://zevo-tek.com/role/NoteC-Inventory NOTE C - INVENTORY false false R10.htm 0010 - Disclosure - NOTE D - LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT Sheet http://zevo-tek.com/role/NoteD-LicensingAgreementAndDistributionAgreement NOTE D - LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT false false R11.htm 0011 - Disclosure - NOTE E - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Sheet http://zevo-tek.com/role/NoteE-AccountsPayableAndAccruedLiabilities NOTE E - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES false false R12.htm 0012 - Disclosure - NOTE F - ADVANCES PAYABLE Sheet http://zevo-tek.com/role/NoteF-AdvancesPayable NOTE F - ADVANCES PAYABLE false false R13.htm 0013 - Disclosure - NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES Notes http://zevo-tek.com/role/NoteG-ConvertibleNotesPayableAndDemandNotes NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES false false R14.htm 0014 - Disclosure - NOTE H - STOCKHOLDERS EQUITY Sheet http://zevo-tek.com/role/NoteH-StockholdersEquity NOTE H - STOCKHOLDERS EQUITY false false R15.htm 0015 - Disclosure - NOTE I - INCOME TAXES Sheet http://zevo-tek.com/role/NoteI-IncomeTaxes NOTE I - INCOME TAXES false false R16.htm 0016 - Disclosure - NOTE J - STOCK OPTIONS AND WARRANTS Sheet http://zevo-tek.com/role/NoteJ-StockOptionsAndWarrants NOTE J - STOCK OPTIONS AND WARRANTS false false R17.htm 0017 - Disclosure - NOTE K - COMMITMENTS AND CONTINGENCIES Sheet http://zevo-tek.com/role/NoteK-CommitmentsAndContingencies NOTE K - COMMITMENTS AND CONTINGENCIES false false R18.htm 0018 - Disclosure - NOTE L - FAIR VALUE MEASUREMENT Sheet http://zevo-tek.com/role/NoteL-FairValueMeasurement NOTE L - FAIR VALUE MEASUREMENT false false R19.htm 0019 - Disclosure - NOTE A - SUMMARY OF ACCOUNTING POLICIES (Policies) Sheet http://zevo-tek.com/role/Note-SummaryOfAccountingPoliciesPolicies NOTE A - SUMMARY OF ACCOUNTING POLICIES (Policies) false false R20.htm 0020 - Disclosure - NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Sheet http://zevo-tek.com/role/NoteE-AccountsPayableAndAccruedLiabilitiesTables NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) false false R21.htm 0021 - Disclosure - NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Tables) Notes http://zevo-tek.com/role/NoteG-ConvertibleNotesPayableAndDemandNotesTables NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Tables) false false R22.htm 0022 - Disclosure - NOTE I - INCOME TAXES (Tables) Sheet http://zevo-tek.com/role/NoteI-IncomeTaxesTables NOTE I - INCOME TAXES (Tables) false false R23.htm 0023 - Disclosure - NOTE A - SUMMARY OF ACCOUNTING POLICIES (Details Narrative) Sheet http://zevo-tek.com/role/Note-SummaryOfAccountingPoliciesDetailsNarrative NOTE A - SUMMARY OF ACCOUNTING POLICIES (Details Narrative) false false R24.htm 0024 - Disclosure - NOTE B - GOING CONCERN MATTERS (Details Narrative) Sheet http://zevo-tek.com/role/NoteB-GoingConcernMattersDetailsNarrative NOTE B - GOING CONCERN MATTERS (Details Narrative) false false R25.htm 0025 - Disclosure - NOTE C - INVENTORY (Details Narrative) Sheet http://zevo-tek.com/role/NoteC-InventoryDetailsNarrative NOTE C - INVENTORY (Details Narrative) false false R26.htm 0026 - Disclosure - NOTE D - LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT (Details Narrative) Sheet http://zevo-tek.com/role/NoteD-LicensingAgreementAndDistributionAgreementDetailsNarrative NOTE D - LICENSING AGREEMENT AND DISTRIBUTION AGREEMENT (Details Narrative) false false R27.htm 0027 - Disclosure - NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) Sheet http://zevo-tek.com/role/NoteE-AccountsPayableAndAccruedLiabilitiesDetails NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) false false R28.htm 0028 - Disclosure - NOTE F - ADVANCES PAYABLE (Details Narrative) Sheet http://zevo-tek.com/role/NoteF-AdvancesPayableDetailsNarrative NOTE F - ADVANCES PAYABLE (Details Narrative) false false R29.htm 0029 - Disclosure - NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Details) Notes http://zevo-tek.com/role/NoteG-ConvertibleNotesPayableAndDemandNotesDetails NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Details) false false R30.htm 0030 - Disclosure - NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Detail Narrative) Notes http://zevo-tek.com/role/NoteG-ConvertibleNotesPayableAndDemandNotesDetailNarrative NOTE G - CONVERTIBLE NOTES PAYABLE AND DEMAND NOTES (Detail Narrative) false false R31.htm 0031 - Disclosure - NOTE H - STOCKHOLDERS EQUITY (Details Narrative) Sheet http://zevo-tek.com/role/NoteH-StockholdersEquityDetailsNarrative NOTE H - STOCKHOLDERS EQUITY (Details Narrative) false false R32.htm 0032 - Disclosure - NOTE I - INCOME TAXES (Details) Sheet http://zevo-tek.com/role/NoteI-IncomeTaxesDetails NOTE I - INCOME TAXES (Details) false false R33.htm 0033 - Disclosure - NOTE I - INCOME TAXES (Details Narrative) Sheet http://zevo-tek.com/role/NoteI-IncomeTaxesDetailsNarrative NOTE I - INCOME TAXES (Details Narrative) false false R34.htm 0034 - Disclosure - NOTE J - STOCK OPTIONS AND WARRANTS (Details Narrative) Sheet http://zevo-tek.com/role/NoteJ-StockOptionsAndWarrantsDetailsNarrative NOTE J - STOCK OPTIONS AND WARRANTS (Details Narrative) false false R35.htm 0035 - Disclosure - NOTE K - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://zevo-tek.com/role/NoteK-CommitmentsAndContingenciesDetailsNarrative NOTE K - COMMITMENTS AND CONTINGENCIES (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: 0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS zvtk-20120630.xml zvtk-20120630.xsd zvtk-20120630_cal.xml zvtk-20120630_def.xml zvtk-20120630_lab.xml zvtk-20120630_pre.xml true true XML 52 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE E- ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)
12 Months Ended
Jun. 30, 2012
Note E- Accounts Payable And Accrued Liabilities Tables  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities are as follows:

 

   

June 30,

2012

   

June 30,

2011

 
Accounts payable    $ 2,389     $ 10,867  
Accrued professional fees     217,262       225,163  
Accrued payroll and payroll taxes     165,372       161,649  
Old disputed accounts payable     136,505       160,756  
Accrued interest     333,598       183,507  
Other accrued liabilities     83,875       32,404  
Total   $ 939,001     $ 774,346